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The EspF protein is translocated into host cells by the type III secretion system of 
enteropathogenic and enterohemorrhagic Es herichia coli (EPEC and EHEC).  EspF 
sequences differ between EPEC and EHEC serotypes in terms of the number of 
SH3-binding polyproline rich repeats and specific residues in these regions as well 
as residues in the amino domain involved in cellular localization.  In this study we 
have compared the capacity of different espF alleles to inhibit: (i) bacterial 
phagocytosis by macrophages; (ii) translocation through an M-cell co-culture 
system; (iii) uptake by and translocation through cultured bovine epithelial cells.  
The espFO157 allele was significantly less effective at inhibiting phagocytosis and 
also had reduced capacity to inhibit E. coli translocation through a human-derived in 
vitro M-cell co-culture system in comparison to espFO127 and espFO26.  In contrast, 
espFO157 was the most effective allele at restricting bacterial uptake into and 
translocation through primary epithelial cells cultured from the bovine terminal 
rectum, the predominant colonisation site of EHEC O157 in cattle and a site 
containing M-like cells. As functional differences could not be simply assigned to 
variation in established interactions of EspF with Sorting Nexin 9 and N-WASP, 
yeast-2-hybrid screening was used to identify additional host proteins that may 
interact with EspF.  The anaphase promoting complex inhibitor, Mad2L2, was 
identified from this screen.   Mad2L2 was then demonstrated to interact with EspF 
variants from EHEC O157:H7, O26:H11 and EPEC O127:H6 by Lumier assays. 
While Mad2L2 has been shown to be targeted by the non homologous Shigella 
effector protein IpaB to limit epithelial cell turnover, we presume that EspF 
interactions with this protein may indicate a similar function to promote EPEC and 
EHEC colonization. 
The final section of work addressed whether bacterial interactions can actually 
induce M-cell differentiation on follicle-associated pithelium.  The work focused on 
bovine rectal primary cell cultures interacting with Salmonella enterica serovar 
Typhimurium. The type III secreted protein, SopB, was required for Salmonella to: 
 III 
 
(i) activate parts of epithelial to mesenchymal transition (EMT) pathway; (ii) 
transform a subset of epithelial cells to a cell type that phenotypically and 
functionally resembles specialized antigen sampling M cells; (iii) induce RANKL 
and downstream RelB dependent NFκB signaling.   The work suggests that 
Salmonella may induce this cellular transformation t  promote its invasion and 
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ETEC enterotoxigenic Escherichia coli 
Esp Escherichia coli secreted protein 
Esc Escherichia coli secretion 
FAC follicular associated crypts 
FAE follicle associated epithelium 
FBS foetal bovine serum 
G gram 
GFP green fluorescent protein 
G proteins  guanine nucleotide binding proteins 
h Hour(s) 
H flagellar antigen 
HC haemorrhagic colitis 
HK ST heat killed Salmonella Typhimurium 
HUS haemolytic uremic syndrome 
IPTG isopropyl β-D-1-thiogalactopyranoside 
K capsular antigen 
Kan kanamycin  
kb kilobase pairs 
kDa kilodalton 
λ lambda  
LB Luria-Bertani 
LEE locus of enterocyte effacement 




Ler LEE encoded regulator 
LPS lipopolysaccharide 
LT heat-labile  
M molar 
MAD2L2 mitotic arrest deficient-like 2 
Map mitochondrion-associated protein (Map), 
MEM minimal essential medium   
mg milligram (10-3 gram) 
min minute(s) 
ml millilitre (10-3 litre) 
mM millimolar (10-3 molar) 
NFIC nuclear factor 1 C-type 
NF κB nuclear factor kappa-light-chain-enhancer of activated  
B     cells    
ng nanogram (10-9 gram) 
NM non-motile 
N-WASP neuronal Wiskott-Aldrich Syndrome protein 
O somatic antigen 
OC ordinary crypts 
OD600 optical density at 600 nm 
OPG osteoprotegerin 
ORFs open reading frames 
PAI pathogenicity islands  
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PFA paraformaldehyde 
PP Peyer’s patches 
RANKL receptor activator of nuclear factor kappa-B ligand 
RNA ribonucleic acid 
rpm rounds per minute 
RT room temperature 
RTPCR real time PCR 
SDS 
 
sodium dodecyl sulphate 
SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis 
sec second 
siRNA small interfering RNA 
SNX9 Sorting nexin 9 
SPI-1 Salmonella pathogenicity island 1 
SPI-2 Salmonella pathogenicity island 2 
SQRT-PCR Semi quantitative real time PCR 




STEC Stx-producing strains of Escherichia coli 
Stx Shiga toxin  
T3SS type III secretion system 
TBE tris-borate/EDTA 
TCA trichloroacetic acid 
TFB              transformation buffer 
Tir translocated intimin receptor 
TRIC Rhodamine 
Tris trishydroxymethylaminomethane 
µg microgram (10-6 gram)  
µl microlitre (10-6 litre) 
µM micromolar (10-6 molar) 
U unitt 
V volt 
Vtx Vero toxin 
VTEC Vtx-producing strains of Escherichia coli 
Y2H Yeast-two- hybrid 








1. Introduction  
Enterobacteriaceae are a large family of bacteria. The members of the 
Enterobacteriaceae are rod-shaped, and their length about 1-5 µm. They are 
facultative anaerobes. These bacteria are able to ferment sugars to produce lactic acid 
and different other end products. The majority also reduce nitrate to nitrite and have 
peritrichious flagella that are used for movement. However a few genera are non-
motile. The members of this family are non-spore forming. The catalase reaction 
varies among the Enterobacteriaceae. Most bacteria of this family are a normal part 
of the gut flora established in humans and other anim ls’ intestines. Certain genera 
and species in this family are capable of causing a bro d spectrum of intestinal and 
systemic diseases, e.g. Salmonella typhi, Shigella dysenteriae and Yersinia pestis 
(edwarda & Ewing 1972). 
1.1 Escherichia coli (E. coli) E. coli was named after the German paediatrician, 
Theodore Escherich, who first identified and described it in 1885 from the faecal 
materials of healthy persons. Many strains/serotypes of E. coli are predominantly 
found as commensal gut flora that colonises the gastrointestinal tract of newborns 
within a few hours of life. The majority do not cause any disease unless the host is 
malnourished, immuno-suppressed or there has been a disturbance in the intestinal 
barrier. Under these circumstances even commensal E. coli can cause disease (Nataro 
& Kaper, 1998). Serologically each E. coli isolate can be grouped by its 
lipopolysaccharide O-antigen, flagellar H-antigen, K-capsule and F fimbriae/pili 
(Robins Browne & Hartland, 2002). The pathogenic strains include six distinct 
categories of E. coli that cause diarrhoea (Nataro & Kaper, 1998). These can be 
referred to as pathotypes: (1) Enterotoxigenic E. coli (ETEC), (2) Enteroinvasive E. 
coli (EIEC), (3) Enteropathogenic E. coli (EPEC), (4) Enteroaggregative E. coli 
(EAEC), (5) Diffuse Adherent E. coli (DAEC), and (6) Enterohaemorrhagic E. coli 
(EHEC). Key factors that define these pathotypes ar genetically-encoded in clusters 
on virulence-related plasmids, chromosomal pathogenicity islands or on phages. E. 
coli, like any other mucosal pathogen, has evolved the strategy to colonize the 
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mucosal surface, evade or modulate the host immune responses and secrete virulence 
factors that help its colonization and persistence. 
 
1.1.1 Enterotoxigenic E. coli (ETEC): are considered to be the major cause of 
diarrhoea for travellers to developing countries and to be a very important cause of 
childhood diarrhoea in developing countries. ETEC are lso associated with 
diarrhoea in animals (Kaper et al., 2004). ETEC cause watery diarrhoea due to 
colonization of the intestinal mucosa via non-intimate diffuse adherence with 
fimbriae and production of enterotoxins (heat stable and/or heat labile toxins) that 
repress gut absorption and increase intestinal secretion. Moreover, ETEC cause 
diarrhoea in animals and F4 (K88) and F5 (K99) antigens are associated with ETEC 
infections of pigs and cattle, respectively (Kaper et al., 2004). ETEC serotypes 
examples include: O6:H16, and O8:H9.  
 
1.1.2 Enteroinvasive E. coli (EIEC): are a significant reason of illness in 
children in developed countries and are biochemically, genetically, and 
pathogenically intimately related to Shigella spp. (Kaper et al., 2004). They cause 
diarrhoea by invasion of epithelial cells followed by multiplication and lysis of the 
infected cell. This can lead to inflammatory colitis and/or secretory bowel syndrome 
(Kaper et al., 2004). EIEC serotypes examples include: O28:NM, O29:NM, 
O112:NM, O124:H30, O124:NM, O136:NM, O136:NM, O143:NM, O144:NM, , 
and O167:NM. 
 
1.1.3 Enteroaggreative E. coli (EAEC):  are a cause of persistent mucoid 
diarrhoea in children and adults in both developing a d developed countries (Kaper 
et al., 2004). They adhere to epithelial cells and each other in an aggregative manner 
by using fimbrial structures known as aggregative adherence fimbriae (AAFS) and 
produce an enterotoxin that can cause mild damage and inflammation of mucosal 
surfaces (Kaper et al., 2004). They do not induce attaching and effacing (A/E) 
lesions (Clarke, 2001). EAEC serotypes examples include: O3:H2, O15:H18, 




1.1.4. Diffuse adherent E. coli (DAEC):  are characterised by a diffuse 
adherence pattern to HEP-2 cells. They are known to be a cause of diarrhoea in 
children less than 1 year old. DAEC strains exhibit non-intimate adherence in 
contrast to EPEC and EHEC adherence, as described in the relevant sections below. 
DAEC produce fimbriae called F1845 that mediate the diffuse adherence (Nataro & 
Kaper 2004). Serotypes are not well defined, but include O126:H27. 
 
1.1.5 Enteropathogenic E. coli (EPEC): are medically-important 
diarrhoeagenic Gram negative pathogens that colonize the gut mucosa. EPEC can 
cause serious intestinal disease in many animal species including cattle and are 
associated with severe diarrhoeal outbreaks among groups of young children in 
nurseries and generally in developing countries (Nataro & Kaper, 1998; Kenny, 
1999; Kaper et al., 2004). The disease process is dependent on intimate attachment 
with the formation of attaching and effacing (A/E) lesions on intestinal mucosa 
leading to effacement of microvilli and associated cytoskeletal re-arrangement. 
Actin-rich pedestals are formed under the bacteria with tight junction damage and 
eventually cell death. This process occurs through injection of effector proteins 
directly into host cells (Nataro & Kaper, 1998). Human EPEC infections are 
considered to arise from human-to-human infection (Spears et al., 2006). It was in 
1945, when a severe outbreak of infant diarrhoea in United Kingdom led Bray to 
identify EPEC pathotype of E. coli for the first time (Frankel & Phillips 2008). 
Although recently, it is rare for this strain to cause large outbreaks in industrialised 
countries, it is still an important cause for potentially fatal infant diarrhoea in 
advanced countries. For long time, the mechanisms by which EPEC caused diarrhoea 
have been undefined and this pathotype could only be identified on the basis of 
serotyping. However, highly advanced techniques since 1979, were used in 
understanding the pathogenesis of EPEC diarrhoea. For these reasons, EPEC is now 
among the best understood of all pathogenic E. oli (Kaper et al., 2004). Examples of 
EPEC serotypes are O26, O55, O86, O111, O114, O119, O 25, O126, O127, O128, 




1.1.6 Verotoxin (VT) producing  E. coli (VTEC) or Shiga toxin (Stx) 
producing  E. coli: are defined by the expression of one or more Shiga toxins also 
known as Verotoxins. In this study they will be referred to as Shiga-toxigenic E. coli. 
These strains may or may not cause disease according to the presence or absence of 
other virulence factors. So they can be divided into two categories: 
1- Typical Enterohaemorrhagic E. coli (EHEC), which are STEC strains that are 
associated with haemorrhagic colitis (HC) and haemolytic-uraemic syndrome (HUS), 
express Stx, form A/E lesions on epithelial cells and possess a 92Kbp plasmid.  
2- Atypical EHEC, which are STEC strains that do not produce A/E lesions and/or 
possess the 92Kbp plasmid (Nataro & Kaper, 1998). 
EHEC are emerging zoonotic pathogens, particularly in industrialised countries 
(Beutin, 2006), although there is very limited data on epidemiology in most 
developing countries. EHEC O157:H7 causes sporadic outbreaks of severe disease in 
humans, the most important being HC and HUS, the latt r results in kidney damage 
and may lead to death (Moon et al., 1983; Griffin & Tauxe, 1991; Boyce t al., 
1995). EHEC O157:H7 is the serotype associated withmost EHEC infections in 
United Kingdom, USA and Japan. As well as the production of Stx, EHEC strains 
produce A/E lesions on intestinal mucosa and in some ways can be considered as 
EPEC strains that have acquired Shiga toxins (Tesh & O'brien, 1991; Naylor et al., 
2005b). Ruminants, particularly cattle, are the main reservoir for certain EHEC 
serotypes, including E. coli O157:H7. EHEC O157:H7 colonises the bovine 
gastrointestinal tract, especially at the terminal rectum, without causing overt disease 
(Naylor et al., 2003). In part this reflects the absence of Shiga toxin receptors (CD77) 
on bovine endothelial cells. 
 
1.1.7 Epidemiology of EHEC O157 
1.1.7a Animals as reservoirs of EHEC  
Cattle are one of the most important host or carrier species of EHEC. High rates of 
colonisation by Stx-positive E. coli have been found in bovine herds in many 
countries ( Wells et al., 1991; Clarke et al., 1994; Hancock et al., 1994; Burnens et 
al., 1995). The rates of carrier animals vary from 10 to 60%. STEC strains are 
usually isolated from healthy animals, but it may cause diarrhoea in young animal 
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followed by asymptomatic colonization (Nataro & Kaper, 1998). Transmission to 
human occurs through various routes; the most important is oral route through water, 
crops, meat, and dairy products intended for human consumption contaminated with 
faecal matter (Akashi et al., 1994; Yarze & Chase, 2000; Licence et al., 2001). 
E. coli O157:H7 may persist in a viable state in faeces for m re than 20 months 
(Beutin, 2006). E .coli O157:H7 has been isolated in many parts of the world, 
including Europe, Asia, Africa, and South America (Griffin, 1995). Various 
epidemiological studies on farms and slaughterhouses have documented a worldwide 
presence of E. coli O157:H7. Faecal pat studies from cattle have shown that E. coli 
O157:H7 occurs more frequently in Canada and United States (Griffin & Tauxe, 
1991) with a prevalence of 1.4% in Japan (Miyao et al., 1998), 1.9% in Australia 
(Cobbold & Desmarchelier, 2000), 0.2 to 60% in USA (Wells et al., 1991; Hancock 
et al., 1994; Faith et al., 1996), 8.6% in Scotland (Synge, 2000) and 4.7% in England 
and Wales (Paiba et al., 2002). 
Seasonal variation in the prevalence of E. coli O157:H7 has been demonstrated, with 
the highest prevalence occuring during the late summer and early autumn (Chapman 
et al., 1997; Hancock et al., 1997; Tutenel et al., 2002). In contrast Ogden et al. 
(2004) revealed that the occurrence in cattle was higher throughout cooler periods 
but that levels of bacterial shedding were highest during warmer periods of the year. 
In addition to cattle, E coli O157:H7 strains have been isolated from a variety of 
animal species including sheep, goats, wild deers, pig , and birds (Chapman, 2000). 
 
1.1.7b Mode of transmission of STEC O157:H7 
The first identified outbreaks of E. coli O157:H7 were associated with consumption 
of ground beef and more outbreaks were associated with consumption of 
undercooked beef and other bovine products, such as unpasteurised milk (Riley et 
al., 1983). Bovine faeces contaminate meat during slaughter or meat processing 
(Armstrong et al., 1996; Barlow et al., 2006). Other animal products, such as raw 
goat’s milk (Bielaszewska et al., 1997), deer jerky (Keene et al., 1997; Renter et al., 
2001), porcine meat, avian and sheep products ( Griffin & Tauxe, 1991; Griffin, 
1995) have also been implicated in human outbreaks of E. coli O157:H7. Vegetables 
and fruits contaminated with animal faeces also play an important role in 
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transmission ( Ackers et al., 1998; Fukushima et al., 1999; Duffy, 2003; Karch et al., 
2005). Furthermore, some outbreaks occur when E. coli O157:H7 contaminates 
unpasteurised apple juice and fermented salami. This illustrates the potential acid 
tolerance of E. coli O157:H7, which potentially can grow and survive in extremely 
acidic conditions that destroy other pathogens (Nataro & Kaper, 1998).  
 
1.1.7c Water sources 
Water sources including the one for recreational uses (Keene et al., 1994), well water 
and even a municipal water system (Swerdlow et al., 1992) have been associated 
with outbreaks. Several outbreaks of E coli O157:H7 have been associated with 
consumption of contaminated drinking water especially from private water supplies ( 
Swerdlow et al., 1992; Jones & Roworth, 1996) or from swimming in lakes or 
paddling pools (Brewster et al., 1994; CDC, 1996). 
 
1.1.7d Contact with animals  
Transmission through direct contact with animals habeen documented in outbreaks 
and sporadic infections by E. coli O157:H7 due to farm visits (Renwick et al., 1993; 
Shukla et al., 1995). Also infections have been reported from visiting petting zoos 
and farms, where direct contact with animals or anim l faeces can easily occur 
(Caprioli et al., 2005). A high profile outbreak in a UK petting farm occurred in 2009 
(http://www.griffininvestigation.org.uk/), in which nearly 100 children were infected 
with 78 people showing symptoms; 22% of them had HUS and 8 patients required 
dialysis and some of them were left with permanent kidney damage. This farm alone 
received nearly 200,000 visitors a year indicating that potential of such farms to 
infect large numbers of individuals. 
 
1.1.7e Person-to-person faecal–oral transmission  
E. coli O157:H7 can cause infection in very low doses (Nataro & Kaper, 1998). 
Person-to-person faecal–oral transmission can easily occur in poor hygiene 
conditions and with close contact (Karch et al., 1999). This mode of transmission is 
responsible for the spread of infection within families (Ludwig et al., 1997) and 
hospitals (Karmali et al., 1988). Person-to-person transmission was the predominant 
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route of infection in outbreaks within day-care settings (Reida et al., 1994) and 
mental institutions (Pavia et al., 1990). 
1.1.7f Epidemiology of non-O157 EHEC  
The significance of non-O157 EHEC in human diseases is less well understood than 
that of EHEC O157:H7 (Karch et al., 2005). E. coli O157:H7 is simply differentiated 
from other E. coli by its inability to rapidly ferment sorbitol. Howev r, non-O157 
STEC are phenotypically the same as commensal non pathogenic E. coli and are not 
detected with sorbitol MacConkey agar. To detect non-O157 STEC, various methods 
are used, such as enzyme immunoassays or PCR, which are classically only 
performed in reference laboratories (Fey et al., 2000). The prevalence of non-O157 
STEC in faecal samples from the Northern USA, in which cattle and other animal 
reservoirs of STEC are plentiful, was determined to be 4.2%. This prevalence was 
elevated than earlier reported in the USA. Five different non-O157 STEC serotypes 
were isolated: O111:NM, O26:H11, O145:NM, O103:H2, and O rough:H2. Four of 
these have been associated with HUS (O111:NM, O26:H11, O145:NM, and 
O103:H2; Griffin et al., 1990; Fey et al., 2000). 
Outbreaks by non O157 STEC have been associated with food, including an outbreak 
of bloody diarrhoea in the USA by STEC O4:H21 in 1994 (pasteurized milk) (CDC, 
1995), and an outbreak in Australia caused STEC O111:H- in 1995 (dry fermented 
sausages) (Paton et al., 1996).  
Many non-O157:H7 serotypes of EHEC have also been implicated with sporadic or 
large-scale human outbreaks. EHEC O26:H11 is the most common non-O157 EHEC 
serogroup associated with human diseases throughout Europe. On the other hand, the 
second most common non-O157 EHEC serogroup associated wi h HUS in Germany 
is O145 (Karch et al., 2005). The non-O157:H7 EHEC strains caused the majority of 
HUS cases in many countries like Argentina (Bentancor et al., 2007) and Australia 
(Pearce et al., 2010), but worldwide O157:H7 is the most common. In general, 
EHEC O145 appears to be shed by cattle less frequently than EHEC O26. Most 
bovine EHEC O26 and O145 isolates possess virulence characteristics identical to 
those isolated from human patients, suggesting that str ins shed by cattle can cause 
human disease (Geue et al., 2002; Jenkins et al., 2003). The Stx2 type causes more 
severe HUS disease than that of Stx1, but Stx1 was more common in bovine EHEC 
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O26 isolates (Karch et al., 2005), and was also the most prevalent one in human 
isolates from patients with HUS or diarrhoea (Karch et al., 2005), thereby providing 
evidence for cattle being major reservoirs for such organisms. In 2011 a sever 
outbreak of HUS and bloody diarrhoea has occurred in Germany. It was caused by 
enteroaggregative E. coli strain O104:H4. This strain acquired the ability to express 
Stx2a by integration of phage (Scheutz e  al., 2011). Fresh sprouts produced by a 
farm in Lower Saxony are accountable for the present outbreak in Germany (CDC, 
2011). 
 
1.1.8 Diseases caused by EHEC 
1.1.8a Disease in cattle  
Some STEC isolates can induce diarrhoea in young calves including strain O157:H7. 
However, this strain is avirulent in older cattle (Pearson et al., 1999. Stordeur et al., 
2000), implying that E. coli O157:H7 lacks certain factors required for virulenc  in 
such animals. 
Serogroups O26, O111, and O118 are virulent to cattle, particularly young calves. E. 
coli O26 has been isolated from clinical cases of haemorrhagic diarrhoea (Pearson et 
al., 1999; Gunning et al., 2001). However, an E. coli O26:H-strain, originally 
isolated from a calf with diarrhoea in 1968, was inoculated into calves and did not 
produce diarrhoea (Mainil et al., 1987), but has subsequently been used to induce 
transient diarrhoea in 4-day old calves (Dziva et al., 2004). Hall and co-workers 
(Hall et al., 1985) experimentally-infected 3 calves with between 109 and 1010 CFU 
of E. coli serogroup O5, inducing diarrhoea for 2-4 days. E. coli O118:H16 is 
frequently associated with calf diarrhoea, and virulence has been confirmed in 
experimentally-challenged new-born calves (Stordeur et al., 2000). 
 
1.1.8b Disease associated with EHEC in human  
Haemolytic uremic syndrome (HUS) is the most serious complication of E. coli 
O157:H7 infection. Clinically, it is associated with microangiopathic haemolytic 
anaemia, thrombocytopaenia, and acute renal failure. It occurs 5-10 days after the 
initial diarrhoeal illness is resolved (Advisory committee on the microbiological 
safety of food, 1995). 
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Haemorrhagic colitis (HC) is characterized by sever bloody diarrhoea indicating 
gastrointestinal haemorrhage (Riley t al., 1983). However, bloody diarrhoea may 
alternate between non-bloody and blood-streaked faeces (Swerdlow et al., 1992; Bell 
et al., 1994). The main pathological feature of the infected colon includes oedema, 
congestion of colonic mucosa, sometimes with ulcers (G iffin et al., 1990). 
Other complications following EHEC O157:H7 infection include: cholecystitis, 
colonic perforation, intussusceptions, pancreatitis, post hemolytic biliary thiasis, post 
infection colonic stricture, rectal prolapse, appendicitis, hepatitis, haemorrhagic 
cystitis, pulmonary oedema, myocardial dysfunction, a d neurological abnormalities 
(Griffin, 1995; Tarr, 1995). 
 
1.1.9 EHEC and EPEC colonization and virulence fact ors     
1.1.9a Shiga toxins  
Shiga toxins are encoded on lambdoid bacteriophages that integrate into the bacterial 
chromosome. This is the major virulence factor thatpl ys a key role in pathogenesis 
of EHEC infections. It is reported to mediate diarrhoea as a result of compromised 
intestinal epithelium integrity; haemorrhagic colitis due to damage to intestinal 
mucosal vasculature and damage to kidneys, circulatory and the central nervous 
system when disseminated systemically leading to life-threatening syndromes such 
as HUS and thrombotisch-thrombozytopenische Purpura TTP (O'Brien & Holmes, 
1987). The role of Stx in pathogenesis of these EHEC diseases has been modelled in 
various experimental studies (Marcato et al., 2005). Two main groups of Stx exist: 
Stx1 and Stx2. Stx1 has a several variants, which are identical to the toxin of Shigella 
dysenteriae (Jackson et al., 1987; Smith et al., 2002). Stx2 is divided into different 
variants e.g. Stx2, Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g. The two subgroups of Stx 
vary in their toxicity and capacity to bind to selected human cells (Jacewicz et al., 
1999). Stx2 and Stx2c are most associated with human diseases but also found in E. 
coli isolated from animals (Boerlin et al., 1999; Bidet et al., 2005; Schmidt et al., 
2000). The toxin consists of two subunits, A and B. The B subunit binds to the host 
cell membrane via the glycolipid receptor Gb3 (Lingwood et al., 1987; Lingwood, 
1993; Lingwood, 1996). It was considered that cattle lack the vascular receptors  for 
Stx, so this host does not suffer the more severe effects of EHEC infection 
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(Pruimboom-Brees et al., 2000). Gb3 is considered to be present in bovine intestinal 
crypt cells (Hoey et al., 2002). Intracellular trafficking in primary bovine intestinal 
cells excludes Stx from endoplasmic reticulum and instead localises it to lysosomes 
leading to its inactivation (Hoey et al., 2003). The A subunit is cleaved to produce an 
A1 peptide with N-glycosidase activity that inhibits protein synthesis through 
cleavage of the 28s ribosomal RNA (Pruimboom-Brees t al., 2000; Hoey et al., 
2003). The mechanisms by which Stx result in HUS are complicated and may be due 
to direct toxicity to endothelium, interference of haemostatic pathways and release of 
chemokines. Alteration of haemostatic pathways results in thrombotic 
microangiopathy (Richardson et al., 1988). Clinical studies have indicated that the 
production of a proinflammatory cytokines (Nataro & Kaper, 1998) sensitize the 
endothelial cells to the action of VT and induce further Gb3 expression (Richardson 
et al., 1988; Van De Kar et al., 1992). Stx increases bacterial adherence and intimin 
attachment. It induces eukaryotic cells to express more receptors for the EHEC 
O157:H7 attachment factor intimin (Robinson et al., 2006). Other additional cell 
cytotoxicity mechanisms have also been proposed, for instance Stx1 and Stx2 
induced apoptosis via inhibiting expression of anti- poptotic Bcl-2 family member, 
Mcl-1 in endothelial cells (Erwert et al., 2003). Stx1 also triggered apoptosis via 
activating caspase- and mitochondria-dependent pathways (Tétaud et al., 2003). 
 
1.1.9b Virulence factors encoded on pO157 
EHEC O157:H7 contains the pO157 plasmid, which encodes the virulence factors 
StcE, enterohaemoloysin, EspP, and KatP (Bauer & Welch, 1996; Brunder et al., 
1997; Lathem et al., 2002; Grys et al., 2005). These are described below. pO157 or 
related plasmids are also present in strain O26:H11 and are also found in some 
human STEC strains (Nataro & Kaper, 1998). The plasmid contributes to STEC 
survival (Boerlin et al., 1999). However, there is conflicting evidence regarding its 
contribution to the development of HC or HUS (Schmidt et al., 1996). The plasmid 





Ehx belongs to the RTX toxin family, members of which are expressed by 
uropathogenic E. coli, Pasteurella haemolytica, and other human and animal 
pathogens (Bauer & Welch, 1996). Ehx is highly conserved amongst STEC strains, 
suggesting that it contributes to survival in someway (Boerlin et al., 1999). However, 
there is conflicting evidence regarding its contribut on to the development of HC or 
HUS (Schmidt et al., 1996; Boerlin et al., 1999).There are three types of E. coli 
haemolysins: β, a cell bound haemolytic factor; α, a cell free factor, and γ 
haemolysins (Smith, 1963; Walton & Smith, 1969). Ehx is encoded by the 92Kbp 
virulence plasmid (pO157) (Schmidt e  al., 1994). Ehx causes β haemolysis when 
cultured on blood agar plates (γ haemolysin does not haemolyse human or rabbit 
RBCs but RBCs of other species). α factor is cytotoxic for human leukocytes and 
fibroblasts in vitro. RBCs haemolysis results in release of iron which is potentially 
important factor for bacterial growth (Nataro & Kaper, 1998). The cytotoxic effect 
and iron released from RBCs are the most important function of α haemolysin in E. 
coli pathogenesis (Cavalieri et al., 1984) 
 
1.1.9d EspP 
The EspP (E. coli secreted protein P) is a protein secreted by EHEC O157 and is one 
member of the serine protease autotransporter of Enterobacteriaceae (SPATE) family 
(Leyton et al., 2003). It cleaves pepsin A and human coagulation factor 5 (Brunder et 
al., 1997). EspP has been reported to be cytotoxic for Vero cells. The protease 
cleaved human coagulation factor V and hence could result in exacerbation of 
haemorrhagic disease in EHEC-infected patients. A role of EspP in pathogenesis is 
consistent with presence of antibodies to the protease in sera from EHEC-infected 
patients (Brunder et al., 1997).  
 
1.1.9e StcE 
StcE (secreted protease of C1 inhibitor from EHEC) is a secreted protein and a C1 
esterase inhibitor. It is secreted from EHEC via a type 2 secretion system and is a 
zinc metalloprotease Cl-esterase inhibitor that regulates complement and other 
mechanisms of inflammation (Grys et al., 2005). StcE has been shown to be 
regulated by the LEE-encoded regulator Ler, and its action results in many 
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pathological effects which may include localized proinflammatory and coagulation 
responses, leading to tissue damage, intestinal oedema and thrombotic abnormalities 
(Lathem et al., 2002). StcE cleavage of C1 esterase inhibitor provides a significant 




KatP is catalase peroxidase that is considered to protect EHEC from reactive oxygen 
intermediates found in host cells (Burland et al., 1998). 
 
1.1.9g H7 flagella 
Flagella are multi-functional organelles that play different roles in the biology of 
bacteria. The motelity functions give specific advantages upon host-adapted 
prokaryotes. Possible benefits of motility include increased ability of nutrient 
gaining, escaping of toxic substances, to access optimal colonization sites within 
hosts and to spreading in the environment during the course of transmission between 
hosts (Girón, 2005). The flagellum also activates the host immune system through 
activation of TLR5 receptors. Once the flagellin monomer is bound to TLR5 
receptors, this activates the NF-ΚB cell signalling pathway resulting in activation of 
inflammatory responses including IL-8 secretion that stimulates the migration of 
neutrophils and dendritic cells to the infection site (Dahan et al., 2002). The bacterial 
flagellum can be described in three parts (Charlier & Glansdorff, 2004): (1) the basal 
body, which is composed of a sequence of rings and a middle rod. The basal body is 
anchored in the inner and outer membranes of the bacteri  and provides the engine 
for the chemotactic apparatus; (2) the hook that is located external to the cell and 
provides the link between the basal body and the filament; and (3) the flagellar 
filament, which is the biggest part of the flagellum. It is formed of repeating sub-
units of the protein flagellin in a helical arrangem nt and often extends many times 
the length of the cell.  
Rotation of this filament (clockwise or counter-clockwise), which is controlled by 
the motor, ultimately determines the swimming or tumbling phenotype that defines 
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whether a bacterium will stay in a particular microenvironment or move away from it 
(Macnab, 1992; Aizawa, 1996). 
The H7 flagellum plays an important role in the initial adhesion of EHEC O157 to 
the bovine terminal rectal epithelium cells (McNeilly et al., 2008). Purified IgA or 
IgG from cattle vaccinated with H7 flagella was able to inhibit bacterial binding to 
rectal primary epithelial (Mahajan et al., 2009). 
 
1.1.9h Type III secretion (TTSS) system and associa ted effector proteins  
The bacteria must defend themselves against various challenges in their environment 
to continue growth and multiply. To deal with these challenges bacteria secrete 
enzymes, proteins and/or toxins. These factors to be secreted from the cytoplasm of 
bacteria to the external environment or directly into the host cells need dedicated 
‘machinery’ to do this, known as secretion systems. The Gram negative bacteria 
possess at least 6 different secretion systems (Gerlach & Hensel, 2007). 
The type I secretion system is expressed by a wide range of Gram negative bacteria 
for secretion of toxins, proteases, and lipases directly into host cell for example α-
hemolysin of E. coli represents the prototypical type I exported factor (Thanabalu et 
al., 1998). 
The type II system is used by different Gram negative bacteria for secretion of 
extracellular enzymes and toxins (exotoxins), for example pullulanase (PulA) 
secretion from Klebsiella oxytoca (Takizawa & Murooka, 1985) and StcE from 
EHEC O157 (Grys et al., 2005). 
Type III secretion will be discussed below. 
Concerning Type IV, this secretion system mediates inter-bacterial DNA transfer, for 
example to protect itself from antibiotic challenge for example the E. coli F plasmids 
(IncF), RP4 (IncP) Trb, R388 (IncW), and Trw genetic exchanges. Type IV system 
can also translocate virulence factors into eukaryotic host cells (Lawley et al., 2003). 
Type V is the simplest protein secretion pathway. Proteins are secreted via an 
autotransporter system (type Va or AT-1), the two-partner secretion pathway (type 
Vb), and the recently described type Vc system (also termed AT-2). Proteins secreted 
via these pathways have similarities in their primay structures as well as striking 
similarities in their modes of biogenesis. IgA1 protease is an example of a protein 
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secreted via this secretion system ( Pohlner et al., 1987; Desvaux et al., 2003). EspP, 
EhaA, and EhaB are also secreted by type V secretion system (Dziva et al., 2007). 
Type VI secretion system has been shown to be important for Gram-negative 
bacterial pathogens virulence in host cell. For example it is required for cytotoxicity 
caused by of V. cholerae toward Dictyostelium amoebae and mammalian J774 
macrophages by a contact-dependent mechanism (Pukatzki et al., 2006).  
 
TTSS are found in many different Gram negative bacteria and are complex 
macromolecular structures used to translocate effector proteins directly from the 
bacterial cytosol into the cytoplasm of eukaryotic cells (Hueck, 1998). The TTSS 
apparatus spans the bacterial inner and outer membranes and exports proteins past 
the cell wall. Two classes of proteins are exported by TTSS: translocon and effector 
proteins. Translocon proteins are required for translocation of effectors across the 
eukaryotic plasma membrane and some may also function as effectors themselves. 
Effector proteins alter host cell physiology and promote bacterial survival in host 
tissues (Mecsas & Strauss, 1996). TTSS is triggered when a pathogen comes in 
contact with host cells (Ginocchio et al., 1994; Menard et al., 1994; Watarai et al., 
1995). The TTSS consist of a basal apparatus with proteins present in the outer and 
inner membranes, and a needle complex that leads to the formation of a pore in the 
host cell membrane. This creates a conduit from the bacterium to the host cell 
through which effector proteins can be translocated (Roe et al., 2003). 
 
1.1.9h.1 TTSS system of EPEC and EHEC 
In EHEC and EPEC all of the genes encoding this protein secretion system are 
expressed from the locus of enterocyte effacement (LEE) (Jarvis et al., 1995; Hueck, 
1998). The LEE regions of EPEC and EHEC have been squenced and consist of 41 
and 54 open reading frames (ORFs), respectively. The additional 13 ORFs found in 
the EHEC LEE fall within a putative P4 family prophage designated 933L; the 
prophage is not present in the prototype EPEC O127:H6 strain E2348/69 but is found 
in a closely related EPEC O55:H7 serotype and other O157:H7 isolates. LEE genes 
are arranged in five large, polycistronic operons, LEE1 to LEE5 of which the first 
three  are identical between EPEC O127 and EHEC O157, and code for the type III 
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secretory apparatus (Elliott et al., 1998; Nataro & Kaper, 1998; Perna et al., 1998; 
Clarke et al., 2003). This is a contact-dependent mechanism in which proteins are 
secreted across bacterial and host cell membranes and inserted directly into the host 
cell cytoplasm (Hueck, 1998). LEE4 encodes the secret d proteins EspA, B, and D 
which form the translocon and a pore required to deliver effector proteins into the 
cytoplasm of host cell (Shaw et al., 2001; Roe et al., 2003; Gauthier et al., 2003). 
LEE 5 encodes an effector protein chaperone, CesT, a  well as intimin and the 
translocated intimin receptor (Hartland et al., 1999) whic is inserted into the host cell 
membrane by the TTSS. Other smaller operons and ORFs are also present in the LEE 
that code for various effector proteins including EspF (Crane et al., 2001), EspG 
(Elliott et al., 2001), EspH (Tu et al., 2003), mitochondrial-associated protein, 
(Kenny & Jepson, 2000), Tir (Kenny et al., 1997), and a chaperone protein CesT for 















Fig. 1.1 The LEE regions consist of 5 operons from LEE1to LEE5. This figure is 





















Fig. 1.2 The TTSS. This figure shows the translocation of bacterial effector protein 
from its production site, through the structural needl , directly into the host cell 
cytoplasm. EspA the sytem needle is formed through the collection of TTSS 
structural proteins, and is approx. 80 nm long. This molecular needle is directly able 
to inject the bacterial effectors directly into the ost cell. This figure is taken directly 





1.1.9h.2 Initial attachment  
EPEC adhere to intestinal epithelial cells depending o  the presence of a plasmid that 
encodes 7nm diameter type 4 and 5 fimbriae that are anchored to the outer membrane 
and combined to form bundles known as bundle forming pili (Cravioto et al., 1979; 
Giron et al., 1991; Bieber et al., 1998). These pili are not encoded by EHEC 
O157:H7, so other initial binding factors may be important. The OmpA outer 
membrane protein of E. coli acts as an adhesion and invasion factor as well as it 
helps in boilfilm formation. These functions are due to four short protein loops that 
come from the protein outside of the cell (Smith e  al., 2007). H7 flagellum plays an 
important role in EHEC O157:H7 initial colonization to bovine terminal rectum 
(McNeilly et al., 2008). F9 fimbriae enhance the initial adherence of EHEC strains 
O26:H- and O157:H7 to bovine epithelial cells and bovine gastrointestinal tissue 
(Naylor et al., 2005b) and were identified as important for cattle colonisation using 
signature-tagged mutagenesis studies (Low et al., 2006). Curli are heteropolymeric 
proteinaceous filamentous appendages that are composed f a large (CsgA) and 
small (CsgB) subunits that affect on the binding activities of several biofilm-forming 
E. coli strains, including STEC (Van Houdt & Michiels, 2005). Although these gene 
clusters are very preserved among E. coli strains, many laboratory strains do not 
create curli due to the silencing of the csgD promoter (Van Houdt & Michiels, 2005). 
It has been shown that among clinical E. coli isolates, curli are expressed in most 
EHEC and ETEC strains, but not in EIEC or EPEC strains, signifying a specific role 
in pathogenicity (Van Houdt & Michiels, 2005). 
 
1.1.9h.3 Attaching and effacing (A/E) lesions and i ntimate attachment  
EHEC and EPEC intimately adhere to host cells forming characteristic 
histopathological lesions in the intestine, known as attaching and effacing (A/E) 
lesions (Andrade & DaVeiga, 1989; McDaniel & Kaper, 1997; Frankel et al., 1998; 
Jerse et al., 1990). Adherence of EHEC and EPEC to epithelial cells causes a variety 
of signal transduction pathways in epithelial cells. Both EHEC and EPEC can 
express a molecular syringe that can export proteins from the bacteria into the host 
cell. This is called a type III secretion system (TTSS) (Fig. 1.5). ‘Effector’ proteins 
are injected. One of the first to be characterized was the translocated intimin receptor 
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(Tir) (Kenny et al., 1997). When Tir is translocated into host cells, it acts as a 
receptor for the bacterial surface protein intimin (Fivaz & van der Goot, 1999). 
Intimin can also bind to an eukaryotic cell receptor called β1 integrin, which travels 
from the basolateral surface to the apical cell surface, to act as receptor to intimin 
(Gullberg & Söderholm, 2006). Nucleolin, a protein i cluded in cell growth 
regulation that can be cell surface-expressed, can also act as eukaryotic intimin 
receptor (Sinclair & O'Brien, 2002; Humphries & Armstrong, 2010). Once the 
bacteria intimately attach to intestinal epithelial ce ls, they cause marked cytoskeletal 
changes including the accumulation of polymerized actin directly beneath the 
adherent bacteria (pedestal formation). The intestinal microvilli are effaced (lost) and 
bacteria are attached on pedestal-like structure of actin (Moon et al., 1983). 
Furthermore, other translocated effectors activate host signaling pathways leading to 
increases in intracellular calcium levels, chloride on secretion, disruption of tight 
junctions (Simonovic et al., 2000), and interference with phagocytosis (Vallance & 
Finlay, 2000). It is interesting that several intimin-negative EHEC serotypes, such as 
O91:H21, O113:H21, and O121:H19 can also cause HUS or bloody diarrhoea as 
well as outbreaks of intestinal disease (Paton et al., 2001; Jelacic et al., 2003). The 
pathomechanism by which these atypical EHEC strains cause disease is not well 
known. Such strains appear to be more frequent outside Europe, specifically in the 
United States (O121:H19) (Jelacic et al., 2003) and Australia (O91:H21 and 
O113:H21) (Paton et al., 2001). In Germany, intimin-negative strains of the 
serotypes O91:H21 and O113:H21 also cause HUS. 
 
1.1.9h.4 Type III secreted effector proteins  
EPEC and EHEC secrete many effector proteins using TTSS; some of them are 
encoded within LEE but a others are not, for example EspC and the glycolytic 
pathway enzyme glyceraldehyde-3-phosphate dehydrogenase. The espC gene that is 
located within a second PAI, encodes immunoglobulin A protease-like protein. This 
protein has no role in adherence or signal transduction. It can be secreted 
independently from TTSS (Clarke t al., 2003).The most important LEE encoded 
proteins are the translocated intimin receptor (Tir), EspB, Map, EspF, EspH, and 
EspG. These proteins are injected directly into host cells. Tir and EspB play crucial 
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role for A/E lesion formation in EPEC (Kenny & Jepson, 2000; Elliott et al., 2001; 
Tu et al., 2003). Tir also links extracellular EPEC/EHEC to the cell cytoskeleton, 
where the extracellular domain of Tir binds intimin (an outer-membrane bacterial 
adhesin protein) ( Kenny et al., 1997; Frankel et al., 2001), while the intracellular 
domain interacts with a number of cytoskeletal proteins (Hartland et al., 1999; 
Kenny, 1999). Inside the eukaryotic cell EPEC tir is phosphotyrosonated by 
phosphotyrosin and binds to the NCK recruit it to polymerize the actin beneath the 
attached bacteria and the formation of A/E lesions. EHEC tir is unable to recruit 
NCK pathway for actin assembly. However, EspFU, a TTSS effector associate with 
tir binds NWASP and stimulates NCK-independent actin assembly pathway 
(Campellone et al., 2004). 
EspB acts as a component of TTSS translocon; it forms the pore of the TTSS needle 
so it is important for translocation of other effectors. It also functions as an effector 
protein that is involved in actin modulation and pedestal formation (Taylor et al., 
1998; Wolff et al., 1998). EspB binds to the actin-interacting region of myosin-1c 
and inhibits the interaction between myosin-1c and ctin. This leads to the inhibition 
of phagocytosis (Iizumi et al., 2007). EspJ targets an essential host molecule or 
complex normally involved downstream of these two phagocytic receptors. It inhibits 
both FcγR- and complement receptor type 3 (CR3) mediated phagocytosis (Marchès 
et al., 2008). Map is targeted to and interferes with mitochondrial function and also 
promotes rapid filopodia formation ( Kenny & Jepson, 2000; Kenny et al., 2002). 
The function of EspG is not known, although homology with Shigella VirA, which 
interacts with tubulin and causes microtubule instabili y, suggests EspG may play a 
similar role in EPEC/EHEC infection (Elliott et al., 2001; Yoshida et al., 2002). 
EspH is a modulator of the host actin cytoskeleton affecting filopodia and pedestal 
formation (Tu et al., 2003). Thus, a number of EPEC/EHEC effectors have be n 
shown to modulate the host cytoskeleton and may be important in the events leading 
to A/E lesion formation.  
 
1.1.9h.4a EspF  
EspF is a focus of this PhD research. It is a multi-f nctional effector protein encoded 
by the LEE Pathogencity Island and injected into the host cell through the TTSS. 
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EspF is a proline-rich protein. Based on the presence of proline-rich repeats (PRRs) 
and SH3 binding motifs, it was anticipated that EspF could be an effector protein and 
subsequent secretion, and translocation assays revealed this to be the case 
(McNamara et al., 2001).  
EspF requires a chaperone, CesF to be translocated into host cells (Clarke et al., 
2003). It is involved in disruption of tight junctions (TJ), possibly through 
manipulation of the actin cytoskeleton (McNamara et al., 2001). It was discovered 
that EspF does not disrupt TJ in intimin negative bacteria, this indicates that the 
intimin-Tir interaction is necessary to activate TJdisruption by EspF (Dean & 
Kenny, 2004; Alto et al., 2007). EspF plays a crucial role in the loss of transepithelial 
electrical resistance, and loss of epithelial barrier function, resulting in increased 
monolayer permeability by its role in redistribution of tight junction proteins, 
including occludins ( Guttman et al., 2006; Nougayrède t al., 2007). Loss of TER 
induced by EHEC was shown to be slower and more modest than that induced by 
EPEC, and this is considered to be due to variation in the EspF protein between the 
E. coli pathotypes (Viswanathan et al., 2004a).  
It has also been shown that EspF causes elongation of the intestinal brush border 
microvilli possibly by inducing actin assembly (Shaw et al., 2005; Marchès et al., 
2008). EPEC EspF plays a role in effacement of microv lli around the attached 
bacteria (Dean et al., 2006). EspF interferes with water and ion re-absorpti n from 
the intestine (by binding) and inhibits the action of the sodium hydrogen exchanger 
NHE3 or the sodium glucose co-transporter SGLT1 (Hodges et al., 2008; Dean et al., 
2006).  
EPEC EspF is targeted to mitochondria, the N-terminal region of EspF acts as a 
mitochondrial import signal; EspF causes an increase in mitochondrial membrane 
permeabilization in addition to release of cytochrome C from mitochondria into the 
cytoplasm and with caspase-9 and caspase-3 cleavage. This process is mediated by 
EspF binding and disruption of the anti apoptosis ho t protein Abcf2 within the 
mitochondria leading to mitochondria and apoptotic cell death (Nougayrède & 
Donnenberg, 2004; Nagai et al., 2005; Nougayrède t al., 2007). The amino acid 
leucine at position 16 is the key amino acid residue in mitochondrial targeting (Nagai 
et al., 2005). EspF is cleaved within the mitochondrial fr ction of EPEC-infected 
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cells, resulting in two distinct forms with the approximate sizes ~28 kDa and ~17 
kDa (Nougayrède & Donnenberg, 2004; Dean et al., 2010). Processing of EspF is 
entirely dependent on an intact mitochondrial membrane potential as the smaller 
cleaved form is not present in cells treated with the mitochondrial inhibitor 
valinomycin (Dean et al., 2010).  
EspF is targeted to the nucleolus, the site for ribosome biogenesis, and disrupts its 
function by relocating nucleolin from the nucleolus to the cytoplasm (Dean et al., 
2010). EspF disrupts cell integrity by interacting with Cytokeratin 18 a eukaryotic 
intermediate filament, making it more soluble (Viswanathan et al., 2004b). 
The PRRs of EspF bind to Sorting Nexin 9 (SNX9) viaits SH3 amino terminal 
region (Marchès et al., 2006; Alto et al., 2007). Each PRR contains two putative 
overlapping SH3 binding domains with the consensus PxxP motif (Mayer, 2001). 
SNX9 is essential for formation of clathrin-coated pits (CCPs) by interacting with 
β2-appendages of adaptor protein complex 2 (AP-2), at the late stages of vesicle 
formation. SNX9 also interacts with clathrin and dynamin-2, two other vital 
molecules in the endocytic process (Lundmark & Carlsson, 2003; Soulet et al., 
2005). SNX9 has two lipid contact domains; a phosphli id-binding region termed 
the phox (PX) domain, the second is a putative Bin/Amphiphysin/Rvs (BAR). The 
BAR domain can reconfigure lipid vesicles or sheets into membrane tubules (Peter et 
al., 2004). SNX9 also has an N-terminal Src homology-3 (SH3) protein active site 
that was recently shown to bind WASP (Badour et al., 2007) and to the activate 
dynamin at clathrin-coated pits (CCPs). Therefore, SNX9 is a vital factor in re-
modelling the membrane and cytoskeletal apparatus during endocytosis (Soulet et 
al., 2005; Alto et al., 2007).  
 
N-WASP plays an important role in endocytosis, by remodelling membranes through 
the spatiotemporal control of several phospholipids and F-actin binding proteins 
(Merrifield et al., 2002; Kaksonen et al., 2006; Holmes et al., 2010). The PRRs also 
contain a functional N-WASP binding motif towards the C-terminal end of each 
repeat (Alto et al., 2007). A direct interaction between actin and EspF from the rabbit 
EPEC strain E22 (Peralta-Ramirez t al., 2008) was revealed to contribute to the 
extent and size of actin-based pedestals in EPEC-infected cells most probably 
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through its direct alteration of the cytoskeleton, even though no role for N-WASP 
was demonstrated (Peralta-Ramirez et al., 2008).  
 
EPEC EspF has been shown to play an important role in inhibition of bacterial 
uptake by macrophages (Quitard et al., 2006; Martinez-Argudo et al., 2007; Marchès 
et al., 2008). EPEC prevents macrophage phagocytosis via inhibition of the 
phosphatidyl inositol-3 (PI3) kinase dependent pathw y of bacterial uptake using 
TTS protein EspF (Celli et al., 2001; Quitard et al., 2006).   
The intestinal mucosa is generally impermeable to macromolecules and 
microorganisms, except at Peyer’s patches, where the lymphoid follicle-associated 
epithelium (FAE) contains M cells that transport anigens and microorganisms to 
antigen presenting cells in the sub-mucosa (Kerneis et al., 1997). Potentially as 
gastrointestinal FAE is less well protected in terms of a mucus barrier, these sites are 
often targeted by bacteria for colonization and invasion. Some EPEC strains exhibit a 
tropism for the specialized follicle-associated epithel um (FAE) overlying 
lymphofollicles in the gut, but resist translocation through the intestinal lumen. This 
inhibition of translocation resembles the capacity of EPEC to inhibit phagocytosis by 
macrophages. This inhibition is dependent on the expression of a bacterial type III 














Table 1.1 Bacterial effectors implicated in epithelial cell function (taken directly 
from Prof. David Gally Teaching lectures). 
Host cellular processes Type III Secreted effector proteins  
Intracellular trafficking  
 
1. Inhibition of vesicle trafficking and protein/petide 
export (NleA) (Kim et al., 2007). 
2. G protein antagonist vacuole positioning (SifA, 
SopE) (Jackson et al., 2008) 
Cytoskeleton 
 
1. Actin polymerization for intimate attachment 
(Tir/EspFu) (Campellone t al., 2004).  
2. Microvillus effacement and inhibition of 
phagocytosis by blocking myosin interactions with 
actin (EspB) (Iizumi et al., 2007).  
3. Inhibition of endocytosis via SNX9 and N-WASP 
binding (EspF) (this study).  
4. Prevent actin depolymerization, binding  to F-actin 
to block protein function (SipA) (Zhou et al., 
1999). SipC and SopB in Salmonella invasion 
(McGhie et al., 2004)  





Deubiquitinating cysteine Proteases (SseL) (Rytkönen 
et al., 2007) Cysteine peptidase-like activity degrades 
α-tubulin (VirA) Ubiquitin ligases (SopA, IpaH)  




1. Kinase manipulation Acetylation of specific 
kinasesat phosphorylation sites  (YopH, AvrA). (Orth, 
2007); Du,and  Galán 2009 (Du & Galán, 2009); 
NleE/NleB, (OspZ and OspF/G) on NFkB activation 
pathways (Newton et al.2010) 
 2. Shielding of an inflammatory 
Factor (YopB) by another (YopK) (Viboud et al., 2003) 
 
Cell turnover & apoptosis 
 
 
1. OspE interaction with ILKinhibits turnover of focal  
adhesion points to ECM; EPEC Cif (Nougayrede t al., 
2001; Kim et al., 2009) 
2. NleH inhibits apoptosis working with Bax inhibitor-
1 & so inhibit caspase-3 activation (Hemrajani et 
al.2010).  
SopB on Akt (Knodler et al., 2005)  
3. IpaB acts on Mad2L2 increases APC activity to 
block the cell cycle (Iwai et al., 2007). 
  
G protein signalling 
 
Activity on guanine nucleotide-binding proteins, such  
as Rho and Rac (YopE, SopE, SptP, SopB) (Galán & 
Zhou, 2000; Murli et al., 2001; Buchwald et al., 2002; 
Aepfelbacher et al., 2004) this activate actin dependent 
bacterial internanalization 
1.2 The genus Salmonella 
Salmonella represents an important group of food borne pathogens. They are Gram 
negative facultative anaerobic bacilli, ferment glucose, and are oxidase negative. The 
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majority of Salmonella species produce hydrogen sulfide that can readily be detected 
by growing the bacteria on media containing ferrous s lfate, such as triple sugar iron. 
The nomenclature of Salmonella is complex (Tindall et al., 2005) and is currently 
considered to contain 2 species: enterica and bongori. Salmonella enterica is divided 
into 6 subspecies: enterica (I), salamae (II), arizonae (III), diarizonae (IV), houtenae 
(V), and indica (VI). Each of these sub-species have multiple serovars (Table 1.2), 
defined by the presence of three major antigens; the "H" or flagellar antigen (some 
time it is two phases, phase 1 and 2 especially for S. Typhimurium), the "O" or 
somatic antigen, and the "Vi" or capsular antigen (referred to as "K" in other 
Enterobacteriaceae), (Lin et al., 2001). 
Table 1.2 S. enterica subspecies and their serovars (taken directly from Grimont, 
2007). 
Species Subspecies  Number of Serovars 
S. enteric  2557 
 Enterica 1531 
 Salamae 505 
 Arizonae 99 
 Diarizonae 336 
 Houtenae 73 
 Indica 13 
S. bongori  22 




1.2.1 Epidemiology of Salmonella: disease transmission   
The majority of cases of human infections by Salmonella resulted from the ingestion 
of contaminated foods of animal origin (Mead et al., 1999). Wild-living birds may 
play an important role in spreading Salmonella to humans and to various animal 
species, via contamination of the surrounding enviro ments, such as water, fresh 
fruits, and vegetables (Bodey et al., 1986; Mahon et al., 1993). Direct person-to-
person transmission through faecal-oral contaminatio  is also possible (Stone et al., 
1993). 
 
1.2.2 Diseases caused by Salmonella 
Salmonella infections can simplistically be divided into two categories: (1) those that 
are relatively host specific and often quite severe l ading to systemic spread and 
sometimes the death of the animal or human; and (2) those that can cause 
gastrointestinal infections in multiple hosts. The first category includes Salmonella 
Typhi in humans and S. Dublin in cattle, whereas the second category includes the 
significant public health pathogens S. Typhimurium and S. Enteritidis. These can be 
both transmitted to humans from contaminated meat products, with S. Enteritidis 
being more commonly associated with poultry products and S. Typhimurium with 
pig and cattle products (Wallis, 2005).  
 
1.2.2a Disease in human  
The disease caused by Salmonella is called Salmonellosis. Salmonellosis has been 
defined as one of the main public-health problems worldwide. Salmonella enterica 
serovar Typhimurium is one of the serotypes most widely associated with human 
infections. Salmonella Typhimurium is transmitted from contaminated meat 
products. Salmonellosis symptoms are usally associated with fever, abdominal pain, 
diarrhoea, nausea, and sometimes vomiting. Furthermor , severe dehydration caused 
by the gastrointestinal infection can be life-threatening in young children and the 






1.2.2b Disease in birds  
Poultry are generally infected with a wide range of Salmonella serovars. S. 
Gallinarum and S. Pullorum are the most widespread serotypes concerned with 
poultry diseases. These serovars cause fowl typhoid an  pullorum disease 
respectively. The disease affects chicken and turkeys and it can also affect game 
birds. S. Pullorum usually infects young birds that show different clinical signs 
including white diarrhoea, lameness, laboured breathing, and occasional blindness. It 
causes mortality and morbidity that could reach 100%. Adult birds are usually 
infected subclinically, and a drop in egg production, fertility or hatchability may 
occur (Kapperud et al., 1998). Fowl typhoid characterised clinically by elevated 
temperature 44-45oC, pale and shrunken combs, greenish-yellow diarrhoea, 
depression, and/or anaemia (Pattison et al., 2008).  
Salmonella enteritidis may accidentally infect poultry. The infection is usually 
asymptomatic and the chicken become chronic carrier (Lister, 1988). However, it 
may produce clinical disease in chicks up to six weeks of age and occasionally in 
adult laying birds. Affected birds are depressed, disinclined to move, and usually 
have diarrhoea (Wray et al., 1996). Mortality may be high in chicks under one week 
of age. Older chicks may show uneven growth and stunting. The diseased birds may 
show lesions of pericarditis and septicaemia (Lister, 1988). 
The symptoms of S. Typhimurium infection in poultry are nearly the same as to those 
caused by S. enteritidis. However, clinical disease due to S. Typhimurium is rarely 
seen in birds over month of age. Infection of adult chickens with S. Typhimurium is 
usally without clinical manifestation ( Wray et al., 1996). 
 
1.2.2c Disease in Cattle  
Cattle are primarily affected by serovars S. Dublin and S. Typhimurium. 
Salmonellosis in cattle is characterised by pyrexia, anorexia, and reduced milk yield 
followed by diarrhoea. S. Dublin could result in a systemic disease and generally 
results in abortion in pregnant cows. Most cases of S. Dublin infection have been 
encountered in young calves (Sojka et al., 1977). Cattle can be infected with 
Salmonella without displaying the clinical symptoms. These animals are referred to 
as active carriers. The active carriage of Salmonella occurs before clinical enteritis or 
____________________________________________________Introduction 
 27 
systemic infection. Infected animals may secrete Salmonella for years or even life. 
Active carriers may excrete Salmonella continuously in concentrations greater than 
105 CFU/g of faeces and thus can be detected by routine bacteriological examination 
(Pullinger et al., 2007).  
Cattle infected with Salmonella exhibiting clinical symptoms can excrete up to 108
CFU/g of faeces. These animals contaminate the surrounding environment 
potentially causing infection of other livestock species in the area. Cattle are most 
likely to be infected by the oral route but infection may also occur via the respiratory 
tract or conjunctiva (Pullinger et al., 2007).. 
 
1.2.2d Disease in pigs 
Pigs are affected by a host-restricted serovar of Salmonella, S. Choleraesuis which 
results in systemic disease. In the 1950’s and 1960’s S. Choleraesuis was the 
predominant serovar isolated from pigs (Sojka et al., 1977). In a European Food 
Safety Authority (EFSA) survey between 2006 and 2007, 87 different serotypes of 
Salmonella were found to affect pigs across Europe. S. Typhimurium was the most 
common serotype of Salmonella isolated with ~40% of the positive pigs infected 
with S. Typhimurium according to EFSA. 
S. Typhimurium typically causes disease in pigs aged btween 6 and 12 weeks and 
rarely in adult pigs. Older animals frequently have subclinical infections which result 
in high transmission rates to surrounding animals if not detected. The initial clinical 
signs of infection include watery diarrhoea. Pigs become anorexic, lethargic, and 
febrile following infection; however mortality is us ally low. The mesenteric lymph 
nodes are usually swollen and intestinal necrosis is often seen as distinct button 
ulcers (Pullinger et al., 2007). 
____________________________________________________Introduction 
 28 
1.2.3 Factors affecting S. Typhimurium adherence and colonisation 
1.2.3a Fimbria 
Fimbriae are proteinaceous appendages in many Gram-negative bacteria. These 
appendages range from 3-10 nanometers in diameter and c n be up to several 
micrometers long. It is also thinner and shorter than a flagellum. Bacteria use the 
fimbriae to help in adherence to one another and to the host cells and some inanimate 
objects. A bacterium can have up to 1,000 fimbriae. The fimbriae are only visible 
with the use of an electron microscope. Fimbrial adhesins of S. Typhimurium play an 
important role during bacterial attachment to and ivasion of the intestinal mucosa 
(Baumler et al., 1997). Type 1 fimbriae are essential for Salmonella adhesion to 
various kinds of epithelial cells (Baumler t al., 1996). Mutation of in lpfC, the gene 
encoding the PE fimbriae outer membrane usher reduce the ability of S. 
Typhimurium to attach to mice peyer’s patches. This mutant alsolo t the ability to 
destroy M cells of the follicle-associated epithelium. (Bäumler et al., 1996). 
 
1.2.3b Type III secretion system  
Salmonellae encode two distinct virulence-associated TTSS within Salmonella 
pathogenicity islands 1 and 2 (SPI-1 and SPI-2) that are measured to be required in 
different aspects of Salmonella’s pathogenicity, although there are many reports of 
overlap in their function. These TTSS inject various Salmonella effectors directly 
into the host cell (Hernandez et al., 2004). The SPI-1 TTSS is active on contact with 
host cells. SPI-1 is required for bacterial invasion of epithelial cells. SPI-1 TTSS 
translocates at least eight effector proteins that mediate several effects, including 
membrane ruffling, bacterial invasion, cell death, and trans-epithelial migration of 
neutrophils (Miao & Miller, 2000). SPI-1 is expressd in growth conditions that are 
consistent with the intestinal environment. This regulation depends on a variety of 
transcription factors encoded within SPI-1 (Miao & Miller, 2000). 
In contrast, SPI-2 expression is induced in phagocytosed bacteria to defend the 
Salmonella-containing vacuole (SCV) from lysosome fusion and the anti-bacterial 
factors present in lysosomes. This TTSS helps in the spread of infection and causes 
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apoptosis of infected cells so it is essential for survival/replication in phagocytic cells 
(Miao & Miller, 2000; Galán, 2001; Waterman & Holden, 2003). 
1.2.3c Salmonella secreted effector proteins  
The initial site of S. Typhimurium infection occurs in the distal small intestine. Here 
the bacteria induce their own uptake, invading non-phagocytic cells by manipulating 
the host actin cytoskeleton resulting in intense membrane ruffling and the formation 
large macropinosomes. The bacteria do this using a range of effector proteins 
injected via the TTSS encoded by Salmonella pathogenicity island 1 (SPI-1) 
(Hernandez et al., 2004; Ly & Casanova, 2007). 
The specialized antigen-sampling intestinal M cells are an important route of 
Salmonella invasion during the early stages of infection through inducing ruffle-like 
entry foci in M cell membrane and cytoskeletal rearangements (Jepson & Clark, 
2001). S. Typhimurium efficient M-cell invasion correlates with the induction of 
cytotoxicity and are accompanied by M-cell destruction and loss of adjacent regions 
of the FAE (Autenrieth et al. 1996; Daniels et al., 1996). The mechanisms by which 
Salmonella invade the intestinal epithelium are being clarified; in vitro studies have 
identified several genes which are required to optimize S. Typhimurium invasion of 
epithelial cells. SPI-1- encoded genes include a type III protein secretion system 
together with several of its target proteins that are required for bacterial invasion 
(Clark et al., 1998). This including SipA, SipC, SopB/SigD, SopE, SopE2, and SptP 
that are known to alter the host cell actin cytoskeleton to drive internalization of 
Salmonella (Ly & Casanova, 2007). 
The Salmonella invasion protein A (SipA), a component of Salmonella Pathogenicity 
Island 1 (SPI-1), is vital for efficient invasion of cultured cells. It binds host F actin, 
enhances its polymerization near the adherent extracellular bacteria, and contributes 
to cytoskeletal rearrangements that internalize the pathogen (Bourdet-Sicard & Van 
Nhieu, 1999; Lilic et al., 2003). Once Salmonella passe through M cells, it binds to 
the surface of macrophages, induces ruffle-like entry foci in the macrophage surface 
and utilize TSS to inject Salmonella outer proteins E (SopE) and SopE2 (Stender, 
Friebel et al. 2001). SopE has GDP/GTP exchange activity specific for Rac and 
Cdc42 (Friebel et al. 2000). SopE is required for invasion of macrophages and 
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capable entry into epithelial cells by alteration of the actin network. It also regulates 
nascent Salmonella-containing vacuoles (SCV). SigD/SopB is an effector protein 
that is encoded by SPI5 and is injected directly into the host cell using SPI-1. SopB 
needs the SigE chaperone for its translocation. It is a phosphatidylinositol 
phosphatase that hydrolyzes phosphatidylinositol 3, 4, and 5 (Norris et al., 1998). 
This manipulates the level of endosomal phosphoinosit de  leading to recruitment of 
sorting nexin 1(SNX1) to SCV and results in the formation of extensive, long-range 
tubules termed ‘spacious vacuole-associated tubules (Bujny et al., 2008; Braun et al., 
2010). These tubules enhance bacterial replication w thin SCVs (Bujny et al., 2008). 
SigD/SopB is also concerned with invasion of the host cell. It binds to the rab5 
GTPase, a central regulator of membrane fusion in early endocytosis. SigD is 
essential for Akt activation as well. Akt stimulates cellular signals that are essential 
and sufficient for host cell survival. Thus, it is possible that Salmonella-induced 
activation of Akt in epithelial cells would increase host cell survival, perhaps 
allowing the pathogen a greater intracellular time frame within which to replicate. 
SigD activates AKT by its phosphorylation at two site , Ser473 and Thr308 (Steele-
Mortimer et al., 2000). Activation of AKT has no function in cell invasion (Steele-
Mortimer et al., 2000). Following translocation, the host cell membrane returns to 
normal and the bacteria reside within SCV. The nascent vacuole is enormous relative 
to the size of the bacterium and has been called a “sp cious phagosome” that 
undergoes a maturation process which allows the bacteri  to multiply (Ly & 
Casanova, 2007). The SCV is modified by the bacteria to prevent maturation into, or 
fusion with lysosomal compartments, thus providing them with protection from 
lysosomes. During a lag period of 2–3 h, the bacteria modulate their vacuolar 
environment before they start to replicate (Hernandez et al., 2004b). Salmonella-
induced apoptosis contributes to the break out of intracellular bacteria from 
exhausted host cells following nutrient deprivation a d the stop of bacterial 
replication. Induction of apoptosis is performed via SPI-1 TTSS effector SipB that 
binds to and activates caspase-1 which mediates apoptosis, and induces the release of 
IL-1β which is required for inflammation (Hersh et al., 1999a; Coburn et al., 2007).  
TTSS-2 effectors modulate host cell functions, especially cytoskeletal organization 
and membrane trafficking, including inhibition of various aspects of endocytic 
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trafficking, an avoidance of NADPH oxidase-dependent killing, the induction of a 
delayed apoptosis-like host cell death (Kuhle & Hensel, 2004). SPI-2 mutants fail to 
replicate within macrophages and epithelial cells (Cirillo  et al., 1998). 
The mechanism by which SPI-2 promotes bacterial virulence is unknown. Although 
a number of translocated effectors of SPI-2 TTSS have been identified, it has been 
shown to promote intracellular survival by inhibition of phagosome–lysosome fusion 
(Brumell & Grinstein, 2004).  
Salmonella-induced filaments (Sifs), are intracellular projections that extend from 
the SCV to the cytoplasm of infected epithelial cells or macrophages (Knodler t al., 
2002). These structures are associated with cell organelle trafficking (Brumell et al., 
2002). They are also necessary for the binding of SCV with the late endosomal 
compartments. Although the advantages of doing this function are unclear, but are all 
potentially about controlling trafficking, position, and maturation of the SCV 
(Brumell et al., 2001).  
SpiC and SifA are Salmonella Pathogenicity Island 2 (SPI-2) TTSS effectors thatare 
injected from the bacteria in the vacuole into the cytosol outside the vacuole. SpiC 
inhibits fusion between the SCV and lysosomes (Shotland et al., 2003). It stimulates 
actin polymerisation that results in cytoskeletal rear angements (Hayward & 
Koronakis, 1999). SifA controls the maintenance of the SCV binds F-actin and 
inhibits its polymerisation, enhances the efficiency of SipC and is necessary for the 








SipA It enhances actin polymerization near the 
adherent extracellular bacteria, and contributes to 
cytoskeletal rearrangements that internalize the 
pathogen.  
(Bourdet-Sicard & 
Van Nhieu, 1999; 
Lilic  et al., 2003a). 
SipB Induction of apoptosis via activation of caspase-1 (Hersh et al., 1999b) 
SopE + E2 It plays a role in recruitment of Arp2/3 to
membrane ruffles. Required for optimal invasion 
of cultured epithelial cells.  
(Stender et al., 2000) 
SopB It is encoded by SPI-5, dependent on SirA, 
inositol phosphate phosphatase that hydrolyzes 
phosphatidylinositol 3,4,5-triphosphate, an 
inhibitor of chloride secretion. It mediates fluid 
secretion by increasing chloride secretion. it also 
affects host cell signalling pathways that may be 
concerned in regulation of cytokine expression 
such as activation of the serine-threonine kinase 
Akt. 
(Eckmann et al., 
1997; Steele Mortimer 
et al., 2000b) 
SopD It has additive effect to SopB in the induction of 
enteritis 
(Jones et al., 1998) 
SopA Involved in the induction of neutrophil 
transepithelial migration 




SipC It nucleates actin polymerisation which results in 
cytoskeletal rearrangements. It also prevents the 
fusion of SCV with endosomes and lysosomes. 
(Hayward & 
Koronakis, 1999; 
Uchiya et al., 1999) 
SifB, SseJ, SseF, 
SseG and PipB 
are localized to Sifs and are required for their 
formation 
(Guy et al., 2000; 
Waterman & Holden, 
2003) 
SopD2 required for Sifs formation (Jiang et al., 2004) 
SifA It prevent binding of SCV with lysosomes and is 
important for binding of SCV with the late 
endosomal compartments by inducing expression 
of other sifs 
 
(Brumell et al., 2001) 
 
1.3 Intestinal epithelium and M cells 
The intestinal immune system must cope with many infectious and toxic assaults that 
may damage the epithelium. The immune system must also recognize epithelial cell 
transformation. Simultaneously, the intestinal immune system must ignore the 
collection of commensal organisms and dietary antige s that do not harm the host. 
To deal with this challenge, the gut-associated lymphoid tissue has developed several 
important modifications in relation to antigen processing to manage its organ-
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specific responsibilities. These include flattened epithelial microfold cells that are a 
kind of intestinal epithelial cells in the follicle-associated epithelium of Peyer’s 
patches (Gebert et al., 1999). 
The epithelium lining the intestinal mucosa is compsed of multiple cell types 
including enterocytes, enteroendocrine, goblet, and Paneth cells. These cells derive 
through asymmetrical division, migration, and differentiation from pluripotent stem 
cells. An additional specialised epithelial cell type, termed M-cells, “membranous” 
or “microfold” cells, can transport antigens and micro-organisms into underlying 
lymphoid tissues and are associated particularly with epithelium overlying the gut- 
associated lymphoid tissue Peyer’s patches (Gebert t al., 1999). This is referred to 
as follicle-associated epithelium (FAE), the site of active immunological function. In 
contrast to villous epithelium, FAE contains very few or no goblet or 
enteroendocrine cells, fewer defensin- and lysozyme-producing Paneth cells, and 
lower membrane-associated hydrolases. FAE is devoid of polymeric 
immunoglobulin receptor that mediate the transcellular transport of immunoglobulin 
A & M and therefore not able to transport protective IgA from the interstitium to the 
lumen. The glycocalyx (glycoprotein secteted by theepithelial cell to coat the 
epithelial surface) of FAE presents array of glycoconjugates different from the 
surrounding villus epithelium (Gebert e  al., 1994; Giannasca et al., 1994; Giannasca 
et al., 1999; Owen, 1999). All these features tend to promote local contact of 
pathogens and intact antigens with FAE, one of its functions. 
The FAE M-cells sample antigens from the lumen directly to the intraepithelial 
lymphoid cells and to sub-epithelial organised lymphoid tissue, initiating a protective 
immune response (Giannasca et al., 1994). M-cells generally lack an organised brush 
border and a well-defined filamentous brush border glycocalyx (FBBG). Their apical 
surfaces have only a thin (20-30nm) glycoprotein coat (Frey et al., 1996) in 
comparison to villus enterocytes which have a highly differentiated structure 
consisting of rigid, closely packed microvilli coated with a 400-500nm thick FBBG 
composed of highly glycosylated transmembrane mucins. Therefore, though the M-
cells are crucial for induction of protective mucosal immune responses, they can be 
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considered as potentially less well-protected sites that act as entry portals to many 
enteropathogens.  
Human M-cells covered by small microfolds over their apical surface, instead of 
microvilli. These microfolds are similar to ruffles on the edges of a macrophage. 
They can enfold a wide range of particles that reach their surfaces. However, in mice 
M-cells are characterized by the presence of small, irregular microvilli instead of 
microfolds. The ultrastructural morphology by transmi sion electron microscopy, 
revealed that murine and human M-cells, are invaginated to form pockets for 
lymphocytes that directly engulf the antigen transcytosed across M cell (Ogra, 1994). 
Murine and human M-cells expressed glycoprotein 2 (GP2) receptors on the surface 
plasma membrane and it is consider to be a specific marker for that cell in those 
species (Hase t al., 2009). 
M cells bind to adjacent cells by tight junctions. M cells have lateral inter-digitations, 
oriented along a basal lamina, and are epithelial cells by all characteristics and not 
posses any features of connective or mesenchymal cells. In fact, M cells have some 
prelysosomes and a few lysosomes may be able to digest some of the material they 
engulf (Owen, 1994).  
 
1.3.1 Development of M cells  
The origin of both villous epithelium and FAE is from crypt stem cells. The intestinal 
crypts can be simplistically considered as formed from a unit of pluripotent stem 
cells that are anchored together as a ring, which gives rise to multiple cell types that 
migrate upward in columns onto several adjacent villi (Bye et al., 1984). FAE is 
formed from a mixture of migrating cells from 12 or more follicle-associated crypts 
(Savidge and Smith, 1995). The follicle-associated crypts can be differentiated 
through two directions. Cells located on one side of the crypt migrate and 
differentiate into villous epithelium with absorptive enterocytes, goblet, and 
enteroendocrine cells, whereas cells on the follicle side of the crypt move onto the 
dome and differentiate into FAE and M-cells (Bye et al., 1984; Gebert et al., 1999; 























Fig. 1.3 The relation of M cell to enterocyte and antigen presenting cells in the 
follicle associated epithelium (FAE). M cell (A) is charcterized by presence of 
fewer and shorter microvilli. The antigen presenting cells are invaginated in middle 
hollow of M cell (Arrow). The absorbtive enterocte (B) is charcterized by long and 
thick brush border.  
The mouse FAE specimens were viewed in a CM 120 transmission electron 






There are various hypotheses regarding the ontogeny of FAE and M-cells: (i) M-cells 
may originate in the crypts as a distinct cell lineag  from specific progenitor stem 
cells via an independent differentiation programme (Bye et al., 1984; Gebert et al., 
1999); (ii) they may derive from enterocytes under the influence of surrounding 
lymphoid micro-environment as enterocytes are subject to different signals from 
lymphocytes (T&B cells) that can play important roles in M cell differentiation in 
these follicles leading to production of M-like cells (Smith & Peacock, 1980; 
Freeman et al., 1995; Savidge, 1996; Kerneis et al., 1997); (iii) exposure to microbial 
pathogens in the lumen may induce enterocytes to specialise into M-cells (Savidge t 
al., 1991; Borghesi et al., 1996; Borghesi et al., 1999; Meynell et al., 1999); or (iv) 
they represent a transient phenotype of FAE enterocytes as they migrate from the 
crypts to the apex of the dome. Certain microbes appe r to exploit the innate 
plasticity of epithelial cells to trigger their transformation into a M cell phenotype 
that suits their habitat or life style, for example, Campylobacter jejuni that increased 
cells expressing the M cell-specific marker, galectin-9, in Caco-2 monolayers. This 
coincided with decreased  numbers of normal epithelial cells that stained enterocyte 
marker, Ulex europaeus agglutinin-1. Also, this culture was charcterised by reduced 
activities of enzymes classically related to absorptive enterocytes such as alkaline 
phosphatase, lactase, and sucrase. These cells are functionally similar to M cells 
(Kalischuk et al., 2010). 
 
Whatever the basis for their ontogeny, M-cells represent an important interface 
between immunogens in the gut lumen and the immune system. This is an intimate 
relationship as evidenced from work showing that FAE secrete certain homing 
chemokines that are involved in function and maintenance of organised mucosal 
associated lymphoid tissue.  
 
1.3.2 Production of M cells in vitro 
M cells arise from pluripotential epithelial stem cells in adjacent crypts and migrate 
to the FAE, where they differentiate into their distinctive phenotypes under the 
influence of the lymphotoxin-β receptor ( Kraehenbuhl & Neutra, 2000; Debard et 
al., 2001). However, M cells develop in mice, which lack T and B lymphocytes, 
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indicating that lymphotoxin can arise from other sources (Debard et al., 2001). Co-
culture of Murine intestinal epithelial cell line (MIE) or Caco-2 cells with Peyer’s 
patches or Raji B cells lead to differentiation of these epithelial cells to cells 
phenotypically and functionally resemble to M cells (Kerneis et al., 1997; 
Verbrugghe et al., 2006; Kanaya et al., 2008).The receptor activator of NF-қB ligand 
(RANKL) is a cytokine expressed by subepithelial stromal cells (B lymphocyte) in 
peyer’s patches immediately beneath FAE and received by its receptor RANK that is 
expressed throughout intestinal epithelial cells promoting differentiation of some 
intestinal epithelial to M cells (Knoop et al., 2009).   
 
1.3.3 Interaction of various enteric bacterial path ogens with M-cells 
As gastrointestinal FAE is less well protected in terms of a mucus barrier, these sites 
are often targeted by bacteria for colonization andinvasion. However, many virulent 
bacteria that do not function as intracellular pathogens use different mechanisms 
included secreted proteins to protect themselves from phagocytosis; some of these 
mechanisms require type III secreted effector proteins (Celli & Finlay, 2002). 
The availability and accessibility of different glycoconjugates, potential ligands for 
the bacterial lectin-like adhesions, facilitates adherence of many enteric pathogens to 
FAE. The diversity of glycoconjugates and apical membrane proteins including β-1 
integrins may allow M-cells in the FAE to sample a wide variety of microbes in the 
gut to induce protective immune responses (Gebert, 1997; Giannasca et al., 1999). 
Although intact commensal bacteria are rarely taken up, numerous pathogens, 
including human immunodeficiency virus, reoviruses, Vibrio cholerae, and Shigella 
species, selectively adhere to M cells, possibly through specialized carbohydrate-
binding mechanisms, and are transported without degra ation (Owen et al., 1986a; 
Owen et al., 1986b; Owen, 1999). It is likely that adherence and uptake of micro-
organisms by M-cells results from selective adherence to FAE and M-cells that 
involves a sequence of molecular interactions including initial recognition of M-cell 
surface oligosaccharides by bacterial lectin-like adhesins, followed by more intimate 
association that would require expression of other additional virulence determinants. 
Processing of M-cell surface molecules and recruitment of integral membrane 
proteins of M-cells to the site of attachment (Corr et al., 2008). 
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Transcytosis by M cells is a highly specialized process. It depends upon the 
interaction of a specific receptor from the bacterial s de with its target receptor on the 
host M cell. For example, E. coli or Salmonella Typhimurium were selectively co-
localized with apical and endogenous GP2, while FimH utants failed to be 
transcytosed across M cells. Transcytosis of naturally FimH- bacteria such as 
Yersinia was not affected in GP2 mutant mice as Yersinia use β-integrin as a 
receptor for interactions with M cells (Hase et al., 2009). 
Once a particle/antigen is translocated through an M-cell, it is immediately exposed 
to phagocytes and antigen-presenting cells. It was shown that the soluble GP2 
opsonized the luminal FimH+ bacteria and increases antibody responses against 
these bacteria (Ermak et al., 1990; Ermak et al., 1994; Farstad et al., 1994; Ermak et 
al., 1995; Hase et al., 2009). 
 
1.3.3a Yersinia 
Yersinia goes through the FAE, in the Peyer’s patches of the ileum where M cells 
express β1 integrins on their apical surface. The β1 integrins act as a receptor for 
enteropathogenic Yersinia species (Clark et al., 1998). 
 
1.3.3b Shigella 
The pathogenesis of Shigella depends on the ability of the bacteria to cross the 
colonic mucosa via M cells associated with Peyer’s patches. Although there is no 
identified receptor for Shigella on M cells, it selectively translocates through M cells. 
Invasive Shigella translocate more significantly across M cells than a on-invasive 
mutant, demonstrating that expression of an invasive phenotype plays a main role in 
Shigella–M cell interactions (Hersh et al., 1999). Shigella induces ruffle-like entry 
foci in M cells. Shigella flexneri is dependent on TTSS effector proteins. 
It translocates the plasmid-encoded invasion antige B (IpaB) via a TTSS. IpaB 
directly binds and activates caspase-1, results in apoptosis, and initiates inflammation 
by causing the maturation of two inflammatory cytokines interleukin 1β and 
interleukin 18. This early inflammatory process leads to quick disruption of the 
epithelial barrier, thereby facilitating further Shigella invasion (Grassme t al., 2001; 
Sansonetti, 2002).  
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1.3.3c Salmonella  
The specialized antigen-sampling intestinal M cells are a route of Salmonella 
invasion by inducing ruffle-like entry foci in M cell membrane and cytoskeletal 
rearrangements (Jepson & Clark, 2001). S. Typhimurium efficient M-cell invasion 
correlates with the induction of cytotoxicity and are accompanied by M-cell 
destruction and loss of adjacent regions of the FAE (Daniels et al., 1996; Jepson & 
Ann Clark, 1998; Bolton et al., 1999). The mechanisms by which Salmonella interact 
with M-cells are considered to be very similar to th se described above in sections 
for Salmonella secreted effector proteins.  
 
1.3.3d EHEC O157:H7  
E. coli O157:H7 colonizes the epithelium of terminal rectum of the cattle (Naylor et 
al., 2003). The majority of E. coli O157:H7 shed from the calves persisted in the 
final 5 cm of the rectum adjacent to the recto-anal junction (Naylor et al., 2003). It 
has been shown that this region of the cattle rectum is characterised by the presence 
of a high density of lymphoid follicles. It is reasonable to postulate that epithelium 
associated with lymphoid dense tissue in the terminal rectum may be crucial for E. 
coli O157:H7 colonisation. The local environment at the sit may be conducive for 
the expression of certain bacterial adhesins, and the availability and accessibility of 
distinct glycoconjugates and other integral membrane proteins on FAE or M-cells 
may be the determining factors in E. coli O157 colonization in the terminal rectum of 
the cattle. It is clear that EHEC interaction with intestinal epithelium is a complex 
phenomenon and involves multiple bacterial and host determinants. If M-cells are 
targeted then the bacterium would need a mechanism to prevent transcytosis, with 
EspF activity being a prime candidate. This function has been demonstrated for 
EPEC O127 EspF (Martinez-Argudo et al., 2007). The aim of the current 
investigation was to gain further understanding of the molecular basis of terminal 
rectum-specific tropism of E. coli O157:H7 in cattle with a particular focus on host 
and bacterial determinants. 
Many bacterial pathogens including, S. Typhimurium (Savidge et al., 1991), 
Streptococcus pneumoniae (Borghesi et al., 1999; Meynell et al., 1999b), Y. 
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pseudotuberculosis (Ragnarsson et al., 2008), and Campylobacter jejuni (Kalischuk 
et al., 2010) have earlier been reported to enhance the number of M cells in the FAE. 
Part of my research focused to determine molecular basis of bacterial mediated 





1. To compare the capacity of different espF alleles to inhibit: (i) bacterial 
phagocytosis by macrophages; (ii) translocation through an M-cell co-culture system; 
(iii) uptake by and translocation through cultured bovine epithelial cells. 
2. Yeast-2-hybrid screening for different EspF variants to identify additional host 
proteins that may interact with EspF and confirmation of interactions using 
localization studies. 
3. To address whether bacterial interactions can induce M-cell differentiation from 
follicle-associated epithelium. The work will focus on bovine rectal primary cell 
cultures interacting with Salmonella enterica serovar Typhimurium and study the 




Materials and Methods 
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2. Materials and Methods 
2.1 Bacterial strain and media 
EPEC, EHEC and other E. coli strains used in this study are described in Table 1.  
Bacteria were cultured in Luria Bertani (LB) broth, MEM-HEPES or DMEM culture 
media with antibiotics included when required at the following concentrations: 
chloramphenicol (cam) 20 µg /ml, kanamycin (kan) 50 µg /ml and ampicillin (amp) 
100 µg/ml. 1 litre of M9 growth medium consists of 200 ml of M9 minimal salts X5 
(Sigma), 20 ml 20% Glucose, 2 ml of 1M MgSO4 and 5 ml of 10% Casamino Acids 
    
Table 2.1.  Bacterial strains used in the study 
Strain Serotype Source 
E. coli ZAP 1139 O26:H11 
 
Cattle isolate, Stx negative; Dr. Chris Low, Scottish Agricultural College, 
Penicuik, Scotland. 
 




Stx phage negative derivative of the sequenced human str in EDL933. 
Provided by Prof. John Leong, Massachusetts Medical S hool, Boston, USA 
(Campellone et al., 2007) 
E. coli TUV93-
0∆espF  
O157:H7 This study 
 




Shiga toxin phage negative human isolate from an outbreak in Walla Walla, 
USA.  Supplied by Dr. Mary Reynolds originally at the University of Atlanta, 
USA (Ostroff et al., 1990)  
E. coli EPEC 
E2348/69 (∆espF) 
O127:H6 Derivative of human isolate supplied by Prof. Brendan Kenny, University of 
Newcastle, UK. (Shaw et al., 2005) 
ZAP 120 O5: H- Prof. Tom Besser 
ZAP 1076 O103:H- 
 
SAC Laboratory stock 
ZAP 286 O127:H6 Prof. Mark Stevens Laboratory stock 
ZAP 124 O26:H2 
 
Prof. Tom Besser Laboratory stock 
ZAP 125 O111:H12 Prof. Tom Besser Laboratory stock 
 
ZAP 268 O103:H2 
 
Prof. Mark Stevens, IAH, Newbury Laboratory stock 
E. coli AAEC 185 O148 
 
Laboratory stock 
E. coli DH5α Rough 
 
Laboratory stock 





E. coli strain K12 Zap 1167 Laboratory stock 
S. Typhimurium SL1334 strain  Prof.  Mark Japson University of Bristol, UK. 
∆ spI1     S. 
Typhimurium 
 Dr Andrew Roe University of Glasgow, UK 




Prof.  Mark Japson University of Bristol, UK. 
∆ sipA     S. 
Typhimurium 
 Prof.  Mark Japson University of Bristol, UK. 





Prof.  Mark Japson University of Bristol, UK. 




Prof.  Mark Japson University of Bristol, UK. 
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Table 2.2 Antibiotics used in the study 
Antibiotic  Source Stock concentration Final 
concentration 
Gentamycin Sigma-Aldrich (fluid) 50mg/ml 15 µg/ml in 
the medium 
Ampicillin Sigma-Aldrich (powder) 100 mg/ml distilled 
water 
100 µg/ml in 
the medium 
Chloramphenicol Sigma-Aldrich (powder) 20 mg/ml of ethanol 20 µg/ml of 
medium 
Kanamycin Sigma-Aldrich, (powder) 50 mg/ml of steril  
distilled water 
50 µg/ml of 
medium 
Spectinomycin Sigma-Aldrich (powder) 50 mg/ml of sterile 
distilled water 
50 µg/ml of 
medium 
 
2.2 Nucleic acid production and manipulation 
2.2.1 Materials used in DNA techniques 
2.2.1a Molecular weight markers: 
1. Gene Ruler 100 bp DNA ladder: Purchased from MBIFermentas. 
2. Gene Ruler DNA 1 kbp ladder: Purchased from MBI Fermentas. 
3. 1 kbp DNA ladder: Purchased from New England Biolabs. 
 
2.2.1b Kits: 
1. Gel and PCR clean up system: Purchased from Promega 
2. Plasmid DNA Purification Gene Jet Kit: Purchased from Fermentas life Science. 
3. QIAprep Spin Miniprep Kit: Purchased from Qiagen. 
4. PureYield TM Plasmid Midiprep System Kit: Purchased from Promega. 
 
2.2.1c Enzymes: 
1. Gateway® BP clonase enzyme mixture: Purchased from Invitrogen. 
2. Gateway® LR clonase enzyme mixture: Purchased from Invitrogen. 
3. Restriction enzymes: BamHI, XbaI, XhoI, NheI, HindIII, EcoRI and BanII: 
Purchased from New England, Biolabs. 
 
2.2.1d Buffers and solutions used in DNA techniques  
1x TAE: Composed of 40 mM Tris base, 20 mM Acetic acid and 2 mM EDTA. 
Distilled water was added up to 1 litre. 
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1x TBE: Tris-BORATE-EDTA consists of 0.09 M Tris base, 0.09 M boric acid and 
0.002 M EDTA disodium salt dissolved in distilled water. 
 
2.2.1e Preparation of whole cell lysates for PCR 
Whole cell lysates for PCR were prepared by taking a single colony from an LB plate 
and mixing with 100 µl of molecular grade (MG) water (Sigma) before heating for 
15min at 100°C in a heated block. 
(b) The PCR primer pairs used in this research study are listed in Table 2. Each 
primer pair was used to amplify espF from different serotypes for both detection and 
for sequencing.   
 
A- Primer set1 was used for amplification of espF from 
1. O26:H11   2. O5:H- 3. O26:H2 4. O111:H12   5. O103:H2     6. O118:H16   
B- Primer set2 was used for amplification of espF from 
7. O103:H-     8. O157:H7    9. O127:H6  
PCR products were gel purified and sent for sequencing by MWG Biotech. 
 
2.2.2 Techniques for nucleic acids manipulation 
2.2.2a RNA extraction and purification 
RNA was isolated according to the manufacturer's instructions using RNeasy Mini 
Kit50®, and Qiashredder protocol (Qiagen). In brief, bovine rectal epithelial cells 
were kept in RNA cell protect at -80oC until use. The cells were centrifuged at 300 g 
for 5 m, the supernatants were removed and the pellts were suspended and disrupted 
in 350-600 µl of a high-salt denaturing lysis buffer containing guanidine 
isothiocyanate solution (RLT buffer). 10 µl of β-Mercaptoethanol per 1 ml of 
supplied RLT buffer. The cell lysates were homogenis d on a QIA shredder column 
(Qiagen, UK) by centrifuging at 13000 rpm for 2 m. The cell lysates were transferred 
to gDNA eliminator spin column and centrifuged at 10000 rpm for 30 sec.  The flow-
throughs were added to the RNA-binding columns (RNeasy spin column) after the 
addition of one volume of 70% ethanol, to create correct resin-binding conditions, 
and centrifuged at 10,000 rpm for 15 sec. Flow-throughs were discarded and the 
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bound RNA was washed once in 350 µl buffer RW1. 80µl of DNase I mix (10 µl of 
DNase I added to 70 µl of buffer RDD and mixed gently) was added directly to 
RNeasy spin column membrane and incubated at RT for 15 min. The RNeasy spin 
column was then washed once in 350µl buffer RW1 and twice in 500 µl buffer RPE 
by centrifuging for 15 sec at 10000 rpm. RNA was eluted in 30 µl of RNase-free 
water. RNA concentration and quality was determined by means of Nanodrop 
Spectrophotometer supplied by British Labtech® Inter ational; these values are 
converted accordingly to cDNA Protocol. 
 
2.2.2b Reverse transcription 
RNA was reverse transcribed to cDNA using a Promega® protocol. Reverse 
transcription was performed according to the manufact rer’s instructions, by adding 
4 µl of MgCl2, 2 µl of 10 X buffer,  2 µl of dNTPs, 0.5 µl of RNase inhibitor, 0.6 µl 
of Reverse Transcriptase, 1 µl of random primers, 1 µg of RNA and RNase free 
water to make a total volume of 20 µl. This mixture was kept at room temperature 
for 10m before the mixture was transferred to water bath and incubated at 42˚С for 
15 m, then to an incubator at 95˚С for 5 m. The mixture was left on ice for 5min. The 
resulting cDNA was incubated with 1 µl of E. coli RNase H at 37°C for 20min for 
removal of the RNA complementary to the cDNA. 
 
2.2.2c Semi quantitative real time-PCR (SQRT-PCR)  
To detect the relative gene expression levels or DNA copy number in tested samples, 
PCR was performed using Expand Long Template PCR System (Roche Diagnostics). 
The reaction was carried out by making a Master Mixwith following volumes: 5 µl 
10X Expand Long Template buffer, 30 µl nuclease-fre molecular water, 2.2 µl 
10mM dNTP, 1 µl of forward and reverse gene-specific primers, 0.75 µl DNA 
polymerase with proofreading activity. 50 µl of Master Mix was transferred to 
individual PCR tubes, and 10 µl of different template cDNA were added 
individually.  PCR tubes were centrifuged for 10 sec b fore running the PCR with an 
initial denaturing step of 94˚С for 2 min followed by 35 three-step cycles of 94˚С for 
10 sec, 56С̊ for 45 sec and 68С̊ for 5 min. 
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Sequence Primer use 
1. espF  1f1  ( BamHIsite) 
2. espF ra  (HindIII site) 
1.caggatccaccacacaatttgatatcggt ( o157 ) 
2.ctaagcttgatataaagaggcataaattatgc ( o 157) 
O157 espF PTS 1 Cloning 
3. R2  BamHI site (O 127 espF ) 




EPEC espF  PTS 1 
Cloning 
5. espF 3 f3 ( BamHI site) 
6. espFb ( HindIII ) 
5. caggatcctcacaatgcaacttaatatcgg  
6.  ctaagcttgatataaaaaggcatgaattatgc 
 
O26 espF  PTS 1 Cloning 
7. Primer set 2f 
8. Primer set 2r 
7. aactgcagttcattagcgtacagactgg. 
18. aaggtacccgactcaacctgtatcaagt 
espF amplification and  
sequencing 
9. Primer set1f 





espF amplification and  
sequencing 
11. espF allelic exchange sacI 
12.  espF allelic exchange sacI BamHI 
 
13.  espF allelic exchange pstI 







                
espF allelic exchange 
 
15. SACB primer 




to check espF allelic 
exchange 
 
17. espF 600 primerf 




to check espF allelic 
exchange 
19. espF  o157  xbaI site 
20.  espF  o157    xhoI  site 
19.agtctagagccaagcttagatataaagagg 
20.  acctcgagccctttcttcgattgctcatag    
O157 espF cloning in 
pET21d for Purification 
of 6xHis-tagged EspF   
21.   espF O 127 xbaI site  
22. O127 espF  xhoI site 
 
21. agtctagattagtggttgggtacgag 
22.  agtctagattagtggttgggtacgag 
EPEC espF   cloning in 
pET21d Purification of 
6xHis-tagged EspF 
23.  O26 espF   xbaI site 
24.   O26 espF  xhoI  site 
23.  agtctaga agctgtacgaaagtttctatg   
24.   acctcgagtgcctttttcgacagttc  
 
O26 espF   cloning in 
pET21d Purification of 
6xHis-tagged EspF 
25. O26 espF gat fore 
26. O26 espF gat rev 
25. GGGG -ACA-AGT-TTG -TAC-AAA-
AAA-GCA-GGC-T(CC-GCC) 
atgcttaatggaattagtcaagc 
26. GGGG -AC -CAC- TTT- GTA- CAA-
GAA-AGC-TGG  ctacacaaaccgcatag 
Ptimer for gateway 
cloning of  EHEC O26 
espF 
27.  espFO157  and espFO127 gat fore 
28.  espFO157  and espFO127 gat rev   
27. GGGG -ACA-AGT-TTG -TAC-AAA-
AAA-GCA-GGC-T(CC-GCC) 
atgcttaatggaattagtaacgc  
28. GGGG -AC -CAC- TTT- GTA- CAA-
GAA-AGC-TGG ctaccctttcttcgattgctcatag 
 
Gateway cloning of  
espFO157  and espFO127  
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Table 2.4 Primers used for RT-PCR and promoter cloning in the study 
Primer name Sequence Primer use 
1.  Primer forward for RANK gcagtgcatttgggctcctgc amplification of RANK from bovine     
terminal rectal epithelial primary cells 
2.  Primer reverse for RANK acgcctcctcacacagggtca amplification of RANK from bovine 
terminal rectal epithelial primary cells 
 
3.  Primer forward for RANKL gccatggtggaaggttcgtggt amplification of RANKL  from 
bovine terminal rectal epithelial 
primary cells 
4.  Primer reverse for RANKL ggcccaacctcggtcatggt amplification of RANKL  from 
bovine terminal rectal epithelial 
primary cells 
5.  Primer forward for E-cadherin caaggcgtctgccctggaagg amplification of Ecaherin  from 
bovine terminal rectal epithelial 
primary cells 
6.  Primer reverse for E-cadherin tgttgtgcggcagcatggga 
 
 
amplification of Ecaherin  from 
bovine terminal rectal epithelial 
primary cells 
 
7.  Primer forward for slug ccgcgctccttcctggtcaa amplification of  slug  from bovine 
terminal rectal epithelial primary cells 
8.  Primer reverse for slug gtggtccacacggcgatggg amplification of slug from bovine 
terminal rectal epithelial primary cells 
9.  Primer forward for vimentin cgcgacaacctggccgaaga 
 
amplification vimentin from bovine 
terminal rectal epithelial primary cells 
10.  Primer reverse for vimentin cgctccaggtcaagacgtgcc 
 
 
amplification of  vimentin  from 
bovine terminal rectal epithelial 
primary cells 
11.  Primer forward for relb tgggggtggcctcctgtccc 
. 
amplification of  relB  from bovine 
terminal rectal epithelial primary cells 
12.  Primer reverse for relb ggtgcccctgcttgtggggg amplification of  relB  from bovine 
terminal rectal epithelial primary cells 
13.  Primer forward for GAPDH gatgctggtgctgagtatgtagtg amplification of GAPDH from bovine 
terminal rectal epithelial primary cells 
14.  Primer reverse for GAPDH atccacaacagacacgttgggag amplification of GAPDH from bovine         
terminal rectal epithelial primary cells 
           15. bt_VIMprom_Nhe_for AAAAGCTAGC 
TGACTCAGCGACCCCACCCTTC 
amplification of RANKL  promoter 
           16.  bt_VIMprom_Xho_rev TTTTCTCGAG 
GTAGCACGGACTGGCTCCGGAA 
amplification of RANKL  promoter 
17.  bt_SNAI2prom_Nhe_for AAAAGCTAGC 
GGTGACTTTATACTGAAAAAGG
CAC 
amplification of Slug  promoter 
18.  bt_SNAI2prom_Xho_rev    TTTTCTCGAG 
AGCATCTCTGCCCCGCAGGTG 
amplification of  Slug   promoter 
19. hs_RANKLprom_NheI_for     AAAAGCTAGC 
CACTCTTCCTCAACATTTACTGA
GG 
amplification of vimeintin  promoter 
20.  hs_RANKLprom_XhoI_rev TTTTCTCGAG 
CTCCCTCCCCTTCTTGTCTG 
amplification of  vimeintin   promoter 
 
 
2.2.2d Agarose gels and electrophoresis 
DNA agarose gel electrophoresis in 1 x TAE or 1x TBE were used to separate DNA 
fragments. According to the fragment size range, appropriate agarose concentrations 
were used e.g. a 1% gel was used for fragments more than 2 Kbp, 1.5% gel for 
fragments between 500 bp and 2 Kbp and a 2% gel for fragments less than 500 bp. 
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Agarose gels consisted of the appropriate amount of agarose (Melford) added to 100 
ml of Tris-BORATE-EDTA (TBE). The solution was heatd in microwave for 1-5 
min until the agarose dissolved; following cooling, safe view (NBS Biologicals) or 
Gel red (Biotium, Inc.) dyes were mixed with the soluti n in a 10 µl/100 ml agarose. 
DNA was mixed with 10x DNA loading buffer (Invitrogen) in a ratio of 5ul of DNA 
to 1 µl of buffer, and then the DNA was loaded into the agarose gel wells. A 100 bp 
or 1 Kb standard ladder (Invitrogen) was also loaded in an additional well. The gel 
was run at 80-120 volts according to the expected DNA fragment size for 30-50 min. 
The gels were imaged under ultraviolet light using a Flowgen Multi-Image cabinet 
and stored using Image capture software. 
 
2.2.2e Purification of PCR product 
PCR products were purified either directly or by separation of the DNA fragment by 
1% TAE agarose gel electrophoresis. The DNA band of the required size was cut out 
from the gel. Both the direct purification and the g l purification were performed 
using the Promega Gel and PCR clean up system according to the manufacturer’s 
instructions. 
 
2.2.2f Determination of DNA concentration 
The concentration and purity of the DNA was determined by measuring the UV 
absorbance at 260 nm and 280 nm. The DNA concentration was calculated with the 
OD260nm (1 OD260nm = 50 µg/ml dsDNA or 33 µg/ml ssDNA). The purity was 
estimated with the OD260nm/OD280nm ratio, with a ratio of approximately 1.8 
indicating a low degree of protein contamination. 
 
2.3 Cloning of different genes used in this study   
2.3.1 Materials used in cloning techniques  
2.3.1a TFB1 solution (1 litre) 
30mM KoAC                         2.94 g 
10mM CaCl2.2H2O               1.47 g 
100mM KCl                          7.45 g 
___________________________________________Materials and Methods 
 48 
15% Glycerol                        150 ml  
Dissolved in 900 ml distilled water and autoclaved, then 100ml of 500 mM 
autoclaved MnCl2 (50 mM final concentration) were added 
 
2.3.1b TFB2 (1 litre) 
75mM CaCl2.2H2O                 11.03 g 
10mM KCl                              0.745 g 
15% Glycerol                            150 ml 
 
Dissolved in 900 ml of distilled water and autoclaved. After that 100 ml of 
autoclaved 100 mM Na-MOPs PH7 (2.09 g MOPs with 10 mM NaOH) were added. 
 
Table 2.5. Plasmids used in this study 
Plasmid Description source 
1.  pMB102 low copy cloning vector with inducible lac promoter Gift from Dr Tammari 
Schneiders, 
University of Belfast 
2.  pAT1 pMB102 containing espFO127  This study 
3.  pAT2 pMB102 containing espFO157 This study 
4.  pAT3 pMB102 containing espFO26 This study 
5.  pUC-gfp pUC18 derivative containing gfp Laboraty stock 
6.  pAJR146 rpsM-GFP+ transcriptional fusion in pACYC184  Laboratory stock 
8.  pDONR-207 Gateway entry cloning vector  Invitrogen 
9.  pDG28 Vector containing sackan cassette. Used to obtain 
sackan cassette 
 Laboratory stock 
             10.  PIB307 
 
vector for allelic exchange used for creation the next 
two plasmids 
 Laboratory stock 
11.  pAT4   pIB307 containing espF flanking regions and sackan 
cassette. Used for espF allelic   exchange in EHEC 
O157:H7 strain TUV93-0 
 This study 
12.  pAT5 PIB307 containing espF flanking regions. U ed for 
deletion of sackan cassette            from chromosome 
after espF allelic exchange in   EHEC O157:H7 strain 
TUV93-0 
 This study 
13.  pKD4 as a template for amplification of kanamycin cassette   Laboratory stock 
             14.  pKM201 
 
Thermal sensitive red-gam expressing plasmid used for 
Preparation of hyper-recombinant EHEC O157:H7 
strain TUV93-0 for espF deletion 
  Laboratory stock 
             15. pTREX-DEST30-prA vector to generate amino terminus protein A fusions for 
LUMIER binding assays 
  Laboratory stocks 
             16.  pRenilla Vector to generate amino terminus luciferas  fusions 
for Lumier binding assays 
  Laboratory stocks 
17.  pAT6-7 espFO157, espFO26 and espFO127 cloned into 
pTREX-DEST30-prA respectively 
 This study 
18. pAT8-10 espFO157, espFO26 and espFO127 cloned into 
pRenilla respectively 
 This study 
19. pAT11-13 espFO157, espFO26 and espFO127 cloned into 
peGFP-DEST respectively 
This study 
20.  pHJ1 SNX9in pDONR223 Gift from Prof.  Juergen 
Haas, University of 
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Edinburgh,      UK. 
21. pAT14-15   pTREX-DEST30-SNX9 pRenilla-SNX vectors 
expressing SNX9-protein A or 
 -luciferase fusion proteins 
 This study 
22. pHJ2 N-WASP  in pDONR223   Gift from Prof.  Juergen 
Haas,   University of 
Edinburgh,      UK 
23. pAT16-17 pTREX-DEST30-N-WASP  pRenilla-N-WASP vectors 
expressing 
 N-WASP-protein A or -luciferase fusion proteins 
   This study 
24. pHJ3 MAD2L2in pDONR223 Gift from Prof.  Juergen 
Haas, University of 
Edinburgh,      UK 
25. pAT18-20     pTREX-DEST30- MAD2L2, pRenilla- 
MAD2L2vectors expressing 
 N-          MAD2L2-protein A or -luciferase fusion 
proteins and MAD2L2 in DSred fusion plasmid  
pDSRED2-DEST 
   This study 
26. pHJ4 
 
NFICin pDONR2234 Gift from Prof.  Juergen 
Haas, University of 
Edinburgh,        UK 
27. pAT21-23      pTREX-DEST30- NFIC, pRenilla- NFICvectors 
expressing 
NFIC -protein A or -luciferase fusion proteins and 
MAD2L2 in DSred fusion plasmid  pDSRED2-DEST 
    This study 
28. pFOP and PTOP- flash pFOP & pTOP -Flash to study transcriptional activity 
of β - catinin 
Invitrogen 
29. pGM1 pGL3 containing RANKL  promoter Gift from Dr Georg 
Malterer,  University of 
Muenchen Germany 
30. pGM2 pGL3 containing Slug  promoter Gift from Dr Georg Malterer  
University of Muenchen 
Germany 
31. pGM3 pGL3 containing vimeintin   promoter Gift from Dr Georg Malterer  
University of Muenchen 
Germany 
32. pCR3 Mammalian , CMV IE Laboratory stock 
33. pRC1&2 sopB wildtype  & sopBc462s cloned  into pTrc99-FF4   Gift from Dr Vassilis 
Koronakis, University of 
Cambridge ,UK 
33. pGM4 sopB cloned into pCR3 plasmid Gift from Dr Georg Malterer  
University of Muenchen 
Germany 
 
2.3.2 Cloning techniques of espF alleles 
2.3.2a Restriction endonuclease digestion 
Restriction endonuclease reactions were performed according to the manufacturer’s 
recommendations. In general, 1.5 µg DNA was digested for 2 h at the appropriate 
temperature with 10-20 U enzyme. Efficiency of the cleavage reaction was 
determined by 1% TAE agarose gel electrophoresis sta ned with ethidium bromide. 
 
2.3.2b Preparation of chemically-competent bacteria  
An overnight colony of bacteria was cultured in 5 ml LB at the appropriate 
temperature with or without antibiotic at 200 rpm. 1 ml of this culture was inoculated 
to 100 ml of LB and was incubated until OD600
 = 0.4–0.6, The bacteria were chilled 
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on ice for 15 min, divided into two Falcon tubes and centrifuged at 4000 rpm, 4°C 
for 8 m. The supernatants were discarded and the pell ts were suspended in 0.4x 
TFB1 (40 ml/100 ml bacterial culture), and placed on ice for 15 min and then 
centrifuged at 4000 rpm, 4°C.  The bacterial pellets were suspended in 0.04 x TFB2 
(4 ml/100 ml of bacterial culture) and kept on ice for 15 min and then stored as 200 
µl aliquots at -70°C. 
 
2.3.2c Preparation of electro-competent cells 
An overnight colony was grown on 5ml LB at appropriate temperature and 200 rpm 
agitation with or without antibiotic according to the culture. Then 1 ml of this culture 
was inoculated into 100 ml of LB and incubated in the previous conditions until 
OD600= 0.3-0.5. The culture then was divided into two 50 ml Falcon tubes and 
chilled on ice for 15 min then centrifuged at 4000 rpm, 4°C for 10 min.  The pellets 
were washed twice with 25 ml of 10% cold glycerol. The pellets were washed again 
with 12.5 ml of ice-chilled glycerol and centrifuged as before. The washed pellets 
were suspended on 0.2 ml of 10% ice-chilled glycerol and 50 µl aliquots stored at -
70°C. 
espF alleles were amplified from the different strains u ing the primers defined in 
Table 2 and the products cloned into pTS1 (Table 3). BamHI and HindIII sites were 
used to clone the alleles from EHEC strains O157:H7 and O26:H11. For EPEC O127 
espF, as this contains a natural HindIII site, an alternative cloning strategy was used: 
pTS1 was digested with HindIII followed by Klenow polymerase (Roche) treatment 
to create a blunt end, and then restricted with BamHI.  The EPEC O127:H6 espF 
PCR product was digested with BamHI and EcoRV and then cloned into the 
restricted pTS1.  Restriction digests were set up as er manufacturer’s instructions 
(New England Biolabs) with the recommended enzyme buffers.  All clones were 
checked by sequencing and matched published database sequences for the alleles 
(where available).  
 
 
2.3.2d Ligation  
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Before ligation, the amount of plasmid and insert DNA was determined by running 
both of them in an agarose gel and comparing the bands with known standards. 
Ligations were performed using T4 ligase enzyme overnight at room temperature. 
Plasmid               1 µl 
Insert               7 µl 
Ligase buffer         2 µl 
Ligase enzyme               1 µl 
 
2.3.2e Electrotransformation of circular DNA 
Before transformation the 2 mm gap cuvettes were chilled on ice for at least 5 min. 1 
µl of ligated plasmid, 0.5 µl of miniprep plasmid or midiprep plasmid were mixed 
with the competent cells and left for 5 m on ice befor  being transferred to the 2mm 
gap cuvettes. The cuvettes were dried and the cells shocked at 2500 volts for 0.005 
sec in an electroporator. 500 µl of SOC or LB broth were added to the cells 
immediately after shocking and the cells were incubated at the appropriate 
temperature for 1-2 h. Then 100 µl of the culture were plated onto LB agar plates 
containing the appropriate antibiotic. 
 
2.3.2f Chemical transformation 
Plasmids or ligation reactions were added to the chemical competent cells and chilled 
on ice for 30 min.  The mixture was heat shocked in a water bath at 42°C for 1 min. 
Then 500 ml of SOC were added and the cells incubated at the appropriate 
temperature for 1-2 h to allow recovery. After that, the culture was plated onto LB 
agar plates containing the appropriate antibiotic. 
 
2.3.2g Purification of plasmid DNA 
The plasmids used in this study were isolated by midiprep alkaline lysis according to 
manufacturer’s instructions (PureYield TM Plasmid Midiprep System kit, Promega, 
UK). The mini prep from the plasmid was used for diagnostic digest and was purified 
using Plasmid DNA Purification Gene Jet Kit: Purchased from Fermentas life 
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Science or QIAprep Spin Miniprep Kit: Purchased from Qiagen according to 
manufacturer’s instructions. 
 
2.3.2h Gateway cloning for different espF for Protein-protein 
interactions 
Gateway cloning of the spF alleles from the different E coli strains was carried out 
to simplify construction of vectors for yeast-2-hybrid analysis of EspF interactions 
with eukaryotic proteins. espF alleles were amplified using a proofreading Taq 
polymerase and the primers defined in Table 2 and cloned into the Gateway™ vector 
pDONR-207 (Table 3) using BP clonase (Invitrogen) to form entry clones. The 
obtained clones were checked for the correct insert by DNA plasmid extraction and 
restriction digestion using BanII. Once in the Gateway™ system, clones were easily 
transferred to the required destination vectors including pTREX-DEST30 (protein A 
fusions) and pRenilla (luciferase fusions).  
The recombination reactions (BP reactions) were performed as the description 
below: 
pDONR201 Vector     150µg 
Purified PCR product     2-7 µl
BP Clonase enzyme mix       1 µl 
 
The reaction was incubated overnight at room temperature. One µl of the reaction 
was transformed to DH5α competent cells, recovered on S.O.C medium for 1-2 h at 
37°C and plated on LB plates containing 15 µg/ml gentamycin and incubated 
overnight at 37°C. The obtained clones were checked for the insert by plasmid 
extraction and digestion using BanII. 
 
2.3.2h.1 Creating an expression clone (LR Reaction)  
Expression clones can be created by excision, integration and recombination of entry 
clone containing the PCR product, recombination sites using the LR clonase 
complex. The destination vectors contain the ccdB gene between the “left” and 
“right” recombination sites. The advantage of this arrangement is that there is 
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virtually no background from vector that has not recombined with the PCR products, 
because the presence of the ccdB gene will inhibit the growth of all standard E. coli 
strains. CcdB protein product interferes with E. coli DNA gyrase thereby inhibiting 
the growth of most E. coli strains used in the lab, such as DH5α™, TOP10 or XL-1 
Blue (Bernard & Couturier, 1992). 
 
2.3.2h.2 LR Reaction  
Destination vector (300ug/µl)      1 µl 
Entry Clone (150ng/µl)      1 µl 
dH2O         1 µl  
LR Clonase enzyme mix (Int, IHF, and Xis.)    1 µl 
 















Fig. 2.1 Gateway cloning technology for cloning and sub-cloning genes. Once a 
DNA segment is cloned into the Gateway system, it can be easily transferred from an 
entry clone into a destination vector (via the LR reaction) to generate an expression 
clone. A DNA segment in an expression clone can be easily transferred into an attP 
pDONR vector (via the BP reaction) to generate an entry clone and then into 
different destination vectors, all without the need for restriction enzymes and ligase. 
This diagram was directly taken from Invitrogen gateway cloning kit. 
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The reaction was incubated for 3-4 h at room temperature. 2 µl of the reaction was 
transformed into DH5α chemical competent cells, recovered on S.O.C medium for 1-
2 h at 37°C and plated on LB plates containing appro riate antibiotic and incubated 
overnight at 37°C. The resulting clones were checked for the insert by plasmid 
extraction and digestion using appropriate restriction enzymes (EcoRI and BamHI 
for Bait and EGFP. XbaI and HindIII for His and GST fusion construct plasmids). 
 
2.4 Allelic exchange for deletion of espF in E. coli O157:H7 
In order to construct plasmids that would facilitate chromosomal exchange, flanking 
regions of espF were PCR amplified (primers 11-18, Table 3) and cloned into a 
temperature sensitive pIB307. A sackan cassette from pDG28 was excised with 
BamHI, cleaned and cloned into the BamHI site of pIB307 containing the spF 
flanking regions. Individual plasmids containing espF flanking regions and sackan 
cassette were then exchanged into the chromosome of TUV93-0, to replace espF 
with the sackan cassette. To achieve this, the plasmid was electroporated into the 
target strain and transformants were selected on LB-CAM plates at 30°C 
(permissive). Transformants were then inoculateCAM broth and cultured overnight 
at 30°C. 10 fold dilutions were spread onto LBC agar pl tes down to 10-7.  These 
were cultured overnight at 42°C (a restrictive temprature that selects for 
chromosome integration).  Six colonies were then select d and the process repeated 
twice. At the end, a colony was taken from each plate ( bout 6 in total). These were 
inoculated into one LB broth overnight at 30°C (to lose the plasmid) and then diluted 
to allow overnight growth at 30°C in LB broth.  This was repeated 3 times. After that 
10 fold dilutions were made and spread onto LB Kan agar plates at 30°C. Individual 
colonies were replica plated onto LB Kan agar and LB Cam agar at 30°C to identify 
those that had undergone successful allelic exchange.  Putative strains containing the 
cassette in place of espF were checked by PCR. 



































Fig.2.2 Allelic exchange to substitute espF of E. coli O157 with sackan cassette; 
taken from with minor modification (Emmerson et al., 2006). The insertion of the 
sacB-kan cassette into the chromosome can be done in 4 steps 1.  Plasmid insertion 
into the wild-type strain chromosome at the non tolerant temperature for plasmid 
replication (42oC). 2. and 3: this new  strain was grown at 28oC in the presence of 
kanamycin to allow the bacteria that got excised an cured the plasmid, leaving the 
cassette on the chromosome. 4. The bacteria were straked on to LBC or LBK, the 
































Fig. 2.3  Allelic exchange to remove sackan cassette in  E. coli O157 (taken from 
Emmerson et al., 2006). 1. To insert the plasmid into the intermediate strain 
chromosome it was selected at the non permissive temperature for plasmid 
replication (42oC).  2 and 3, these bacteria were grown at 28oC in the absence of 
antibiotics to enhance the bacteria that have excisd (Step 2) and later cured (Step3) 
the inserted plasmid. Step 4: the bacteria were allowed to grow on media containing 
sucrose, LBK or normal LB to select for successful train constructs. 
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2.4.1 Removal of sackan cassette from the chromosome 
To achieve this, the plasmid pIB307 containing both espF flanking regions (but no 
cassette) was electroporated into TUV93-0 containing the sackan cassette integrated 
into its chromosome and transformants were selected on LB-CAM plates at 30°C.  
Ten transformants were then inoculated into LB CAM broth at 42°C and sub-
cultured four times over a 48h period. Serial dilutions of these cultures were plated 
onto LB-CAM plates at 42°C. 10 single colonies were th n inoculated into LB broth 
at 30°C for 48 h of logarithmic growth, and serial dilutions were plated onto LB-
sucrose agar (6%, wt/vol; no NaCl). Individual colonies were replica plated onto LB, 
LB-CAM, and LB-KAN at 30°C to identify those that had undergone successful 
allelic exchange. Those that did not grow on both LB-CAM and LB-KAN but grew 
in LB agar were checked by PCR for loss of the sackan cassette and deletion of espF. 
2.5 Analysis of type III secretion profiles and Esp F secretion  Red-promoted 
To analyse type III secretion profiles and EspF secretion from the EPEC O127:H6 
∆espF and complemented strains; were cultured in M9 media. EspD was detected as 
previously described (Naylor et al., 2005b; Roe et al., 2007), using mononclonal 
antibody kindly supplied by Prof. Chakraborty (Giess n). EspF was detected using 
polyclonal antibodies supplied from Prof. Sasakawa (Tokyo) (Nagai et al., 2005) and 
Prof. Hecht (University of Illinois at Chicago) (Viswanathan et al., 2004a). Briefly 
EPEC O127:H6 ∆espF and complemented strains was grown with shaking overnight 
at 37°C in Luria-Bertani broth supplemented with ampicillin (100 µg/ml). The 
cultures were then diluted 1:100 in M9 minimal salt X5 (Sigma) supplemented with 
0.4% (w/v) glucose, 0.05% (w/v) Casamino Acids, and 2mM MgSO4 and were 
grown standing at 37°C and 5% CO2 to an OD600 of 0.4  at this time IPTG was added 
to the culture to 1mM. The cultures continued to grw to OD600 = 1 and were 
centrifuged (5000 g) for 30 min to pellet the bacteria. The supernatant containing the 
secreted proteins was precipitated using 10% (w/v) trichloroacetic acid (TCA) 
overnight at 4°C. TCA precipitated supernatants were c ntrifuged (5000g) for 30 min 
at 4°C. The supernatants were discarded and the pell ts were left to dry and 
resuspended in 200 µl of 1.5M tris-HCl pH8.8. EspD and EspF were detected by 
SDS page and Western blotting. 
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2.6 Protein techniques 
2.6.1 Materials and supplements used in protein tec hniques 
Table 2.6 Antibodies used in this study. 
Antibody Source use 
Anti-vimentin high affinity, mouse 
monoclonal antibody 
Roche Diagnostcs It was used at 1/1000 for immunoblotting 
and 1/100 for immunofluorescence. 
Anti-slug, rabbit monoclonal antibody SantaCruz 
Biotechnology 
It was used at, 1/1000 for immunoblotting 
and 1/2000 for immunofluorescence. 
Anti-β-actin, mouse monoclonal 
antibody 
Sigma It was used at 1/1000 for immunoblotting 
Anti-β-Catenin rabbit polyclonal Sigma It was used at 1/1000 for immunoblotting 
and 1/100 for immunofluorescence. 
ATP synthase subunit alpha mouse 
monoclonal antibody 
Invitrogen It was used at 1/1000 for immunoblotting 
E-Cadherin rabbit polyclonal Cell Signaling It was used at 1/1000 for immunoblotting. 
Phospho GSK3 beta (Ser9) rabbit 
polyclonal IGg 
Thermo Scientific It was used for immunoblotting at 1/1000 
GSK3 beta rabbit monoclonal antibody Thermo Scientific It was used for immunoblotting at 1/250 
Goat Anti LEF1 Sigma It was used for immunoblotting 1/250 
LGR5 (C_16) mouse polyclonal SantaCruz 
biotechnology, INC 
It was used for immunofluorescence at 
1/100 
RANK (H-300) rabbit polyclonal SantaCruz 
biotechnology, INC 
It was used at 1/1000 for immunoblotting 
RANKL (L300) rabbit polyclonal Cell Signaling It was used at 1/1000 for immunoblotting 
RelB rabbit polyclonal Santa Cruz 
biotechnology, INC 
It was used at 1/200 for immunoblotting 
and 1/50 for immunofluorescence 
Anti Nanog   It was used at 1/100 for 
immunofluorescence 
Pancytokeratin rabbit polyclonal Cell Signaling It was 1/100 for immunofluorescence 
Pan-Cadherin  it was used at 1/1000 for immunoblotting 
Goat anti-mouse HRP coupled Jackson, 
Hamburg,Germany. 
It was used at 1/1000 for immunoblotting 
Goat anti-rabbit HRP coupled Jackson, Hamburg, 
Germany 
It was used at 1/1000 for immunoblotting 
Rabbit anti- goat HRP coupled Jackson, Hamburg, 
Germany 
It was used at 1/1000 for immunoblotting 
Alexa fluor®488 goat anti-mouse IgG Invitrogen It was used at   1/500 for 
immunofluorescent. 
Alexa fluor®594 goat anti-rat IgG Invitrogen It was used at 1/4000 for 
immunofluorescent 
histone core antibody,  sheep polyclonal gene tex It was used at 1/200 for immunoblotting 
Rabbit polyclonal Phospho-β- catenin 
(Ser33/3/37/thr41) 
Cell Signaling It was used at 1/1000 for immunoblotting 
AKT Rabbit polyclonal Cell Signaling It was used at 1/1000 for immunoblotting 
Phospho-AKT (Ser473) Rabbit 
polyclonal 
Cell Signaling It was used at 1/1000 for immunoblotting 
mouse monoclonal PCNA (PC10) Santa Cruz 
Biotechnology 
It was used at 1/50 for immunofluorescent 
Rabbit anti goat HRP coupled Sigma It was used at 1/1000 for immunoblotting 
Goat anti mouse HRP coupled antibody Invitrogen It was used at 1/1000 for immunoblotting 
Goat anti mouse antibody TRITC ABD Serotec It was used at 1/100 for immunofluorescent 
Goat anti- rabit antibody TRITC Invitrogen It was used at 1/100 for immunofluorescent 
Alexafluor 488-conjugated goat anti-rat 
IgG 




Dako It was used 1/500 for immuno-
histochemistry staining 
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Mouse monoclonal anti-his Qiagen It was used at 1/5000 for immunoblotting 
Anti mouse -GP2/glycoprotein rat mono 
clonal antibody 




Table 2.7 Cell signal inhibitors  used in this study  






10µM 5h before the challenge 
AKT inhibitor  Calbiochem used at 20µM 5h before the challenge 
SN50 NF-KB inhibitor Calbiochem used at 50µM 5h before the challenge 
GSK-3 β inhibitor SB 
415286 
Sigma used at 50µM for 5h before the challenge 
PI3 kinase inhbitor LY 
294002 
Calbiochem used at 50µM 5h before the challenge 
OPG Sigma used at 50ng/ml an hour before the challenge with bacteria 
β-catenin/Tcf inhibitor, 
FH535 








used at 1µg/ml overnight before the challenge 
Recombinant human 
soluble RANK Ligand 
(RANKL) 
Prospec used at 50ng/ml  24h before the challenge or analysis 









2.6.1a Protease inhibitors: 
Complete, EDTA free, protease inhibitor cocktail tablets, purchased from Roche 
Diagnostics. One tablet was used for 50 ml of lysis buffer. 
 
2.6.1b BCA protein assay reagent:  
Protein quantification kit, purchased from Thermo Scientific. It was used according 
to manufacturer's instructions. 
 
2.6.1c Protein Ladder: 
Pre-Stained Standard, purchased from Biorad, supplied ready to use. 5µl were loaded 
for small gels. (2)  His-tagged protein marker purchased from Qiagen. 
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2.6.1d Cell staining reagents: 
1. DAPI, purchased from Invitrogen.  Used 1/5000 in PBS 
2. Alexa Fluor 647 phalloidin purchased from Molecular Probes and it was used 1/40 
in PBS  
3. Phalloidin TRITC purchased from Sigma. Used 1/100 in PBS 
4. Phalloidin FITC purchased from Sigma. Used 1/100 in PBS  
5. DAKO Autostainer Plus System (DAKO, Capinteria, CA) was used for immuno-
histochemistry staining 
6. Vectastain Elite ABC kit (Vector Laboratories) and NovaRED Peroxidase 
Substrate kit (Vector Laboratories) were used for immuno-histochemistry staining 
 
2.6.1e Cell lysis buffers  
1. NP40 1 litre consists of  
 
1 M Tris PH 7.5 20 ml 
5 M NaCL  30 ml 
1 M MgCL2 5 ml 
NP40 10 ml 
DH2O up to1 litre 
 
2. protein Lysis buffer 
 Tris-HCl pH 7.4     20 mM  
 NaCl       150 mM  
Triton x-100     3% 
 EDTA      1 mM 
Protease inhibitors (Sigma) according to manufacturing instruction. 
 
2.6.1f The Proteo-Extract R Subcellular Proteome Ex traction Kit  
purchased from Calbiochem® & Novagen®. Used for extraction of proteins from 
different cell components (cytoplasmic, membranous and nuclear) 
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2.6.1g 12% SDS gel consists of 
Acrylamide (40% solution) 3.75 ml 
1.5M Tris   PH (8.8) 3.75 ml 
SDS 10% (w/v)   0.1 ml 
DH2O   3.6 ml 
APS 10% (w/V)   0.1 ml 
TEMED (Sigma) 0.01 ml 
 
Stacking gel (4%)  
 
Acrylamide (40% solution)                        1 ml
0.5 M Tris PH (6.8) 2.5 ml 
10% (w/v) SDS 0.1 ml 
DH2O 6.4 ml 
10% (w/V) APS 0.1 ml 
TEMED                                            0.01 ml 
 
2.6.1h SDS Running buffer- per litre             
Trizma base 15 g 
Glycin 72 g 
SDS   5 g 
D H2O Up to 1 litre 
 
2.6.1i Transfer buffer- per litre 
2.42 g Tris (hydroxymethyl) Methylamin 
11.54 g glycine 
200 ml Methanol  
Distilled H2O to one litre 
 
2.6.1j ECL reagents 
2.6.1j.1 ECL purchased from thermo scientific 
2.6.1j.2 ECL prepared in the lab: 
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A) Luminol (Fluka 09253) 
250 mM in DMSO (0.886 g / 20 ml) aliquots in 1ml and kept in dark at -20°C. 
B) p-Coumaric acid (Sigma C9008) 
90 mM in DMSO (0.296 g/20 ml) aliquots in 0.44 ml and kept in dark at -20°C. 
 
ECL solution1:  
Stock Luminol 1ml 
P-Coumaric acid 0.4 ml 
1.0 M TRis 10 ml 
DH2O upto  100 ml 
                                                                                                                
ECL solution 2: 
H2O2 (30%)  64 µl 
1.0 M Tris  (pH 8.5) 10 ml 
DH2O Up to 100 ml 
Solution 1 and 2 kept at 4°C. 
 
2.6.1k Denature/purification buffer (100ml): 
0.1 M NaH2PO  1.56 g NaH2PO4·H2O (MW 137.99 g/mol) 
0.01 M Tris    0.12 g Tris (MW    g/mol) 
8 M Urea   48.048 g Urea (MW   g/mol) 
H2O    100 ml 
Adjust pH to using conc.  By NaOH and HCL. 
 
2.6.1l Buffers for purification under native condit ions  
2.6.1l.1 Lysis buffer: 
10 mM imidazole in PBS   pH to 8.0 
2.6.1l.2 Wash buffer: 
20 mM imidazole in PBS   pH to 8.0 
2.6.1l.3 Elution buffer: 
250 mM imidazole in PBS   pH to 8.0 
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2.6.2 Extraction of cell proteins 
2.6.2a Total cell lysate 
Bovine terminal rectal epithelial cells were released from tissue culture plates using a 
tissue scraper, and 600 µl of lysis buffer that consisted of 20 mM Tris-HCl pH7.4 
150 mM NaCl, 3% Triton X-100, 1 mM EDTA, and proteas  inhibitors (Sigma) 
according to manufacturing instruction. 
 
2.6.2b Extraction of proteins from cell fractions  
The ProteoExtractR Subcellular Proteome Extraction Kit (Calbiochem® & 
Novagen®) is designed for reproducible extraction of subcellular proteomes from 
mammalian cells. Based on different solubilities of certain subcellular compartments, 
the S-PEK utilizes proprietary chemistries to yield four sub-proteome fractions 
which are enriched in cytosolic, membrane/ organelle, nuclear, and cytoskeletal 
proteins. The kit was used according to the manufact rer's instructions.  In brief the 
kit was used as follows: The cells were washed twice by adding one ml ice-cold 
wash buffer at 4°C 5 m each. 400 µl S-PEK Extraction Buffer I was added to each 
well and incubate at 4°C under gentle agitation. The supernatant was collected and 
kept as cytosolic fraction. S-PEK Extraction Buffer II was added at 400µl/well and 
incubated for 30min at 4°C under gentle agitation.  The supernatant was collected 
and kept as membranous fraction   S-PEK Extraction Buffer III 200 µl/well and 
incubate at 4°C under gentle agitation for 10 m. The supernatant was collected and 
kept as nuclear fraction. Protease inhibitor was added to all S-PEK Extraction Buffer 
was added at 2 µl/well and benzonase was added to S-PEK Extraction Buffer III at 
0.5 µl/well. 
 
2.6.2c Protein procedures 
2.6.2c.1 SDS-PAGE 
Sodium dodecyl sulphate polyacrylamide gel (SDS-PAGE) electrophoresis was 
performed using the Biorard system. The resolving gels (12%) were prepared with 
3.3 ml H2O, 4.0ml 30% Acrylamide mix, 2.5 ml 1.5 M Tris (pH 8.8) and 0.1ml 10% 
SDS. Prior to pouring the gel, 0.1 ml of 10% Ammonium persulfate (APS) and 0.01 
ml of TEMED (Sigma) were added. The solution for generating the resolving gel 
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was mixed and, after pouring, the gel was overlaid with propanol. After 
polymerisation, the isopropanol was removed and the s acking gels were prepared 
with 6.1 ml H2O, 1.3 ml 30% Acrylamide mix, 2.5 ml of 0.5M Tris (pH 6.8) and 0.1 
ml 10% SDS. Prior to pouring the gel 0.1 ml 10% Ammonium persulfate and 0.01 ml 
TEMED (Sigma) were added. The stacking gel solution was poured on top of the 
separation gel and a comb was fixed. After polymerisation, the glass plates 
containing the gel were assembled in the gel electrophoresis apparatus. Samples were 
loaded on the gel together with a protein ladder. The cell lysate was added to an 
equal volume of 2x sample extraction buffer (Sigma). The mixture was boiled for 
5min, loaded onto a 12% acrylamide denaturing gel and run at 150 V for 60 to 80 
min. 
 
2.6.2c.2 Western blot 
Proteins were transferred to a nitrocellulose membrane (Amersham Biosciences, UK) 
using a Trans-Blot semi-dry Transfer Cell (Bio-Rad, UK). Blotting was performed at 
15 V for 30m. The nitrocellulose membrane was blocked with fresh blocking buffer 
(5% (w/v) non-fat dried milk in 0.1% (v/v) Tween-20 in PBS) and incubated for an 
hour at RT or overnight at 4°C.  The next day, it was washed three times in fresh 
buffer (0.1% (v/v) Tween-20 in PBS). Primary antibody was diluted to appropriate 
concentration in 5% milk in the previous buffer and left on the membrane for 1h on a 
gyro rocker at RT or overnight at 4°C. The membrane was washed 3 times for 15 
min each as above. The secondary antibody was added to the nitrocellulose 
membrane at a dilution of 1:1000 or according to manuf cturer instructions in 5% 
(w/v) non fat dried milk in 0.1% (v/v) Tween-20 in PBS and left for 1 h as above. 
Following washing, the blotted proteins were detected using the ECL Western 
blotting detection system (GE health care, UK), according to the manufacturer’s 
instructions. The membranes were exposed to Fuji Medical X-Ray film (Fujifilm 
Europe GmbH) for different time periods and films were developed using 
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2.6.3 Purification of 6xHis-tagged EspF 
EHEC O157:H7 espF was cloned into pET21d using primers (19&20) table (2.3). 
This plasmid was electrotransformed into E. coli strain BL21 (DE3). From this clone 
an overnight culture was grown in 25 ml of LB with Ampicilin 100 µg/ml at 37°C 
and 200 rpm agitation. These amount of culture were then inoculated in a litre of LB 
with antibiotic under the previous conditions until OD600= 0.5. The culture then was 
induced for protein expression using IPTG 1mM final concentration for 4 h. The 
culture was divided into  two 500 ml bottles and centrifuged at 4000g for 20 min at 
4°C, the pellet then was either used or frozen at -20°C until use.    
 
2.6.3a Preparation of cleared E. coli lysates under native conditions 
The cell pellet was thawed for 15 min on ice and was suspended in lysis buffer at 5 
ml per 3 g wet weight. One mg/ml of lysozyme and protease inhibitor cocktail 
specific to be used with histidine-tagged protein purification (Sigma) was added to 
the suspended pellet. The pellet was then incubated on ice for 30 min. The mixture 
was Sonicated on ice using a sonicator equipped with a micro-tip. Using four 20 sec 
bursts using Soniprep150 (SANYO MSE) at power 6 with a 30 seconds cooling 
period between each burst. The lysate was centrifuged at 14,000 xg for 30 min at 4°C 
to pellet the cellular debris and supernatant was saved. 1 ml of 50% Ni-NTA slurry 
(resin) (Sigma) was added to 5 ml cleared lysate and mix gently by shaking at 
gyroracker for 30-60 min. The lysate–Ni-NTA mixture was loaded into a disposable 
chromatography column with the bottom outlet capped. The bottom cap was 
removed and the column flow-through was collected. The flow-through saved for 
SDS-PAGE analysis.  
The column then was washed twice with 4 ml wash buffer; wash fractions were 
collected for SDS-PAGE analysis. The protein was eluted 4 times with one ml 
elution buffer. The eluate was collected in four tubes and analyze by SDS-PAGE.  
 
2.6.3b Preparation of cleared E. coli lysates under denaturing 
conditions  
The cell pellet was thawed for 15 min on ice and suspended in denature purification 
buffer (pH8) at 5ml per 3 g wet weight. Cells were stirred for 30 min on gyroracker 
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at room temperature. Lysis was complete when the solution becomes translucent. 
The lysate was centrifuged at 14,000 x g for 30 min at room temperature to pellet the 
cellular debris, and the supernatant was saved (cleared lysate). 5µl of 2x SDS-PAGE 
sample buffer was added to 5 µl supernatant and stored at –20°C for SDS-PAGE 
analysis. 1ml of the 50% Ni-NTA slurry was added to 5 ml lysate and mix gently by 
shaking at gyroraker for 30–60 min at room temperature. The lysate–resin mixture 
was loaded carefully into a disposable chromatography column with the bottom cap 
still attached. The bottom cap was removed and the flow-through was collected. 
Flow-through sample was collected for SDS-PAGE analysis. The column then 
washed twice with 4ml of denature purification buffer (PH6.3). Wash fractions kept 
for SDS-PAGE analysis. The recombinant protein was eluted 4 times with one ml 
denature purification buffer (PH4.5).  Samples were collected for analysis by SDS-
PAGE. 
 
2.6.3c Dialysis  
The elute was poured into dialysis tube with pour diameter 14 KD and was soaked 
into sterile solution of PBS in a ratio 1 ml of elute in a litre of PBS for overnight. The 
PBS was changed for another overnight and the buffer fre  protein was collected and 
saved at -20°C. 
 
2.7 Yeast techniques 
2.7.1 Solutions for Yeast production 
2.7.1a YPD Medium for growing up yeast  
For 1 litre 
20g Peptone 
10g yeast extract 
 Make up in 900 ml, and autoclave. 
 Add 100 ml of 20% sterile-filtered glucose once autoclaved. 
If making YPD plates, add 30 g Agar per Litre. 
 
2.7.1b SD Medium (for transformed yeast) – For 1 Li tre 
___________________________________________Materials and Methods 
 68 
26.7 g minimal SD base 
0.64 g –Leu –Trp drop-out supplement 
20 g Agar 
Make upto 900 ml 
Autoclave, when cool, 100 ml amino acid supplements : Trp for AH109 (minus Leu); 
Leu was added for Y187 (minus Trp). 
Stock Amino Acid solutions – 10 x stocks 
Tryptophan – 200 mg in 1 Litre 
Leucine – 1 g in 1 Litre 
 
2.7.1c SBEG – 500 ml 
Sorbitol, 1 M final conc 91.1 g 
1 M Bicine, pH 8.35 with NaOH, sterile 5 ml 
PEG 15 ml 
DH2o up to 500 ml 
Filter sterilised.  Bicine  final concentration : 10 mM 
 
2.7.1d PEG/Bicine Solution – for 100 ml 
PEG (powder)       40 g 
1 M Bicine, pH 8.35 with NaOH, sterile    20 ml 
DH2O up to 100 ml  
Filter sterilised. Final Bicine concentration 200 mM 
2.7.1e NB Buffer – for 100 ml 
Na Cl       0.88 g  
1M Bicine       1 ml 
 DH2O up to 100 ml  
Final concentration of Bicine is 10 mM.   
Final concentration of NaCl is 0.15 M
 
2.7.1f Mating medium 
SD-LW  472.5 ml 
5% YPDA      25 ml 
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Pen/Strep     2.5 ml 
 
2.7.1g Diploid Selection Medium 500ml 
SD-LW  497.5 ml 
Pen/Strep      2.5 ml 
 
2.7.1h Detection medium 
SD-LWH (SD no L, W, H)   497.5 ml 
Pen/Strep         2.5 ml 
50µM 4MuX  
3-AT (standard range: 0-20 mM 3-AT) 
4-MuX: 4-Methylumbelliferyl-alpha-D-galactoside (FW:338.3, Sigma M-7633) 
Dissolve in dimethylformamide – 100 mg in 5.917 ml to make 50 µM (1000 x) 
3-AT: 3-amino-triazol.  4.2 g in 50 ml to make 1 M stock (100  xs for 10 mM 3-AT) 
Both are toxic and should be handled under a fume hood. 
 
2.7.2 Yeast -2-hybrid (Y2H) system for detecting pr otein-protein 
interactions  
The Y2H was first described by Fields & Song in 1989 and at present used to 
identify protein-protein interactions in eukaryotic cells. Y2H is based on the theory 
that a transcription factor consists of a DNA binding domain (BD) that binds to the 
promoter and an activation domain (AD) that recruits the transcription complex. 
These domains are independently not functional but when they are brought together 
the activity of the transcription factor is restored (Fields & Song, 1989). In the Y2H 
system a protein of interest (X) is fused to the DNA-binding domain (DNA-BD) of 
yeast transcription factor (Bait), whereas a Protein Y is fused to the transcriptional 
activation domain (TA) (Prey).  





Fig. 2.4 The mechanism yeast-two-hybrid system  
This system was used to identify the protein-protein interaction. The protein to be 
screened (X) is fused to the DNA-binding domain (DNA-BD) of yeast transcription 
factor (Bait) while the other protein from the library to be identified (Y) is fused to 
the transcriptional activation domain (TA) (Prey). If these two proteins interact 
together the transcription factor activity is reconstituted and auxotrophic genes such 
as hiS3 that give growth to the cells in which an interaction has occurred are then 
expressed. This figure was taken directly from (Stephens & Banting, 2000). 
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Both fusions are targeted to the nucleus of the yeast and if protein X and Y interact, 
the transcription factor activity is reconstituted and auxotrophic genes such as hiS3 
that give growth to the cells in which an interaction has occurred are then expressed 
(Fig. 2.4). 
 
2.7.2a Production and transformation of competent y east  
Yeasts are eukaryotic micro-organisms typically measuring 3–4 µm in diameter, 
however some yeasts can reach over 40 µm. they are cl ssified in the kingdom 
Fungi. They are unicellular organism however some of them can be multicellular 
through the formation of a string of connected budding (Walker et al., 2002). 
Two yeast strains were used in this study, AH109 and Y187 provided by (Ragnhild 
Eskeland, MRC). Bait plasmid (pGBKT7) contains Trp gene that enable AH109 to 
grow on Leu+ve, Trp-ve plates. Prey plasmid (pGADT7) contains Leu gene that help 
Y187 grow on Trp +ve, Leu -ve plates. For different EspFs screen: Yeast strain Y187 
for Prey and Yeast strain AH109 for Bait 
 
2.7.2b Production of competent yeast 
An overnight culture of each yeast strain was produce  by inoculating one fresh 
growing colony using a metal inoculating loop into 50 ml YPD media in a 250 ml 
flask using sterile techniques. The cultures were incubated at 30°C and rotated at 260 
rpm overnight. The overnight culture was inoculated into 300 ml YPD and was 
grown under the previous conditions until OD600 = 0.5.  The culture was divided into 
6 sterile tubes previously child on ice. The cells were pelleted by centrifugation at 
930 xg for 10 min at 4°C. The supernatant was discarded carefully as the pellet does 
not stick as well as bacteria and the cells were re-suspended in 25 ml ice child SBEG 
solution. The cells were pelleted by centrifuging at 930 x g for 10 min at 4°C and the 
supernatant was discarded. The palette was suspended i to 840 µl cold SBEG 
solution. All suspended yeast cells were collected together to be use as competent 
yeast.  
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2.7.2c Transformation competent yeast 
The transformation must be done at the same day at room temperature. 1 µg of 
plasmid was added to an Eppendorf. 100 µl of the appropriate competent yeast strain 
added to each Eppendorf, and mixed well with the DNA by pipetting several times. 
750 µl PEG/Bicine solution was added and mixed by pipetting up and down. The 
complex was incubated at 30°C and incubated at 900 rpm for an hour. The cells were 
heat shocked by incubation at 45°C in a water bath for 5 min. the cells were pelleted 
by centrifuging for 2 min at 2700 x g.  The supernatant was discarded and the pellet 
suspended in 1ml NB buffer. The cells were centrifuged under the previous 
conditions and the cells were suspended in 200µl NB buffer. The whole 200 µl of 
cells were plated onto SD PLUS TRP (minus Leu  for Prey) or SD PLUS LEU 
(minus Trp  for Bait) under sterile conditions (preferably in a hood, or on a bench 
next to a flame) and left to dry in the hood, and then incubated at 30°C.  Colonies 
started to appear after 2-3 days. 
 
2.7.2d Production of glycerol stocks for yeast cult ures 
A yeast colony was picked and added to 3-5ml SD drop-out media in a 15 ml 
centrifuge tube (Plus TRP minus LEU for Prey; Plus LEU minus TRP for Bait). The 
culture was grown for 2-3 days at 30°C and shaking at 260 rpm or until visible yeast 
pellet was observed at the bottom of the tube. The culture was stored at -80°C in a 
final sterile glycerol concentration of 25%. 
 
2.7.2e Direct mating for Y2H screens  
This protocol is designed for mating bait against multiple defined preys. The other 
orientation (prey against multiple baits) works analogously.  Before starting this 
assay, please ensure the prey and bait constructs are transformed in different but 
compatible yeast strains (Y187 and AH109). All the growth media contains pen-
strep, so contaminations should not occur.   
Yeast bait and prey clones streaked from glycerol stock  on selective agar plates and 
incubated for 1-3 days at 30°C. The haploid yeast was inoculated in 5 ml liquid 
medium for pre-culture should be at the day. The 5 ml freshly grown yeast was 
inoculated in 25 ml of a single-selective liquid medium - SD minus Trp for Bait and 
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SD minus Leu for Prey. The cultures were incubated overnight at 30°C and shaking 
at 220 rpm in an appropriate vessel. So that cells don’t grow too densely overnight as 
high density of the culture impairs mating efficiency. The original protocol suggests 
an OD600 of 1.0 to 1.2 as a benchmark to achieve high mating efficiency. 100 µl 
mating media (double-selection –LW SD/5% YPDA; minus Leu and minus Trp) was 
add to the required number of wells of a U-bottom micro-titre plate. This was the 
mating plate. A U-bottom plate must be used at this stage to enable close proximity 
of yeast cells. The bait cultures suspended and 25 µl transferred to each appropriate 
well of the mating plate. The prey cultures suspended and 25 µl transferred from 
each culture to the mating plate. The plate was centrifuged at 2000 rpm for 30 sec at 
room temperature to bring cells in close proximity to each other at the bottom of each 
well. This was to facilitate mating. The plate(s) were incubated at 30°C overnight 
without shaking to allow the cells to mate. It is important to set up the mating in the 
morning when the cells haven’t grown to saturation. The wells of a flat-bottom 
microtitre plate sated up with 150 µl of fresh double-selective media (SD –L-W/pen-
strep no YPDA).This to be the diploid selection plate. The yeast pellets suspended in 
the mating plate and 10 µl transferred from each culture to the diploid selection plate. 
The plate(s) incubated at 30°C without shaking for 2 days. The diploid cells checked 
visually for growing (to saturation or close to satur tion). The detection media was 
prepared as described overleaf. This was a triple-knoc -out SD media (no Trp, Leu 
or His) with a fluorescent detection compound 4-MuX and 3-AT, which inhibits 
auto-activation of baits. Usually a range of 3-AT con entrations is tested from 0, 0.5, 
1, 2.5, 5 and 10, sometimes up to 20mM 3-AT. Duplicate assay plates prepared by 
adding 150 µl detection media (detection plate) or SD-LW (control diploid selection 
plate) to a sufficient number of wells of flat-bottom microtitre plates. The SD-LW 
plates will confirm that diploid yeast cells are in fact growing during the detection 
assay. The diploid cultures suspended in the diploid selection plate and 10µl 
transferred from each culture to each detection and control plate, covered with gas-
permeable lids and placed in a plastic bag. The cells incubated at 30°C for 3-7 days, 
no shaking.  3 days is usually sufficient to detect an interaction. The cells suspended 
in the control plate and absorbance measured at OD600 to confirm yeast cell growth 
and that the mating has in fact worked. This should be blanked with double knock-
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out selective media. The fluorescence readout was measured using a fluorescence 
reader: excitation at 365 nm; emission at 448nm.  Any measurement of fluorescence 
will indicate that a protein interaction has occurred. According to the original 
protocol by Manfred Koegl, cells have to be passaged once more (10 µl culture into 
150 µl detection medium) to see a difference between positive and negative wells in 
some cases, since high fluorescence signals from false-positive interactions are not 
maintained in the second passage.  
 
2.8 LUMIER assays 
For LUMIER assays, proteins were transiently expressed in HEK293 cells as hybrid 
proteins with the Staphylococcus aureus protein A tag or Renilla reniformis 
luciferase fused to their amino termini. 20 ng of each expression construct was 
transfected into HEK293 cells using 0.05 µl of lipofectamine 2000 (Invitrogen) in 96 
well plates. After 40 h, the medium was removed and cells were lysed on ice in 10 µl 
of ice-cold lysis buffer (20 mM Tris pH 7.5, 250 mM NaCl, 1% TritonX-100, 10mM 
EDTA, 10mM DTT, Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail 
(both Roche) and 25 units/µl Benzonase (Novagen) final concentration). Sheep-anti-
rabbit IgG-coated magnetic beads were also added (Invitrogen, Dynabeads M280, 
2mg /ml final concentration) and incubated on ice for 15 min. 100 µl of washing 
buffer (PBS, 1mM DTT) was added per well and 10% of the diluted lysate removed 
to determine the luciferase activity present in each sample before washing. The rest 
of the sample was washed 6 times in washing buffer. Luciferase activity was 
measured in the lysate as well as in washed beads. Negative controls were wells 
transfected with the plasmid expressing the luciferas  fusion protein and a vector 
expressing a dimer of protein A. For each sample, four values were measured: the 
luciferase present in 10% of the sample before washing (“input”), the luciferase 
activity present on the beads after washing (“bound”), and the same values for the 
negative controls (“input nc”, and “”bound nc”). Normalised signal to noise ratios 
were calculated as follows (bound/input)/(bound nc/input nc) (Braun et al., 2008). 
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2.9 Cell Culture 
2.9.1 Tissue culture media and supplements 
2.9.1a Basic Media 
DMEM: purchased from Sigma, supplied in 500 ml sterile bottles, supplemented 
with 4.5 g/L glucose and stored at 4°C. 
RPMI 1640 medium purchased from Gibco-BRL, supplied in 500 ml sterile bottles 
and stored at 4°C. 
 
2.9.1b Other sterile solutions and supplements 
Foetal Calf Serum (FCS): Purchased from Gibco, liquid s pplied sterilised in 500 ml 
bottles. FCS was aliquoted into 50 ml sterile bottles and stored at -20°C. 
Glutamine: Purchased from Lonza, L-glutamine solutin was available in 100 ml 
sterile bottles supplied at 29.2 mg/ml in 0.85% NaCl, pH 4.7-6.0. The stock solution 
was stored at -20°C in 5 ml aliquots. 5 ml of L-glutamine was added to 500 ml of 
media. Non-essential Amino Acid: Purchased from Lonza, liquid supplied in 100 ml 
sterile bottles. The 100 x solution was diluted with media to 1x solution and stored at 
4°C. Penicillin/streptomycin: Purchased from Lonza, Penicillin/streptomycin 
solution was formulated to contain 20000 U/ml penicillin and 20000 µg/ml 
streptomycin. It was aliquoted into 5 ml aliquots and stored at -20°C. It was used at 5 
ml per 500 ml media. Phosphate-Buffered Saline (PBS): Purchased from Lonza, 
liquid supplied in 500 ml sterile bottles. PBS was formulated to contain 0.0067 M 
PO4.and stored at 4°C. Trypsin EDTA: Purchased from Lonza, Liquid supplied 
sterilised in 100 ml sterile bottles. Trypsin EDTA solution contains 200 mg/L EDTA 
and 170.000 U/L trypsin. 
 
Table 2.8 Macrophage and Caco2 growth medium 
Reagent Supplied conc. Required final conc. Volume added 
DMEM 4.5 g glucose/litre As supplied 440 ml 
FBS 100% 10% 50 ml 
L-glutamine 200 mM (100X) 1X 5 ml 
Pen-Strep 100% 1% 5 ml 
  Total volume 500 ml 
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Table 2.9 HeLa cells growth medium 
Reagent Supplied conc. Required final conc. Volume added 
MEM As supplied As supplied 440 ml 
FBS 100% 10% 50 ml 
L-glutamine 200 mM (100X) 1X 5 ml 
Pen-Strep 100% 1% 5 ml 
 Total volume 500 ml 
 
2.9.1c Reagents used for isolation of bovine primer y cells: 
DMEM     Sigma D5796 
MEM D-Valine   Lonza BE02-020F 
Hanks BSS    Sigma H9269  
FBS      Sigma F0643 
Gentamicin (50mg/ml)   Sigma G1397 
Pen/Strep (10,000 Units/ml) Invitrogen 15140122 
Fungizone  (250µg/ml)  Invitrogen 15290026 
L-glutamine (200mM)  Invitrogen 25030024 
Collagenase     Sigma C2674: Add 1.67 ml DMEM and store 
in 250 µl aliquots at -20°C 
Dispase I    Roche 04942086001: Add 1ml DMEM. Store 
at 4oC. 
Insulin     Sigma I2643: Add 1450 µl DMEM. Store in 
125 µl aliquots at -20°C  
Epidermal Growth Factor  Sigma E4127 (Reconstitute in 1ml of 1%BSA 
in PBS. Store in 10µl aliquots at -20°C)  
Vitrogen Collagen    Nutacon 5409 
 
2.9.1d Media for washing tissue after flushing of l uminal contents  
HBSS      500 ml 
Gentamicin   (25µg/ml)  250 µl 
Fungizone  (5µg/ml)     5 ml 
Pen/strep (100 Units/ml)     5 ml 
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2.9.1e Digestion Medium 
DMEM    100 ml 
FBS (1%)      1 ml 
Gentamicin             250 µl 
Pen/Strep      1 ml 
 
2.9.1f Enzymes: added once digestion medium has bee n added to cells 
Collagenase       250 µl (75 U/ml) 
Dispase I      250 µl (20 µg/ml)  
 
2.9.1g Differential Centrifugation Solution 
DMEM     500 ml 
D-Sorbitol (2%)    10 g 
Dissolve sorbitol in small quantity of DMEM and then filter sterilize it before adding 
to the DMEM bottle 
 
2.9.1h Collagen Solution 
Sterile Distilled Water   45 ml 
Acetic Acid     150 µl   
Vitrogen Collagen    6 ml 
Filter sterilise water and acetic acid before adding to collagen. 
 
2.9.1i Primary culture Medium 
DMEM       480 ml 
2% FBS     10 ml 
L-glutamine (2 mM)    5 ml 
Gentamicin (25 µg/ml)    250 µl 
Pen/Strep (100 Units/ml)   5 ml 
Epidermal Growth Factor (10ng/ml) 5 µl   
Insulin (0.25U)    125 µl 
Filter sterilise all additives before adding to DME 
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2.9.1j Feeding Medium 
MEM-D Valine    465 ml 
5% FBS       25 ml 
L-glutamine (2 mM)       5 ml 
Gentamicin (25µg/ml)              250 µl 
Pen/Strep (100 Units/ml)      5 ml 
Epidermal Growth Factor (10 ng/ml)      5 µl  
Insulin (0.25 U)                 125 µl
Filter sterilise all additives before adding to MEM-D Valine 
 
Table 2.10 Monoclonal antibodies used in immuno cytochemical screening of 
bovine rectal primary epithelial cell cultures 
Monoclonal 
Antibody 
Specificity Cellular Expression Source Reference 
CC21 CD21 Follicular Dendritic Cells, 
Mature B Cells  




Dendritic Cells IAH (Howard et al., 1993)  
CC15 Bovine 
WC1 
γδ T Cell IAH (Howard et al., 1989)  
ILA-12 CD4 T helper Cells ILRAD  (Teale et al., 1987)  
ILA-51 CD8 Cytotoxic T Cells ILRAD (Teale t al., 1987)  
ILA-156 CD40 B cells, Antigen 
Presenting Cells 
ILRAD (Norimatsu et al., 2003) 
ILA-111 CD25 Activated T and B Cells, 
Macrophages 
ILRAD (Choy et al., 1990) 
ILA-43 CD2 αβT cells, Natural Killer 
cells 





(BAI  et al., 1986) 
ILRAD - International Laboratory for Research on Animal Diseases, Nairobi, Kenya 
IAH- Institute for Animal Health, Compton 
 
2.9.2 Techniques used in cell cultures 
2.9.2a Maintenance of cell lines 
All cell lines were maintained in incubators at 37°C or 38.5°C supplied with 5% 
CO2. Cells were grown on a variety of tissue culture plasticware depending on the 
nature of the experiment. Cultures were grown to 90-95% confluency, washed with 
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PBS and trypsinised from the flasks with trypsin soluti n (Lonza, Belgium). Cells 
were incubated at 37°C until all cells were dissociated from the flask. Cells were 
recovered by adding growth media containing 5 or 10% serum. Cells were 
centrifuged at 1000 rpm for 10 min in a benchtop centrifuge. The cells pellets were 
re-suspended in growth medium and counted by use of a haemocytometer. Cells 
were seeded at a density required by the experimental design. 
 
2.9.2b Splitting of cells  
1X solution of Trypsin-EDTA (Invitrogen (Gibco) 15400-054) [10X] was prepared 
in a balanced salt solution (PBS)]. Cell supernatant was poured and 10 ml of 
Trypsin-EDTA was added swirl, to ensure the entire growing surface is covered and 
the flask was incubated for 5-10 min. The flask was then agitated to loosen the cells 
(ensure cells lifting by looking down microscope). 5 ml media was add to quench 
Trypsin-EDTA and the contents of the flask transferred into Falcon tube and 
centrifuged for 5min and the cell pellet were plated with fresh media. 
  
2.9.2c Freezing of cell lines 
Cells were resuspended in 1 ml of pre-cooled freezing medium. The freezing 
medium consists of equal amount of FCS and 20% DMSO in FCS (Fluka, Germany). 
Cells were aliquoted in sterile freezing ampoules (Nunc, UK) at a density 2 x 106 
cells/vial. Cells were transferred to a cryopreservation box (Nalgene) and frozen 
overnight at -80°C. The next day, the cells were transferred to the liquid nitrogen 
storage tank. 
 
2.9.2d Thawing of frozen cell lines 
Frozen ampoules were transferred from the liquid nitrogen in dry ice and thawed 
rapidly by warming in a 37°C water bath. Thawed cells were transferred into 20 ml 
universal tubes and recovered by adding equal volumes of growth media slowly and 
then adjusted to 5 ml. Cell suspension were centrifuged for 1200 rpm for 5 min and 
the supernatant were removed and the pelt was resusp nded in fresh medium and 
cultured into 25 ml flask. 
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2.9.2e Phagocytosis assays. 
The murine macrophage cell line (RAW 264.7) was cultured in DMEM (Sigma) 
supplemented with 10% heat inactivated foetal bovine serum (FBS, Sigma), 1 unit of 
penicillin, 1µg/ml of streptomycin and 2mM L-glutamine (final concentrations). 
Cells were grown at 37°C in 5% CO2 and moisture. The bacteria, transformed with 
pUC-gfp (Table 3) were inoculated from LB broth overnight cultures into DMEM to 
OD600 = 0.3. For wildtypes strains it was diluted 1/10 and 100 µl was added to each 
well (MOI of 20 bacteria per cell).  When analysed, the espF alleles were induced 
with IPTG (1mM).  At OD600 = 0.7 the bacterial cultures were then diluted 1:5 into 
pre-warmed DMEM and 300 µl added to the macrophages (initially seeded at 1x 105 
cells/well the day before).  The cells were then incubated at 37°C in 5% CO2 in a 
moist box for the desired incubation time. The cells were washed three times with 
sterile phosphate buffered saline (PBS) and fixed using 2.5% paraformaldehyde , PH 
7.4. After three washes with PBS, the samples were incubated for 90 min with the 
relevant anti-LPS antibody (MAST Group Ltd) at 1:100 and following washes 
incubated with Alexa Fluor 594-conjugated goat anti-rabbit immunoglobulins 
antibody (1/2000, Molecular Probes) for an hour.  The slides were then washed three 
times with PBS and mounted with Hydromount (National Di gnostic) and cover slips 
applied. Slides were examined by fluorescence microscopy using a Leica Q 
fluorescence microscope and appropriate filter sets.  All bacteria, internal and 
external, express GFP whereas only the bacteria external to the macrophages stain 
with the anti-O157 LPS antibody.  This differential staining allows the proportion of 
internalized bacteria to be quantified. 
 
2.9.2f Bacterial binding assays on caco-2 cells 
Caco2 cells were infected with ∆ espF EPEC containing the following plasmids 
1. ∆espF EPEC + (pAJR145) GFP chloramphenicol(cam 
2. ∆espF EPEC + pTS1 plasmid containing EPEC  espF(Amp) + GFP(Cam) 
3. ∆espF EPEC + pTS1 plasmid containing espF EHEC O157:H7 (AMP) +  GFP 
(Cam) 
4. ∆espF EPEC + pTS1 plasmid containing espF EHEC O26:H11 (Amp) +  GFP 
(Cam). 
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For the assays, the bacteria were cultured as for the macrophage assays to an OD600 = 
0.7. The bacteria were then diluted 1:100 in DMEM prior to infection. A multiplicity 
of infection of 10:1 (bacteria: Caco2 cell) was used and the infection allowed to 
progress for 2 h at 37°C in a 5% CO2. Cells were washed gently twice with PBS and 
fixed in 4% PFA and then kept in a fridge overnight. PFA was removed and the 
bacteria stained and analyzed as described for the macrophage assay. 
 
2.9.2g Transfection of adherent HeLa and Caco2 cell s using Effectene 
(QIAGEN) transfection reagents 
Effectene reagent (Qiagen, UK) is a lipid based reagent that is suitable for the 
transfection of plasmid DNA into cultured eukaryotic cells. It is used with a special 
condensed DNA enhancer. The enhancer is used first to condense the DNA 
molecules, whilst the effectene reagent subsequently coats the condensed DNA 
molecules with cationic lipids. 
Cells were plated in  48 well plates at a density of  5x104 in 400 µl DMEM with FCS 
and antibiotics 48h before transfection to reach optimal confluence for transfection 
(40-70%, approx. 2x105 cells per well). 150 ng of total DNA was diluted EC buffer 
to a final volume of 50 µl then 1.2 µl of enhancer was added to the above solution 
and mixed together by vortex and incubated for 5 min at room temperature to allow 
formation of condensed DNA. Then 4 µl of effectene was added to the above 
solution and incubated for 10 min at room temperature to allow formation of the 
DNA transfection complex. At the same time the medium was removed from the 
plates and the cells were washed with PBS and 200 µl of fresh medium added 
(DMEM containing serum and antibiotic). After the lipid-DNA complex formation, 
200 µl of fresh medium (DMEM containing serum and atibiotic) was then added to 
the DNA mixture. This complex was poured onto adherent cells drop by drop, and 
swirling carried out to ensure an even distribution. Protein expression was 
determined 48-72 h post transfection and stable cells were selected by removing the 
media and adding 200 µg/ml of G418 (Invitrogen) in fresh medium. The transfection 
efficiency was checked after 24 h using eGFP expression as a positive readout. 
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2.9.2h Addition of Mitochondrial marker  
For use of this marker, the cells slides were fixed an  permeablized using 200 µl of 
2% (v/v) formalin and 0.2 Triton X-100 in PBS [4ml of 10% formalin, 16 ml PBS 
and 40µl of Triton] for 20min at room temperature, and then washed twice with PBS. 
Mito Tracker (Molecular Probes) was added at different concentrations: 125, 250 or 
500 nM in PBS for 30 min and then washed two times with PBS before mounting 
and analysis as described for the macrophage assay. 
 
2.9.2i Bovine primary rectal epithelial cell cultur es  
Terminal rectal tissue from adult cattle was obtained from a local abattoir. The 
specimens were placed in Hank’s Balanced Salt Solution (HBSS) containing 
gentamicin (25 µg/ml) on ice and transported to the laboratory. Thesp cimens were 
longitudinally opened and luminal contents flushed out with HBSS. Two pieces of 
mucosal epithelium 3 cm and 25 cm proximal to recto-anal junction were excised 
and washed vigorously several times in HBSS with gentamicin (25 µg/ml), penicillin 
(100 U/ml), streptomycin (30 µg/ml) and amphotericin B (200µg/ml) in a sterilized  
tissue collecting pot to remove mucus and any adhering contaminants/ materials.  
The procedure for primary cell culture was essentially as described by (Booth et al., 
1995; Hoey et al., 2003) with a few modifications. 24-well tissue-culture plates 
(Coring incorporated, USA) and chamber slides (Nagle Nunc international USA) 
were coated with bovine collagen solution (Nutacon 5409) 500 µl/well and allowed 
to dry overnight into the class II cabinet. Collagen coated plates and chamber slides 
were stored at -20°C until required. Collagen-coated plates were removed from -
20°C and rehydrated with 500 µl PBS or HBSS (Sigma H9269). Pots containing 
tissues were sprayed outside with 70% ethanol before taking into the class II cabinet. 
The rectal pieces were removed and placed on paper tow l in the class II hood. The 
mucosal epithelium was scraped with a sterile glass slide and the scrapings collected 
into a 50ml centrifuge tube.  
In order to wash the scrapings the tube was filled up to 50ml with HBSS, mixed 
vigorously, centrifuged at 1200 rpm for 2 min and the supernatant was discarded.  
This step was repeated until the supernatant became quit  clear (about 5 times). 
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Sometimes a lot of mucus attached to the crypts, to remove this; the mucus above the 
pellet was sucked up by pipetting. The crypts pellet is more compact and has a 
slightly greyer colour. Floating material was removed after the 4th wash. 40 ml of 
supernatant was discarded after the last wash and the pellet was transferred to fresh a 
50 ml tube. Digestion medium was added to the pellet (no more than 10ml) to make 
the final volume 25 ml. 250 µl of Collagenase (75 U/ml) (Sigma) and Dispase I (20 
µg/ml) (Roche) were added. Digestion was performed with the tube taped 
horizontally to the shaker at 37°C for 80 min. After digestion, the digestion mix was 
pipetted up and down gently to loosen cells. One drop was taken onto a Petri dish to 
check for the integrity of the crypts. Crypts were seen under the microscope as small 
cylindrical structures of variable sizes and shapes with lots of other digested tissue 
debris around.  
 
Digested material was put into another tube and allowed to settle for 2min. The tube 
was filled up to 50 ml with HBSS and pipetted gently to disrupt crypts clumped 
together. The digestion mix then centrifuged for 2 min at 1200 rpm. One drop of the 
supernatant was examined under the microscope for the presence of crypts by taking 
a drop from 20 ml mark on the tube. If there were still crypts in the supernatant, the 
mix should be split into 2 tubes and diluted with HBSS, mixed by gentle pipetting 
and centrifuged at 1200 rpm for 2 min. This step was repeated again for crypts in 
supernatant from the 25 ml mark. (If clear, 25 ml of the supernatant was removed 
and the tube was filled up with differential centrifugation medium and mixed gently. 
The mix was centrifuged at 700 rpm for 2 min). The supernatant was checked for 
crypts at the 25 ml mark and removed if clear. The tube was filled up with 
differential centrifugation medium (optional), pipetted up and down gently to mix 
and centrifuged at 1200 rpm for 2 min. A drop of supernatant was checked for 
presence of crypts after each spin from the 20 ml mark on tube. If there were still 
crypts there, check at 30ml mark and so on. Remove clear supernatant and add more 
differential centrifugation medium. Each time the amount of medium was reduced by 
10 ml. This process was repeated until supernatant became clear of crypts. 
Supernatant was kept when there were a few crypts jus  in case there were none in 
the pellet. The pellet was washed with HBSS and resuspended in an appropriate 
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amount of Primary culture medium depending on size of pellet. The required final 
concentration should be 5000 crypts per ml; this can be adjusted by count of the 
number of crypts in 10 µl on a Petri dish. The appropriate amount of culture medium 
was added.  
 
HBSS was removed from collagen coated plates and 800 µl of primary culture 
medium was added. 3 or 4 drops of the crypts were add d (from a 10 ml pipette) to 
each well to add 500-700 crypts to each well. The crypts were cultured in primary 
culture medium for 24 h. At this stage most of the crypts had attached to the surface 
and the non-adherent tissue debris was removed and media was replaced with MEM 
D-Val selective medium supplemented 1% or 2.5% batch tested FCS, 0.25 U/ml 
insulin, 10 ng/ml EGF and 30 µg/ml gentamicin. This medium inhibits any fibroblast 
contaminants in the culture (Frauli & Ludwig, 1987; Lazzaro et al., 1992; Hoey et 
al., 2003). 50% of the medium was replaced every two days. The epithelial cells 
proliferated from attached crypts and formed a conflue t monolayer within 6 to 8 
days of culture. The cultures were incubated at 37°C in an atmosphere of 5% CO2, 
95% air with 90% relative humidity. 
Bovine rectal tissues with intact anal canal about 30 cm proximal to recto-anal 
junction were brought from the abattoir in a polystyrene box with ice to transport the 
tissue.  
 
2.9.2j Characterisation of bovine primary rectal cu ltured cells.  
The epithelial origin of the cells was confirmed by immuno-staining for cytokeratin 
intermediate filaments. The cells at five days of culture were fixed with 2% 
paraformaldehyde, permeabilized with cold acetone for 5 min, washed with 
phosphate-buffered saline (PBS) and stained with a pan-cytokeratin monoclonal 
antibody (Sigma 1:300) for 3 h at 25°C. The cells were washed with PBS and the 
monoclonal was detected using FITC-labelled goat anti-mouse mAb (1:80) (Sigma). 
The cell nuclei were stained with TO-PRO Iodide (Molecular Probes). The stained 
cells were mounted in fluorescence mounting medium Fluoromount (DAKO) and 
examined using a Leica DMLB epifluoresence microscope. To ascertain if lymphoid 
cells were present in primary cell cultures from the crypts isolated from lymphoid 
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rich mucosal tissue, immuno-staining was carried out with a panel of seven 
monoclonal antibodies (Table 2.10) specific for different immune cell types of cattle. 
The cells were fixed either in paraformaldehyde (3.5%) or non-formaldehyde zinc 
acetate based fixative. Briefly, cells at 72 h of culture were washed twice in PBS and 
fixed in freshly prepared zinc salt fixative solution (0.1M Tris base buffer with Ca 
acetate 0.5% pH 7-7.4, containing Zn acetate 0.5% and Zn chloride 0.5%). After 
initial blocking of endogenous peroxidase activity with 0.3% hydrogen peroxide for 
5 min and the non-specific binding with 25%  normal goat serum for 30 min  the 
cells were immuno-labelled overnight at 4°C (Table 2.4). The primary antibody 
binding was detected using goat anti-mouse peroxidase l belled secondary antibody 
(Horizontal En Vision Plus HRP system, Dako, Ely, UK) for 30 min at RT. The 
slides were developed in a citrate buffer containing 3,3'diaminobenzidine 
hydrochloride for 7-8 min. Cell monolayers were counterstained with haematoxylin, 
rinsed, dehydrated and mounted. Tris-buffered saline (TBS, 0.05M Tris HCl, 0.15M 
NaCl, pH 7.6) was used to wash the slides between each stage of the labelling 
procedure and to dilute normal goat serum and antibodies. As a negative control 
primary antibody was replaced with TBS in the staining protocol.   
Uptake of inert micro-particles has been used as a functional assay for M-cells with 
in vitro cultures (Kerneis et al., 1997). FITC-conjugated latex beads of 0.5 µm size 
(Polysciences Inc., Germany) were diluted (1:1000) in DMEM containing 2% fetal 
bovine serum. Aliquots (100 µl) of diluted beads were pipetted evenly on to 6-day 
old cultures and incubated at 37 °C for 45 min. Thecells were washed three times in 
phosphate-buffered saline, fixed and permeabilized with 2% (w/v) PFA/ 0.25% (v/v) 
Triton X-100 at room temperature for 20 min. Staining of F-actin was done with 
Phalloidin-FITC/ TRITC (diluted 1:20 in PBS; Molecular Probes) for 45 min at room 
temperature in the dark. For co-localization studies with vimentin, the cells were 
incubated with mouse anti-vimentin monoclonal antibody (1:100) (Sigma) and 
incubated overnight at 4°C. This primary antibody was detected with Alexa 594-
tagged rabbit anti-mouse or goat anti-mouse monocloal antibodies as per the 
manufacturer’s instructions. The cell nuclei were stained with TO-PRO Iodide 
(Molecular Probes). The mounted slides were examined by confocal microscopy.  To 
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examine the position of the beads, 0.4 µm optical sections were acquired and 
processed via Imaris Surpuss Module (Bitplane) computer software programme. For 
co-localisation studies with micro-particles the infected cells were washed three 
times with pre-warmed (37°C) MEM/HEPES and further incubated with FITC-
conjugated latex beads of 0.5 µm size (Polysciences Inc., Germany) for 45 min and 
processed for immuno-fluorescence as described above.  
 
2.9.2k Staining primary Bovine Epithelial cells for  FACS 
The percentage of cells expressing vimentin in the bovine terminal rectal primary 
epithelial cell cultures were detected using flow cytometry (FACS). Briefly, the cells 
were removed from plates by trypsinisation. The cells were transferred to sterile 
universal and centrifuged at 200 x g for 5 min. The supernatant removed and the 
pellet washed once with PBS. The cells were fixed an  permeabilised in 500 µl Cell 
Permeabilisation solution (Becton Dickenson) for 10min at room temperature. The 
cells washed in PBS with 0.5% Bovine Serum Albumin and 0.1% Sodium Azide. 
The cells divided between an appropriate numbers of tubes. One tube left without  
primary antibody as control for each vimentin antibody and spin down at 2500 rpm 
for 3 min. Primary antibody diluted in FACS medium (DMEM, 1% FBS, 0.1% 
Sodium Azide) was added to the cell pellet and vortexed. The cells were incubated at 
4oC for 30 min, spined down as above and washed twice in FACS medium. The 
secondary antibody added to each tub including a tube with no primary staining 
(negative control). The cells then incubate at 4oC for 30 min, centrifuged as before, 
and washed twice in FACS medium. The cell pelts were r -suspended in 200 µl
FACS medium and measure fluorescence on the FACS Calibur. 
The work presented in this figurer 3.2.8a A, B, and C. and 6.2.1 was done by Dr 
Arvind Mahajan and Ms Edith Paxton while figures 5.2.4, 5.2.6 and 6.2.1 were done 
by Ms Edith Paxton. 
 
2.9.2l Trancytosis assays 
Caco-2 and primary bovine terminal rectal epithelial cells were allowed to establish 
monolayers on 0.4 µm pore size polycarbonate filters of 35 mm Transwell chambers 
(Corning incorporated, USA) by growing them for 2-3 weeks until confluences. 
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Before seeding primary bovine terminal rectal epithel al cells, the Trans well plates 
were coated with collagen (Nutagen). Integrity of cell monolayer, polarization, and 
formation of tight junctions were tested by measuring the TER using epithelial 
Voltohmmeter (WPI, USA). Only filters of cell monolayers that displayed the 
required TER were used for bacterial transcytosis asay: for Caco-2, 200–300 /cm2; 
bovine terminal rectal primary epithelial cells, 100 /cm2. To establish M-cell co-
culture system RajiB cells were seeded in the lateral chamber of the Trans well 
developed Caco-2 monolayers for 6 days to signal differentiation of human colon-
derived Caco-2 cells and convert some of them to M like cells.   
E. coli were prepared as for the phagocytosis assay while S. Typhimurium were 
grown overnight in LB and diluted 1 in 100 in LB and left to grow in the conditions 
as for E. coli. Before the challenge with bacteria the cells were washed twice with 
MEM-Hepes without antibiotic an hour before the bacterial culture reach OD600 = 0.4 
and 300 µl of that media was added to each well. 3 wells of confluent cells were 
infected using 100 µl of bacterial suspension for each well. The infected cells were 
incubated at 37°C, 5% CO2 and moisture for 1h for E. coli or 30 min in case of S. 
Typhimurium. The medium was removed from the lateral well. The collected 
bacteria were 10 fold serial diluted in PBS. 100 µl of each dilution was triplicate 
plated on LB plate or LB plate with ampicillin. The plates were incubated at 37°C for 
overnight and counted next day. To use inhibitor and RANKL with Salmonella, The 
inhibitors were added to the cell one overnight befor  challenging with bacteria. 
 
2.9.2m Kanamycin protection assay to detect intrace llular E. coli in 
bovine terminal rectum epithelium 
Bacteria were prepared as for the phagocytosis assay.  The bovine primary epithelial 
cells were washed twice with MEM-Hepes without antibiotic one hour before the 
bacterial culture reached OD600 = 0.4 and wells of confluent epithelial monolayer 
were infected using 100 µl of bacterial suspension for each well. The infected cells 
were incubated at 37°C, 5% CO2 and moisture for 1.5 h. The bacterial suspension 
was removed and the wells were washed 4 times with PBS to remove the non 
attached bacteria. 500 µl of MEM-Hepes containing 750 µg/ml of kanamycin was 
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added to each well of the infected cells. The infected cells were then incubated for 
3hr and then washed 3 times with PBS. 300 µl of 0.1% triton (in PBS) was added to 
each well to lyse the cells. The bacteria were colle ted after scraping of the cells, 
serially diluted in PBS, and triplicate plated onto LB plates with appropriate 
antibiotics. The plates were incubated at 37°C for overnight and colonies counted the 
next day. 
 
2.9.2n Using cell signalling inhibitors to check th e pathway Salmonella 
Typhimurium using to convert epithelial cell to ant igen sampling M cell  
The bovine rectal epithelial cells were treated for 5 h with final concentrations 50 µM 
for SN50 NF-KB inhibitor, PI3 kinase inhbitor LY 294002, GSK-3 β inhibitor, SB 
415286. AKT inhibitor was used at 20 µM. Proteasomal-inhibitor MG132 and β-
catenin/Tcf inhibitor, FH535 10 µM. DMSO was used alone as control. Thereafter, 
the cells were infected with Salmonella Typhimurium for 2 h or 100 ng / ml of 
RANKL was added for overnight. The cells then were harvested. The protein 
concentrations of the cellular lysates were measured and 10 µg of protein from each 
sample was subjected to SDS-PAGE and immunoblotting. The same inhibitors were 
added to the cells on the transwell plates and the cells were challenged with S. 
Typhimurium for transcytosis assay. 
 
2.9.2o Establishment of an in vitro M cell co-culture model (Martinez-
Argudo  et al., 2007).  
Co-culture of Caco-2 cells with Raji B cells and measurement of bacterial 
translocation. Caco-2 cells were grown for 14 days (in DMEM (Sigma) 
supplemented with 10% Fetal bovine serum, 1% L glutamine and 1% 
penicillin/streptomycin (Sigma) on transwell polycarbonate inserts– 3 µm pore) to 
allow differentiation and development of microvilli. These cells were then co-
cultured with Raji B cells 0.5x106 in the basal compartment for 6 days. Bacteria were 
prepared as describe for the phagocytosis assays and 100µl of bacterial suspension 
added to each upper chamber. Bacterial counts from the lower chamber were 
determined at 60 min. relative to the inoculum. 
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- Raji B cells were grown in RPMI 1640 medium (Gibco-BRL) supplemented with 
10% fetal calf serum, 1% Glutamine (Gibco), 0.1 mg l-1 streptomycin and 100 unit 
ml-1 penicillin (Sigma) at 37°C in 5% CO2. (Martinez-Argudo et al., 2007). 
- Caco-2 cells were grown in DMEM (Sigma) supplemented with 20% foetal calf 
serum, 1% nonessential amino acids, 1% Glutamine and 1% of pen-strep (Sigma) at 
37°C in 5% CO2. 
 
2.9.2p Measurement of bacterial translocation throu gh an in vitro M-like 
cell co-culture 
Bacteria were prepared as for the phagocytosis assay. The transwells were washed 
three times with DMEM without antibiotic an hour before the bacterial challenge. 
100 µl of bacterial suspension were added to each upper chamber. Samples from the 
basolateral chamber were plated at 60 min after being 10 fold diluted. Serial dilutions 
from the inoculum were plated to calculate the number of bacteria inoculated. The 




To isolate the primary terminal rectal epithelium, fresh rectal tissues were obtained 
from a local abattoir. The primary bovine rectal epithelial cells were isolated from 
the bovine terminal rectal mucosa using Collagenase and Dispase I enzymes to 
separate the intestinal crypts from the adherent tissues. These crypts were grown in 
collagen-coated glass coverslips until confluent as de cribed previously (Mahajan et 
al., 2005). The isolated cells were grown on glass coverslips or in 8-well culture 
glass slides (BD Falcon, USA). The glass slides and coverslips were coated with 
bovine collagen solution (Nutacon 5409) and allowed to ry overnight into the class 
II cabinet. Collagen-coated plates were removed from -20°C and re-hydrated with 
500µl PBS or HBSS (Sigma H9269). The cells were incubated t 37°C and 5% CO2. 
After 24 - 48 h of incubation (depending on concentration of crypts), half the media 
was removed and replaced with Feeding media (this get removed any remaining 
fibroblasts in the culture). Cells were fed every other day until being confluent. Once 
the cells become confluent, they were challenged with S. Typhimurium for 2 h. Cells 
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were fixed and permeablised with a solution consisted of 2% (v/v) formalin and 
0.2% (v/v) triton X-100 in PBS. The cells were washed gently with PBS three times. 
the cells were blocked by 3% BSA diluted in PBS buffer or 1hr, then cells were 
stained for with 1/100 primary antibodies diluted in PBS, overnight at 4°C. The cells 
were washed with PBS three times. The monoclonal antibody was detected with 
TRITC or FITC-labelled, secondary antibody (1:100), 1 h in darkness at RT. The 
cells were washed three times with PBS and stained with phalloidin 647 or TRITC. 
Cells were washed 3 times with PBS and then stained with DAPI 1/5000 (Invitrogen, 
UK) for 15 min and then washed 2 times with PBS. The glass coverslips were fixed 
onto a glass slide with fluorescence mounting medium (Vectashield). The slides were 
stored at 4°C in darkness. The slides were examined using Zeiss axiovert confocal 
microscope, objective x10. 
Uptake of inert micro-particles and S. Typhimurium (SL1344) has been used as in 
vitro functional assay for M-cells in cultures (Clark et al., 1994; Kerneis et al., 
1997). FITC-conjugated latex beads of 0.2 µm size (Polysciences Inc., Germany) 
were diluted (1:1000) in DMEM containing 2% foetal bovine serum. Aliquots (100 
µl) of diluted beads were pipetted evenly on to 6-day old cultures and incubated at 
37°C for 45 min; then the cells were washed three tim s in phosphate-buffered saline 
and Salmonella Typhimurium (SL1344) (MOI 1:100) were added to thecell for 10 
min. The cells were washed three times in phosphate-buff red saline, fixed and 
permeabilized with 2% (w/v) PFA/ 0.25% (v/v) Triton X-100 at room temperature 
for 20 min. Staining of F-actin was done with Phalloidin-647 (diluted 1:40 in PBS; 
Molecular Probes) for 45 min at room temperature in the dark. For co-localization 
studies with vimentin, the cells were incubated with mouse anti-vimentin monoclonal 
antibody (1:100) (Sigma) and incubated overnight at 4°C. This primary antibody was 
detected with Alexa 594-tagged rabbit anti-mouse or g at anti-mouse polyclonal 
antibodies as per the manufacturer’s instructions (I vitrogen). The cell nuclei were 
stained with either TO-PRO Iodide (Molecular Probes) or DAPI (Merck). The 
mounted slides were examined by confocal microscopy.  To examine the position of 
the beads, 0.4 µm optical sections were acquired and processed via Imaris Surpuss 
Module (Bitplane) computer software programme.  
___________________________________________Materials and Methods 
 91 
2.9.2r Confocal microscopy  
Confocal data were acquired using a 1024 x 1024 pixel image size, a Zeiss Plan 
Apochromat 1.4 NA x63 oil immersion lens and a multi-track (sequential scan) 
experimental set up on a Zeiss LSM510. Image data, acquired at Nyquist sampling 
rates, were deconvolved using Huygens software (Scientific Volume Imaging, 
Netherlands), and the resulting three-dimensional models were analyzed and 
orthogonal views were created using NIH ImageJ software, final figures were 
assembled in Adobe Photoshop. 
 
2.9.2s Scanning electron microscopy  
Samples were fixed in 3% glutaraldehyde in 0.1 M sodium cacodylate buffer; pH 
7.3, for 24 h then washed in three 10 min changes of 0.1M sodium cacodylate.  
Specimens were then post-fixed in 1% osmium tetroxide in 0.1 M sodium cacodylate 
for 45 min, and then washed in three 10 min changes of 0.1M Sodium Cacodylate 
buffer. These sections were then dehydrated in 50%, 70 , 90% and 100% normal 
grade acetones for 10 min each, then for a further two 10-min changes in analar 
acetone.  Dehydrated samples were then critical point dried in a Polaron E 3000 
series II drying apparatus, mounted on aluminium stubs , coated in an Emscope SC 
500 sputter coater with a 10nm thick layer of gold palladium, and viewed in a 
Hitachi S-4700 Scanning electron microscope. 
 
2.9.2t Transmission electron microscopy 
For TEM, samples were fixed in 3% glutaraldehyde in 0.1 M Sodium Cacodylate 
buffer, pH 7.3, for 2 h then washed in three 10min changes of 0.1M Sodium 
Cacodylate. Specimens were then post-fixed in 1% osmium tetroxide in 0.1 M 
sodium cacodylate for 45 min, and then washed in three 10 min changes of 0.1 M 
sodium cacodylate buffer.  These sections were then dehydrated in 50%, 70%, 90% 
and 100% normal grade acetones for 10 min each, then for a further two 10-min 
changes in analar acetone. Samples were then embedded in Araldite resin. Ultrathin 
sections, 60 nm thick were cut, stained in uranyl acet te and lead citrate then viewed 
in a Phillips CM 120 transmission electron microscope. 
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2.10 Dual luciferase reporter assay 
The dual luciferase reporter assay system (Promega, UK) provides an efficient 
method to measure the response of a reporter promoter. It relies on the use of two 
luciferase plasmids one of which is the firefly reporter (Photinus pyralis) and the 
second is the Renilla plasmid (Renilla reniformis). Firstly the firefly luciferase 
reporter is measured by adding Luciferase Assay Reagent II (LAR II) to generate a 
“glow-type” luminescent signal. After quantifying the firefly luminescence, this 
reaction is quenched, and the Renilla luciferase reaction is initiated by 
simultaneously adding Stop & Glo® Reagent to the same tube. The Stop & Glo® 
Reagent also produces a “glow-type” signal from theR nilla luciferase, which 
decays slowly over the course of the measurement. 
Dual luciferase reporter assays were performed as the following: Caco-2 cells were 
seeded out onto 24 well plates at a density of 8x104 cells per well and incubated 
overnight at 37°C and 5% CO2. The next day cells were transfected using effectin 
(Quiagene) according to the manufacturing instructions. The transfection mix was 
added to the cell containing 20 ng Renilla, 180 ng of sopB cloned into pCR3 
expression vector/pCR3 expression vector used as control and 100 ng of luciferase 
reporter plasmid  (pTOP flash, pFOP flash, Slug, RANKL and Vimentin promoters 
cloned in luciferase reporter vector pGL3). 
 
2.10.1 Assays for Transcriptional Response to a β-Catenin/Tcf 
Transcriptional Promoter Element.   
Activated Wnt signaling pathway leads to the dephosrylation, stabilization, and 
nuclear translocation of β-catenin. The stabilized β-catenin complexes with the 
TCF/LEF transcription factors, leading to the activa ion of Wnt-responsive genes 
slug, vimentin, c-myc, siamois, and cyclin D1. The effect of SopB on β-catenin/Tcf 
transcriptional activity was studied by transient co-transfection of Caco-2 cells with 
sopB/PCR3and the pTOP-Flash reporter plasmid in which the expression of 
luciferase is promoted by three tandem copies of the optimal Tcf-response element 
(CCTTGATC) adjacent to the minimal c-fos promoter. Control cultures were 
transiently transfected with sopB/PCR3 and the pFOP- lash reporter plasmid 
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containing all of the regulatory elements of the pTOP-Flash plasmid, except that the 
Tcf response motifs contain mutations (CCTTGGCC) that prevent its functional 
activation by Tcf. 48h after transfection cells were washed once with PBS and the 
complete growth media was exchanged. LiCl 10 mM final concentration was added 
as positive control for pTOP flash, pFOP in PCR3 transfected cells. 
 
2.10.2 Effect of SopB on transcriptional activity o f Slug, RANKL 
Slug-induced repression of E-cadherin at transcriptional level and triggers a complete 
epithelial to mesenchymal transition.  
Receptor activator of NFκB ligand (RANKL) expression is known to be associated 
with transformation of epithelium to mesenchymal cell EMT that may be through 
induction of transcription factor Slug. 
To study the effect of SopB on Slug promoter activity Caco-2 cells transiently 
transfected with SopB and Slug promoter cloned from bovine genome.  SN50 (NFκB 
inhibitors) was added to the cells transfected with sopB to examine if SopB induce 
slug transcription through activating the NFκB pathway 
To study the effect of SopB on RANKL promoter activity Caco-2 cells transiently 
transfected with SopB and RANKL promoter cloned from bovine genome.  SN50 
NF-KB inhibitor β- Catenin/TCF inhibitor, FH535 SB 415286 AKT inhibitor lY 
294002 were added to the cells 48 h after transfection to study the path way that 
SopB use to induce RANKL promoter activity. 
 
2.10.3 Luciferase assay to measure effect of RANKL on transcription of 
Slug and Vimentin  
To investigate effect of RANKL on transcriptional activity and the down stream 
signaling pathways Slug and Vimentin specific luciferase based assays were 
conducted in presence of pharmacological inhibitors specific to NFκB or Wnt 
pathway: 100 ng / ml of RANKL was added 48 after Caco-2 cell was transfected 
with 100 ng/ well from Vimentin or Slug promoter and 20 ng Renilla plasmid. In the 
main time of adding RANKL, the pharmacological inhibitors was added to the cells 
as following: AKT inhibitor 20 µM; 50 µM final concentration from LY 294002 (PI3 
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kinase inhbitor), SN50 (NFκB inhibitor), or 10 µM from FH535 (β -catenin/Tcf 
inhibitor). Positive control SB 415286 (GSK-3 β inhibitor) was used in 50 µM final 
concentration. These agents were added to the cells 48 h after transfection.  In some 
of the assays LiCl (10 mM final concentration) was added as positive control. 
15 h later the media was aspirated and drained completely followed by addition of 50 
µl of 1 x Passive lysis buffer (PLB; Promega, UK). Then, plates were left for 1 h on a 
shaker to allow for efficient lysis of the cells. The total cell lysate were transferred 
into 96 well black plate (BD Falcon,USA). Analysis was performed by addition of 30 
µl of LARII reagent (Promega, UK) to each well. The reading was performed on a 
polar star plate reader (Polar star optima, BMG Biotech) on the luminescence setting. 
After the plate was read, 30 µl of ‘Stop and Glo’ (Promega, UK) was added to each 
well to quench the firefly luciferase activity and read again on the same settings to 
measure Renilla luciferase activity. Relative luciferase activity was calculated by 
normalizing the firefly luciferase value to that of the Renilla luciferase. To 
standardise the luciferase activity of samples within t e same experiment set, the 
relative luciferase values were divided by the control samples mean. 
2.11 Small interfering RNA (siRNA) 
The abbreviation, also known as short interfering RNA or silencing RNA, stands for 
a class of double-stranded RNA molecules, 20-25 nucleotides in length that play a 
variety of roles in biology. The most important usage for siRNA is the RNA 
interference (RNAi) pathway, where it interferes with the expression of a specific 
gene. 
Bovine primary terminal rectal epithelial cells were grown until 40-60% confluence. 
For RelB knockdown a final concentration of 40nM bovine RelB siRNA was used.  
The siRNAs were transfected into cells by using lipofectamine transfection reagent 
(Invitrogen) as described by the manufacturer. After 48 h, the transfected cells were 
treated with RANKL (100 ng/ml) overnight then infect d with wildtype Salmonella 
Typhimurium for 2 h or left untreated and harvested for Western blotting or RT-PCR 
analysis. All siRNA duplex oligonucleotides were synthesized by Invitrogen). 
Sequences are shown in Table 2.7. 
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2.12 In vivo mice studies to investigate role of SopB in epithel ial cells 
transformation:  
S. Typhimurium SL1334 and its sopB mutant were transformed with the pAJR146 
plasmid (Table 2.5) were grown overnight in LB-CAM at 37°C with minimum 
aeration. Following centrifugation the bacterial pelets were re-suspended in LB and 
the OD600 measured. The bacteria were diluted to give a concentration of 10
8/100 µl 
in LB and 100 µl were injected to each C57/BL6 mouse two loops were ligated. One 
loop for bacterial inoculums and the other were receiving media alone to serve as a 
control. 5 mice were used for each bacterial strain. The infection period was between 
90min. After infection the Peyer’s patches were isolated from the rest of the intestine 
– they were used for confocal studies – washed, fixed, stained for GP-2 (green) and 
actin (far red 647 nm (blue)), and mounted for micros opy. The remaining intestine 
from each loop was washed and divided up for RNA extraction – RNA protect was 
added (2 ml/sample). Protein extraction – Protein lysate buffer (with protease 
inhibitor) was added (2 ml/sample), Histo-pathology – were fixed with 10% formalin 
(2 ml/sample) and Cryo- sectioning – OTC were added (2 ml/sample). This 
experiment was carried ou with help of Dr David Donaldson at the Roslin Institute. 
 
2.12.1 GP-2 receptors staining in mouse Ligated int estinal loop assay  
For the ligated intestinal loop assay, mice were anaesthetized with avertin and kept 
warm on a 37°C warming pad during the assay. pAJR146 containg S. Typhimurium 
and sopB mutant (108 C.F.U.) were injected into the ligated intestinal loop. After 
incubation for 90min, the mice were killed and Peyer’s patches were excised from 
the intestine. 
 






Fig. 2.5 Mouse ligated loops to study the interaction of S. Typhimurium with 
FAE (~2-3 cm) 
 
___________________________________________Materials and Methods 
 97 
2.12.2 Whole-mount immuno-staining of the follicle associated 
epithelium (FAE) of Peyer’s patches (PP) 
In order to detect M cells in the FAE of PP, sections of intestinal tissue containing 
Peyer’s patches were whole mount stained for GP2 as previously described   (Hase et 
al., 2009).  Briefly, PP were excised and washed with cold HBSS. The PP were then 
fixed with cytofix/cytoperm (BD biosciences) for 1hr on ice followed by washing 
with PBS. Non-specific staining was blocked by incubating the tissues in PBS 
containing 0.5% BSA and 0.1 saponin (w/v). M cells were visualised by an 
incubation with anti-mouse GP2 (clone 2F11-C3, 5 µg/ml) (MBL international) 
followed by Alexafluor 488-conjugated goat anti-rat IgG (4 µg/ml) (Invitrogen) and 
the tissues were counter-stained with Alexafluor 647-conjugated Phalloidin (7.5 
U/ml) (Invitrogen). Stained PP were mounted in cavity slides in PBS/30% Glycerol 
(v/v)/0.05% Sodium Azide (w/v) and stored at 4oC. Z-stack images of the FAE of 
individual PP follicles were obtained using a Zeiss LSM5 confocal microscope 
(Zeiss). 
 
2.12.3 Immuno-histochemistry staining 
The cryo specimens were cut into 3-mm-thick sections. The  frozen sections were 
taken out for 30 min to get to RT. Immuno-histochemical staining was performed 
using DAKO Autostainer Plus System (DAKO, Capinteria, CA). It was used 
according to manufacturer instructions.  Briefly, the slides were fixed with acetone 
for 10 min at RT, air dried for 15 min. The sections were treated with 
Methanol/H2O2 (1%) for 10 min at RT to block the endogenous peroxidases. The 
sections were washed in PBS/BSA (0.2%) for 5 min and blocked with 100 µl of 
normal goat serum diluted 1/20 (Jackson immunoreseach) (normal serum according 
to the secondary) at RT for 15 min. The sections were incubated for 1 h with 
primary, polyclonal antibody against Slug (1:400) at RT or 4 oC overnight. Negative 
controls were performed by omission of the primary ntibody. The sections were 
washed as above and incubated with the secondary antibody 1/500 in PBS/BSA 
(0.2%). (for slug goat anti-rabbit immunoglobulins/Biotinylated (Dako cat no, 
Eo432) Washed mentioned above. The staining signal was detected using Vectastain 
Elite ABC kit (Vector Laboratories) and NovaRED Peroxidase Substrate kit (Vector 
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Laboratories). The sections were counterstained with Mayer’s haematoxylin and then 
mounted. The images were acquired using a laser-scan Nikon E800 Microscope. 
2.13 Statistical design and analyses 
All statistical analyses were carried out in R (v 2.10.1 © The R Foundation for 
Statistical Computing) and Minitab software. Overall differences between strains 
were first assessed, and if there were statistically significant differences then post-
hoc Tukey pair-wise comparisons were carried out.  
 
Two types of statistical models were used, when considering differences between 
strains in the percentage of intracellular bacteria at either set time intervals as 
determined by fluorescence microscopy, or as a measur  of phagocytosis were 
examined by General Linear Models with binomial errors to account for the 
percentage nature of the data. To ensure that any differences between experiments 
was accounted for in the time interval analysis, which of 3 experiments the data 
came from was also entered as a covariate. 
For all other statistical analyses, analysis of co-variance of log10 transformed 
number of bacteria post-translocation were carried out to assess differences between 
strains. To adjust for differences in pre-translocation levels and experiments the 
number of bacteria pre-translocation and which of the 3 experiments the 
translocation carried out were entered as covariates. Log transformation was 
undertaken to normalize the residuals. Statistical significance was taken when 
P<0.05. Statistical analyses in chapter 3 and chapter six excpt figure (6.2.6) were 
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3. Comparative Analysis of EspF  Variants in the Inhibition of 
E. coli Phagocytosis by Macrophages and the Inhibition of E. coli 
Translocation Through Human- and Bovine-Derived M-c ells 
3.1 INTRODUCTION 
Enterohaemorrhagic E. coli EHEC are emerging zoonotic pathogens, particularly in 
industrialized countries (Beutin, 2006). HEC strains cause sporadic outbreaks of 
severe disease in humans, the most important being hemorrhagic colitis (HC) and 
hemolytic uremic syndrome (HUS), the latter results in kidney damage and may lead 
to death (Griffin & Tauxe, 1991; Boyce et al., 1995). Shiga toxins (Stx) produced by 
EHEC strains are the main factors responsible for these serious outcomes in humans. 
By contrast, Enteropathogenic E. coli (EPEC) are another pathogenic type of E. coli 
that can also cause severe intestinal disease in humans but there is no clear evidence 
these strains are zoonotic although EPEC strains do circulate and cause diseases in 
animals (Moon et al., 1983). Human EPEC infections are not usually associated with 
HC and HUS as the strains do not produce Shiga toxins. 
Our understanding of EHEC pathogenesis is primarily based around studies on the 
EHEC O157 and EHEC O26 serogroups that are associated wi h most human EHEC 
infections in Europe, North America, and Japan (Karmali, 1989; Karmali, 2004; 
Karch et al., 2005). Both serogroups are considered to be present in ruminants, in 
particular cattle as the primary reservoir (Karmali, 1989; Bettelheim, 2000; Naylor et 
al., 2003; Naylor et al., 2005a). While there are many EPEC serotypes, extensiv  
research has been carried out on the sequenced human EPEC O127 strain E2348/69. 
EHEC and EPEC strains express a type III secretion system (T3SS) that is important 
for colonisation of the human or animal host (Moon et al., 1983; Jarvis et al., 1995; 
Hueck, 1998; Shaw et al., 2001). The T3SS injects effector proteins into host cells 
that manipulate cellular processes to promote the colonisation and persistence of the 
bacterium in the gastrointestinal tract ( Nougayrede t al., 2001; Elliott et al., 2002; 
Dean et al., 2006; Iizumi et al., 2007; Echtenkamp et al., 2008; Marchès et al., 
2008). The primary phenotype associated with T3S is int mate attachment between 
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the bacterial outer-membrane protein intimin and the T3SS translocated intimin 
receptor (Tir) (Kenny et al., 1997). In both EHEC and EPEC, the genes encoding 
this protein secretion system are expressed from the locus of enterocyte effacement 
(LEE) pathogenicity island ( Jarvis et al., 1995; Hueck, 1998). While several effector 
proteins are also expressed from the LEE, a number of additional secreted effector 
proteins have been identified that are expressed primarily from integrated phage 
elements scattered throughout the O157 chromosome (Tobeet al., 2006). EHEC and 
EPEC strains have different combinations of effector pr teins, potentially reflecting 
host adaptation and differences in pathogenesis.  
EspF is a LEE-encoded effector protein that requires the CesF chaperone to be 
translocated by the T3SS into host cells (Elliott et al., 2002). EspF has multiple 
proline-rich domains which act by binding to SH3 domains or Enabled/VASP 
homology 1 (EVH1) domains of host cell signalling proteins (Crane et al., 2001). 
For example EspFEPECO127 binds to Sorting Nexin 9 (SNX9) via its SH3 amino 
terminal region (Marchès et al., 2006; Alto et al., 2007). EspF is involved in 
disruption of tight junctions and increases monolayer permeability in part through 
the redistribution of occludins ((McNamara et al., 2001; Nougayrède & Donnenberg, 
2004; Viswanathan et al., 2004a; Nougayrède t al., 2007). EspF sequences differ 
between EPEC and EHEC strains and the EHEC O157 variant has a more modest 
impact on transepithelial electrical resistance (TER) (Viswanathan et al., 2004a). 
EspF in combination with other effectors inhibits the water transporter SGLT-
1(Dean et al., 2006). EspFEPECO127 is targeted to mitochondria with the N-terminal 
region of EspF functioning as an import signal. EspFEPECO127 causes an increase in 
mitochondrial membrane permeabilization in addition t  the release of cytochrome C 
from mitochondria into the cytoplasm and subsequent caspase-9 and caspase-3 
cleavage leading to cell death (Crane et al., 2001; Nougayrède & Donnenberg, 2004; 
Nagai et al., 2005; Nougayrède Nougayrède et al., 2007). More recent work has 
demonstrated that EspF can lead to loss of nucleolin from the nucleolus, an activity 
driven by EspF’s activity on mitochondria (Dean et al., 2010). EspFEPECO127 also 
plays an important role in inhibition of bacterial uptake by macrophages (Quitard et 
al., 2006), preventing macrophage phagocytosis via inhibition of phosphatidyl 
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inositol-3 (PI3) kinase dependent pathway of bacterial uptake (Nougayrede t al., 
2001; Quitard et al., 2006).  
Intestinal epithelium is composed of multiple cell types including absorptive 
enterocytes, enteroendocrine, goblet, and Paneth cells. These cells derive through 
asymmetrical division migration and differentiation from pluripotent stem cells. An 
additional specialised epithelial cell type, termed M-cells (“membranous” or 
“microfold” cells), are associated particularly with epithelium overlying gut-
associated lymphoid tissue. This is referred to as follicle-associated epithelium 
(FAE) and is a site of active immunological function. In contrast to villous 
epithelium, FAE contains no or fewer goblet cells (Owen, 1999), defensin- and 
lysozyme-producing Paneth cells (Giannasca et l., 1994; Giannasca et al., 1999) and 
expresses low amounts of membrane-associated hydrolases (Owen & Bhalla, 1983). 
The M-cells generally lack the distinct microvilli and thick filamentous brush border 
glycocalyx (Frey et al., 1996) and instead have variable microfolds. Together, these 
features of M-cells promote contact of antigens with gut epithelium and result in 
sampling of antigens from the intestinal lumen and transfer to antigen presenting 
cells (APCs) within an intra-epithelial pocket (Neutra et al., 1996) on its basolateral 
side (Ermak et al., 1994; Farstad et al., 1994; Iwasaki & Kelsall, 2000). EspFEPECO127 
has also been shown to inhibit EPEC translocation across antigen-transporting 
epithelial M-cells in an in vitro model (Martinez-Argudo et al., 2007) based on a 
published co-culture system (Kerneis t al., 1997). 
In cattle, the terminal rectum is rich in lymphoid follicle-associated epithelium 
(FAE) containing M-cells (Mahajan et al., 2005). As this is the predominant site 
colonized by EHEC O157 in cattle (Naylor et al., 2003), we hypothesized that EspF 
may have an important role in cattle colonisation by inhibiting translocation of the 
organism by M-cells and that the sequence differences of EspF in EHEC O157:H7 
may reflect selection for its function in the bovine host. To test this, we have 
compared the capacity of different espF alleles to inhibit phagocytosis and limit 
bacterial translocation through M-cells derived in a co-culture system with their 
capacity to inhibit bacterial uptake into and translocation through cells cultured from 
the bovine terminal rectum. 
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3.2 RESULTS 
3.2.1 Strain specific susceptibility to phagocytosi s by cultured 
macrophages.   
Previous research has demonstrated that EspF is able to inhibit bacterial uptake into 
macrophages, although the majority of previous research examining this inhibition 
has been focused on the EspFO127 variant from EPEC O127 E2348/69. As an initial 
experiment EHEC O157 & O26 and EPEC O127 were compared for their capacity 
to inhibit their non-opsonised phagocytosis into cultured macrophages. EPEC O127 
bound in significantly higher numbers to the macrophages (Fig. 3.2.1A, P<0.001) 
and the majority remained external (Fig. 3.2.1B and C). EHEC O26 exhibited 
adherence phenotype similar to EHEC O157 but significantly less than EPEC O127 
(Fig 3.2.1A, P<0.001), however, resisted uptake by macrophages (Fig. 3.2.1B and 
C). By contrast EHEC O157 adhered at lower levels and  significantly higher 
proportion was phagocytosed (Fig. 3.2.1B-C). For example at 90 min post addition 
63% (+/-3%) of EHEC O157 bacteria were internalised compared to only 33% (+/-
5%) of EPEC O127 or 31% (+/-.3%) for O26 (Fig. 3.2.1B). 
 
3.2.2 PCR amplification of espF of different EHEC serotypes  
To functionally analyse the differences in function of EspF from different EHEC and 
EPEC strains, the different espF genes were amplified by polymerase chain reaction 
(PCR). DNA templates used for the amplification of espF were extracted from E. 
coli O26:H11, E. coli O5:H-, E. coli O26:H2, E. coli O111:H12, E. coli O103:H2, E. 
coli O118:H16, E. coli O103:H-, E. coli O157:H7, and E. coli O127:H6. The primers 
were designed based on alignments of the different published espF sequences. The 
primers are defined in Table 2.3 (Materials & Methods) and the amplification 
conditions were the same for all the ORFs (Materials & Methods). Variable sizes of 
PCR products (0.7-0.8 kb) were obtained on amplification of the espF alleles from 







































Fig. 3.2.1 A comparison of EHEC O157, O26 and EPEC O127 interactions with 
RAW 264.7 macrophages. Confluent monolayers of the mouse macrophages were
infected with EPEC O127:H6 (E2348/69), EHEC O26:H11 (ZAP 1139) EHEC 
O157:H7 (ZAP1163) strains and the number of bacteria inside (green) or outside 
(red) of the macrophages determined by fluorescence mi roscopy as detailed in the 
Materials and Methods. (A) Mean (± 95% confidence int rvals) number of adherent 
bacteria per macrophage at 30 min following addition of the bacteria at an MOI of 
100. (B) Percentage (±95% confidence intervals) of intracellular bacteria at the time 
points shown as determined by fluorescence microscopy for EHEC O157 (), EPEC 
O127 () and EPEC O26 (). *** denotes a significant difference of <0.001 for 
O157 vs EPEC;+++ for O157 vs O26, and xxx for EPEC vs O26. (C) Confocal 
images were acquired using a Zeiss Plan Apochromat 1.4 NA x63 oil immersion lens 
and a multi-track (sequential scan) experimental set up on a Zeiss LSM510. Scale bar 
5µm.  






















Fig. 3.2.2a PCR amplification of espF from different EHEC serotypes. Samples 
were run on 2% agarose gels as described in materials and methods. Lane M, 100bp 
DNA ladder. Lanes 1-9 (A,B) espF of different EHEC serotypes (A) O26:H11 (Lane 
1), O5:H- (Lane 2), O26:H2  (Lane 3) O111:H12 (Lane 4), O103:H2 (Lane 5), 
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Fig. 3.2.2b Alignment of EspF amino acid sequences from EHEC O157:H7 
(EDL933); EPEC O127:H6 (E2348/69) and EHEC O26:H11 (ZAP1139). The 
proline-rich repeats (PRR) are boxed with EHEC O157 containing an additional 4th 
repeat. Amino acid differences from the EHEC O157 sequence are bolded. A binding 
site for Sorting Nexin 9 (SNX9) is highlighted in grey within the PRRs (Alto et al., 
2007). The putative N-WASP binding region is within the middle of the PRRs (Alto 
et al., 2007), although the most significant sequence divrs ty between these variants 
is at the ends of each PRR. The leucine at position 16 (arrow) has been shown to be 
essential for EspF translocation into mitochondria and this is changed to the similar 
aliphatic amino acid isoleucine in EHEC O26 (Nagai et al., 2005). Analysis of NCBI 
E. coli O157:H7 sequences showed no significant variation in the predicted EspF 
amino acid sequence. The predicted EspF from an E. coli O26:H2 strain was 
identical to that shown for E. coli O26:H1. The other O26 strains espF sequence 
were similar to O26:H11. 
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Analysis of NCBI E. coli O157:H7 sequences showed no significant variation in the 
predicted EspF amino acid sequence. The predicted EspF from an E. coli O26:H2 
strain was identical to that shown for E. coli O26:H11. 
EHEC and EPEC serotypes express different variants of EspF (Fig. 3.2.2b). EHEC 
O157 contains four polyproline repeat regions compared to three in the EPEC O127 
and EHEC O26 strains. In addition, the three sequences differ within the polyproline 
repeat regions and in the amino terminus of the protein shown to be important for 
organelle targeting (Alto et al., 2007; Dean et al., 2010). 
 
3.2.3 Cloning of espF of  EPEC O127:H6 and  EHEC strains O157:H7 
and O26:H11 
To determine the relative contribution of the different espF alleles in inhibiting 
phagocytosis, these were amplified from E. coli O157, O127, and O26 and cloned 
into pMB102 (Table 2.2) under control of a pTAC inducible promoter. espF of E. 
coli O26:H11 and O157:H7 and EPEC O127:H6 were amplified by PCR using 
primers as described in (Table 2.3 Materials & Methods). PCR products as well as 
pTS1 were digested with restriction endonucleases (Table 2.3) and ligated together 
using T4 ligase enzyme before being transformed into DH5α competent cells. To 
confirm that the cloned products were the correct size and that the cloning 
procedures were successful pTS1 was extracted from the transformed colonies for 
espF from EHEC O157 and O26 were digested using restriction endonucleases (Fig. 
3.2.3a). The colonies for EPEC espF were screened by PCR (Fig. 3.2.3b) as the 
HindIII site was lost from the plasmid by making it blunt as EPEC espF containing 
HindIII  site in its sequence. All these clones were confirmed by sequencing. 
 
3.2.4 Strain specific susceptibility to phagocytosi s is associated with 
espF allele expression.    
EHEC and EPEC serotypes express different variants of EspF (Fig. 3.2.2b). EHEC 
O157 contains four polyproline repeat regions compared to three in the EPEC O127 
and EHEC O26. In addition the three sequences differ within the polyproline repeat 
regions and in the amino terminus of the protein shown to be important for organelle 
targeting (Alto et al., 2007; Dean et al., 2010). 


















Fig. 3.2.3a Diagnostic digests of pTS1. Clones of O26:H11 espF and O157:H7 
espF obtained by digestion with BamHI and HindIII enzymes as described in 
materials and methods. Electrophoresis was carried out through a 0.8% agarose gel. 
Lane M, 1Kb DNA ladder. Successful clones were at expected size bands appear at 
















Fig. 3.2.3b PCR amplification of espF of EPEC O127:H6 for cloning into 
pTS1(A).  Diagnostic PCR of espF clones into the pTS1 expression plasmid (B). 
A DNA segment of expected size (700bp) was seen in lane 8. Lane M, 1Kb DNA 
ladder and M1 is 100bp ladder. Samples were electrophoresed in 2% agarose gel as 
described in Materials and Methods. 
M          O26    O157
1000bp
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To determine the relative contribution of the different espF alleles in inhibiting 
phagocytosis, these were amplified from E. coli O157, O127 and O26 and cloned into 
pMB102 (Table 2.5 Materials & Methods) under control of a pTAC promoter that is 
inducible with IPTG. The sequences were confirmed as identical to those published 
on the NCBI database for these serotypes resulting in predicted amino acid sequences 
shown in Fig. 3.2.2b. The clones were transformed into EPEC E2349/69∆espF (Table 
2.1 Materials & Methods) and secretion profiles examined Fig. 3.2.4a. All strains 
secreted comparable levels of the translocon protein EspD; EspF secretion was 
detected from all three complemented strains by Western blotting (Fig. 3.2.4a), but 
with potentially lower levels detectable for the O26 variant. (Fig.3.2.4a). The 
complemented strains were then compared in the macrophage phagocytosis assay at a 
90 min post-infection time point (Fig.3.2.4b). All three alleles were able to 
complement the espF knockout (Fig. 3, P<0.001), although the espFO157 allele was 
significantly less effective at inhibiting uptake in comparison to the spFO127 and 
espFO26 alleles (Fig.3.2.4b, P<0.001). These results confirm that the capacity of EPEC 
O127 and EHEC O157 strains to inhibit phagocytosis correlates with the activity of 
the respective spF allele.  
 
3.2.5 The role of the EspF in adherence to epitheli al cells 
It has been reported that EPEC EspF has no role in A/E lesion formation, altering 
signal transduction or invasion of host cells (McNamera & Donnenberg 1998; 
McNamera et al., 2001). In this study espF clones from EHEC O157:H7 and 
O26:H11 were compared with the EPEC O127 espF clone to investigate if the 
EHEC variants play any role in bacterial attachment or invasion of eukaryotic cells. 
To study the role of the EspF varaints in adherence to pithelial cells, Caco2 cells 
were infected with the ∆espF EPEC strain transformed with the different espF 
alleles.and incubated for 1h at 37°C, 5% CO2. The infected cells were fixed in 4% 
PFA. Bacteria were imaged and quantified following fluorescence microscopy, either 
directly if expressing a GFP plasmid or following O-antigen specific antibody 
staining followed by detection with an Alexafluor 594 conjugated secondary 
antibody. There were no significant differences betwe n different espF alleles and 
adherence to the Caco2 cells (Fig. 3.2.5). 

















Fig. 3.2.4a Levels of EspD and EspF secretion by EPEC O127 ∆espF and 
complemented with the three espF alleles. Supernatants were prepared and 
separated in a standard SDS denaturing gel which was then stained with Colloidal 
Coomassie blue.  The bottom panel shows the staining for the main EspD/B band. 
The middle panel shows the same samples with detection for EspD. The top panel 
shows detection of EspF. The supernatants were prepared from equal volumes of 
bacteria (50 ml) cultured to an optical density at 600 nm of 1.0. Experimental details 
are given in the Materials and Methods section.  
 
 
















Fig. 3.2.4b Comparative analysis of espF of EPEC O127:H6 and EHEC strains 
O157:H7 and O26:H11 interaction with macrophages. (A) confluent monolayer of 
RAW264.7 macrophages was infected with a panel of GFP−labelled ∆espF EPEC 
strains transformed with espF cloned from EPEC O127:H6, EHEC O157:H7 and 
EHEC O26:H11. The proportions of extra−cellular bacteria were determined at 90 
min. The infected cells were fixed in 4% PFA. Bacteria were stained with O−antigen 
specific antibody detected with Alexafluor 594 conjugated secondary antibody. The 
intra cellular (green) versus total bacteria (green + red/orange) were imaged and 
quantified as described in Materials and Methods. Majority of EPEC O127:H6 and 
EHEC O26 were seen outside of macrophages while EHEC O157 were internalize. 
(B) Inhibition of phagocytosis (mean ± 95% confidence intervals) by different espF 
alleles. *** denotes a statistical significance of P<0.001.  
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Fig. 3.2.5 Adherence to Caco-2 of EPEC O127 ∆espF and the strain 
complemented with the three espF alleles. Adherence was determined at 60 min 
post addition to the Caco-2 and detected by counting bacteria per microscope field. 
The experiments were repeated in triplicate with at le st 10 fields enumerated for 
each strain in each repetition.  Details of the assay are provided in Materials and 
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3.2.6 Deletion of espF alleles from E. coli O157 strain TUV93-0 to 
study its role on the interaction of E. coli with primary cultures of 
bovine rectal epithelial cells  
Previous work has established that EHEC O157:H7 colonises the terminal rectum of 
cattle, the main reservoir host (Naylor et al., 2005a).   
   To investigate the role of EspF in EHEC O157:H7 colonization of bovine rectal 
epithelium I aimed to construct an espF deletion in the EHEC O157:H7 strain 
TUV93-0. To facilitate exchange into the wildtype locus on the chromosome, the 
flanking regions of espF gene were PCR amplified (Fig. 3.2.6a) and cloned into
pIB307 (Table 2.5 Materials & Methods), a temperature sensitive plasmid (Fig. 
3.2.6b). The construction of a clean deletion is a two step process, in the first a 
counter-selectable marker is introduced (sacB) adjacent to a selectable marker (kan), 
in the second step the clean deletion is introduced by removal of this two gene 
cassette. The sackan cassette from pDG28 (Table 2.5 Materials & Methods) was 
excised with BamHI (Fig. 3.2.6c), cleaned up and cloned into the BamHI site of 
pIB307 (Fig. 3.2.6d). The plasmid (pAT4) containing the two espF flanking regions 
and the sackan cassette was  used for recombination of the sackan cassette into the 
chromosome of strain TUV93-0 to replace espF with the cassette (Fig. 3.2.6e and 
Material & Methods). Once this strain was confirmed, allelic exchange was then 
carried out using the pIB307 plasmid containing  the wo espF flanking regions 
(pAT5) to obtain clean deletion espF O157:H7 strain TUV93-0 (Fig. 3.2.6f and 
































Fig. 3.2.6a PCR amplification of espF flanking region from E. coli O157:H7. 
About 1Kbp of the upstream (Lane1) and downstream (Lane2) espF flanking of E. 
coli O157:H7 were amplified using primers as described in Materials and Methods. 


















Fig. 3.2.6b Diagnostic digests of pIB307 clones containing with two espF flanking 
regions. The up stream (A) and down stream (B) flanking region of espF were 
digested with SacI & BamHI; and pstI & BamHI enzymes, respectively Lane M, 1Kb 
DNA ladder. Lanes 1-4 (A) and Lanes 1,3,4,7,8,10 (B) show successful clones with 
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Fig. 3.2.6c Electrophoresis of pIB307 cloned with 2espF flanking regions and 
sackan cassette. pIB307 cloned with 2 espF flanking regions were digested with 
BamHI (lane1) and sackan cassette  after being digested with BamHI from pDG28 
and gel purified (lane2). Lane M, 1Kb DNA ladder.Agarose electrophoresis was run 

















Fig. 3.2.6d Diagnostic digest for pIB307 cloned with the two espF flanking 
regions and the sackan cassette. Digestion with BamHI enzyme released the cassette 
at 4000bp (Lane1). BamHI and PstI digestion gave four expected bands as Pst1 cut 
twice within the cassette (lane2 (A). SacI digestion gave an expected segment 
10000bp demonstrating successful cloning of the two espF flanking regions and the 
sackan cassette (Lane 2); pDG28 plasmid without the SacI sites was used as a control 
(Lane1) (B).  Lane M, 1Kb DNA ladder. The digested products were electrophoresd 














































Fig. 3.2.6e Diagnostic PCR for espF O157:H7 knock-out. The obtained strains and 
control TUV93-0 were amplified using 1kp primers external to espF lane1-5 (A). 
Lane1 is control wild type TUV93-0 , lane 2-5 are th  tested knockout strain which 
should have expected band at 6000bp while the control strain at 2800bp. In addition 
primers start from espF ATG and 1kp away from espF reverse primer were used in 
lane (a - e)  (A) while a is the control wiled type that release expected band at 1800bp 
and (b – e) are the tested knockout strain that should give no bands with that primers. 
1kp primer external to downstream of espF and 3 primer of sacB (B) and  1Kb primer  
external upstream to espF and 5 primer of sacB (C). Lane 1 is control wild type strain 
TUV93-0 that should give no bands with sacB primers, lane 2-5 are the tested 
knockout strain which should have expected band at 2800bp (B) and at 5500bp (C) 
Samples were run on 1% agarose gel as described in materials and methods. Lane M, 
1Kb DNA ladder. 
 
 























Fig. 3.2.6f Diagnostic PCR for sackan cassette deletion to obtain clean espF 
mutant in E. coli O157:H7 strain TUV93-0. PCR amplification from the 
obtained strains and control TUV93-0 containing sackan cassette at the site of 
espF were done using sacB primers for detection of sackan cassette (A). Lane 1 is 
control ∆ espF O157:H7 strain TUV93-0 containing sackan cassette tha should 
give band at 1.2Kb, lane 2-5 are the tested knockout strain which should have no 
bands, so all were successful. Primer pairs 600bp up and down streams to espF 
were also used (B). Lane 1 is control wild type O157:H7 strain TUV93-0 that 
should give band at 1.8Kb. Lane 2-5 are the tested knockout strain which should 
have expected bands at 1.2Kb, so all were successful. Lane M, 1Kb DNA ladder. 
Samples were run on 1.5% agarose gel as described in Materials and Methods. 
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3.2.7 Strain specific variation in M-cell transloca tion is associated with 
EspF variation.  
Co-culturing of human Caco-2 cells and lympho-epithel al B cells in vitro leads to the 
differentiation of a subset of epithelial cells into antigen-transporting cells (M-cells) 
(Kerneis et al., 1997; Lo et al., 2004). This “M cell” culture system can then be used 
to analyse bacterial translocation and the capacity of bacteria to inhibit this trafficking 
(Martinez-Argudo et al., 2007). Evidence for M-cell translocation in the ass y is 
provided by comparison of translocation through a standard Caco-2 monolayer which 
should occur at significantly lower levels (Fig. 3.2.7 A-C). To determine the 
contribution of espF to the translocation of EHEC O157 through this M-cell ulture 
system, a defined deletion of espF was constructed in E. coli O157:H7 TUV93-0 
(Table 2.1). Translocation of the EHEC O157 ∆espF strain was significantly higher 
than the wild type strain across both the Caco-2/rajiB co-culture and the Caco-2 
monolayer.  The levels of translocation were restored to those of the wild type by 
complementation with espF0157 in trans (Fig. 3.2.7A).   
The EHEC O157, O26 and EPEC O127 strains were then compared in the same co-
culture translocation assay. EHEC O157 demonstrated significantly higher levels of 
translocation compared with EPEC O127 and EHEC O26 (Fig. 3.2.6b B, P<0.001). 
To examine whether the spF alleles have an effect on the level of translocatin 
inhibition, EPEC E2349/69∆espF transformed with the three amplified and cloned 
espF alleles was analysed in the same assay. All three complemented the spF 
mutation in the EPEC∆espF strain to a significant level (Fig. 3.2.7C, P<0.001). As 
with the phagocytosis assay, the espFO157 allele was the least effective of the three 
being significantly less effective than the espFO127 allele at inhibiting translocation. 
This was the case for translocation across both the Caco-2/rajiB co-culture and the 
Caco-2 monolayers, although translocation through the co-culture system always 
occurred at significantly higher levels (P<0.001). Given the correlation with strain 
origin, these differences again indicate variation n EspF activity between the 



































Fig. 3.2.7 Translocation of EPEC and EHEC strains across a Caco−2 and 
lympho−epithelial M−cell co−culture system (black bars (A,C,E)) and Caco−2 
cells only (white bars (B,D,F)). (A,B) espF is required to inhibit EHEC O157 
TUV93−0 translocation through M−cells. Translocation f EHEC O157 TUV93−0 
compared with an isogenic espF deletion mutant and complemented with espFO157 
(pAT1, Table 2.5). (C,D) Comparative translocation f EPEC O127:H6 strain 
E2348/69, EHEC O157:H7 ZAP 198 EHEC O26:H11 across the co−culture system. 
(E,F) Comparative translocation of an EPEC O127∆espF mutant complemented with 
the three defined espF alleles. ** & *** statistical significance of P<0.05, P<0.01 & 
P<0.001, respectively.  
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3.2.8 The significance of espF alleles on the interaction of E. coli with 
primary cultures of bovine rectal epithelial cells.   
The terminal rectum of cattle contains a high number of lymphoid follicles and M-
like cells that are present in the follicle-associated epithelium (FAE) (Mahajan et al., 
2005). Primary cells were cultured from a mixed population of crypts isolated from 
this bovine terminal rectum (Materials & Methods). The cells in the monolayers 
expressed cytokeratins (Fig. 3.2.8a A) indicative of pithelial cells. Screening with a 
panel of antibodies (Table 2.10 Materials & Methods) provided no indication of 
contaminating cells, such as fibroblasts and other m senchymal cells (This work was 
done by Dr Arvind Mahajan). It was apparent that a small proportion of cells 
expressed Vimentin, an intermediate filament protein indicative of M-cells (Fig. 
3.2.8a A). A subset of Vimentin-expressing cells endocytosed latex fluorescent 
microparticles (Fig. 3.2.8a C&C1). Salmonella enterica serovar Typhimurium 
preferentially targets M cells in the gut (Clark et al., 1994) and therefore were used 
to test if the bacteria and the latex particles were internalised by vimentin expressing 
cells in culture. Indeed, during early stages of infection S. Typhiumurium interacted 
primarily with vimentin expressing cells in culture (Fig. 3.2.8a D) that also had 
internalised the latex beads (Fig. 3.2.8a E), a further indication that these cells can be 
considered M-cells based on previous M-cell characte isation studies (Kerneis et al., 
1997). Taken together, this data indicates that primary cells cultured from crypts 
isolated from bovine rectal FAE do contain a subset of cells with characteristics of 
M-cells and are capable of taking up particles including bacteria. 
To determine the significance espF has on the interaction of E. coli O157 with these 
primary cells, translocation across these primary cell cultures was then assessed for 
the wild type strains, the EHEC O157 ∆espF deletion and EPEC ∆espF 
complemented with the three different alleles. In agreement with the co-culture 
translocation assay, espF significantly contributed to inhibition of translocation 
through these cultured cells; however, in clear contrast to the ‘human’ co-culture 
system, in the bovine assay EHEC O157 was significatly better at inhibiting 
translocation compared to EPEC O127 and EHEC O26 (P<0.001). In line with this, 
the espFO157 allele showed the highest activity in restricting transcytosis in the EPEC 
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∆espF background, although this was not significant (Fig. 3.2.8b C) by comparison 
with the two other alleles. As an alternative assesment of the function of these 
alleles on the bovine primary cells, an intracellular kanamycin protection assay was 
developed that determined the intracellular bacterial numbers at 90 min post 
infection. The relative percentage of bacteria taken up into cells is low but increased 
significantly on deletion of espF (Fig. 3.2.8c A). EHEC O157 was taken up into cells 
at significantly lower levels compared to EPEC O127 and EHEC O26 (Fig. 3.2.8c B, 
P<0.001) in agreement with the transcytosis results. This assay was then carried out 
with the three espF alleles in the EPEC E2348/69∆espF strain. All three espF alleles 
reduced uptake significantly (Fig. 3.2.8c C, P<0.001) with the espFO157 variant 
showing significantly higher activity than the espFO127 (Fig. 3.2.8b E, P<0.05) and 
espFO26 (P<0.001) alleles.  
The fact that the relative activities of the espF clones are reversed in the bovine 
assays indicates that the differences measured between the variants are not due to 
expression or secretion levels.  This is supported by the correlations with the relative 
activity levels of the parental strains in the different assays. Taken together, it is 
likely that the relative activities are due to different functional capacities of the EspF 
variants and in turn these are dependent on the host cell type in which the variants 
are acting.    
 























Fig. 3.2.8a Characterization of bovine primary rectal epithelial cells. (A) 
Heterogeneous population of epithelial cells in a primary cell culture from the bovine terminal rectum. 
A five day old culture was prepared and immuno-labelled to detect: vimentin (green); pan-
cytokeratins (red) and nuclei (blue) as described in Materials and Methods. A subset of the cells 
expressed the intermediate filament protein, vimentin (green), indicative of M-cells. (B) Vimentin 
expressing cells were quantified using flow cytometry from 4 independent primary cultures (SD+0.3). 
(C) Micro-particle co11 localization with vimentin expressing cells. A subset of vimentin expressing 
(red) cells interacted with fluorescent micro-particles (green). C1 inset image digitally magnified 
by a factor of 4. The primary rectal epithelial cells were incubated with latex particles (green) (0.2µm 
size) at 37o14 C, 5% CO2 for 45 min; fixed, permeabilized and labeled with anti-vimentin (red) and 
TO-PRO nuclear stain (blue). (D) Orthogonal section demonstrating Salmonella Typhimurium uptake 
by vimentin expressing cells during early stages of interaction. The cells were infected with mid-log 
phase S. Typhimurium (pUC18GFP-labelled SL1344 strain) at a MOI of 1:100 at 37o18 C, 5% CO2 
for10 min. (E) Orthogonal section demonstrating combined uptake of S. Typhimurium (white arrow, 
DAPI-stained) and micro-particles (yellow arrow, green) by vimentin positive cells (red) in a bovine 
rectal primary culture. The cells were incubated with latex particles (green) for 45 min, washed 
(3xPBS) and further infected with mid-log phase S. Typhimurium at an MOI of 1:100 for 10 min. The 
infected cells were fixed, labeled with anti-vimentin (red) and DAPI nuclear stain. Confocal images 
were acquired using Zeiss LSM510 x 63 objective). Scale bar 10µm. 
 
 






























Fig. 3.2.8b Interaction of EHEC and EPEC strains with cultured epithelial cells 
from the bovine terminal rectum (Transcytosis). (A) espF limits EHEC O157 
TUV93−0 uptake into rectal primary cells. Comparative transcytosis levels (%) of EHEC 
O157 TUV93−0 compared with an isogenic espF deletion mutant and complemented with 
espFO157 (pAT1, Table 2.2).(B) Comparative transcytosis leve s (%) of wild type strains: 
EPEC O127:H6 E2348/69, EHEC O157:H7 TUV93−0 and EHEC O26:H11 on interaction 
with bovine rectal primary cells. (C) Comparative transcytosis levels (%) of an EPEC 
O127DespF mutant complemented with the three defined espF alleles. * & *** indicate a 
statistical significance of P<0.05 and P<0.001, respectively.  
 

























Fig. 3.2.8c Interaction of EHEC and EPEC strains with cultured epithelial cells 
from the bovine terminal rectum (internalization). (A) espF limits EHEC O157 
TUV93-0 uptake into rectal primary cells. Intracellular levels of EHEC O157 TUV93-0 
compared with an isogenic espF deletion mutant and complemented with espFO157 (pAT1, 
Table 2.2). (B) Comparative intracellular levels of wild type strains: EPEC O127:H6 
E2348/69, EHEC O157:H7 TUV93-0 and EHEC O26:H11 on interaction with bovine rectal 
primary cells. (C) Comparative intracellular levels of an EPEC O127DespF mutant 
complemented with the three defined spF alleles. *&*** indicate a statistical significance 
of P<0.05 and P<0.001, respectively.  
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3.2.9 Molecular basis to the comparative activity o f EHEC and EPEC 
espF alleles 
Previous work has established that EspF has a number of interacting partners in 
eukaryotic cells including interactions with both Sorting Nexin 9 (SNX9) and N-
WASP. As SNX9 is important for endocytosis dynamics and N-WASP is central to 
actin polymerization, we investigated by LUMIER bindi g assay whether 
differences in the interactions of the EspF variants with these proteins could account 
for the differences in functional levels measured in this study. To quantify the 
binding activity, the three EspF variants as well as their binding partners SNX9 
(human) and N-WASP (human) were cloned into plasmid that express either protein 
A-tagged proteins or Renilla luciferase fusion proteins (Fig. 3.2.9 a&b and Materials 
& Methods). Cell lysates containing both sets of tagged proteins were generated and 
then the protein A-tagged complexes removed using antibody-coated beads. Total 
fluorescence and captured fluorescence were measured and z-scores for each 
interaction calculated by comparison with a large bank of negative non-interacting 
controls (Barrios-Rodiles et al., 2005). The results confirmed the interaction of all 
the EspF variants with both SNX9 and N-WASP (Fig. 3.2.9 c). The EspF O157 
variant demonstrated a significantly weaker interaction with luciferase-linked SNX9 
compared to the other variants and had the lowest interaction score of the three with 





































Fig. 3.2.9a Gate way cloning of different espF alleles for protein- protein 
interaction:  Scanned image of gel red stained 1% TAE agarose gel which shows 
PCR amplification of of EPEC O127:H6  and EHEC serotypes O157:H7 and 
O26:H11 respectively. BanII digests of different espF clones in the entry vector 
pDONR 207 and cloning of these three alleles into different destination vectors to 
create expression clones. XhoI and XbaI digests of different ORF clones in the 
pcDNARenilla. XhoI and NheI digests of different ORF clone into PTREX. Lane M 
contains 1 kbp plus DNA ladder (Invitrogen). Lane 1-3 espF of EPEC O127:H6 and 

























Fig 3.2.9b Gateway cloning of NWASP and SNX9 alleles for protein- protein 
interaction studies: Scanned image of gel red stained 1% TAE agarose gel which 
shows XhoI and XbaI digests of NWASP and SNX9 clones in the entry vector 
pDONR 223 and cloning of these two alleles into different destination vectors to 
create expression clones. XhoI and XbaI digests of different ORF clones in the 
pcDNARenilla. XhoI and NheI digests of different ORF clone into PTREX. Lane M 
contains 1 kbp plus DNA ladder (Invitrogen). 
 
A                   B                    C



























Fig 3.2.9c EspF and human SNX9 or NWASP interaction in the LUMIER 
binding assay.the espF alleles were expressed with a protein A tag and then 
immobilized on immunoglobulin beads. SNX9 and N-WASP were expressed with 
Renilla luciferase tags and incubated with the immobilized EspF variants. The 
luminescence signals were measured and z-scores calculated by subtracting the 
population mean from an individual raw score and then dividing the difference by the 
population standard deviation. FOS Jun used as control positive. 
 
_______________________________________________Results Chapter 3 
 128 
3.3 DISCUSSION 
Enteropathogenic Escherichia coli is known to inhibit phagocytosis via inhibition of 
PI 3-kinase activity and this has been shown to be due to the activity of the type III 
secreted effector EspF (Celli et al., 2001; Quitard et al., 2006). While more recent 
research has established that a number of secreted proteins can also function to 
inhibit uptake into cells, including EspB  (Iizumi et al., 2007), EspJ (Marchès et al., 
2008) and EspH (Dong et al., 2010). The inhibition of EPEC translocation through 
M-cells has been shown to be dependent on espF, presumably in a manner analogous 
to its activity on macrophages. Comparison of EspF protein sequences from EPEC 
O127, EHEC O26, and EHEC O157 shows a number of differences in both the 
localization domain and in the number and sequence of proline-rich repeats. The aim 
of this study was to investigate if these differencs affected the capacity of the EspF 
variants to: (i) inhibit bacterial phagocytosis into macrophages; (ii) inhibit M-cell 
translocation in a human-derived Caco-2/Raji-B co-culture system; (iii) inhibit 
uptake into bovine primary epithelium, containing M-like cells, cultured from the 
terminal rectum of cattle, the predominant colonisation site of EHEC O157:H7 in 
cattle.   
Strain comparisons demonstrated that both EPEC O127 E2348/69 and E. coli 
O26:H11 had a much greater capacity to block non-opsonized phagocytosis into 
cultured murine macrophages when compared with EHEC O157:H7. Both the EHEC 
O157 and EHEC O26 strains adhered to the macrophages t lower levels than the 
EPEC O127 strain (Fig. 3.2.1 A-C). To determine whether this strain difference 
could be accounted for by variation in the EspF effector protein, the genes from the 
three serogroups, EPEC O127, EHEC O157, and EHEC O26 were cloned and 
expressed in EPEC O127 that was deleted for espF. While the espF alleles from both 
O127 and O26 completely complemented the mutant, the espFO157 allele showed a 
significantly reduced ability to block phagocytosis. This indicates that the initial 
strain observations may be accounted for by differences in the espF alleles. This 
result does not rule out important anti-phagocytic functions for the other effector 
proteins but does indicate synergistic roles with EspF and a significant dependence 
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on EspF. The different alleles did not alter the leve  of attachment of the 
complemented EPEC strain to Caco-2 cells in line with previous research that 
indicates EspF has no direct role in attachment as well as attaching and effacing 
lesion formation (McNamara & Donnenberg, 1998; Naylor et al., 2005b; Shaw et 
al., 2005). 
It was then investigated whether the different spF alleles varied in their capacity to 
inhibit E. coli translocation through M-cells. The rationale for investigating this 
function is the finding that EHEC O157:H7 predominately colonizes the terminal 
rectum of its main reservoir host, cattle, and thatis site is rich in lymphoid follicles 
(Naylor et al., 2003). Epithelium associated with lymphoid follicles is subject to 
different signals from the high abundance of B and T cells in these follicles leading 
to production of M-cells (Guttman et al., 2007) that sample lumen particles from the 
gut, delivering them to antigen presenting cells that initiate appropriate adaptive 
immune responses at these sites. M-cells have been postulated to be an important cell 
for the initial uptake or colonisation by different enteric bacterial pathogens such as 
Salmonella, Shigella and E. coli ( Kohbata et al., 1986; Jensen et al., 1998). For 
EHEC O157:H7, it is a cell type that the bacteria wll encounter when colonizing the 
terminal rectum ( Naylor et al., 2003; Mahajan et al., 2005) and consequently 
inhibiting translocation may promote colonisation fr example by providing an initial 
attachment site and/or limiting bacterial presentation o the host’s immune system. 
The origin of M-cells is unclear as studies either support their derivation from 
enterocytes via extrinsic stimuli (lumenal antigens a d/or lymphoid-follicle derived 
signals) or conclude that they originate from lineag  specific precursor cells (Smith 
& Peacock, 1980; Savidge & Smith, 1995; Savidge, 1996; Gebert et al., 1999). An 
M-cell co-culture system was first defined in 1997 (Kerneis et al., 1997) and makes 
use of the capacity of Raji-B cells to signal differentiation of human colon-derived 
Caco-2 cells. Initial experiments demonstrated that espF from EHEC O157 is 
required to limit EHEC O157 translocation through M-cells but that the EHEC O157 
espF allele was again reduced in its capacity to limit translocation of E. coli when 
compared with the O127 and O26 alleles. This finding mirrored the relative capacity 
of the specific strains to inhibit their translocation, again demonstrating the 
significance of the spF allele for the strain phenotype.  
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The strains and espF alleles were then compared on primary cells cultured from 
crypts isolated from the bovine terminal rectum. These cultures were further 
characterised in this study. A subset of the primary cells expressed the intermediate 
filament protein, vimentin, that is found in rabbit intestinal M-cells (Clark et al., 
1993). M-cells in the terminal rectum of cattle have been demonstrated to express 
vimentin as the predominant intermediate filament pro ein (Mahajan et al., 2005) and 
the same staining was apparent in the cultured primary cells. A subset of vimentin 
expressing cells were also able to take up S. Typhimurium (Fig. 3.2.8a D), and S. 
Typhimurium and beads together (Fig. 3.2.8a E). Therefore, the bovine rectal 
primary cultures contain a subset of cells that expr ss vimentin and have 
characteristics of M-cells. There was a significant role for espF in inhibiting bacterial 
uptake into cells and translocation through these cells and the activity of the strains 
correlated with that of the spF alleles.  An important result was that in contrast to 
the previous experiments on mouse macrophages and the human-derived M-cell co-
culture system, EHEC O157 was the most effective strain at inhibiting uptake and 
translocation and this correlated with the relative activity of the espF alleles (Fig. 
3.2.8b). Taken together the results indicate that EHEC O157 and the spFO157 allele 
are more effective at inhibiting uptake into bovine M-cells compared with the O26 
and O127 strains and alleles, a reversal of the situation observed for the interactions 
with murine macrophages and the human co-culture system. 
There are multiple phenotypes associated with EspF in addition to inhibition of 
phagocytosis, including inhibition of water transport and disruption of tight junctions 
mitochondria and the nucleolus (Viswanathan et al., 2004a). Uptake functions are 
likely to be related to EspF interactions with N-WASP and Sorting Nexin 9 (SNX9) 
(Alto et al., 2007). N-WASP stimulates actin filament assembly by direct activation 
of the Arp2/3 complex and SNX9 is essential for clathrin-coated pits (CCPs) at the 
late stages of vesicle formation. SNX9 binds to β2-appendages of adaptor protein 
complex 2 (AP-2) and interacts with clathrin and dynamin-2, two other important 
molecules in the endocytic process (Lundmark & Carlsson, 2003; Soulet et al., 
2005). SNX9 has two lipid interaction domains; a phospholipid-binding region 
termed the phox (PX) domain followed by a putative Bin/Amphiphysin/Rvs (BAR) 
lipid-binding domain. The BAR domain is a banana-shped helical dimer that senses 
_______________________________________________Results Chapter 3 
 131 
membrane curvature and can reconfigure lipid vesicl or sheets into membrane 
tubules (Alto et al., 2007). SNX9 also possesses an N-terminal Src homology-3 
(SH3) protein interaction region that was recently shown to bind WASP (Badour et 
al., 2004) and to functionally activate dynamin at CCPs. Therefore, SNX9 is an 
important factor in re-modelling the membrane and cytoskeletal during endocytosis 
(Alto et al., 2007; Soulet et al., 2005). The SH3 domain of SNX9 binds to the PPRRs 
of EspF (Dean et al., 2010).  Despite both direct and indirect (via SNX9) activation 
of N-WASP, EspF is not considered to have a role in A/E lesion formation 
(McNamara et al., 2001; McNamara & Donnenberg, 1998). To determine if the 
different EspF variants have different affinities for SNX9 and N-WASP, the 
interactions were assayed inside transfected HEK293 cells using a LUMIER assay 
(Barrios-Rodiles et al., 2005) and described in Materials and Methods. This assay 
confirmed that all three EspF variants bound to both N-WASP and SNX9, although 
EspFO157 showed a lower affinity for SNX9 and for N-WASP bycomparison with 
the other two variants.  A specific region in the PRRs of EspF (shaded grey in Fig. 
3.2.2b) interacts directly with SNX9 through its SH3 domain–binding motif. There 
are only minor differences in this region between the serotypes examined in this 
study and we cannot determine whether these or their pr sentation, due to sequence 
changes in flanking regions, account for the differences observed.   
The published Bos taurus sequence for SNX9 (NCBI) contains a number of changes 
over the human variant used in the LUMIER assays, however these differences are 
mainly present in the amino terminus of the predicted bovine SNX9 and lie outside 
the SH3 domain. There are also very few sequence differences between the predicted 
Bos taurus N-WASP protein sequence (NCBI) and the human variant. Taken 
together, our results indicate that there are likely to be other protein interactions 
involving EspF that could also contribute to the host specificity demonstrated in this 
study. The greatest region of diversity between the variants lies in the motif adjacent 
to the first PRR, with no established function for this EspF region. Future work will 
aim to identify other interacting partners for EspF and address how important M-cell 
interactions are for colonisation of cattle at the erminal rectum or whether other 
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4. Identification of host proteins interacting with Es pF 
4.1 INTRODUCTION 
EspF, a LEE-encoded effector protein is translocated into host cells in a T3S system 
dependent manner. EspFO127 disrupts tight junctions, causes an increase in 
mitochondrial membrane permeabilization leading to cell death, inhibits bacterial 
uptake by macrophages and restricts translocation across antigen sampling M-cells in 
the gut. From the previous results chapter LUMIER binding assays demonstrated 
differences in the interactions of the EspF variants with SNX9 and N-WASP; it may 
be that other yet uncharacterized interactions may contribute to the host-based 
variation in EspF activity determined in this study.  
 
In this study, protein-protein interactions for three EspF variants from EHEC O157 
EHEC O26 and EPEC O127 were analysed using yeast -2- hybrid approaches.   
     Protein-protein interactions underlie many biological systems and global 
screening techniques to identify specific protein-protein interactions have been 
developed. The most established of these is Yeast 2-hybrid screening that, despite 
limitations, is still an excellent and evolving system for high-throughput screening of 
interactions.  The Y2H approach is based on the Gal4-b sed yeast-two-hybrid (Y2H) 
system (Fields & Song, 1989). The bait proteins are fus d to the Gal4 DNA binding 
domain and the ‘prey’ proteins to the Gal4 activation domain. If the bait and the prey 
interact then this generates an active transcription factor activity leading to the 
expression of an easily detected reporter gene. Major advances in the technique have 
allowed it to be used in yeast mating protocols that can be automated (Fromont-
Racine et al., 1997). Another major advance that has facilitated the approach has 
been the ease with which large libraries can be created and relevant DNA sequences 
sub-cloned using the Gateway recombinational cloning (Walhout et al., 2000). While 
these high- throughput techniques have been applied to xamine protein interactions 
within a single species (Rain et al., 2001; LaCount et al., 2005), there is increasing 
use of the technique to screen individual targets against ‘host’ organism cDNA 
libraries.  





Figure 4.1 The yeast-two-hybrid system. The binding domain (BD) of the yeast 
transcription factor GAL4 fused with the protein to be screened (X) in bait. The 
protein liberary to be identified as interactors (Y) was fused to activating domain 
(AD) of the yeast trancretion factor GAL4. If X and Y interact together, the activity 
of the transcretion factor will be  reconstituted and initiating the transcription of a 
gene under regulation of the up-stream activation sequence (UAS) (Fields & Song, 
1989). 
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Applied to infectious disease research, there have been a number of studies that have 
taken specific proteins from the infectious agent and identified interacting proteins 
from human protein libraries. 
From this, tremendous progress has been made in understanding the molecular basis 
of the disease, process, for example in the field of enteropathogenic E. coli disease 
(Hemrajani et al., 2010; Shames et al., 2010). 
Furthermore, once libraries are created then the identified interacting partners can 
easily be sub-cloned into a variety of vectors to all w the interactions to be verified 
and the biology to be investigated. Several Y2H screens in the recent years have 
identified very important interactions that have been crucial in understanding EHEC 
O157:H7 pathogenesis. The type III secretion system of EHEC O157:H7 translocates 
approximately 50 proteins into host cells that contribu e to bacterial persistence and 
shedding.  The functions of these ‘effector’ proteins are being elucidated in several 
labs across the world. The Y2H assay has previously been used to identify that EspF 
interacts with the eukaryotic proteins Cytokeratin 18, N-WASP and Sorting Nexin 9 
(SNX9). Subsequent work has aimed to elucidate the importance of these 
interactions for bacterial colonization of intestinal cells ( Viswanathan et al., 2004b; 
Marchès et al., 2006; Alto et al., 2007). 
The aim of this work is the identification of host specific proteins that interact with 
the EspF secreted effector protein from EHEC O157:H7 and to confirm any 
interactions with co-localisation studies.  
 
4.2 RESULTS 
4.2.1 Gateway cloning of different espF alleles 
4.2.1.1 Cloning of espF alleles into the pDONR 207 vector 
espF alleles were amplified using primers (27&28) for EPEC and EHEC O157:H7 
espF and primer (25&26) for EHEC O26:H11 espF. The PCR products were purified 
before being cloned into the donor vector according to the manufacturer’s 
instructions to form the entry clones. These entry clones can be easily subcloned into 
different destination and expression vectors to be us d for different purposes. The 
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cloning into the pDONR 207 vector was initially confirmed by restriction digestion 
with BanII enzyme (Fig. 4.2a). MAD2L2 and NFIC were cloned into the pDONR 
223 vector by Prof.  Juergen Haas, University of Edinburgh, UK initially and I 
confirmed this clones by restriction digest with XbaI and NheI enzymes and 
sequencing. 
4.2.1.2 Sub-cloning of espF from entry clones into multiple destination 
vectors 
4.2.1.2a Plasmids for Y2H and Co-IP 
In order to use the Y2H system to investigate interactions between EspF proteins and 
eukaryotic proteins, espF entry clones were sub-cloned into the Y2H bait pGBKT7- 
DEST and the eukaryotic entry clones library was sub-cloned into the prey vector 
pGADT7-DEST. Both vectors are destination vectors with different resistance genes, 
ampicillin in case of the prey vector and kanamycin for the bait vector. The prey and 
bait clones were confirmed by a double restriction digest using EcoRI and BamHI 
restriction enzymes (Fig. 4.2a   and 4.2b respectively). 
 
4.2.1.2b Plasmids for LUMIER pull-down assay 
In order to use LUMIER pull-down assay for validation of interactions, a subset of 
EspF, and specific identified target eukaryotic proteins (Mad2L2 and NFIC) were 
sub-cloned from the pDONR 207 or pDONR 223 entry clones into the LUMIER 
Renilla and protein A-tagged vectors pcDNA-Renilla and pT-REx-A (Fig 4.2a and 
4.2b, respectively). Both vectors are expression vectors with an ampicillin resistance. 
The Renilla-tagged clones were confirmed by a double restriction digest using XhoI 
and XbaI restriction enzymes, and the protein A-tagged clones were confirmed by a 
double restriction digest using XhoI and NheI restriction enzymes (Fig. 4.2a and 
4.2b, respectively). 
 
4.2.1.2c Plasmids for eukaryotic transient-expressi on to validate the 
Y2H positive interaction 
In order examine possible  EspF co-localisation with identified eukaryotic targets 
(Mad2L2 and NFIC) in the cell, the spF entry clones were sub-cloned into the N-
terminal GFP-tagged peGFP-DEST vector that contain k namycin resistant cassettes.  






















Fig 4.2a Gateway cloning of different espF alleles to study protein-protein 
interactions.  Scanned image of gel red stained 1% TAE agarose gel which shows 
PCR amplification of the three different espF alleles, from EPEC O127:H6 and 
EHEC serotypes O157:H7 and O26:H11 respectively (A). BanII digests of different 
espF clones in the entry vector pDONR 207 (B) and cloning of these three alleles 
into different destination vectors to create expression clones. EcoRI and BamHI 
digest of different ORF clones in Bait (C).  EcoRI and BamHI digest of different 
espF clones in the peGFP vector (C). XhoI and XbaI digests of different ORF clones 
in the pcDNARenilla (D). XhoI and NheI digests of different ORF clone into PTREX 
(D). Lane M contains 1 kbp plus DNA ladder (Invitrogen) Lanes 1-3 espF of EPEC 

































Fig 4.2b Gateway cloning of Mad2L2 and NFIC genes for protein-protein 
interaction studies: Scanned image of gel red stained 1% TAE agarose gel which shows 
XhoI and XbaI digests of mad2L2 and nfiC clones in the entry vector pDONR 223 (A)and 
cloning of these two alleles into different destination vectors to create expression clones. 
EcoRI and BamHI digests of different ORF clones in Bait and prey(B&C). XhoI and XbaI 
digests of different ORF clones in the pcDNARenilla(D). XhoI and NheI digests of different 
ORF clone into PTREX (E). EcoRI and BamHI digests of different ORF clone into PDSred 
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The expression clones were confirmed by a double restriction digest using EcoRI and 
BamHI (Fig. 4.2b). On the other hand, Mad2L2 and NFIC entry clones were sub-
cloned into the N-terminal PD tagged pDSRED2-DEST containing kanamycin 
resistant cassettes. Clones were confirmed by a double restriction digest using XhoI 
and NheI restriction enzymes (Fig. 4.2b). 
 
4.2.3 Y2H screening to identify eukaryotic proteins  that interact with 
EspF 
To identify physical interactions occurring between EspF and different eukaryotic 
cell proteins, different EspF bait clones were screened against a human cDNA prey 
library using the yeast two-hybrid system. Both theEspF bait clones and human 
cDNA prey clones library were transformed into compatible yeast strains. Two 
different yeast strains were used to generate Y2H prey and bait arrays, AH109 (α 
mating type) for the preys and Y187 (α mating type) for the baits. The transformed 
prey clones were grown on plates of mating media lacking leucine and the 
transformed bait clones were grown on plates of mating media lacking tryptophan. 
The vectors have the appropriate cassettes that allow the transformed yeast to grow 
on the selective plate lacking the appropriate amino acid (Prey plasmid pGBKT7 
contains Trp gene that enable AH109 to grow on Leu-v , Trp+ve plates. Bait plasmid 
pGADT7 contains Leu gene that help Y187 grow on Trp –ve, Leu +ve plates. These 
two strains were allowed to mate together and if the mating success the new clone 
can grow on the double-selection –LW SD/5% YPDA; minus Leucin and minus 
Trptophan. For different EspFs screen: Yeast strain Y187 for Prey and Yeast strain 
AH109 for Bait). The transformed yeast clones were t sted in collaboration with Dr. 
Peter Uetz and Thorsten Stellberger at the Institute of Toxicology and Genetics, 
Karlsruhe, Germany, in a robot-assisted Y2H assay in 96- well plate format. In a 
matrix analysis, all EspF and human cell proteins were tested against each other. 
Since the Y2H assay can generate a number of false po itive interactions, each 
pairwise interaction was tested in duplicates. If two of the matings were positive the 
interactions were scored as positive. If only one replicate was positive, the 
interaction was scored non-reproducible and negative. The positive results from the 
Y2H array were visualised and analysed using Cytoscape bioinformatics software



















Fig 4.2.2e Comparative binding analysis between EspF variants and human 
Mad2L2. In the LUMIER binding assay the spF alleles were expressed with a 
protein A tag and then immobilized on immunoglobulin beads while Mad2L2 was 
expressed with Renilla and incubated with the immobilized EspF variants. The 
luminescence signals were measured and z-scores calculated by subtracting the 
population mean from an individual raw score and then dividing the difference by 
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Screening of yeast transformants yielded two positive hits for EspF of EHEC 
O157:H7 and one positive for EspF from EHEC O26:H11, but not interactions for 
EspF from EPEC O27:H6. The two interactions for EspFO157 were with the CCAA-
binding transcription factor (NFIC) and actin2. EspFO26 interacted with the mitotic 
arrest-like 2 (MAD2L2) protein. 
 
4.2.4 LUMIER binding assays  
To confirm the interaction of EspFO26 with Mad2L2 and establish whether the other 
variants could also interact with it, the three EspF variants and Mad2L2 (human) 
were cloned into plasmids that produce either protein A-tagged proteins or Renilla 
luciferase fusion proteins as described in Materials nd Methods. Cell lysates 
containing query luciferase fusions and protein A-tagged proteins were generated 
and then the protein A-tagged complexes removed using antibody-coated beads. 
Total fluorescence and captured fluorescence were measured and z-scores for each 
interaction calculated by comparison with a large bank of negative non-interacting 
controls (Barrios-Rodiles et al., 2005). The results demonstrated that all the EspF 
variants were interacting with Mad2L2 (Fig 4.2.2e). The work was done in 
collaboration with Dr Manfred Koegl and Gibriellia Siszler. 
 
4.2.5 Confocal microscopy to validate the interacti on of EspF and 
Mad2L2 
To confirm the co-localization of EspF and Mad2L2 proteins. HEK93 cells grown on 
chamber glass slide were transfected with an EspF N-terminal GFP tagged 
expression plasmid (pAT11-13), and a Mad2L2 DSred tagged expression plasmid 
(pAT20). 72 hr after transfection, cells were fixed, stained with DAPI and examined 
by fluorescence microscopy. The images indicate co-lo alisation of EspF and 
Mad2L2 in the nucleus (Fig 4.2.2f). 
 
4.2.6 Purification of His-tagged EspF 
The EHEC O157:H7 espF allele was amplified from genomic DNA using Expand 
DNA polymerase and the primers (19&20) Table 2.3.












Fig 4.2.2f  Confocal microscopy to validate the interaction of EspF and Mad2L2 
Cells were transfected with the expression plasmid peGFP-DEST (Promega) 
expressing EspF tagged to GFP, and pDSRED2-DEST (Promega) expressing DS 
red-tagged Mad2L2. After 72 hr, the cells were fixed and permeabilized with 2% 
(w/v) formalin / 0.25% (v/v) Triton X-100. The cells were incubated with DAPI 
1/5000 to stain the nucleus (blue). The slides mounted in fluorescence mounting 
medium (DAKO). The pictures were acquired using a Leica TCS NT confocal 








Fig 4.2.2g  Confocal microscopy to validate the interaction of EspF and NFIC. 
Caco-2 cells were transfected with pAT11 expressing GFP-tagged EspF expression 
plasmid peGFP-DEST (Promega), and DS red -tag NFIC expression plasmid 
pDSRED2-DEST (Promega). After 72 hr, the cells were fix d and permeabilized 
with 2% (w/v) formalin / 0.25% (v/v) Triton X-100. The cells were incubated with 
DAPI 1/5000 to stain the nucleus (blue). The slides mounted in fluorescence 
mounting medium (DAKO). The pictures were acquired using a Leica TCS NT 
confocal system (x 63 objective).   
 
EspF GFP                  NFIC DS red                Nucleus        Merge
EspF GFP                     Mad2L2 DS red                     Nucleus                      Merge




















Fig 4.2.2h Purification of E. coli O157:H7 histidine-tagged EspF (A) Diagnostic 
digests of pET21-d clones of EHEC O157:H7 espF obtained by digestion with XbaI 
and XhoI as described in Materials and Methods. Electrophoresis was carried out 
through a 0.8% agarose gel. Lane M, 1Kb DNA ladder. Successful clones (lanes 1 & 
2) contain a 700bp band. (B) SDS PAGE gel of whole cell lysate from BL21 with 
pET21-D-espFO157 before and after IPTG induction. (C) Western blot analysis of the 
same samples using anti polyhistidine antibody.  
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The PCR product was purified and cloned into pET-21d by digesting both PCR and 
vector with XbaI/XhoI (New England Biolabs, Inc.) to obtain a plasmid that can 
express a polyhistidine-tagged EspF fusion protein-EspF-His. E. coli BL21/DE3 was 
transformed with pespF-His to optimize expression of EspF-His induction with 
IPTG. The culture was centrifuged and the lysate was obtained by sonication in 
lysate buffer. The EspF-His was purified using a nickel column resin, dialyzed in 
PBS and then stored at -20 °C. 
 
4.2.7 Discussion 
Both enteropathogenic and enterohemorrhagic E. coli persist in human or animal 
hosts by attachment to epithelial cells that line th gastrointestinal tract. Type III 
secreted effector proteins manipulate the actin cytoskeleton and innate responses of 
host cells to promote intimate bacterial attachment a d persistence The well 
characterized translocated effector protein EspF is as ociated with tight junction 
disruption, water channel dysregulation and inhibition of bacterial uptake into M-
cells.  It localizes to both mitochondria and the nucleolus and is known to interact 
with Sorting Nexin 9, N-WASP and Abcf2.  In this study yeast-2-hybrid screening 
was used to identify additional host proteins that may interact with EspF. The 
anaphase promoting complex inhibitor, Mad2L2, was identified from this screen. 
Mad2L2 was then demonstrated to interact with EspF variants from EHEC O157:H7, 
O26:H11 and EPEC O127:H6 by Lumier assays in which Protein A-tagged EspF 
was recovered from transfected cell lysates attached to luciferase linked Mad2L2, the 
reciprocal approach also confirmed the specificity of the interaction. EspF was also 
shown to co-localise with Mad2L2 in cells and the impact of EspF on the cell cycle 
will be investigated in the future work. While Mad2L2 has been shown to be targeted 
by the non homologous Shigella effector protein IpaB to limit epithelial cell 
turnover, I hypothesis that the interaction of EspF with MAD2L2 might have a 
similar function to promote EPEC and EHEC colonization. 
MAD2L2 is also known as Mad2-related protein and is an inhibitor of the anaphase 
promoting complex (APC)-Cdh1 (Pfleger t al., 2001). Activation of APC during 
interphase (G1/S) leads to cell cycle arrest at G2/M. MAD2L Cdh1 binding inhibits 
the activity of the Cdh1-APC complex and, thus, functions as a mitotic spindle 
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assembly checkpoint protein, preventing the onset of anaphase until all chromosomes 
are properly aligned at the metaphase plate. Mad2L2 plays a pivotal role in 
translational DNA synthesis (TLS) in S phase (Cheung et al., 2006) and it also 
participates in the spindle assembly checkpoint, similarly to Mad2 (Reimann et al., 
2001) . 
Shigella IpaB was shown to sequester MAD2L2 away from the APC-Cdh1 complex, 
leading to unregulated APC activity during interphase and subsequent cell cycle 
arrest (Table 1.1 Introduction & Iwai et al., 2007). Cell division plays an essential 
role in the innate immune defense against infection as the rapid turnover of epithelial 
cells limits bacterial colonization. It is possible that slowing this turnover could 
prolong bacterial colonization by inceraese the ability of bacteria to multiply  (Iwai et 
al., 2007). 
MAD2L2 has been shown to bind to TCF4-catenin complex that inhibit cell 
proliferation and enhance differentiation of epithelium cells to mesenchymal cells 
EMT (Naishiro et al., 2001; Hong et al., 2009).The binding of MAD2L2 to TCF4-
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5. Interaction of Salmonella Typhimurium with intestinal epithelial cell 
5.1 Introduction 
5.1.1 The intestinal immune system  
The intestinal immune system must defend against the many infectious and toxic 
assaults that may breach the epithelium and cause intestinal injury. The intestinal 
immune system must simultaneously ignore the multitude of commensal organisms 
and dietary antigens that are not threats to the host.
To deal with this challenge, the gut-associated lymphoid tissue has evolved several 
important modifications of antigen sampling and processing, humoral immunity, and 
cellular immunity.  These include flattened epithelial “microfold cells” that are a 
kind of intestinal epithelial cell in the follicle-associated epithelium of Peyer’s 
patches. These cells can transport antigens and micro-organisms into underlying 
lymphoid tissues. The basal membrane of M cells is invaginated to form a pocket 
where cells of haematopoietic origin such as dendritic cells, macrophages, and 
lymphocytes in intimate contact with extruded antigen or intact organisms (Gebert, 
1997). All of these cell types play a fundamental role in M cell differentiation 
(Ermak & Owen, 1986). M cells actively pinocytose luminal antigens but do not 
possess lysosomes, so antigens are not degraded or processed (Czerkinsky et al., 
1999). Although intact commensal bacteria are rarely engulfed, numerous pathogens, 
including human immunodeficiency virus  (Knoop et al., 2009), reoviruses, Vibrio 
cholerae, and Shigella species, selectively adhere to M cells, possibly through 
specialized carbohydrate- binding mechanisms, and are transported without 
degradation  (Owen et al., 1986a; Owen et al., 1986b). M-cells generally lack the 
distinct microvilli and thick filamentous brush border glycocalyx (Owen et al., 1977; 
Frey et al., 1996) and instead have variable microfolds. That morphological change 
on M cells surface is regulated by the distribution of microvillar proteins such as 
actin and villin (Kerneis et al., 1997; Kanaya et al., 2008). Therefore, the 
disorganization of microvilli in M cells is not only a typical morphology of this cell 
type but also essential for the transcytosis of macromolecules. In particular, the 
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crucial role of lymphocytes in M cell differentiation has been demonstrated in vitro 
by M cell models using human colon adeno-carcinoma cell line Caco-2 cells and 
murine intestinal crypt-derived cell-line mICcl2 cells ( Kerneis et al., 1997; El Bahi 
et al., 2002). Caco-2 cells differentiate into cells resembling M cells during co-
culture with Peyer’s patches (PPL) or Raji B cells. These M-like cells have some of 
the in vivo characteristics, such as transcytosis activity, a decrease of sucrase-
isomaltase and villin expression, disorganization of microvilli and a change of β-1 
integrin localization (Kerneis et al., 1997). Murine intestinal epithelial cell line 
(MIE) is able to differentiate into M cells following co-culture with intestinal 
lymphocytes or PPL co-stimulated with anti-CD3/CD28 mAbs. Following this, these 
cells display features typical of M cells, such as transcytosis activity, the 
disorganization of microvilli,  enhanced expression of annexin V and Sgne-1, which 
are thought to be markers for M cells (Verbrugghe et al., 2006; Kanaya et al., 2008).  
 
5.1.2 M cell development  
M cells arise from pluripotential epithelial stem cells in adjacent crypts and migrate 
to the follicle-associated epithelium, where they differentiate into their distinctive 
phenotypes under the influence of the lymphotoxin β receptor (Kraehenbuhl & 
Neutra, 2000; Debard et al., 2001). Interaction of Peyer’s patch lymphocytes, 
particularly B cells, facilitates M cell differentia ion, (Kerneis et al., 1997) but M 
cells develop in Rag- 1-/- mice, which lack T and B lymphocytes, indicating that 
lymphotoxin can arise from other sources (Debard et al., 2001).  
 
Certain microbes appear to exploit the innate plasticity of epithelial cells to trigger 
their transformation into a cell phenotype that suits their habitat or life style. S. 
Typhimurium can activate different pathways of cellular differentiation to transform 
a subset of epithelial cells to cells that phenotypically and functionally resemble to 
specialized antigen sampling microfold/M cells in the gut (Savidge t al., 1991).  
Other numerous studies have reported an increased M cell number and/ or enhanced 
trancytosis activity at the FAE following microbial challenge. In vivo studies in 
rabbit demonstrated an increased the number of cells which is morphologically and 
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functionally resembles to M cell phenotype following microbial challenge. The 
increased transcytosis of microspheres across FAE to PP tissues after challenge with 
Streptococcus pneumoniae could either be explained by induction of the M cell 
phenotype and/or an increased transport rate in already present M cells (Meynell et 
al., 1999b). Similar results have been shown in various n vitro models, for example, 
Y. pseudotuberculosis nduced a substantial increase in transcytosis of nanoparticles 
across Caco-2 monolayers, with only a very moderate eff ct on paracellular 
translocation (Ragnarsson et al., 2008). Campylobacter jejuni increased cells 
expressing the M cell-specific marker, galectin-9, in Caco-2 monolayers and reduced 
numbers of enterocytes that stained with the absorptive enterocyte marker, Ulex 
europaeus agglutinin-1, and reduced activities of enzymes typically associated with 
absorptive enterocytes (alkaline phosphatase, lactase, and sucrase). These cells are 
also functionally similar to m cell  phenotype as these cells were able to internalized 
commensal E. coli (Kalischuk et al., 2010). 
 
5.1.4 The wnt ( β-catenin) pathway  
Wnt is very important cell signalling pathway that ctivates target genes in the 
nucleus. Wnts are secreted glycoproteins that bind to frizzled seven 
transmembranespan receptors. under normal conditions, W t is not activated, which 
lead to a degradation of cytosolic β-catenin(Jamora et al., 2003; Waterman, 2004). 
Normally, β-catenin is phosphorylated by casein kinase Iα (CKIα) and/or CKIϵ at 
Ser45. This in turn enables glycogen synthase kinase 3β (GSK3β) to phosphorylate 
serine/threonine residues 41, 37 and 33 of β-catenin. Phosphorylation of these last 
two residues triggers ubiquitylation of β-catenin by βTrCP and degradation in 
proteosomes (Jamora et al., 2003; Waterman, 2004).  
Phosphorylation of β-catenin occurs in a multi-protein complex containing the 
scaffold protein axin, which can form a homodimer or a heterodimer with the related 
protein conductin/axin2. In the presence of Wnts, di hevelled (Dsh) blocks β-catenin 
degradation possibly via phosphorlation of GSK3β.  
Stabilised β-catenin enters the cell nucleus and associates with LEF/TCF 
transcription factors, which leads to the transcription of Wnt, target genes (Hülsken 
& Behrens, 2000). 





















Fig. 5.1.4 Activation of Wnt pathway stimulates EMT.  
(a) under normal conditions Wnt is not expressed an Dsh dose not phosporylate 
GSK3 β. β-catenin is phosphorylated by GSK3 β leading to its degredation by the 
proteosome. (b) Wnt is activated and binds to receptor  frizzled that activate Dsh lead 
to phosphorylation of GSK3 β (inactivation) and the β-catenin increase in the 
cytoplasm and transolocated to the nucleus and ac as co factor for transcription factor 
TCF/LEF. This figure is derived directly from phm.utoronto.ca/angers/research.html 
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5.1.3 Epithelial-mesenchymal transition or transfor mation (EMT)  
EMT is physiologically important for the development especially in embryogenesis, 
in which epithelial cells acquire properties of mesenchymal cells (Thiery et al., 
2009). Pathologically, it may lead to metastasis and cancer formation (Geiger & 
Peeper, 2009). The most important cell signalling pathway involved in EMT are 
peptide growth factors, Src, Ras, Ets, integrin, Wnt/beta-catenin and Notch. The 
activation of one or more of these cell signalling activates the transcription factors 
Snail and Slug. Both of these proteins are transcriptional repressors of E-cadherin 
and their expression induces EMT (Larue & Bellacosa, 2005). The activation of the 
phosphatidylinositol 3' kinase (PI3K)/AKT also act as a central feature of EMT 
which is important during embryonic development (Larue & Bellacosa, 2005). The 
activated Akt induces a transcription factor, Snail, which is known to repress 
expression of the E-cadherin gene through inactivation of GSK3β. this leads to the 
accumulation of β-catenin in the cytoplasm which acts as a cofactor for the 
transcription factor LEF/TCF (lymphoid enhancer factor/T cell factor) (Grille et al., 
2003). 
 
The H. pylori injects the effector protein cytotoxin associated gne A (CagA) via a 
T4ss into epithelial cells, which stimulates multiple signal transduction pathways 
associated with EMT. H. pylori selectively activates β-catenin pathway that lead to 
accumulation of β-catenin in the nucleus. the translocated β-catenin work with 
TCF/LEF as transcription factor that mediate the  EMT and consequently lead to 
gastric ulcer (Murata-Kamiya et al., 2007).. 
 
Although many bacterial pathogens have been associated with increased numbers of 
M cells, there is no work that elucidates the underlying molecular mechanisms. 
Current work set out to test if bacterial pathogens can drive EMT mediated cellular 
transformation of epithelial cells in to M cell phenotype and hence their increased 
number following bacterial infection.  We have used a combination of cellular and 
molecular approaches to establish this unique featur  of host-pathogen interaction 
using S. Typhimurium a model organism. 
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5.2 Results 
We have identified both the key bacterial effector protein and the eukaryotic signal 
molecules that orchestrate epithelial cell transformation. S. Typhimurium 
preferentially targets antigen sampling M cells to enter the mucosal epithelium. Our 
results show that S. Typhimurium targets a subset of epithelial cells in intestinal 
crypts, associated with lymphoid follicular tissue, to a cell type that phenotypically 
and functionally resembles M cells in the gut.  
 
5.2.1 S. Typhimurium transforms intestinal epithelial cell s in to M cell 
phenotype in a RANKL dependent manner 
Previous in vivo studies in mice reported that a short term exposure (1-3 hours) to 
certain bacterial pathogens induced dramatic alterna io s of FAE, including a marked 
increase in operational M cells in topographically restricted areas of the FAE 
(Borghesi et al., 1996; Borghesi et al., 1999; Meynell et al., 1999). To investigate 
molecular basis to these observations we expanded on our findings about the role of 
RANKL in M cell biology/differentiation, and set out to test whether following 
bacterial challenge the increased M cell activity is RANKL mediated. To these end 
primary intestinal epithelial cells from terminal rectum were infected with S. 
Typhimurium, a bacterium known to preferentially target M cells, and analysed for 
the expression of RANKL. In time course infection studies with S. Typhimurium, it 
was observed a temporal increase both in protein and tr script levels of for RANKL 
as well as vimentin and Slug, markers associated with M cell phenotype and EMT, 
respectively (Fig. 5.2.1). In addition, the gradual decrease in E-cadherin expression 
(Fig. 5.2.3 A & B)  a feature associated with EMT (Larue & Bellacosa, 2005), that 
further confirms S. Typhimurium mediated epithelial cellular transformation in 
infected cultures.  
 
Since β-catenin/TCF can directly trans-activate RANKL (Shin et al., 2005), vimentin 
(Gilles et al., 2003) and Slug (Vallin et al., 2001), I explored the possibility if 
increased levels of these three proteins correspond to the levels of β-catenin.   
 





















Fig. 5.2.1 S. Typhimurium  induced temporal increase in mRNA expression of 
RANKL, RANK, Slug and Vimentin.  Terminal BRE cells were infected with S.
Typhimurium strain (SL1344) at 37oC, 5% CO2 for 10 min, extracellular bacteria 
were removed by washing and cells were incubated further for indicated time points. 
Following S. Typhimurium infection of epithelial cells, cell lysates were processed 
for preparation of RNA. CDNA was prepared from each sample and the PCR were 
performed using primer for RANKL, RANK, Slug and Vimentin. (Table 2.4 
Materials & Methods) GAPDH were used as a control for equal loading. Results are 
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Fig. 5.2.2 S. Typhimurium  induced temporal increase in protein level of 
RANKL, RANK, Slug and Vimentin. Terminal BRE cells were infected with 
Salmonella Typhimurium strain (SL1344) at 37oC, 5% Co2 for 10 min, extracellular 
bacteria were removed by washing and cells were incubated further for indicated 
time points. Following S. Typhimurium infection of epithelial cells, cell lysates were 
processed for immunoblotting. Immunblots were stripped and re-probed with panel 
of antibodies as indicated. Molecular mass standards (kDa) are indicated. actin were 
used as a control for equal loading. Results are repres ntative of three independent 
experiments. 


































Fig. 5.2.3 S. Typhimurium induces transformation of primary inte stinal 
epithelial cells. Heterogeneous population of epithelial cells in a primary cell culture 
from the bovine terminal rectum were isolated and cultured on 6 well plates 
(Materials and Methods). Five day old cultures were co-cultured with S. 
Typhimurium strain SL1344 for different time points. Suppression of tight junction 
protein E-cadherin was induced gradually and this was detected using 
immunobloting (A) and semiquantitative RT-PCR (B). Results are representative of 
three independent experiments.  































Fig. 5.2.4 S. Typhimurium affects subcellular localisation of beta-catenin. 
Heterogeneous population of epithelial cells in a primary cell culture from the bovine 
terminal rectum were isolated and cultured on 6 well plates (Materials and Methods). 
Five day old cultures were co-cultured with S. Typhimurium strain SL1344.  
Subcellular protein fractions were separated using a ProteoExtract kit (Materials and 
Methods).The samples were analysed by immunoblotting using anti- β catenin or 
anti-β-actin primary antibodies followed by HRP-conjugated secondary antibodies. 
Histone and actin were used as a control for equal loading. Results are representative 
of three independent experiments. 
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Fig. 5.2.5 S. Typhimurium challenge redistributributed β-catenin in Bovine 
Rectal epithelial cell. Heterogeneous population of epithelial cells in a primary cell 
culture from the bovine terminal rectum were isolated and cultured on glass cover 
slips (Materials and Methods). Five day old cultures were co-cultured with S. 
Typhimurium strain SL1344 for different time points. The cells were fixed and 
permeabilised in 2 %( v/v) formalin/ 0.2% (v/v) Triton X-100.  (A) control cells were 
stained for beta-catenin red in the tight junctions. (B-D) Infected cells were analysed 
for beta-catenin localisation in cellular compartments by immuno-fluorescence 
staining. Beta-catenin (red) primarily localised at the membranes in uninfected cells 
and during the course of infection (B) 10 min, (C) 30 min and (D) 60 min it was 
translocated to cytoplasm (arrow) and nucleus (blue). Images were acquired using 






















Fig. 5.2.6 S. Typhimurium enhances Slug expression and its localisation in the 
nucleus. Heterogeneous population of epithelial cells in a primary cell culture from 
the bovine terminal rectum were isolated and cultured on 6 well plates (materials and 
methods). Five day old cultures were co-cultured with S. Typhimurium strain 
SL1344. Subcellular protein fractions were separated using ProteoExtract kit 
(materials and methods).The samples were analysed by immunoblotting using 
antibodies as indicated. S. Typhimurium infection increased nuclear loclization f 
slug. Histone was used as a control for equal loading. Results are representative of 
three independent experiments. 
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Fig. 5.2.7 S. Typhimurium up-regulates the intra-nuclear transcription factor 
Slug in a Primary Bovine Rectal epithelial cell. Heterogeneous populations of 
epithelial cells in a primary cell culture from the bovine terminal rectum were 
isolated and cultured on glass cover slips (Materials and Methods). Five day old 
cultures were co-cultured with S. Typhimurium strain SL1344 for different time 
points. The cells were fixed and permeabilised in 2%( v/v) formalin/ 0.2% (v/v) 
Triton X-100.  (A) Cells expressed slug (red) in nucle s (blue), immunolabelling was 
done as described in Materials and Methods. (B-D) Gradual increase in Slug 
localisation following infection with S. Typhimurium (GFP- labelled) for the times 
shown.  Images were acquired using Zeiss Axiovert microscope, (objective x 63). 
Results are representative of three independent experiments
A B
C D
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Indeed, we observed a temporal increase in β-catenin levels that coincided with 
increased RANKL, Vimentin, RANK and Slug in time course S. Typhimurium 
infection experiments (Fig. 5.2.1). Following S. Typhimurium challenge, β-catenin 
was redistributributed to the nucleus as seen both via immunoblotting and 
immunofluorscence staining of infected epithelial cells Fig. 5.2.4 &5.2.5). The 
cytoplasmic and nuclear redistribution of β-catenin and the de novo expression of 
vimentin are frequently involved in the epithelial-to-mesenchymal transition 
associated with increased invasive/migratory properties of epithelial cells.   
 
Slug, a member of a zinc finger family of transcriptional/ repressors, is an established 
downstream mediator of the β-catenin/TCF pathway. Increased intranuclear 
accumulation of Slug functions as both a transcription repressor, for example E-
cadherin and activator, for example vimentin to promote EMT. Following S. 
Typhimurium challenge during initial stages of infection Slug was redistributed from 
the nucleus to the cytoplasm and during time course experments its levels 
significantly increased in the nucleus as seen both by immunoblotting and 
immunofluorscence staining of infected epithelial cel s (Fig. 5.2.6 & 5.2.7). 
 
5.3.1 S. Typhimurium but not E. coli K12 activates EMT  
To investigate if the EMT is activated specifically in the presence of pathogenic S. 
Typhimurium or it is non specific processes that can be induced by other non 
pathogenic bacteria such as E. coli K12. Terminal BRE cells were infected with 
wild-type S. Typhimurium (SL1344) or E. coli K12 (Zap 1167) strain and at 
incubated at 37oC, 5% Co2 for 3 h. The western blot results showed that the lev l of 
Vimentin was higher only with S. Typhimurium infection indicating that the EMT 
process is specific for S. Typhimurium infection but not for  E. coli K12 (Fig. 5.3.1). 
 
























Fig. 5.3.1 S. Typhimurium but not E. coli K12 activates the Wnt signalling 
pathway. Heterogeneous population of epithelial cells in a primary cell culture from 
the bovine terminal rectum were isolated and cultured on 6 well plates (Materials and 
Methods). Five day old Terminal BRE cells were infected wild-type S. Typhimurium 
(SL1344) or E. coli K12 (Zap 1167) strain and at incubated at 37oC, 5% Co2 for 3 
hrs. The cell lysates were processed for Western blotting as indicated. Immunblots 
were stripped and re-probed with panel of antibodies as indicated. Molecular mass 
standards (kDa) are indicated. Actin was used as a control for equal loading.  Graph 
represent mean -fold changes of band intensity from two separate experiments ± S.E. 
with the value of control as 1 arbitrary. Western blot films were quantified using 
Quantity One software (Bio-Rad, Richmond, CA), and each sample was normalised 
using the actin signal. 
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5.4 S. Typhimurium induced ultra-structural changes and E MT in the 
epithelial architecture  
To examine if the observed changes in EMT markers co elate with morphogenic 
modifications, the S. Typhimurium infected intestinal epithelial cells were processed 
for ultrastructural studies. Unaffected control epithelial cells were marked by the 
presence of dense microvilli as seen in the Fig. 5.4 1. Following S. Typhimurium 
challenge we observed a stark loss of microvilli, seen as “baldy patches” on infected 
cells. Some of the acutely infected cells showed a complete loss of microvilli. Time 
course infection studies demonstrated acute morphological and structural changes in 
infected cells.  
To further investigate whether S. Typhimurium mediated increase in number of 
functional M cells was due to rapid re-differentiation of enterocytes into M cells or 
rather arise from pre-determined undifferentiated stem cells from FACs changing 
phenotype that contribute towards increased number M like cells in culture. S. 
Typhimurium can induce vimentin, a typical marker of M cells; induce molecular 
and phenotypic alterations typical of cellular transformation (5.4.2), suggest a 
possibility that S. Typhimurium can drive a subset of lineage specific epithelial cells 
towards M cell phenotype. 
 
5.5 S. Typhimurium transforms epithelial cell in to M cel l phenotype in a 
SopB dependent manner 
To identify bacterial factors that have a role in initiating epithelial cell transformation 
into M cell phenotype, infection studies were done with a panel of wild type and 
mutant S. Typhimurium strains. For initial testing we targeted Salmonella 
pathogenicity island-1 (SPI-1) encoded  type 3 secretion system (T3SS) that mediate 
early bacterial invasion (Galan, 1996), membrane ruffling (Hardt et al., 1998), 
apoptosis (Guiney, 2005), and tight junction disruption (Jepson et al., 1996; Tafazoli 
et al., 2003).  
BRE cells were infected with various bacterial mutants and the expression of target 
proteins, identified with EMT signalling, was examined by Western blotting. 
 
 






Fig. 5.4.1 S. Typhimurium induced ultra-structural changes in the epithelial 
architecture. Heterogeneous population of epithelial cells in a primary cell culture 
from the bovine terminal rectum were isolated and cultured on thermonex cover slips 
(Materials and Methods). Five day old cultures were co-cultured with Salmonella 
typhimurium strain SL1344 for different time points. (A) a typical epithelial 
monolayer with dense apical microvilli. Early stages of S. Typhimurium induced 
changes in cell morphology at 60 min of infection (C), seen as electron dense spots 
around attached bacterium (arrow). During course of infection epithelial cells 
undergo pronounced, sequential morphological and molecular changes characterised 
by partial loss of apical microvilli at 120 min (D&E) or complete loss of microvilli at 
180 min (F). A typical S. Typhimurium infected cell with internalized bacteria seen 
as silhouettes (arrow head), microvilli lost and surro nded by normal epithelial cells. 
The specimens were examined using a Hitachi 4700 Field Emission Scanning 
Electron Microscope. Results are representative of three independent experiments.
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Fig. 5.4.2 S. Typhimurium induces transformation of primary inte stinal 
epithelial cells. Heterogeneous population of epithelial cells in a primary cell culture 
from the bovine terminal rectum were isolated and cultured on glass cover slips 
(Materials and Methods). Five day old cultures were co-cultured with S. 
Typhimurium strain SL1344 for different time points. The cells were fixed and 
permeabilised in 2 %( v/v) formalin/ 0.2% (v/v) Triton X-100. (A) A subset of 
primary epithelial cells in culture expressed interm diate filament protein vimentin 
(B) S. Typhimurium gets attached and internalized in vimentin expressing cells 
within 10 min of infection (B-C). With the progression of infection S.Typhimurium 
start to attack the epithelial cells (D), and after 180 min the number of vimentin 
expressing cells starts to increase in reponse to S. Typhimurium infection (E). Images 
were acquired using Zeiss Axiovert, objective xx63. Internalized bacteria are shown 
in x-y view from orthogonal z-section images. In (F) the cells were removed from 
plates by trypsinisation and stained with a vimentin antibody (Material & Methods), 
Flow cytometry results from 5 independent experiments expressed as mean ± SEM 
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Initial experiments with heat killed S. Typhimurium and invA mutant strain that lack 
a functional SPI-I T3SS, showed no change in protein expression of RANKL, β -
catenin, Slug and Vimentin when compared with wild type S. Typhimurium (Fig. 
5.5.1), confirming that the observed changes in protein expression are indeed SPI- 1 
dependent. Next, we investigated the role of specific SPI-1 effectors. We focused on 
three SPI-1-secreted effectors that activate Rho family GTPases (i.e. SopB, SopE and 
SopE2) and another that directly interacts with actin (i.e. SipA) (Lilic et al., 2003b). 
We hypothesised for these effectors to be crucial in triggering signal cascades 
underlying cellular architecture/ cytoskeleton modifications during transformation of 
epithelial cell phenotype. SPI-1 and sopB mutants showed a significant reduced 
adherent phenotype comparable with other effector mutants (sipA, sopE and sopE2) 
and wildtype S. Typhimurium (Fig. 5.5.2). As shown in Fig. 5.5.3 & Fig. 5.5.4 the 
enhanced protein levels of RANKL, beta-catenin, Slug and Vimentin following 
infection with wild type S. Typhimurium were suppressed in presence of a sopB 
deletion. This data provide evidence that S. Typhimurium can trigger events similar 
to EMT perhaps in a SopB dependent manner. To further confirm the role of SopB in 
Wnt/ β-catenin signalling regulation and RANKL expression, we analyzed 
transcriptional activity using specific reporter gene assays. Caco-2 cells were co- 
transfected with luciferase reporter plasmid containing wild type (TOP Flash) or 
mutated (FOP Flash) LEF/TCF binding sites and PCR3 plasmid containing SopB. 
The firefly luciferase activity was normalised relative to renilla luciferase activity. 
As shown in Fig. 5.5.6, SopB directly regulates luciferase activity with in 48 h post-
transfection (fold compared with FOpflash). LiCl, a known activator of β catenin 
signalling (Stambolic et al., 1996), was used as a positive control.    
Recent studies on the transcriptional regulation of the rankl gene have identified 
several transactivators that cooperate to activate ts ranscription including NFκB and 
β-catenin /TCF signaling, (Fan et al., 2004; Fu et al., 2002; Mori et al., 2006). To 
further confirm the role of SopB in regulation of RANKL expression and determine 
underlying mechanisms, we performed RANKL-reporter g ne assays in the presence 
of pharmacological inhibitors specific to S. Typhimurium mediated signalling in 
intestinal infected cells. 



















Fig. 5.5.1 S. Typhimurium activates Wnt pathway in a SPI-1 dependent 
manner. Heterogeneous population of epithelial cells in a primary cell culture from 
the bovine terminal rectum were isolated and cultured on 6 well plates (Materials and 
Methods). Five day old terminal BRE cells were infected with, heat killed S. 
Typhimurium (HKS), wild-type (S. Typhimurium) or SpI-1 mutant of S. 
Typhimurium strain (SL1344) and incubated at 37oC, 5% Co2 for 3 hrs. The cell 
lysates were processed for western blotting as indicated.  Immunblots were stripped 
and re-probed with panel of antibodies as indicated. Molecular mass standards (kDa) 
are indicated. Actin was used as a control for equal lo ding. Results are 
representative of two independent experiments. 
 
 





























Fig. 5.5.2 Comparative adhesion of wildtype S. Typhimurium and SPI-1 mutant 
strains to bovine terminal rectal epithelial primaries. Heterogeneous population 
of epithelial cells in a primary cell culture from the bovine terminal rectum were 
incubated with S. Typhimurium and SPI-1 mutant strains at 37oC, 5% Co2 for 30 
min. spI-1 and sopB mutants showed a significant reduction in adherence in 
comparison to other the effectors mutants or wildtype S. Typhimurium. Results are 
representative of three independent experiments and presented as * p<0.05 relative to 
wildtype S. Typhimurium. 
 




























Fig. 5.5.3  Role of SPI-1 encoded T3S effectors on transcription of EMT specific 
gene targets. Heterogeneous population of epithelial cells in a primary cell culture 
from the bovine terminal rectum were isolated and cultured on 6 well plates 
(Materials and Methods). Five day old cultures were inf cted with S. Typhimurium 
strain SL1344 at 37oC, 5% Co2 for 2 h. The cells were lysed at different time points 
and RNA were collected (Materials and Methods). The samples were analysed by 
PCR using primers (Table 2.4 Materials and Methods). The values represent mean -
fold changes of band intensity from two separate experiments ± S.E. PCR films were 
quantified by using Quantity One software (Bio-Rad, Richmond, CA), and each 
sample was normalised using the GAPDH signal. 
 










Fig. 5.5.4 S. Typhimurium activates Wnt pathway in a SopB-dependent 
manner. Bovine rectal epithelial cells were infected wild-type S. Typhimurium or 
mutant derivative of S. Typhimurium strain (SL1344) at 37oC, 5% Co2 for 3 h. The 
cell lysates were processed for western blotting studies as indicated. Immunblots 
were stripped and re-probed with panel of antibodies specific to Wnt pathway 
signalling molecules (A) and its EMT specific targets (B) as indicated. Molecular 
mass standards (kDa) are indicated. Actin was used a  a control for equal loading. 
The values represent mean -fold changes of band intensity from two separate 
experiments ± S.E. with the value of control as 1 arbitrary. Western blot films were 
quantified by using Quantity One software (Bio-Rad, Richmond, CA), and each 
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Fig. 5.5.6 SopB mediated increased β -catenin promoter transcriptional activity. 
Caco-2 cells were transiently co-transfected with a plasmid encoding for SopB and β 
catenin-promoter constructs, inserted in pGL3 plasmid. Cells co-transfected with 
PCR3 and pGL3 plasmids were used as negative control. 48 h post transfection LiCl 
(10 mM) was added to the promoter co-transfected with PCR3 as control positive. 
Cells were harvested and lysed 15 h later and Firefly luciferase (Luc) and Renilla 
Luciferase (RLuc) activities were measured by using the dual luciferase reporter 
assay system (Promega). Data are represented as reltive uciferase activity 
(normalized to RLuc activity), with *, p<0.05 relative to non-infected cells, and are 


























































































Fig. 5.5.7 SopB mediated increased RANKL - promoter transcriptional activity 
was suppressed in presence of NF-κB peptide inhibitor SN50 and Wnt pathway.  
Caco-2 cells were transiently transfected with a plsmid encoding SopB and a 
RANKL - promoter construct, 48 h post transfection, Akt-1/2 inhibitor 20 µM; (PI3 
kinase inhibitor) LY 29400250 µM, SB 415286 (GSK-3 β inhibitor),  SN50 (NFκB 
inhibitor), or FH535 (β -catenin/Tcf inhibitor), 10 µM were added to SopB 
transfected cell to study the pathway. Cells were harvested and lysed 15 h later and 
Firefly luciferase (Luc) and Renilla Luciferase (RLuc) activities were measured by 
using the dual luciferase reporter assay system (Promega). Data are represented as 
relative luciferase activity (normalized to RLuc activity), with *, p<0.05 relative to 














































































Fig. 5.5.8 SopB mediated increased SLUG - promoter transcriptional activity 
was suppressed in the presence of the NF-κB peptide inhibitor SN50.  Caco-2 
cells transiently co-transfected with SopB-PCR3 and SLUG- pGL3 or their 
respective negative controls. Transcriptional activity was measured in presence or 
absence of NFκB inhibitor (SN50; 50 µM). Cells were harvested and lysed 15 h later 
and Firefly luciferase (Luc) and Renilla Luciferase (RLuc) activities were measured 
using the dual luciferase reporter assay system (Promega). Data are represented as 
relative luciferase activity (normalized to RLuc activity), with *, p<0.05 relative to 
control cells that co-transfected with PCR3 and Slug promotor, and are 
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The bovine RANKL promoter sequence was cloned upstream of the Luc reporter 
gene in the pGL3 basic vector, and the construct, (named RANKL luc-construct), 
was assayed after Caco-2 cells transfections performed with SopB expression 
plasmid. As shown in Fig. 5.5.7, transient transfection with SopB resulted in an 
increase in RANKL luciferase activity relative to the control (cells co-transfected 
with PCR3 and RANKL promoter), promoter less pGL3-basic vector, demonstrating 
for a direct role for SopB in RANKL transcription. In presence of inhibitors: AKT 
inhibitor 20 µM; 50 µM final concentration from PI3 kinase inhbitor LY 294002, SB 
415286 (GSK-3 β inhibitor), SN50 (NFκB inhibitor), or FH535 (β -catenin/Tcf 
inhibitor), 10 µM, the RANKL luciferase activity was significantly reduced. 
However, the RANKL luciferase activity was significantly increased following 
challenge with SB415286, GSK-3 inhibitor. Taken together, these results suggest 
that SopB mediated PI3 kinase, NF-κB and β-catenin signalling regulates RANKL 
expression at the transcriptional level. In order to investigate the effect of SopB 
SLUG - promoter transcriptional activity, Caco-2 cells were transient transfected 
with SopB in the presence or absence of NF-κB peptide inhibitor SN50. The result 
showed that SopB mediated increased SLUG - promoter transcriptional activity in 
NF-κB dependent manner (Fig. 5.5.8) 
 
5.6 Identification of SOPB domain required to induc e Wnt Pathway 
SopB protein following translocation in to host cell performs multiple functions 
including its role in actin rearrangements, phagocyt sis and biogenesis of the 
Salmonella-containing vacuole in infected cells (Jepson et al., 1996; Zhou et al., 
2001; Terebiznik et al., 2002). SopB phosphatase activity is required for the
activation of the serine threonine kinase Akt, also kn wn as protein kinase B, in 
infected epithelial cells (Steele-Mortimer t al., 2000). Earlier we identified Akt 
activation as one of the early and essential steps in SopB mediated Gsk3 beta 
inactivation central to Wnt/beta-catenin signalling pathway (Fig. 5.5.5). We 
hypothesised for SopB phosphatase activity to be critical to its role in activation of 
wnt pathway. To this end we infected BRE cells with SopB deficient strains 
complemented with either catalytically active (psopB) or inactive SopB point mutant 
(psopB C460S) plasmids.  
























Fig. 5.6.1 SopB activates Wnt pathway in a phosphatase dependent manner.  
Heterogeneous population of epithelial cells in a primary cell culture from the bovine 
terminal rectum were isolated and cultured on 6 well plates (materials and methods). 
Five day old terminal BRE cells were infected with WT S. Typhimurium, ∆sopB S. 
Typhimurium, ∆sopB S. Typhimurium complemented with WT sopB or sopB 
mutated in C460S at 37oC, 5% Co2 for 3 h. The cell lysates were processed for 
western blotting studies as indicated. Immunblots were stripped and re-probed with 
panel of antibodies as indicated. Molecular mass standards (kDa) are indicated. Actin 
was used as a control for equal loading. This figure is representative of two 
experiments.
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The cell lysates were immuno-detected for β-catenin and β-catenin –phosphorylation, 
as indicators of Wnt/ β-catenin signalling and vimentin and EMT indicator (Fig. 
5.6.1). 
 
As shown earlier, S. Typhimurium mediated Akt-phosphorylation was dependent on 
SopB, because an isogenic sopB deletion strain (∆sopB) showed the presence of 
significant phospho- β-catenin when complemented with psopB, the phospho- β-
catenin disappeared (Fig. 5.6.1). Furthermore, comple entation of sopB with a 
catalytically inactive mutant, SopB C460S, show more phospho- β-catenin. This 
indicates that the conserved cysteine residue Cys-460, which is essential for the 
inositol phosphatase activity required for Akt activa on by SopB (Steele-Mortimer t
al., 2000), is also necessary for activating the Wnt/ β-catenin signalling pathway. 
 
5.7 GSK3β is central to S. Typhimurium-induced up-regulation of β-
catenin  
To confirm GSK3β role in S. Typhimurium-induced up-regulation of β-catenin and 
thus activation of Wnt/ β-catenin pathway, the cells were infected in the presence of 
pharmacological inhibitors specific to signalling pathways important in regulation of 
GSK3β activation and its target substrates. Bovine rectal epithelial cells before the S. 
Typhimurium infection were pre-treated with a panel of following inhibitors: 
LY294002, (an inhibitor of PI3K pathway) 50 µM; SN50 (NFκB inhibitor), 50 µM; 
Akti-1/2, an allosteric inhibitor of Akt1 and Akt2 isozymes 20 µM; MG132 
(proteosome inhibitor) 10 µM, and SB415286 (GSK3 inhibitor) 50 µm. Pre-treatment 
with SN50, LY294002 and Akti-1/2, inhibitors suppress d β-catenin, RANKL, 
SLUG and Vimentin, while SB415286 and MG132 elevated heir levels in S. 
Typhimurium infected epithelial cells (Fig. 5.7.1 A). Pre-treatment of cells with 
LY294002 and Akti-1/2 completely inhibited S. Typhimurium induced GSK3β 
phophorylation and inactivation (Fig. 5.7.1 B). Together, these results suggest that S. 
Typhimurium in a SopB dependent manner induces PI3K activity leading to Akt 
activation that phophorylates and inactivates GSK3β, and thus the increased 
cytosolic β-catenin and the downstream Wnt/ β-catenin mediated Slug and vimentin 
proteins.  




























Fig 5.7.1 S. Typhimurium activates NFkB and Wnt signalling pathways. 
Heterogeneous population of epithelial cells in a primary cell culture from the bovine 
terminal rectum were isolated and cultured on 6 well plates (Materials and Methods). 
Five day old cultures were treated with DMSO, SN50, (NFκB inhibitor), 50 µM; 
LY294002, (AKT inhibitor) 20 µM, SB415286 (GSK3 inhibitor) 50 µM or MG132 
(proteosome inhibitor) 10 µM for 5 h before being infected with S. Typhimurium 
strain (SL1344) at 37oC, 5% Co2 for 10 min, extracellular bacteria were removed by 
washing and cells were incubated further for 3 h. Cells were processed for western 
blotting  using anti-RANKL, Slug, vimentin, total P-GSK & P-GSK-3B. Actin was 



































Fig. 5.8.1 Confocal laser microscopy image of whole-mount staining of mouse 
Peyer’s patch FAE (n = 10). Five C57/BL6 mice were infected with S. 
Typhimurium SL1334 and C57/BL6 mice with a sopB mutant of S. Typhimurium 
SL1334 for 90 min. (A) the Peyer’s patches were isolated from the rest of the 
intestine washed, fixed, stained for GP-2 (green) and actin (far red 647nm (blue). Z-
stack images of the FAE of individual PP follicles were obtained using LSM5 
confocal microscope (Zeiss). (B) The number of GP-2 expressing cells per follicle 
were increased significantly in wildtype S. Typhimurium infection whereas there was 
no increase with the  ∆ sopB S. Typhimurium mutant. 



































Fig. 5.8.2 Elevated diaminobenzidine (DAB) enhanced Prussian blue staini g in 
mice Peyer’s patch FAE sections (n = 10). (A) Five C57/BL6 mice were infected 
with S. Typhimurium SL1334 and other Five C57/BL6 mice with sopB mutant, S. 
Typhimurium SL1334 for 90 min.  The Peyer’s patches w re isolated from the rest of 
the intestine. The cryospecimens were cut into 3-µm-thick sections and subjected to 
DAB staining using anti-slug antibody (Materials & Methods). Slug expression was 
increased significantly with wildtype S. Typhimurium infection where as there was 
no effect when ∆sopB S. Typhimurium was used. The Slug expression was measured 
as % of area of DAB staining compared to the total st ining on the slide using imagJ 
software. The images were acquired using a laser-scan Nikon E800 Microscope. 
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5.8 S. Typhimurium increases the number of M cell in mice  through 
activation of slug expression 
To investigate whether SopB is important for S. Typhimurium mediated in vivo 
induction of M cells; murine ligated loops were infected with wildtype S. 
Typhimurium or a sopB mutant strain (∆sopB). To quantify any change in M cell 
numbers PPs from respective infected mice were immuno-stained as whole tissue 
mounts and counted for expression of GP2 positive cells. Unlike SopB mutant strain 
the number of GP2 expressing cells significantly increased during infection with the 
WT S. Typhimurium strain (Fig. 5.8.1 A & B). 
Following on from in vitro studies that identified transcription factor Slug to be 
central to epithelial - M cell transformations, we examined for any change in its 
expression in infected murine tissue sections of PPs. Immunohistochemistry analysis 
demonstrated a statistically significant increase in Slug expression in tissue sections 
from mice infected with WT strain but not with that of SopB mutant strain (∆sopB) 
(Fig. 5.8.2 I & II). 
 
5.9 Discussion 
Studies have suggested that microbes such as S. Typhimurium and Streptococcus 
pneumoniae can induce either increased number of M cells in FAE (Savidge et al., 
1991; Borghesi et al., 1999; Meynell et al., 1999), or increased trancytosis activity 
with constant number of M cells (Gebert et al., 2004) raising the possibility that 
microbes may drive enhanced M cell number/ activity in a RANKL dependent 
manner. To follow up this hypothesis I set out to investigate molecular basis to 
microbial driven increase in M cell number. To this end time course conducted 
infection studies with wild type S. Typhimurium and examined for expression of 
RANKL and members of Wnt pathway including, β-catenin, Slug and vimentin, 
associated with EMT. The finding confirmed a temporal increase in expression of all 
these factors both at the transcript and protein levels.  
To this end I compared the effect of viable versus heat inactivated and wild type 
versus SPI-1 mutant S. Typhimurium strains on the expression of RANKL, and Wnt 
pathway proteins including, β-catenin, Slug and vimentin, associated with EMT. This 
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work results confirmed that the fact that S. Typhimurium up-regulates β- catenin and 
its target genes, I set out to test up-stream components that could have direct 
increased β-catenin expression. Cytosolic β-catenin, a known target for GSK3β -
phosphorylates and thereby marks the protein for ubiquitinylation and subsequent 
proteosomal degradation (Behrens, 2000), resulting in its inability to stimulate 
TCF/LEF transcription factors. GSK3β inhibition, through its phosphorylation at 
Ser-9 by Akt kinase (Cross et al., 1995), could therefore, lead to increased β-catenin. 
To test if S. Typhimurium mediated increased β catenin expression depended on 
GSK3β activity, protein lysates from S. Typhimurium infected epithelial cultures 
were compared for active and inactive forms of GSK3β. Western blot analysis of 
protein lysates revealed an induction of GSK3β Ser-9 phosphorylation by the 
wildtype strain but not by sopB mutant strain (Fig. 5.5.5). These data suggests tha S. 
Typhimurium in a SopB-dependent manner inhibits GSK3β, and hence the increased 
β-catenin and its downstream TCF/LEF mediated target genes, including vimentin 
and Slug, both of which are critical in EMT. To investigate whether SopB can 
directly control β-catenin activity, central to EMT, Caco-2 cells were co- transfected 
with luciferase reporter plasmid containing wild type (TOP Flash) or mutated (FOP 
Flash) LEF/TCF binding sites and PCR3 plasmid expressing SopB. The firefly 
luciferase activity was normalised relative to renilla luciferase activity. As shown in 
Fig. 5.5.6, SopB directly regulates luciferase activity with in 48 h post-transfection 
(fold compared with Fop Flash). LiCl, a known activa or of β-catenin signalling 
(Stambolic et al., 1996), was used as a positive control.    
The presence of putative cis elements for Lef-1, in bovine SLUG gene promoter 
raised the possibility that Lef-1 may be implicated in the modulation of SLUG 
expression as previously demonstrated in other species such as human and chicken 
(Lambertini et al., 2010). We hypothesised for SopB to activate SLUG transcription 
perhaps in NF-κB dependent manner as shown previously (Fig. 5.5 8). The bovine 
SLUG promoter sequence was cloned upstream of the Luc reporter gene in the pGL3 
basic vector and tested in Caco-2 cells on activation by SopB. As shown in Fig. 
5.5.8, transient transfection with SopB resulted in an increase in SLUG luciferase 
activity relative to the cell co-transfected with PCR3 and SLUG luc-construct, 
demonstrating for a direct role for SopB in activation of transcription factor SLUG. 
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GSK3β a known target for PI3K/Akt kinases (Doble & Woodgett, 2003), 
phosphorylates and marks cytosolic β-catenin for ubiquitinylation and subsequent 
proteosomal degradation (Behrens, 2000), as well as repress NF-κB dependent 
expression of certain target genes, like Snail, associated with EMT (Bachelder et al., 
2005). To identify up-stream regulators and to confirm that GSK3β plays a role in S. 
Typhimurium-induced up-regulation of β-catenin, we infected cells in the presence 
of pharmacological inhibitors specific to signalling pathways, nuclear factor -κB, 
phosphoinositide 3-kinase (PI3K)/Akt pathways, important in regulating GSK3β and 
its target substrates. Bovine rectal epithelial cells before the S. Typhimurium 
infection were pre-treated with a panel of following inhibitors: LY294002 (50 µM), 
an inhibitor of PI3K pathway; SN50, an inhibitor of NF-κB pathway (50µM), Akti-
1/2, an allosteric inhibitor of Akt1 and Akt2 isozymes (20 µm) ; MG132 (10 µm), 
proteosome inhibitor and SB415286 (50 µM) GSK-3 inhibitor. None of these 
inhibitors showed any effect on viability of S. Typhimurium. As seen in Fig. 5.7.1  
pre-treatment with SN50, LY294002 and Akti-1/2 inhibitors suppressed β-catenin, 
while SB415286 and MG132 elevated its levels in S. Typhimurium infected 
epithelial cells suggesting a role for GSK3β in S. Typhimurium mediated regulation 
of β-catenin. The results suggest that the suppressed GSK3β activity had an 
enhanced cascade effect on downstream β-catenin/TCF/LEF mediated targets, 
including RANKL, vimentin and Slug (Fig. 5.7.1), which are defining proteins in 
EMT. 
These findings provide evidence for a unified signalli g mechanism driven by 
convergence of GSK3β regulated signalling molecules that confer acquisition of the 
mesenchymal phenotype and in this instance trigger epithelial to M cell 
transformation. S. Typhimurium mediated GSK-3 beta suppression is central to EMT 




Receptor activator of nuclear factor kappa-B 
ligand (RANKL) induces transformation of 
intestinal epithelial cells to antigen-sampling M 
cells 
_______________________________________________Results Chapter 6 
 180 
6. Receptor activator of nuclear factor kappa-B ligand  (RANKL) induces 
transformation of intestinal epithelial cells i to antigen-sampling M cells 
6.1 INTRODUCTION 
Mucosal-associated lymphoid tissue, a major compartmen  of the immune system 
that operates at the mucosal level, is present throug ut the intestine either as 
isolated lymphoid follicles or as lymphoid follicle aggregates such as Peyer’s patches 
in the small intestine. The lymphoid tissue is separated from the intestinal milieu by 
the follicle-associated epithelium (FAE) composed of numerous enterocytes and a 
relatively small number of highly specialized M cells. 
Epithelial cells usually exist as sheets of immotile, tightly packed, well-coupled, 
polarized cells with distinct apical, basal and later l surfaces. Remarkably, these cells 
can dramatically alter their morphology to become motile, fibroblast-like 
mesenchymal cells in a process of epithelial-mesenchymal transition (EMT). This 
process and the reverse, mesenchymal-epithelial transi ion, occur repeatedly during 
normal embryonic development. A phenomenon similar to physiological EMT 
occurs during the pathophysiological progression of some cancers (Geiger & Peeper, 
2009) . 
The TNF superfamily member receptor activator of NFk-B ligand (RANKL) recptor 
RANK is selectively expressed by subepithelial stromal cells in PP domes (Knoop et 
al., 2009). It has also been reported that it could be secreted within villus epithelium 
(Knoop et al., 2009). it is essential for the formation of follicle associated M cell as 
the mice mutant in RANKL or using of Ab-mediated neutralization of RANKL in 
adult wild-type mice markedly eliminated most PP M cells. RANKL also has been 
shown to be essential for M cell survival (Knoop et al., 2009). RANKL acts through 
its specific receptor (RANK) and plays an important developmental role in multiple 
tissues. it is important for development of lymph nodes and osteoclast so its 
deficiency lead to absence of lymph node and malformed skeleton (Kong et al., 
1999). 
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6.2 RESULTS 
Following recent publication on RANKL as one of the critical factors controlling 
differentiation of M cells in vivo, we set out to test if RANKL could be used as a 
supplement to induce M cell phenotype in a primary epithelial cell culture model 
system. With the knowledge that interaction of intestinal crypts with their specialized 
microenvironment or “niche” is critical for their maintenance and differentiation i
vivo, we hypothesized that primary intestinal epithelial cells isolated from different 
regions of the gut, may vary in their responses to RANKL.   To test these hypotheses, 
epithelial crypts isolated from lymphoid follicle (LF) dense bovine terminal rectum, 
follicular associated crypts (FACs) or LF deficient proximal rectum were cultured in 
the presence of purified RANKL. RANKL-treated epithelial cells in these two 
culture systems were compared for phenotypic and fuctional characteristics of M 
cells.  
 
Ultrastructural studies on proximal and terminal bovine rectal tissue revealed 
morphologically distinct crypt populations at these two sites (Fig. 6.2.1 B & C). 
Unlike crypts with apical round fissure in proximal rectum, most crypts in the follicle 
dense terminal rectum, exhibited longitudinal fissure morphologically alike “Dome 
Associated Crypts” previously identified as source for M cell progenitors in mice 
Peyer’s patches (Gebert e  al., 1999). Gebert et al. (1999) demonstrated that “Dome 
Associated Crypts” associated with lymphoid follicles are distinct from ordinary 
intestinal crypts in size, shape, cellular compositi n, and location and represent a 
sub-population of cells predetermined as M cells before attaining their morphological 
and functional features. We hypothesized that the FACs in our culture model system 
represent “Dome Associated Crypts” composed of distinct subset of predetermined 
FAE and M cell precursors or cells in transitional stages, that following appropriate 
immune stimuli, like RANKL, can differentiate into functional M cells.   
Immunofluorscent staining for vimentin, a known marker for FAC and FAE in cattle 
revealed that a subset of crypts and epithelial cells were stained positive for vimentin 
in the primary cell cultures from terminal rectum (Fig. 3.2.8a chapter 3). The cells in 
culture express pan-cytokeratin, as a marker for epith lium (Fig. 3.2.8a chapter 3) 
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By western blotting the cells cultured from both FAC and OC were comparable in 
expression for RANKL receptpr RANK, vimentin and epithelial specific markers, 
tubulin and E-cadherin (Fig. 6.2.1D).   
 
RANKL-treated epithelial cells in these two culture systems were compared for 
phenotypic and functional characteristics of M cells. Intermediate filament protein 
vimentin is a known marker for follicle associated pithelium (FAE) and M cells in 
cattle and rabbit (Meynell et al., 1999) and cattle (Mahajan et al., 2005). 
 
S. Typhimurium typically targets M cells as portal ofentry to translocate across 
intestinal epithelium. Bacterial trafficking across intestinal epithelial cells is applied 
as an in vitro functional assay to measure M cell activity in culture. RANKL- treated 
epithelial cells that were specifically cultured from FACs demonstrated an increased 
(i) expression of vimentin protein (Fig. 6.2.2) as well as number of vimentin 
expressing cells (Fig. 6.2.3),  S. Typhimurium translocation across epithelial cells 
and their intracellular uptake in kanamycin protection assays (Fig. 6.2.4) confirming 
a change in both the cellular phenotype and the functio al  attributes that resemble to 
M cells in the bovine host  (Czerkinsky et al., 1999). 
 
Following a recent work that reported RANKL association with epithelial-
mesenchymal transition (EMT) (Odero-Marah et al., 2008).We hypothesised that 
RANKL mediated increase in M cell specific marker and function expression of  M 
cell specific marker, vimentin, and  increased S. Typhimurium translocation  across 
RANKL-treated cells might as well be  due to RANKL dependent transformation  of 
a specific subset of epithelial cells  in culture in to a cell type that phenotypically and 
functionally resembles specialised antigen sampling M cell. To follow this 
hypothesis we analysed RANKL-treated cultures for the expression of the 
transcription factor Slug that has previously been associated with RANKL mediated 
epithelial transformation (Knoop et al., 2009). Indeed, in our culture models  
RANKL induced expression of Slug (Fig. 6.2.2), specifically in epithelial cells 
cultured from FACs is suggestive of similar mechanisms underlying RANKL 
mediated transition of a subset of intestinal epithelial cells in to M cell phenotype.  
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To determine molecular mechanisms underlying RANKL mediated cellular 
transformation we hypothesised for a potential roleof NFκB and Wnt/beta-catenin, 
the known upstream signalling activators of EMT transcription factor Slug (Saegusa 
et al., 2009). To test this hypothesis BRE cells, treated with RANKL in presence of 
pharmacological inhibitors specific to each of these signalling pathways, were 
examined for expression of vimentin. Indeed, in thepr sence of NFκB inhibitor 
SN50 and beta-catenin inhibitor FH535, the RANKL-mediated enhanced Vimentin 
expressions were suppressed whilst in presence of proteosomal inhibitor (MG132) its 
protein levels were elevated (Fig. 6.2.5). To examine whether RANKL regulates slug 
and vimentin promoter activity as well to determine the underlying signalling 
mechanisms, intestinal epithelial cells transfected with respective lucifrase reporter 
constructs were tested for their activity in presence of pharmacological inhibitors 
specific to NFκB and β-catenin signalling pathways. As seen in Fig. 6.2.6, pre-
treatment of RANKL-treated epithelial cells with inhibitors SN50 and FH535 
suppressed while GSK-3β inhibitors (SB415286 and LiCl), enhanced SLUG and 
Vimentin promoter activity. Together, these results suggest a role for both NFκB and 
Wnt/beta-catenin signalling during RANKL mediated increase in Slug and vimentin 
expression, the classical EMT markers.       
Further, we reasoned that the enhanced uptake or translocation of S. Typhimurium 
across RANKL-treated epithelial cells is due to a ch nge in an epithelial cell subset 
to M-like cell phenotype that S. Typhimurium is known to preferentially target 
during invasion of intestinal epithelium (Clark et al., 1994). RANKL signals through 
its receptor RANK (receptor activator of NFκB) and a downstream pathway that 
involves tumer necrosis factor (TNF) receptor associated factor 6 (TRAF6)  and the 
activation of NFκB. RANKL-RANK interaction can be blocked by Osteoprtegerin 
(OPG), a decoy receptor for RANKL. To determine specificity of RANKL as well 
the consequent NFκB signalling in inducing M cell phenotype, S. Typhimurium 
translocation studies, in vitro functional assay for M cell activity were done in 
presence of OPG and NFκB inhibitor SN50. Indeed, in presence of both these 
inhibitors, the RANKL mediated enhanced translocation of S. Typhimurium was 
significantly reduced (Fig. 6.2.7). Thus, suggesting a role for RANKL mediated 
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NFκB dependent factors in enhancing S. Typhimurium translocation across epithelial 
cells. 
The results so far suggest a role for RANKL in inducing epithelial transformation 
which is restricted to a sub set of cells cultured specifically from FACs and not from 
the OCs. We reasoned that the observed  distinct effects of RANKL on epithelial 
cells cultured from these two crypt types may be because of differential expression of 
epithelial  molecules critical to RANKL mediated signalling. To this end we 
screened epithelial cells from both culture systems for expression of RANK, the 
RANKL receptor, and Relb, one of the NFκB transcription factors, required for 
RANKL mediated cellular/ osteoclast differentiation (Vaira et al., 2008). Although 
RANK was expressed by epithelial cells in both culture model systems, the RelB 
expression was limited to cells cultured from FACs only.  
Unlike other members of NFκB, RelB has a much more restricted tissue distribution 
(Fig. 6.2.8) including FAE (Yilmaz et al., 2003). RelB plays a critical role in 
constitutive expression of NFκB regulated genes in lymphoid organs and its 
deficiency has been associated with multiple lymphoid organ defects (Vaira et al., 
2008) including  the absence of Payer’s patches (Yilmaz et al., 2003). We postulate 
that a subset of epithelial cells in FAC cultures, that express RelB, on exposure to 
RANKL differentiate into fully operational M cells. 
To further investigate role of RelB in inducing RANKL-mediated cellular 
transformation, RelB was depleted by siRNA knockdown. As speculated RelB K/O 
epithelial cells were only partly responsive to RANKL and as a consequence showed 
limited effect on expression of Slug and vimentin (Fig. 6.2.9a) and S. Typhimurium 
translocation across epithelial cells (Fig. 6.2.9b). These experiments confirm RelB as 
one essential factor critical to RANKL- mediated  
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Fig. 6.2.1 Characterisation of proximal and terminal rectal epithelial cells. 
Bovine rectal tissue fixed in 70% (V/V) acetic acid to show lymphoid dense area in 
the terminal rectum (A).  SEM images of intestinal crypts at the bovine rectum (B-
C).  Proximal rectal crypts (ordinary crypts, OC) with central round fissure are 
structurally distinct from crypts with longitudinal fissure (follicular associated crypts, 
FAC) at the lymphoid follicle (grey nodules) dense bovine terminal rectum. (D) 
Immunblot analysis of cells cultured from proximal and terminal rectal crypts. Five 
day old cultures were lysed using protein lysate buffer and protein lysates were 
collected (materials and methods).The samples were analysed by immunoblotting 
using anti-RANK, e-cadherin, vimentin and Tubulin atibodies as indicated. Actin 
was used as a control for equal loading.   
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Fig. 6.2.2 Effect of RANKL on primary intestinal epithelial cells. Proximal and 
terminal rectal epithelial cells primed with RANKL at100 ng/ml for 5 days were 
stained for Slug and Vimentin. The immunoblotmembranes were stripped and re-
probed with an anti-actin antibody. The results are representative from one of two 
independent experiments.  
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Fig. 6.2.3 RANKL induces the expression of Slug and Vimentin in bovine rectal 
epithelial cell. Heterogeneous population of epithelial cells in a primary cell culture 
from the bovine terminal rectum were isolated and cultured on glass cover slips 
(materials and methods). Epithelial cells were incubated overnight with RANKL 
(100ng/ml). The cells were fixed and permeabilised in 2 % ( v/v) formalin/ 0.2% 
(v/v) Triton X-100. The cells were analysed for Slug and vimentin expression and 
localisation in cellular compartments by immuno-fluorescence staining. Slug (A&B) 
(red) primarily localised at the nucleus in control cells and following exposure to 
RNKL, Slug expression was increased and localised in the cytoplasm. 
(C&D)Vimentin  (red) and nucleus (blue). Increased xpression of Vimentin in 
RANKL treated cells is seen as speckled staining.  Images were acquired using Zeiss 
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Fig. 6.2.4 RANKL primed cells were used for S. Typimurium internalization (A) 
and trancytosis (B) studies – in vitro M cell functional assays. 
Heterogeneous population of epithelial cells in a primary cell culture from the bovine 
proximal & terminal rectum were isolated and cultured on 6 well and transwell plates 
(materials and methods). Cells were challenged withS. Typhimurium as explained in 
materials and mehthods. (A) The bacteria was incubated with the cells at 37oC, 5% 
CO2 for 30 min; the bacteria was removed and the cells were washed 3 times with 
PBS and treated with kanamycin (750 µg/ml) for 3 h. (B) Epithelial cells in the upper 
chamber of the transwell were challenged with  S. Typhimurium as explained in 
materials and mehthods for 30 min and the bacteria were collected from the lower 
chamber, serially diluted  and plated.*** p<0.01 relative to the control. The results 
are representative from one of 3 independent experiments. 
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Fig. 6.2.5 RANKL induces vimentine expression involves NFkB and Wnt 
signalling pathways. Terminal rectal epithelial cells were treated for 24 hours with 
RANKL in the presence or absence of SN50 (NF-κB peptide inhibitor), MG132 
(proteosomal inhibitor) 10 µM and β -catenin inhibitor (FH35) 10 µM. The protein 
concentrations of vimentin were analysed by Western blotting using antibodies as 
indicated (Materials & methods). The results are representative from one of 2 

































































Fig. 6.2.6 Vimentin and Slug promoter transcription activity is suppressed in 
the presence of NF-κB peptide inhibitor (SN50), Beta catenin inhibitor 
(FH535), but not by the GSK-3 inhibitor SB 415286. SLUG and Vimentin 
promoter constructs, inserted in pGL3 plasmid, were co-transfected in to the Caco-2 
cell lines with a pRTK-Luc (Promega), to normalize transfection efficiency. 
100ng/ml of RANKL was added 48 hr post transfection, together with 50 µM for 
SN50 NF-κB peptide inhibitor and GSK-3 β inhibitor, SB 415286. β -catenin/Tcf 
inhibitor, FH535 10 µM or LiCl 10 mM final concentration as control positive. Cells 
were harvested and lysed 15 hr later and Firefly luciferase (Luc) and Renilla 
Luciferase (RLuc) activities were measured by using the Dual Luciferase Reporter 
Assay System (Promega). Data are represented as reltive luciferase activity 
(normalized to RLuc activity), and are representative of two independent 
experiments. * p<0.05 relative to the control The gr y bars represent the slug 

























































































Fig. 6.2.7 RANKL-dependent induced increased S. Typimurium trancytosis in 
terminal rectal epithelial cells was significantly reduced in presence of RANKL 
decoy receptor OPG and NF-κB peptide inhibitor SN50. Heterogeneous 
population of epithelial cells in a primary cell culture from the bovine terminal 
rectum were isolated and cultured on 6 well plates (materials and methods). OPG 
50ng/ml and 50 µM of SN50 (NF-κB peptide inhibitor) was added to five day old 
Terminal BRE cells 15 hour before challenging with S. Typhimurium. The bacteria 
was incubated with the cells at 37oC, 5% Co2 for 30 min. in presence of both these 
inhibitors, the RANKL mediated enhanced translocation of S. Typhimurium was 
significantly at  p<0.05 relative to the control and are representative of three 
































Fig. 6.2.8 RelB expression is limited to terminal rectal epithelial cells. 
Heterogeneous population of epithelial cells in a primary cell culture from the 
bovine proximal and terminal rectum were isolated an  cultured on 6 well plates 
(Materials and Methods). Five day old cultures were lysed using protein lysate 
buffer. The protein lysates were collected (Materials nd Methods). The samples 
were analysed by immunoblotting using anti-RANK, RelB primary antibodies. RelB 
expression is limited to terminal rectal epithelial ce ls. The immunoblot-membranes 
were stripped and reprobed with anti-actin antibody. The results are representative 
from one of 2 independent experiments.  

























Fig. 6.2.9a RANKL induced expression of Slug and Vimentin in bovine rectal 
epithelial cell through activation of transcription factor RelB. Heterogeneous 
population of epithelial cells in a primary cell culture from the bovine terminal 
rectum were isolated and cultured on 6 well plates (Materials and Methods). Five day 
old the cells were double transfected with two sets of relB siRNA (Materials and 
Methods). 48 h later control and relB (siRNA) transfected rectal epithelial cells were 
treated with RANKL (100ng/ml) for overnight. Whole cell extracts were immuno-
detected for Slug and Vimentin. The same membrane was stripped and reprobed with 
anti-actin antibody. The results are representative from one of 2 independent 
experiments. 
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Fig. 6.2.9b RANKL dependent increased S. Typimurium trancytosis was 
significantly reduced in the presence of relB (siRNA) rectal epithelial cells. 
Heterogeneous population of epithelial cells in a primary cell culture from the bovine 
terminal rectum were transfected with RelB siRNA. 48 h later it was incubated with 
RANKL 100ng/ml overnight. The cells were challenged with S. Typimurium at 
37oC, 5% Co2 for 30 min. RelB siRNA treated and control non transfectd cells 
showed a significant reduced trancytosis activity for S. Typhimurium comparable 
with RANKL treated cells. Results are presented as p<0.05 relative control. The 
results are representative from one of 3 independent experiments.  
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signalling as it has been shown previously during its role in RANKL-dependent 
osteoclast differentiation (Vaira et al., 2008). 
Tissue specific expression of RelB may explain for distinct effects of RANKL on 
primary epithelial cells cultured specifically from FACs. Earlier demonstrated that 
“Dome Associated Crypts” associated with lymphoid  follicles are distinct from 
ordinary intestinal crypts in size, shape, cellular composition, and location and 
represent a sub-population of cells predetermined as M cells before attaining their 
morphological and functional features (Gebert and colleagues1999).  
Together these results suggest that the FACs in our culture model system perhaps 
represent “Dome Associated Crypts” composed of distinct sub-sets of predetermined 
FAE and M cell precursors or probably cells in transitional stages, that following 
appropriate immune stimulus, in this instance RANKL, can differentiate in to 
functional M-cell phenotype. RANKL in NFκB and Wnt/ β-catenin dependent 
manner activate transcription factor Slug, typically associated with EMT that 
transforms a specific subset of epithelial cells in to M like cells. 
 
6.3 Discussion 
Despite the basic functional and ultra structural fe tures of M cells known for over 
30 years (Owen & Jones, 1974), some basic aspects of M cell biology, including 
their origin and differentiation, are still unclear. Debate continues on whether M cells 
are a distinct lineage arising directly from crypt stem cells or can instead arise from 
normal FAE enterocytes with the plasticity to transform in to M cells in presence of 
certain stimuli, whether they could arise from ordinary intestinal crypts or their 
formation is restricted to specialised follicle/dome-associated crypts within the 
lymphoid dense intestinal tissue. M cells have been documented primarily in the 
FAE and occasionally on villous epithelium (Borghesi t al., 1999; Jang et al., 2004). 
Specific factors released from lymphoid tissue beneath FAE have the potential to 
induce M cell differentiation in the FAE and promote their function of antigen uptake 
(Kerneis et al., 1997; Mach et al., 2005). Recent work by  identified RANKL as one 
such critical factor controlling differentiation of M cells (Knoop and colleagues 
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2009). M cell deficit in RANKL-null mice was corrected by systemic administration 
of exogenous RANKL and antibody-mediated neutralisation of RANKL in adult 
wild-type mice significantly reduced M cell numbers. However, specific 
mechanism(s) underlying RANKL mediated M cell differentiation has not yet been 
elucidated.  Using in vitro epithelial cell culture model system it has been co firmed 
seminal work of (Knoop et al., 2009), and confirmed a role for RANKL in inducing 
M cell activity. This study hypothesised a role forRANKL, a known inducer of 
EMT, in transforming a subset of epithelial cells in culture to a cell type that 
functionally and phenotypically is identical to M cell. This work provides evidence 
that RANKL induces transcription factor Slug, central o EMT, which perhaps drives 
a subset of epithelial cells to a cell phenotype typical of M cell.  Slug belongs to a 
family of zinc-finger transcription factors that are essential in promoting EMT, both 
during defined stages of embryonic development and during early stages of cancer 
progression (Cano et al., 2000; Thiery et al., 2009). Slug in addition to many target 
genes like mucin-1,  collagen IIaI or MMP-2 (matrix metalloproteinase-2) (Guaita et 
al., 2002; Yokoyama et al., 2003; Martínez-Estrada et al., 2006), up-regulates the 
intermediate filament protein vimentin and C-myc (Cano et al., 2000) and represses 
tight junctional proteins including E-cadherin and Claudin. Thus it can drive major 
morphogenic changes in cellular architecture needed for establishment of a modified 
cell phenotype with altered functional attributes.  here it is shown that RANKL 
transforms a subset of epithelial cells to display typical features of M cells, such as 
transcytosis activity, the disorganization of microvilli, and the expression of M cell 
specific marker vimentin.  
 
The finding  of this study also demonstrate that the effect of RANKL in promoting M 
cell phenotype is restricted only to intestinal crypts cultured from LF dense terminal 
rectum but not to the ones cultured from LF deficient proximal rectum.  Perhaps 
crypts cultured from LF dense rectum are the specialised Follicle associated crypts, 
that previously have been associated with origin and development of M cells (Gebert 
et al., 1999). One possibility is that FACs may have either been already programmed 
or primed with specific cues from surrounding lymphoid follicles /microenviornment 
to yield cell subsets alike M cells or FAE (Neutra et al., 2001). Possibly RANKL 
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acts as a final trigger for these cells in transient to acquire a fully differentiated and 
functional M cell phenotype in culture. We identified RelB as a distinct, NF-κB 
family member, protein that was constitutively expressed only in FAC cell culture.  
RelB as one of the critical down stream mediators of the lymphotoxin-beta recptor 
(LTβR) signalling is indispensable for PP development (Yilmaz et al., 2003). Earlier 
lymhotoxin has been reported as one essential cytokine required for development and 
differentiation of FAE and M cells (Kraehenbuhl & Neutra, 2000; Debard et al., 
2001), as well as for inducing expression of FAE specific chemokine CCL20 
(Anderle et al., 2005). RelB- deficient mice display a complex phenotype including 
lack of lymhnodes, splenomegaly and multiple defects in immune responses (Weih et 
al., 2001). The fact that RelB is constitutively express d in FAC and FAE (Yilmaz et 
al., 2003; Wang et al., 2009) and is critical to RANKL-mediated alternative NF-κB 
signalling that is essential in inducing cellular differentiation (Vaira et al., 2008), I 
tested if RelB is indispensable for RANKL mediated M cell differentiation in culture 
in this work. Indeed, FAC epithelial cultures depleted of RelB showed no effect of 
RANKL on either expression of molecular markers or functional phenotype of cells. 
Taken together, these results suggest that RelB is critical for RANKL mediated 
induction of epithelial - M cell transformation/ M cell differentiation and perhaps 
selective expression of RelB in FACs/FAE is one such basis for M cell formation is 
restricted to specialised follicle/dome-associated crypts within the lymphoid dense 
intestinal tissue. However, this work does not define whether RANKL/RelB 
interaction provides lineage specificity to M cell precursors/progenitors in FACs or it 
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7. Final discussion and future work  
EPEC and EHEC constitute a significant risk to human health. EPEC is the cause of 
severe infantile diarrhoeal disease in the developing world, while EHEC is an 
emerging zoonotic pathogen primarily in industrialized countries that causes 
sporadic outbreaks of severe disease in humans. The most important are 
haemorrhagic colitis (HC), and haemolytic uremic syndrome (HUS). The 
chromosomal locus of enterocyte effacement (LEE) pathogenicity island encodes a 
type III secretion system (TTSS) that translocates multiple effector proteins into host 
cells. TTSS and the multiple effectors are important colonisation factors and 
therefore presents as potential targets for vaccine interventions.  In this study, I have 
tried to further our understanding of the role of EspF, a proline-rich repeat (PPRRs) 
effector protein, in EHEC and EPEC pathogenesis, focusing on allelic variants 
between strains.  
 
I have studied the role of EspF in the interaction of EHEC and EPEC strains with 
murine macrophages and human-derived M cells. From this work, it was 
demonstrated that in comparison to EspFO127 and EspFO26, the EspFO157 variant was 
significantly less effective at inhibiting phagocytosis and also had a reduced capacity 
to inhibit E. coli translocation through a human-derived in vitro M-cell co-culture 
system. One explanation for this might be an increased ability of both the EPEC 
O127 and EHEC O26 EspF variants to interact with Human Sorting Nexin-9 (SNX9) 
and neuronal Wiskott - Aldrich syndrome protein (N-WASP) that are known to play 
an important role in endocytosis and phagocytosis. However, these interactions are 
unlikely to account for the finding that the EHEC O157 EspF was the most effective 
variant at restricting bacterial uptake into and translocation through primary 
epithelial cells cultured from the bovine terminal rectum, the predominant 
colonisation site of EHEC O157 in cattle and a sitecontaining M-like cells.  As there 
are no significant differences in the sequences of these two eukaryotic proteins, 
SNX9 and N-WASP, between human and bovine hosts, it is possible that other 
unknown interactions with bovine host cell proteins may play a role in phagocytosis 
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and endocytosis and that these may differ between host species leading to specific 
evolution of the EspFO157 variant for function in cattle.   
 
To examine other possible interactions, Y2H screening with a human expression 
library was initiated in collaboration with Prof. Juergen Haas at the University of 
Edinburgh. The results from this study revealed that EspF may interact with both 
MAD2L2 and NFIC and future work needs to examine how important such 
interactions could be for E. coli pathogenesis. It is known that the Shigella effector 
protein, IpaB, interacts with MAD2L2 the (Mitotic spindle assembly checkpoint 
protein MAD2B). MAD2L2 normally interacts with an an phase-promoting 
complex/cyclosome (APC) to progress the cell cycle normally as MAD2L2 inhibits 
APC functions. IpaB binding to MAD2L2 in this case APC will stop the cell cycle 
and prevent epithelial cell turnover.  As cellular tu nover is a key way that bacteria 
can be removed from the epithelium, then this activity will promote bacterial 
colonisation. I anticipate that EspF, through its interaction with MAD2L2, may have 
a similar function so future work should be aimed at understanding the biological 
importance of this interaction. Additional future work could involve the generation 
of a protein expression library from bovine intestinal epithelial cells and a study of 
the interaction of these bovine host proteins with EspF; with follow up studies on any 
positive interactions. This work would further define the molecular events preventing 
EHEC uptake into bovine M cells.   
 
Another key question is how important is this inhibitory activity to the colonisation 
of cattle; is colonisation of the terminal rectum predominately driven by the initial 
interaction of EHEC O157:H7 with M-cells.  Testing of an EHEC O157 espF mutant 
should be carried out in cattle. This was to be part of my PhD but time, 
administrative (GMO permission) and financial restrictions have prevented this.  
 
The next area to consider if EspF is shown to be critical is the value of its inclusion 
in vaccine preparations to limit excretion of EHEC O157 from cattle. An effective 
vaccine is still required for use in cattle and this would limit financial loses in the 
cattle industry and protect public health.    
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The second key part of my research was about antigen sampling M-cells; an 
important component of the intestinal mucosa immune system.  The number of these 
cells has been shown to be increased when epithelial cells are challenged with 
number of micro-organisms including S. Typhimurium. However no one has studied 
the mechanisms underlying this differentiation leading to an increase in M cell 
numbers. So in this study I aimed to study bacterial factors that my promote such a 
phenomena. Specifically, I focused on pathways central to cell differentiation which 
I speculated to be modulated by S. Typhimurium. One of the salient findings was that 
S. Typhimurium effector protein SopB activates the Wnt pathway which leads to 
cytosolic stabilization of β-catenin. The stabilized β-catenin accumulates in the 
cytoplasm and translocates to the nucleus and acts as a co-factor for TCF/LEF 
transcription factor. Once β-catenin binds to TCF/LEF it activates the transcription of 
Wnt pathway proteins including Slug and Vimentin. Slug also acts as a transcription 
factor that induces transcription of vimentin and represses the transcription of E-
Cadherin, a marker typical of epithelium. This leads to the transformation of the cells 
from epithelium to mesenchymal. It is known that Vimentin is a marker of M cells in 
rabbits and bovine species. Expression of vimentin is a co-relate of EMT as well as a 
marker for M cells across species including rabbits and bovine. Increased expression 
of vimentin following bacterial challenge, therefore, perhaps represents the cellular 
transformation of epithelial cells in to M cell phenotype in an EMT signalling 
dependent manner. Associated with this, I have shown that the cells expressing 
vimentin in bovine intestinal epithelial primaries have an uptake function similar to 
M cells. 
 
It is know that RANKL (Receptor activator of nuclear f ctor kappa-B ligand) is a 
protein that can induce M cell ‘transformation’. My results have shown that S.
Typhimurium effector protein SopB increased the expr ssion of RANKL at both the 
transcriptional and protein levels. RANKL induced the transformation of epithelial 
cells to the M cell phenotype in bovine terminal rectal primaries through the 
activation of the NF-kB pathway, in particular through the RelB transcription factor. 
This stimulates the transcription of the transcription factor Slug that stimulates the 
transcription of Vimentin, the M cell phenotype marker.  
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Taken together EspF is very important protein for E. coli O157 colonisation at the 
bovine terminal rectum that prevents its up takes by M cell. Salmonella effector 
protein SopB plays a crucial role in converting follicular associated epithelium to the 
antigen transporting M cell phenotype and thereby promoting bacterial translocation 
across gut. The future work will investigate if any of the EHEC effector proteins 
have a function identical to SopB and thereby could in uce transformation of 
epithelial cells. 
 
7.1 Concluding remarks  
The espFO157 allele was significantly less effective at inhibiting phagocytosis and 
also had reduced capacity to inhibit E. coli translocation through a human-derived in 
vitro M-cell co-culture system in comparison to espFO127 and espFO26.  In contrast, 
espFO157 was the most effective allele at restricting bacterial uptake into and 
translocation through primary epithelial cells cultured from the bovine terminal 
rectum, the predominant colonisation site of EHEC O157 in cattle and a site 
containing M-like cells. Yeast-2-hybrid screening was used to identify additional 
host proteins that may interact with EspF. The anaphase promoting complex 
inhibitor, Mad2L2, and nuclear factor IC (NFIC) was identified from this screen. 
 
The work focused on bovine rectal primary cell cultures interacting with Salmonella 
enterica serovar Typhimurium. The type III secreted protein, SopB, was required for 
Salmonella to: (i) activate parts of epithelial to mesenchymal transition (EMT) 
pathway; (ii) transform a subset of epithelial cells to a cell type that phenotypically 
and functionally resembles specialized antigen sampling M cells; (iii) induce 
RANKL and downstream RelB dependent NFκB signalling. The work suggests that 
Salmonella may induce this cellular transformation t  promote its invasion and 






















Fig. 7.1 Schematic diagram to define role of S. Typhimurium dependent 
activation of Wnt/ β-catenin pathway in induction of cellular 
differentiation. S. Typhimurium in a SopB dependent manner activates Akt kinase 
(phosphorylation), that phosphorylates and inhibits GSK-3β, hence the increased 
cytosolic β-catenin. The free β-catenin binds to members of the T-cell factor (TCF) 
family of transcription factors (including LEF-1), then translocates to the cell nucleus 
and regulates transcription of RANKL, Slug, vimentin and E-cadherin. SopB 
dependent induction of Wnt/β-catenin pathway is critical to trans-differentiation of 
epithelial cells in to M cell phenotype in the bovine terminal rectal “Follicle 
Associated Crypt (FACs)” - epithelial cells. It works by induction of RANKL that in 
a RelB dependent manner triggers Slug and the downstream cellular trans-
differentiation. In the FACs- epithelial cells the Wnt/β-catenin dependent changes in 
Slug expression and the enhanced RANKL expression acts in synergy to induce 
cellular transdifferentiation. In the bovine proximal rectal “Ordinary Crypt” 
epithelial cells in absence of RelB/ RANKL signalling the Wnt/b catenin mediated 
Slug activation of its own is not sufficient enough to induce the cellular trans-


































Abe, A., De Grado, M., Pfuetzner, R. A., Sánchez SanMartín, C., DeVinney, R., 
Puente, J. L., Strynadka, N. C. J. & Finlay, B. B. (1999). Enteropathogenic 
Escherichia coli translocated intimin receptor, Tir, requires a specific haperone for 
stable secretion. Molecular microbiology 33, 1162-1175. 
 
Ackers, M. L., Mahon, B. E., Leahy, E. & other authors (1998). An outbreak of 
Escherichia coli O157: H7 infections associated with leaf lettuce consumption. The 
Journal of infectious diseases 177, 1588-1593. 
 
Aepfelbacher, M., Trasak, C., Wiedemann, A. & Andor, A. (2004). Rho-GTP 
binding proteins in Yersinia target cell interaction. The Genus Yersinia, 65-72. 
 
Aizawa, S. I. (1996). Flagellar assembly in Salmonella typhimurium. Molecular 
microbiology 19, 1-5. 
 
Akashi, S., Joh, K., Mori, T. & other authors (1994). A severe outbreak of 
haemorrhagic colitis and haemolytic uraemic syndrome associated withEscherichia 
coli 0157: H7 in Japan. European Journal of Pediatrics 153, 650-655. 
 
Alto, N. M., Weflen, A. W., Rardin, M. J. & other authors (2007). The type III 
effector EspF coordinates membrane trafficking by the spatiotemporal activation of 
two eukaryotic signaling pathways. The Journal of cell biology 178, 1265-1278. 
 
Anderle, P., Rumbo, M., Sierro, F., Mansourian, R., Michetti, P., Roberts, M. A. 
& Kraehenbuhl, J. P. (2005). Novel Markers of the human follicle--associated 
epithelium identified by genomic profiling and microdissection. Gastroenterology 
129, 321-327. 
 
Andrade, J. & DaVeiga, V. (1989). An endocytic process in HEp-2 cells induced by 
enteropathogenic Escherichia coli. Journal of medical microbiology 28, 49-57. 
 
Armstrong, G. L., Hollingsworth, J. & Morris Jr, J.  G. (1996). Emerging 
foodborne pathogens: Escherichia coli O157: H7 as a model of entry of a new 
pathogen into the food supply of the developed world. Epidemiologic Reviews 18, 
29-51. 
 
Bachelder, R. E., Yoon, S. O., Franci, C., De Herreos, A. G. & Mercurio, A. M. 
(2005). Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription. 
The Journal of cell biology 168, 29-33. 
 
Badour, K., Zhang, J., Shi, F., Leng, Y., Collins, M. & Siminovitch, K. A. (2004). 
Fyn and PTP-PEST–mediated regulation of Wiskott-Aldrich syndrome protein 
(WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor 
engagement to WASp effector function and T cell activ tion. The Journal of 




Badour, K., McGavin, M. K. H., Zhang, J., Freeman, S., Vieira, C., Filipp, D., 
Julius, M., Mills, G. B. & Siminovitch, K. A. (2007). Interaction of the Wiskott–
Aldrich syndrome protein with sorting nexin 9 is required for CD28 endocytosis and 
cosignaling in T cells. Proceedings of the National Academy of Sciences 104, 1593-
1598. 
 
BAI, Y., MURAGAKI, Y., OBATA, K., IWATA, K. & OOSHI MA, A. (1986). 
Immunological properties of monoclonal antibodies to human and rat prolyl 4-
hydroxylase. Journal of biochemistry 99, 1563-1570. 
 
Barlow, R. S., Gobius, K. S. & Desmarchelier, P. M. (2006). Shiga toxin-
producing Escherichia coli in ground beef and lamb cuts: results of a one-year study. 
International journal of food microbiology 111, 1-5. 
 
Barrios-Rodiles, M., Brown, K. R., Ozdamar, B. & other authors (2005). High-
throughput mapping of a dynamic signaling network in mammalian cells. Science's 
STKE 307, 1621-1625. 
 
Bauer, M. E. & Welch, R. A. (1996). Characterization of an RTX toxin from 
enterohemorrhagic Escherichia coli O157: H7. Infection and immunity 64, 167-175. 
 
Baumler, A. J., Tsolis, R. M., Bowe, F. A., Kusters, J. G., Hoffmann, S. & 
Heffron, F. (1996). The pef fimbrial operon of Salmonella Typhimurium mediates 
adhesion to murine small intestine and is necessary for fluid accumulation in the 
infant mouse. Infection and immunity 64, 61-68. 
 
Baumler, A. J., Tsolis, R. M., Valentine, P. J., Ficht, T. A. & Heffron, F. (1997). 
Synergistic effect of mutations in invA and lpfC on the ability of Salmonella 
Typhimurium to cause murine typhoid. Infection and immunity 65, 2254-2259. 
 
Bäumler, A. J., Tsolis, R. M. & Heffron, F. (1996). The lpf fimbrial operon 
mediates adhesion of SalmonellaTyphimurium to murine Peyer's patches. 
Proceedings of the National Academy of Sciences of the United States of America 93, 
279-83. 
 
Behrens, J. (2000). Control of Catenin Signaling in Tumor Development. Annals of 
the New York Academy of Sciences 910, 21-35. 
 
Bell, B. P., Goldoft, M., Griffin, P. M. & other authors (1994). A Multistate 
outbreak of Escherichia coli O157: H7--associated bloody diarrhea and hemolytic 
uremic syndrome from hamburgers: Jama 272, 1349-1353. 
 
Bentancor, A., Rumi, M., Gentilini, M., Sardoy, C., Irino, K., Agostini, A. & 
Cataldi, A. (2007). Shiga toxin producing and attaching and effacing Escherichia 
coli in cats and dogs in a high hemolytic uremic syndrome incidence region in 




Bernard, P. & Couturier, M. (1992). Cell killing by the F plasmid CcdB protein 
involves poisoning of DNA-topoisomerase II complexes* 1. Journal of molecular 
biology 226, 735-745. 
 
Bettelheim, K. A. 2000. Role of non-O157 VTEC. Symp. Ser. Soc. Appl. Microbiol. 
29,38S-50S. 
 
Beutin, L. (2006). Emerging enterohaemorrhagic Escherichia coli, causes and 
effects of the rise of a human pathogen. Journal of Veterinary Medicine Series B 53, 
299-305. 
 
Bidet, P., Mariani-Kurkdjian, P., Grimont, F., Brah imi, N., Courroux, C., 
Grimont, P. & Bingen, E. (2005). Characterization of Escherichia coli O157: H7 
isolates causing haemolytic uraemic syndrome in France. Journal of medical 
microbiology 54, 71-75. 
 
Bieber, D., Ramer, S. W., Wu, C. Y., Murray, W. J., Tobe, T., Fernandez, R. & 
Schoolnik, G. K. (1998). Type IV pili, transient bacterial aggregates, and virulence 
of enteropathogenic Escherichia coli. Science 280, 2114-2118. 
 
Bielaszewska, M., Janda, J., Blahova, K. & other authors (1997). Human 
Escherichia coli O157: H7 infection associated with the consumption f 
unpasteurized goat's milk. Epidemiology and infection, 299-305. 
 
Bodey, G. P., Fainstein, V. & Guerrant, R. (1986). Infections of the 
gastrointestinal tract in the immunocompromised patient. Annual review of medicine 
37, 271-281. 
 
Boerlin, P., McEwen, S. A., Boerlin-Petzold, F., Wilson, J. B., Johnson, R. P. & 
Gyles, C. L. (1999). Associations between virulence factors of Shiga toxin-
producing Escherichia coli and disease in humans. Journal of Clinical Microbiology 
37, 497-503. 
 
Bolton, A. J., Osborne, M. P., Wallis, T. S. & Stephen, J. (1999). Interaction of 
Salmonella choleraesuis, Salmonella Dublin and Salmonella Typhimurium with 
porcine and bovine terminal ileum in vivo. Microbiology 145, 2431-2441. 
 
Booth, C., Patel, S., Bennion, G. & Potten, C. (1995). The isolation and culture of 
adult mouse colonic epithelium. Epithelial cell biology 4, 76-86. 
 
Borghesi, C., Regoli, M., BERTELLI, E. & NICOLETTI,  C. (1996). 
Modefications of the follecle associated epithelium by short term exposure to a non 




Borghesi, C., Taussig, M. J. & Nicoletti, C. (1999). Rapid appearance of M cells 
after microbial challenge is restricted at the perihery of the follicle-associated 
epithelium of Peyer's patch. Laboratory Investigation 79, 1393-1401. 
 
Boucrot, E., Henry, T., Borg, J. P., Gorvel, J. P. & Méresse, S. (2005). The 
intracellular fate of Salmonella depends on the recruitment of kinesin. Science 308, 
1174-1178. 
 
Bourdet-Sicard, R. & Van Nhieu, G. T. (1999). Actin reorganization by SipA and 
Salmonella invasion of epithelial cells. Trends in Microbiology 7, 309-310. 
 
Boyce, T. G., Swerdlow, D. L. & Griffin, P. M. (1995). Escherichia coli O157: H7 
and the hemolytic-uremic syndrome. New England Journal of Medicine 333, 364-
368. 
 
Braun, P., Tasan, M., Dreze, M. & other authors (208). An experimentally 
derived confidence score for binary protein-protein interactions. Nature methods 6, 
91-97. 
 
Braun, V., Wong, A., Landekic, M., Hong, W. J., Grinstein, S. & Brumell, J. H. 
(2010). Sorting nexin 3 (SNX3) is a component of a tubular endosomal network 
induced by Salmonella and involved in maturation of the Salmonella containing 
vacuole. Cellular Microbiology 12, 1352-1367. 
 
Brewster, D., Brown, M., Robertson, D., Houghton, G., Bimson, J. & Sharp, J. 
(1994). An outbreak of Escherichia coli O157 associated with a children's paddling 
pool. Epidemiology and infection 112, 441-447. 
 
Brumell, J. H., Tang, P., Mills, S. D. & Finlay, B. B. (2001). Characterization of 
Salmonella induced filaments (Sifs) reveals a delayed interaction between 
Salmonella containing vacuoles and late endocytic compartments. Traffic 2, 643-653. 
 
Brumell, J. H. & Grinstein, S. (2004). Salmonella redirects phagosomal maturation. 
Current opinion in microbiology 7, 78-84. 
 
Brunder, W., Schmidt, H. & Karch, H. (1997). EspP, a novel extracellular serine 
protease of enterohaemorrhagic Escherichia coli O 157: H 7 cleaves human 
coagulation factor V. Molecular microbiology 24, 767-778. 
 
Buchwald, G., Friebel, A., Galán, J. E., Hardt, W. D., Wittinghofer, A. & 
Scheffzek, K. (2002). Structural basis for the reversible activation of a Rho protein 
by the bacterial toxin SopE. The EMBO Journal 21, 3286-3295. 
 
Bujny, M. V., Ewels, P. A., Humphrey, S., Attar, N., Jepson, M. A. & Cullen, P. 
J. (2008). Sorting nexin-1 defines an early phase of Salmonella-containing vacuole-




Burland, V., Shao, Y., Perna, N. T., Plunkett, G., Blattner, F. R. & Sofia, H. J. 
(1998). The complete DNA sequence and analysis of the large virulence plasmid of 
Escherichia coli O157: H7. Nucleic acids research 26, 4196-4204. 
 
Burnens, A., Frey, A., Lior, H. & Nicolet, J. (1995). Prevalence and clinical 
significance of vero-cytotoxin-producing Escherichia coli (VTEC) isolated from 
cattle in herds with and without calf diarrhoea. Journal of Veterinary Medicine Series 
B 42, 311-318. 
 
Bye, W., Allan, C. & Trier, J. (1984). Structure, distribution, and origin of M cells 
in Peyer's patches of mouse ileum. Gastroenterology 86, 789-801. 
 
Campellone, K. G., Robbins, D. & Leong, J. M. (2004). EspFU is a translocated 
EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent 
actin assembly. Developmental cell 7, 217-228. 
 
Campellone, K. G., Roe, A. J., Løbner-Olesen, A. & other authors (2007). 
Increased adherence and actin pedestal formation by dam-deficient 
enterohaemorrhagic Escherichia coli O157: H7. Molecular microbiology 63, 1468-
1481. 
 
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del 
Barrio, M. G., Portillo, F. & Nieto, M. A. (2000). The transcription factor snail 
controls epithelial-mesenchymal transitions by repressing E-cadherin expression. 
Nature cell biology 2, 76-83. 
 
Caprioli, A., Morabito, S., Brugère, H. & Oswald, E. (2005). Enterohaemorrhagic 
Escherichia coli: emerging issues on virulence and modes of transmission. 
Veterinary research 36, 289-311. 
 
Cavalieri, S. J., Bohach, G. A. & Snyder, I. (1984). Escherichia coli alpha-
hemolysin: characteristics and probable role in pathogenicity. Microbiology and 
Molecular biology reviews 48, 326-343. 
 
CDC (2011). Investigation update: Outbreak of Shiga toxin-producing E. coli O104 
(STEC O104:H4) infections associated with travel to Germany  
 
 
CDC (1995).Outbreak of acute gastroenteritis attributable to Escherichia coli 
serotype O104:H21-Helena, Montana, 1994. MMWR Morb Mortal Wkly Rep 44, 
501-503. 
 
CDC (1996). Lake-associated outbreak of Escherichia coli O157:H7-Illinois, 1995. . 




Celli, J., Olivier, M. & Finlay, B. B. (2001). Enteropathogenic Escherichia coli 
mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. 
The EMBO Journal 20, 1245-1258. 
 
Celli, J. & Finlay, B. B. (2002). Bacterial avoidance of phagocytosis. Trends in 
Microbiology 10, 232-237. 
 
Chapman, P., Siddons, C., Cerdan Malo, A. & Harkin, M. (1997). A 1-year study 
of Escherichia coli O157 in cattle, sheep, pigs and poultry. Epidemiology and 
infection 119, 245-250. 
 
Chapman, P. A. (2000). Methods available for the detection of Escherichia coli 
O157 in clinical, food and environmental samples. World Journal of Microbiology 
and Biotechnology 16, 733-740. 
 
Charlier, D. & Glansdorff, N. (2004). Escherichia coli and Salmonella: cellular and 
molecular biology edited by R. Curtiss III.Washington, DC: ASM Press. 
http://www.ecosal.org. 
 
Cheung, H. W., Chun, A., Wang, Q. & other authors (2006). Inactivation of 
human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to 
DNA-damaging agents. Cancer research 66, 4357-4367. 
 
Choy, M., Walker-Smith, J., Williams, C. & MacDonald, T. (1990). Differential 
expression of CD25 (interleukin-2 receptor) on lamina propria T cells and 
macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis. Gut 
31, 1365-1370. 
 
Cirillo, D. M., Valdivia, R. H., Monack, D. M. & Fa lkow, S. (1998). Macrophage 
dependent induction of the Salmonella pathogenicity island 2 type III secretion 
system and its role in intracellular survival. Molecular microbiology 30, 175-188. 
 
Clark, M., Jepson, M., Simmons, N., Booth, T. & Hirst, B. (1993). Differential 
expression of lectin-binding sites defines mouse intestinal M-cells. Journal of 
Histochemistry and Cytochemistry 41, 1679-1687. 
 
Clark, M., Jepson, M., Simmons, N. & Hirst, B. (1994). Preferential interaction of 
Salmonella typhimurium with mouse Peyer's patch M cells. Research in 
microbiology 145, 543-552. 
 
Clark, M., Hirst, B. H. & Jepson, M. A. (1998). M-cell surface beta 1 integrin 
expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse 
Peyer's patch M cells. Infection and immunity 66, 1237-1243. 
 
Clarke, R., Wilson, J., Read, S. & other authors (1994).Verocytotoxin-producing 
Escherichia coli (VTEC) in the food chain: preharvest and processing perspectives, 
____________________________________________________References 
 209 
p. 17-24 In M. A. Karmali and A. G. Goglio (ed.), Recent advances in Verocytotoxin-
producing Escherichia coli 
infections. Elsevier Science, Amsterdam. 
 
Clarke, S., Haigh, R., Freestone, P. & Williams, P. (2003). Virulence of 
enteropathogenic Escherichia coli, a global pathogen. Clinical Microbiology Reviews 
16, 365-378. 
 
Clarke, S. C. (2001). Diarrhoeagenic Escherichia coli--an emerging problem? 
Diagnostic microbiology and infectious disease 41, 93-98. 
 
Cobbold, R. & Desmarchelier, P. (2000). A longitudinal study of Shiga-toxigenic 
Escherichia coli (STEC) prevalence in three Australian dairy herds. Veterinary 
microbiology 71, 125-137. 
 
Coburn, B., Sekirov, I. & Finlay, B. B. (2007). Type III secretion systems and 
disease. Clinical Microbiology Reviews 20, 535-549. 
 
Corr, S. C., Gahan, C. C. G. M. & Hill, C. (2008). M cells: origin, morphology and 
role in mucosal immunity and microbial pathogenesis. FEMS Immunology & 
Medical Microbiology 52, 2-12. 
 
Crane, J. K., McNamara, B. P. & Donnenberg, M. S. (2001). Role of EspF in host 
cell death induced by enteropathogenic Escherichia coli. Cellular Microbiology 3, 
197-211. 
 
Cravioto, A., Gross, R., Scotland, S. & Rowe, B. (1979). An adhesive factor found 
in strains of Escherichia coli belonging to the traditional infantile enteropathogenic 
serotypes. Current Microbiology 3, 95-99. 
 
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M. & Hemmings, B. A. 
(1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein 
kinase B. Nature 378, 785-789. 
 
Czerkinsky, C., Anjueie, F., McGhee, J. R. & other authors (1999). Mucosal 
immunity and tolerance: relevance to vaccine development. Immunological reviews 
170, 197-222. 
 
Dahan, S., Busuttil, V., Imbert, V., Peyron, J. F., Rampal, P. & Czerucka, D. 
(2002). Enterohemorrhagic Escherichia coli infection induces interleukin-8 
production via activation of mitogen-activated protein kinases and the transcription 
factors NF-{kappa} B and AP-1 in T84 cells. Infection and immunity 70, 2304-2310. 
 
Daniels, J., Autenrieth, I. B., Ludwig, A. & Goebel, W. (1996). The gene slyA of 
Salmonella Typhimurium is required for destruction of M cells and intracellular 
survival but not for invasion or colonization of the murine small intestine. Infection 




Dean, P. & Kenny, B. (2004). Intestinal barrier dysfunction by enteropathogenic 
Escherichia coli is mediated by two effector molecules and a bacterial surface 
protein. Molecular microbiology 54, 665-675. 
 
Dean, P., Maresca, M., Schüller, S., Phillips, A. D. & Kenny, B. (2006). Potent 
diarrheagenic mechanism mediated by the cooperative action of three 
enteropathogenic Escherichia coli-injected effector proteins. Proceedings of the 
National Academy of Sciences of the United States of America 103, 1876-1881. 
 
Dean, P., Scott, J., Knox, A., Quitard, S., Watkins, N. & Kenny, B. (2010). The 
enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process 
regulated by mitochondrial dysfunction. PLoS Pathogens 6, 119-127. 
 
Debard, N., Sierro, F., Browning, J. & Kraehenbuhl, J. P. (2001). Effect of 
mature lymphocytes and lymphotoxin on the development of the follicle-associated 
epithelium and M cells in mouse Peyer's patches. Gastroenterology 120, 1173-1182. 
 
Desvaux, M., Parham, N. J. & Henderson, I. R. (2003). Le système de sécrétion 
de type V chez les bactéries Gram-négatives secretion system of the gram negative 
bacteria. Biofutur 237, 34-37. 
 
Doble, B. W. & Woodgett, J. R. (2003). GSK-3: tricks of the trade for a multi-
tasking kinase. Journal of cell science 116, 1175-1186. 
 
Dong, N., Liu, L. & Shao, F. (2010) A bacterial effector targets host DH-PH 
domain RhoGEFs and antagonizes macrophage phagocytosis. The EMBO journal 29, 
1363-1376. 
 
Du, F. & Galán, J. E. (2009). Selective inhibition of type III secretion activated 
signaling by the Salmonella effector AvrA. PLoS Pathogens 5, e1000595. 
 
Duffy, G. (2003). Verocytoxigenic Escherichia coli in animal faeces, manures and 
slurries. Journal of applied microbiology 94, 94-103. 
 
Dziva, F., van Diemen, P. M., Stevens, M. P., Smith, A. J. & Wallis, T. S. (2004). 
Identification of Escherichia coli O157: H7 genes influencing colonization of the 
bovine gastrointestinal tract using signature-tagged mutagenesis. Microbiology 150, 
3631-3645. 
 
Dziva, F., Mahajan, A., Cameron, P., Currie, C., McKendrick, I. J., Wallis, T. 
S., Smith, D. G. E. & Stevens, M. P. (2007). EspP, a Type V secreted serine 
protease of enterohaemorrhagic Escherichia coli O157: H7, influences intestinal 
colonization of calves and adherence to bovine primary intestinal epithelial cells. 






Edwards, P. R. and W. H. Ewing (1972). Identification of Enterobacteriaceae. 
Third edition. 
 
Echtenkamp, F., Deng, W., Wickham, M. E., Vazquez, A., Puente, J. L., 
Thanabalasuriar, A., Gruenheid, S., Finlay, B. B. & Hardwidge, P. R. (2008). 
Characterization of the NleF effector protein from attaching and effacing bacterial 
pathogens. FEMS microbiology letters 281, 98-107. 
 
Eckmann, L., Rudolf, M. T., Ptasznik, A. & other authors (1997). D-myo-
Inositol 1,4,5,6-tetrakisphosphate produced in human intestinal epithelial cells in 
response to Salmonella invasion inhibits phosphoinositide 3-kinase signaling 
pathways. Proc Natl Acad Sci U S A94, 14456-14460. 
 
El Bahi, S., Caliot, E., Bens, M., Bogdanova, A., Kerneis, S., Kahn, A., 
Vandewalle, A. & Pringault, E. (2002). Lymphoepithelial interactions trigger 
specific regulation of gene expression in the M cell- ontaining follicle-associated 
epithelium of Peyer's patches. The Journal of Immunology 168, 3713-3720. 
 
Elliott, S. J., Wainwright, L. A., McDaniel, T. K.,  Jarvis, K. G., Deng, Y. K., Lai, 
L. C., McNamara, B. P., Donnenberg, M. S. & Kaper, J. B. (1998). The complete 
sequence of the locus of enterocyte effacement (LEE) from enteropathogenic 
Escherichia coli E2348/69. Molecular microbiology 28, 1-4. 
 
Elliott, S. J., Krejany, E. O., Mellies, J. L., Robins-Browne, R. M., Sasakawa, C. 
& Kaper, J. B. (2001). EspG, a novel type III system-secreted protein from 
enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. 
Infection and immunity 69, 4027-4033. 
 
Elliott, S. J., O'Connell, C. B., Koutsouris, A., Brinkley, C., Donnenberg, M. S., 
Hecht, G. & Kaper, J. B. (2002). A gene from the locus of enterocyte effacement 
that is required for enteropathogenic Escherichia coli to increase tight-junction 
permeability encodes a chaperone for EspF. Infection and immunity 70, 2271-2277. 
 
Emmerson, J. R., Gally, D. L. & Roe, A. J. (2006). Generation of gene deletions 
and gene replacements in Escherichia coli O157: H7 using a temperature sensitive 
allelic exchange system. Biological procedures online 8, 153-162. 
 
Ermak, T., Steger, H. & Pappo, J. (1990). Phenotypically distinct subpopulations 
of T cells in domes and M-cell pockets of rabbit gu-associated lymphoid tissues. 
Immunology 71, 530-537. 
 
Ermak, T., Bhagat, H. & Pappo, J. (1994). Lymphocyte compartments in antigen-
sampling regions of rabbit mucosal lymphoid organs. The American journal of 




Ermak, T. H. & Owen, R. L. (1986). Differential distribution of lymphocytes and 
accessory cells in mouse Peyer's patches. The Anatomical Record 215, 144-152. 
 
Ermak, T. H., Dougherty, E. P., Bhagat, H. R., Kabok, Z. & Pappo, J. (1995). 
Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's 
patch M cells. Cell and tissue research 279, 433-436. 
 
Erwert, R. D., Eiting, K. T., Tupper, J. C., Winn, R. K., Harlan, J. M. & 
Bannerman, D. D. (2003). Shiga toxin induces decreased expression of the anti-
apoptotic protein Mcl-1 concomitant with the onset of endothelial apoptosis. 
Microbial pathogenesis 35, 87-93. 
 
Faith, N., Shere, J., Brosch, R., Arnold, K., Ansay, S., Lee, M., Luchansky, J. & 
Kaspar, C. (1996). Prevalence and clonal nature of Escherichia coli O157: H7 on 
dairy farms in Wisconsin. Applied and Environmental Microbiology 62, 1519-1525. 
 
Fan, X., Roy, E. M., Murphy, T. C., Nanes, M. S., Kim, S., Pike, J. & Rubin, J. 
(2004). Regulation of RANKL promoter activity is associated with histone 
remodeling in murine bone stromal cells. Journal of cellular biochemistry 93, 807-
818. 
 
Farstad, I., Halstensen, T., Fausa, O. & Brandtzaeg, P. (1994). Heterogeneity of 
M-cell-associated B and T cells in human Peyer's patches. Immunology 83, 457-464. 
 
Fey, P. D., Wickert, R., Rupp, M., Safranek, T. & Hinrichs, S. (2000). Prevalence 
of non-O157: H7 shiga toxin-producing Escherichia coli in diarrheal stool samples 
from Nebraska. Emerging Infectious Diseases 6, 530-533. 
 
Fields, S. & Song, O. (1989). A novel genetic system to detect protein-protein 
interactions. Nature 340, 245-246. 
 
Fivaz, M. & van der Goot, F. G. (1999). The tip of a molecular syringe. Trends in 
Microbiology 7, 341-343. 
 
Frankel, G. and A. D. Phillips (2008). "Attaching effacing Escherichia coli and 
paradigms of Tir triggered actin polymerization: getting off the pedestal." 
Cellular Microbiology 10, 549-556. 
 
Frankel, G., Phillips, A. D., Rosenshine, I., Dougan, G., Kaper, J. B. & Knutton, 
S. (1998). Enteropathogenic and enterohaemorrhagic Escherichia coli: more 
subversive elements. Molecular microbiology 30, 911-921. 
 
Frankel, G., Phillips, A. D., Trabulsi, L. R., Knutton, S., Dougan, G. & 
Matthews, S. (2001). Intimin and the host cell--is it bound to end in Tir (s)? Trends 




Frauli, M. & Ludwig, H. (1987).  Inhibition of fibroblast proliferation in a culture of 
human endometrial stromal cells using a medium containing D-valine. Archives of 
Gynecology and Obstetrics 241, 87-96. 
 
Freeman, T., Bentsen, B., Thwaites, D. & Simmons, N. (1995). H+/di-tripeptide 
transporter (PepT1) expression in the rabbit intestin . Pflügers Archiv European 
Journal of Physiology 430, 394-400. 
 
Frey, A., Giannasca, K., Weltzin, R., Giannasca, P., Reggio, H., Lencer, W. & 
Neutra, M. (1996). Role of the glycocalyx in regulating access of microparticles to 
apical plasma membranes of intestinal epithelial cells: implications for microbial 
attachment and oral vaccine targeting. The Journal of experimental medicine 184, 
1045-1059. 
 
Friebel, A., H. Ilchmann, et al. (2001). SopE and SopE2 from Salmonella 
typhimurium activate different sets of RhoGTPases of the host cell. Journal of 
Biological Chemistry 276, 34035-34040. 
 
Fromont-Racine, M., Rain, J. C. & Legrain, P. (1997). Toward a functional 
analysis of the yeast genome through exhaustive two-hybrid screens. Nature genetics 
16, 277-282. 
 
Fu, Q., Jilka, R. L., Manolagas, S. C. & O'Brien, C. A. (2002). Parathyroid 
hormone stimulates receptor activator of NF B ligand and inhibits osteoprotegerin 
expression via protein kinase A activation of cAMP-response element-binding 
protein. Journal of Biological Chemistry 277, 48868-48875. 
 
Fukushima, H., Hoshina, K. & Gomyoda, M. (1999). Long-term survival of Shiga 
toxin-producing Escherichia coli O26, O111, and O157 in bovine feces. Applied and 
Environmental Microbiology 65, 5177-5181. 
 
Galan, J. (1996). Molecular and cellular bases of Salmonella entry into host cells. 
Current Topics in Microbiology and Immunology 209, 43-60. 
 
Galan, J. E. & Curtiss 3rd, R. (1991). Distribution of the invA,-B,-C, and-D genes 
of Salmonella Typhimurium among other Salmonella serovars: invA mutants of 
Salmonella typhi are deficient for entry into mammalian cells. Infection and 
immunity 59, 2901-2908. 
 
Galán, J. E. & Zhou, D. (2000). Striking a balance: modulation of the actin 
cytoskeleton by Salmonella. Proceedings of the National Academy of Sciences 97, 
8754-8761. 
 





Gauthier, A., Puente, J. L. & Finlay, B. B. (2003). Secretin of the enteropathogenic 
Escherichia coli type III secretion system requires components of the type III 
apparatus for assembly and localization. Infection and immunity 71, 3310-3319. 
 
Gebert, A., Rothkötter, H. J. & Pabst, R. (1994). Cytokeratin 18 is an M-cell 
marker in porcine Peyer's patches. Cell and tissue research 276, 213-221. 
 
Gebert, A. (1997). The role of M cells in the protection of mucosal me branes. 
Histochemistry and cell biology 108, 455-470. 
 
Gebert, A., Fassbender, S., Werner, K. & Weissferdt, A. (1999). The 
development of M cells in Peyer's patches is restricted to specialized dome-
associated crypts. American Journal of Pathology 154, 1573-1582. 
 
Gebert, A., Steinmetz, I., Fassbender, S. & Wendlandt, K. H. (2004). Antigen 
transport into Peyer's patches: increased uptake by constant numbers of M cells. 
American Journal of Pathology 164, 65-72. 
 
Geiger, T. R. & Peeper, D. S. (2009). Metastasis mechanisms. Biochimica et 
Biophysica Acta (BBA)-Reviews on Cancer 1796, 293-308. 
 
Gerlach, R. G. & Hensel, M. (2007). Protein secretion systems and adhesins: the 
molecular armory of Gram-negative pathogens. I ternational Journal of Medical 
Microbiology 297, 401-415. 
 
Geue, L., Segura-Alvarez, M., Conraths, F., Kuczius, T., Bockemühl, J., Karch, 
H. & Gallien, P. (2002). A long-term study on the prevalence of shiga toxin-
producing Escherichia coli (STEC) on four German cattle farms. Epidemiology and 
infection 129, 173-185. 
 
Giannasca, P., Giannasca, K., Falk, P., Gordon, J. & Neutra, M. (1994). 
Regional differences in glycoconjugates of intestinal M cells in mice: potential 
targets for mucosal vaccines. American Journal of Physiology- Gastrointestinal and 
Liver Physiology 267, G1108-1121. 
 
Giannasca, P., Giannasca, K., Leichtner, A. & Neutra, M. (1999). Human 
intestinal M cells display the sialyl Lewis A antigen. Infection and immunity 67, 946-
953. 
 
Gilles, C., Polette, M., Mestdagt, M., Nawrocki-Raby, B., Ruggeri, P., 
Birembaut, P. & Foidart, J. M. (2003). Transactivation of vimentin by -catenin in 
human breast cancer cells. Cancer research 63, 2658-2664. 
 
Ginocchio, C. C., Olmsted, S. B., Wells, C. L. & Gal n, J. E. (1994). Contact with 
epithelial cells induces the formation of surface appendages on Salmonella 




Giron, J. A., Ho, A. & Schoolnik, G. K. (1991). An inducible bundle-forming pilus 
of enteropathogenic Escherichia coli. Science 254, 710-713. 
 
Girón, J. A. (2005). Role of flagella in mucosal colonization. Colonization of 
mucosal surfaces, 213-236. 
 
Gorvel, J. P. & Meresse, S. (2001). Maturation steps of the Salmonella-containing 
vacuole. Microbes and infection 3, 1299-1303. 
 
Grassme, H., Jendrossek, V. & Gulbins, E. (2001). Molecular mechanisms of 
bacteria induced apoptosis. Apoptosis 6, 441-445. 
 
Griffin, P., Olmstead, L. & Petras, R. (1990). Escherichia coli O157: H7-
associated colitis. A clinical and histological study of 11 cases. Gastroenterology 99, 
142-149. 
 
Griffin, P. M. & Tauxe, R. V. (1991). The epidemiology of infections caused by 
Escherichia coli O157: H7, other enterohemorrhagic E. coli, and the associated 
hemolytic uremic syndrome. Epidemiologic Reviews 13, 60-98. 
 
Griffin, P. M. (1995). Escherichia coli O157: H7 and other enterohemorrhagic 
Escherichia coli. Infections of the gastrointestinal tract, 739–761. 
 
Grille, S. J., Bellacosa, A., Upson, J., Klein-Szanto, A. J., Van Roy, F., Lee-
Kwon, W., Donowitz, M., Tsichlis, P. N. & Larue, L. (2003). The protein kinase 
Akt induces epithelial mesenchymal transition and promotes enhanced motility and 
invasiveness of squamous cell carcinoma lines. Cancer research 63, 2172-2178. 
 
Grimont, P. A. D. & Weill, F. X. (2007). Antigenic formulae of the Salmonella 
serovars. 9th edition.WHO collaborating centre for reference and research on 
Salmonella, Institut Pasteur, Paris, France. 
 
Grys, T. E., Siegel, M. B., Lathem, W. W. & Welch, R. A. (2005). The StcE 
protease contributes to intimate adherence of enterohemorrhagic Escherichia coli 
O157: H7 to host cells. Infection and immunity 73, 1295-1303. 
 
Guaita, S., Puig, I., Franc , C. & other authors (2002). Snail Induction of 
Epithelial to Mesenchymal Transition in Tumor Cells Is Accompanied by MUC1 
Repression andZEB1 Expression. Journal of Biological Chemistry 277, 39209-
39216. 
 
Guiney, D. (2005). The role of host cell death in Salmonella infections. Role of 
Apoptosis in Infection, 131-150. 
 
Gullberg, E. & Söderholm, J. D. (2006). Peyer's patches and M cells as potential 
sites of the inflammatory onset in Crohn's disease. Annals of the New York Academy 




Gunning, R., Wales, A., Pearson, G., Done, E., Cookson, A. & Woodward, M. 
(2001). Attaching and effacing lesions in the intestines of two calves associated with 
natural infection with Escherichia coli O26: H11. The Veterinary Record 148, 780-
782. 
 
Guttman, J. A., Samji, F. N., Li, Y., Vogl, A. W. & Finlay, B. B. (2006). Evidence 
that tight junctions are disrupted due to intimate bacterial contact and not 
inflammation during attaching and effacing pathogen infection in vivo. Infection and 
immunity 74, 6075-6084. 
 
Guttman, J. A., Kazemi, P., Lin, A. E., Vogl, A. W. & Finlay, B. B. (2007). 
Desmosomes are unaltered during infections by attaching and effacing pathogens. 
The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 
290, 199-205. 
 
Guy, R. L., Gonias, L. A. & Stein, M. A. (2000). Aggregation of host endosomes 
by Salmonella requires SPI2 translocation of SseFG and involves SpvR and the fms–
aroE intragenic region. Molecular microbiology 37, 1417-1435. 
 
Hall, G., Reynolds, D., Chanter, N., Morgan, J., Parsons, K., Debney, T., Bland, 
A. & Bridger, J. (1985). Dysentery caused by Escherichia coli (S102-9) in calves: 
natural and experimental disease. V terinary Pathology Online 22, 156-163. 
 
Hancock, D., Besser, T., Kinsel, M., Tarr, P., Rice, D. & Paros, M. (1994). The 
prevalence of Escherichia coli O157. H7 in dairy and beef cattle in Washington 
State. Epidemiology and infection 113, 199-207. 
 
Hardt, W. D., Urlaub, H. & Galán, J. E. (1998). A substrate of the centisome 63 
type III protein secretion system of Salmonella typhimurium is encoded by a cryptic 
bacteriophage. Proceedings of the National Academy of Sciences of the United States 
of America 95, 2574-2579. 
 
Hartland, E. L., Batchelor, M., Delahay, R. M., Hale, C., Matthews, S., Dougan, 
G., Knutton, S., Connerton, I. & Frankel, G. (1999). Binding of intimin from 
enteropathogenic Escherichia coli to Tir and to host cells. Molecular microbiology 
32, 151-158. 
 
Hase, K., Kawano, K., Nochi, T. & other authors (209). Uptake through 
glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response. 
Nature 462, 226-230. 
 
Hayward, R. D. & Koronakis, V. (1999). Direct nucleation and bundling of actin 
by the SipC protein of invasive Salmonella. Embo J 18, 4926-4934. 
 
Hemrajani, C., Berger, C. N., Robinson, K. S., Marchès, O., Mousnier, A. & 
Frankel, G. (2010). NleH effectors interact with Bax inhibitor-1 to block apoptosis 
____________________________________________________References 
 217 
during enteropathogenic Escherichia coli infection. Proceedings of the National 
Academy of Sciences 107, 3129-3135. 
 
Hernandez, L. D., Hueffer, K., Wenk, M. R. & Galan, J. E. (2004). Salmonella 
modulates vesicular traffic by altering phosphoinostide metabolism. Science 304, 
1805-1807. 
 
Hersh, D., Monack, D. M., Smith, M. R., Ghori, N., Falkow, S. & Zychlinsky, A. 
(1999a). The Salmonella invasin SipB induces macrophage apoptosis by binding to 
caspase-1. Proceedings of the National Academy of Sciences of the United States of 
America 96, 2396-2401. 
 
Hersh, D., Monack, D. M., Smith, M. R., Ghori, N., Falkow, S. & Zychlinsky, A. 
(1999b). The Salmonella invasin SipB induces macrophage apoptosis by binding to 
caspase-1. Proc Natl Acad Sci U S A96, 2396-2401. 
 
Hodges, K., Alto, N. M., Ramaswamy, K., Dudeja, P. K. & Hecht, G. (2008). The 
enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen 
exchanger 3 activity. Cellular Microbiology 10, 1735-1745. 
 
Hoey, D., Sharp, L., Currie, C., Lingwood, C., Gally, D. & Smith, D. (2003). 
Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to 
lysosomes and abrogation of toxicity. Cellular Microbiology 5, 85-97. 
 
Hoey, D. E. E., Currie, C., Else, R. W., Nutikka, A., Llngwood, C. A., Gally, D. 
L. & Smith, D. G. E. (2002). Expression of receptors for verotoxin 1 from 
Escherichia coli O157 on bovine intestinal epithelium. Journal of medical 
microbiology 51, 143-149. 
 
Holmes, A., Muhlen, S., Roe, A. J. & Dean, P. (2010). The EspF Effector, a 
Bacterial Pathogen's Swiss Army Knife. Infection and immunity 78, 4445-4453. 
 
Hong, C. F., Chou, Y. T., Lin, Y. S. & Wu, C. W. (2009). MAD2B, a novel TCF4-
binding protein, modulates TCF4-mediated epithelial-mesenchymal 
transdifferentiation. Journal of Biological Chemistry 284, 19613-19622. 
 
Howard, C., Sopp, P., Parsons, K. & Finch, J. (1989). In vivo depletion of BoT4 
(CD4) and of non T4/T8 lymphocyte subsets in cattle with monoclonal antibodies. 
European journal of immunology 19, 757-764. 
 
Howard, C., Sopp, P., Bembridge, G., Young, J. & Parsons, K. (1993). 
Comparison of CD1 monoclonal antibodies on bovine cells and tissues. Veterinary 
immunology and immunopathology 39, 77-83. 
 
Hueck, C. J. (1998). Type III protein secretion systems in bacterial pathogens of 




Hülsken, J. & Behrens, J. (2000). The Wnt signalling pathway. Journal of Cell 
Science 113, 3545. 
 
Humphries, R. M. & Armstrong, G. D. (2010). Sticky situation: localized 
adherence of enteropathogenic Escherichia coli to the small intestine epithelium. 
Future Microbiology 5, 1645-1661. 
 
Iizumi, Y., Sagara, H., Kabe, Y. & other authors (2007). The enteropathogenic E. 
coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting 
myosin function. Cell Host & Microbe 2, 383-392. 
 
Iwai, H., Kim, M., Yoshikawa, Y. & other authors (2007). A bacterial effector 
targets Mad2L2, an APC inhibitor, to modulate host cell cycling. Cell 130, 611-623. 
 
Iwasaki, A. & Kelsall, B. (2000). Localization of distinct Peyer's patch dendritic cell 
subsets and their recruitment by chemokines macrophage inflammatory protein 
(MIP)-3 , MIP-3 , and secondary lymphoid organ chemokine. The Journal of 
experimental medicine 191, 1381-1394. 
 
Jacewicz, M. S., Acheson, D. W. K., Binion, D. G., West, G. A., Lincicome, L. L., 
Fiocchi, C. & Keusch, G. T. (1999). Responses of human intestinal microvascular 
endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. 
Infection and immunity 67, 1439-1444. 
 
Jackson, L. K., Nawabi, P., Hentea, C., Roark, E. A. & Haldar, K. (2008). The 
Salmonella virulence protein SifA is a G protein antagonist. Proceedings of the 
National Academy of Sciences 105, 14141-14146. 
 
Jackson, M. P., Neill, R. J., O'Brien, A. D., Holmes, R. K. & Newland, J. W. 
(1987). Nucleotide sequence analysis and comparison of the structural genes for 
Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from 
Escherichia coli 933. FEMS microbiology letters 44, 109-114. 
 
Jamora,C., DasGupta,R., Kocieniewski,P., and Fuchs,E. (2003). Links between 
signal transduction, transcription and adhesion in epithelial bud development 
Nature 422, 317-322. 
 
Jang, M. H., Kweon, M. N., Iwatani, K. & other authors (2004). Intestinal villous 
M cells: an antigen entry site in the mucosal epithelium. Proceedings of the National 
Academy of Sciences of the United States of America 101, 6110-6115. 
 
Jarvis, K. G., Girón, J. A., Jerse, A. E., McDaniel, T. K., Donnenberg, M. S. & 
Kaper, J. B. (1995). Enteropathogenic Escherichia coli contains a putative type III 
secretion system necessary for the export of proteins involved in attaching and 
effacing lesion formation. Proceedings of the National Academy of Sciences of the 




Jelacic, J. K., Damrow, T., Chen, G. S. & other authors (2003). Shiga toxin-
producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. The 
Journal of infectious diseases 188, 719-729. 
 
Jenkins, C., Pearce, M., Smith, A. & other authors (2003). Detection of 
Escherichia coli serogroups O26, O103, O111 and O145 from bovine faeces using 
immunomagnetic separation and PCR/DNA probe techniques. Letters in applied 
microbiology 37, 207-212. 
 
Jensen, V. B., Harty, J. T. & Jones, B. D. (1998). Interactions of the invasive 
pathogens Salmonella Ttyphimurium, Listeria monocytogenes, and Shigella flexneri 
with M cells and murine Peyer's patches. Infection and immunity 66, 3758-3766. 
 
Jepson, M., Lang, T., Reed, K. & Simmons, N. (1996). Evidence for a rapid, direct 
effect on epithelial monolayer integrity and transepithelial transport in response to 
Salmonella invasion. Pflügers Archiv European Journal of Physiology 432, 225-233. 
 
Jepson, M. A. & Ann Clark, M. (1998). Studying M cells and their role in 
infection. Trends in Microbiology 6, 359-365. 
 
Jepson, M. A. & Clark, M. (2001). The role of M cells in Salmonella infection. 
Microbes and infection 3, 1183-1190. 
 
Jerse, A. E., Yu, J., Tall, B. D. & Kaper, J. B. (1990). A genetic locus of 
enteropathogenic Escherichia coli necessary for the production of attaching and 
effacing lesions on tissue culture cells. Proceedings of the National Academy of 
Sciences of the United States of America 87, 7839-7843. 
 
Jiang, X., Rossanese, O. W., Brown, N. F., Kujat Choy, S., Galán, J. E., Finlay, 
B. B. & Brumell, J. H. (2004). The related effector proteins SopD and SopD2 from 
Salmonella enterica serovar Typhimurium contribute to virulence during systemic 
infection of mice. Molecular microbiology 54, 1186-1198. 
 
Jones, I. & Roworth, M. (1996). An outbreak of Escherichia coli O157 and 
campylobacteriosis associated with contamination of a drinking water supply. Public 
Health 110, 277-282. 
 
Jones, M. A., Wood, M. W., Mullan, P. B., Watson, P. R., Wallis, T. S. & 
Galyov, E. E. (1998). Secreted effector proteins of Salmonella dublin act in concert 
to induce enteritis. Infect Immun 66, 5799-5804. 
 
Kaksonen, M., Toret, C. & Drubin, D. (2006). Harnessing actin dynamics for 




Kalischuk, L. D., Leggett, F. & Inglis, G. D. (2010). Campylobacter jejuni induces 
transcytosis of commensal bacteria across the intesti al epithelium through M-like 
cells. Gut Pathogens 2, 1-7. 
 
Kanaya, T., Miyazawa, K., Takakura, I. & other authors (2008). Differentiation 
of a murine intestinal epithelial cell line (MIE) toward the M cell lineage. American 
Journal of Physiology-Gastrointestinal and Liver Physiology 295, G273-284. 
 
Kaper, J. B., Nataro, J. P. & Mobley, H. L. T. (2004). Pathogenic Escherichia 
coli. Nature Reviews Microbiology 2, 123-140. 
 
Kapperud, G., Stenwig, H. & Lassen, J. (1998). Epidemiology of Salmonella 
Typhimurium O: 4–12 infection in Norway. American journal of epidemiology 147, 
774-782. 
 
Karch, H., Schubert, S., Zhang, D., Zhang, W., Schmidt, H., Olschlager, T. & 
Hacker, J. (1999). A genomic island, termed high-pathogenicity island, is present in 
certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infection 
and immunity 67, 5994-6001. 
 
Karch, H., Tarr, P. I. & Bielaszewska, M. (2005). Enterohaemorrhagic 
Escherichia coli in human medicine. International journal of medical microbiology 
295, 405-418. 
 
Karmali, M., Arbus, G., Petric, M., Patrick, M., Roscoe, M., Shaw, J. & Lior, H. 
(1988). Hospital-acquired Escherichia coli O 157: H 7 associated haemolytic 
uraemic syndrome in a nurse. Lancet 1, 526. 
 
Karmali, M. A. (1989). Infection by verocytotoxin-producing Escherichia coli. 
Clinical Microbiology Reviews 2, 15-38. 
 
Karmali, M. A. (2004). Infection by Shiga toxin-producing Escherichia coli. 
Molecular biotechnology 26, 117-122. 
 
Keene, W., Sazie, E., Kok, J., Rice, D., Hancock, D., Balan, V., Zhao, T. & 
Doyle, M. (1997). An outbreak of Escherichia coli O157: H7 infections traced to 
jerky made from deer meat. JAMA, the journal of the American Medical Association 
277, 1229-1231. 
 
Keene, W. E., McAnulty, J. M., Hoesly, F. C., Williams, L. P., Hedberg, K., 
Oxman, G. L., Barrett, T. J., Pfaller, M. A. & Fleming, D. W. (1994). A 
swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli 
O157: H7 and Shigella sonnei. New England Journal of Medicine 331, 579-584. 
 
Kenny, B., DeVinney, R., Stein, M., Reinscheid, D., Frey, E. & Finlay, B. (1997). 
Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence i to 




Kenny, B. (1999). Phosphorylation of tyrosine 474 of the enteropathogenic 
Escherichia coli (EPEC) Tir receptor molecule is essential for actin nucleating 
activity and is preceded by additional host modifications. Molecular microbiology 
31, 1229-1241. 
 
Kenny, B. & Jepson, M. (2000). Targeting of an enteropathogenic Escherichia coli 
(EPEC) effector protein to host mitochondria. Cellular Microbiology 2, 579-590. 
 
Kenny, B., Ellis, S., Leard, A. D., Warawa, J., Mellor, H. & Jepson, M. A. 
(2002). Co-ordinate regulation of distinct host cell signalli g pathways by 
multifunctional enteropathogenic Escherichia coli effector molecules. Molecular 
microbiology 44, 1095-1107. 
 
Kerneis, S., Bogdanova, A., Kraehenbuhl, J. P. & Pringault, E. (1997). 
Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that 
transport bacteria. Science 277, 949-952. 
 
Kim, J., Thanabalasuriar, A., Chaworth-Musters, T. & other authors (2007). 
The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting 
mammalian COPII function. Cell Host & Microbe 2, 160-171. 
 
Kim, M., Ogawa, M., Fujita, Y. & other authors (2009). Bacteria hijack integrin-
linked kinase to stabilize focal adhesions and block cell detachment. Nature 459, 
578-582. 
 
Knodler, L. A., Celli, J., Hardt, W. D., Vallance, B. A., Yip, C. & Finlay, B. B. 
(2002). Salmonella effectors within a single pathogenicity island are differentially 
expressed and translocated by separate type III secretion systems. Molecular 
microbiology 43, 1089-1103. 
 
Knodler, L. A., Finlay, B. B. & Steele-Mortimer, O. (2005). The Salmonella 
effector protein SopB protects epithelial cells from apoptosis by sustained activation 
of Akt. Journal of Biological Chemistry 280, 9058-9064. 
 
Knoop, K. A., Kumar, N., Butler, B. R. & other authors (2009). RANKL is 
necessary and sufficient to initiate development of antigen-sampling M cells in the 
intestinal epithelium. The Journal of Immunology 183, 5738-5747. 
 
Kohbata, S., Yokoyama, H. & Yabuuchi, E. (1986). Cytopathogenic effect of 
Salmonella typhi on M cells of murine ileal Peyer's patches in ligated ileal loops: an 
ultrastructural study. Microbiology and immunology 30, 1225-1237. 
 
Kong, Y. Y., Yoshida, H., Sarosi, I. & other authors (1999). OPGL is a key 
regulator of osteoclastogenesis, lymphocyte development and lymph-node 




Kraehenbuhl, J. P. & Neutra, M. R. (2000). Epithelial M cells: differentiation and 
function. Annual Review of Cell and Developmental Biology 16, 301-332. 
 
Kuhle, V. & Hensel, M. (2004). Cellular microbiology of intracellularSalmonella 
enterica: functions of the type III secretion system encoded by Salmonella 
pathogenicity island 2. Cellular and molecular life sciences 61, 2812-2826. 
 
LaCount, D. J., Vignali, M., Chettier, R. & other authors (2005). A protein 
interaction network of the malaria parasite Plasmodium falciparum. Nature 438, 103-
107. 
 
Lambertini, E., Franceschetti, T., Torreggiani, E., Penolazzi, L., Pastore, A., 
Pelucchi, S., Gambari, R. & Piva, R. (2010). SLUG: a new target of lymphoid 
enhancer factor-1 in human osteoblasts. BMC Molecular Biology 11, 13. 
 
Larue, L. & Bellacosa, A. (2005). Epithelial–mesenchymal transition in 
development and cancer: role of phosphatidylinositol 3 kinase/AKT pathways. 
Oncogene 24, 7443-7454. 
 
Lathem, W. W., Grys, T. E., Witowski, S. E., Torres, A. G., Kaper, J. B., Tarr, 
P. I. & Welch, R. A. (2002). StcE, a metalloprotease secreted by Escherichia coli 
O157: H7, specifically cleaves C1 esterase inhibitor. Molecular microbiology 45, 
277-288. 
 
Lathem, W. W., Bergsbaken, T. & Welch, R. A. (2004). Potentiation of C1 
esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157: H7. 
The Journal of experimental medicine 199, 1077-1087. 
 
Lawley, T., Klimke, W., Gubbins, M. & Frost, L. (2003). F factor conjugation is a 
true type IV secretion system. FEMS microbiology letters 224, 1-15. 
 
Lazzaro, V., Walker, R., Duggin, G., Phippard, A., Horvath, J. & Tiller, D. 
(1992). Inhibition of fibroblast proliferation in L-valine reduced selective media. 
Research communications in chemical pathology and pharmacology 75, 39-48. 
 
Leyton, D. L., Sloan, J., Hill, R. E., Doughty, S. & Hartland, E. L. (2003). 
Transfer region of pO113 from enterohemorrhagic Es herichia coli: similarity with 
R64 and identification of a novel plasmid-encoded autotransporter, EpeA. Infection 
and immunity 71, 6307-6319. 
 
Licence, K., Oates, K., Synge, B. & Reid, T. (2001). An outbreak of E. coli 0157 
infection with evidence of spread from animals to man through contamination of a 
private water supply. Epidemiol Infect 126, 135-138. 
 
Lilic, M., Galkin, V. E., Orlova, A., VanLoock, M. S., Egelman, E. H. & 
Stebbins, C. (2003a). Salmonella SipA polymerizes actin by stapling filaments with 




Lilic, M., Galkin, V. E., Orlova, A., VanLoock, M. S., Egelman, E. H. & 
Stebbins, C. (2003b). Salmonella SipA polymerizes actin by stapling filaments with 
nonglobular protein arms. Science 301, 1918-1921. 
 
Lin, F. Y. C., V. A. Ho, et al. (2001). The efficacy of a Salmonella Typhi Vi 
conjugate vaccine in two-to-five-year-old children. New England Journal of 
Medicine 344, 1263-1269. 
  
Lingwood, C. A., Law, H., Richardson, S., Petric, M., Brunton, J., De Grandis, 
S. & Karmali, M. (1987). Glycolipid binding of purified and recombinant 
Escherichia coli produced verotoxin in vitro. Journal of Biological Chemistry 262, 
8834-8838. 
 
Lingwood, C. A. (1993). Verotoxins and their glycolipid receptors. Advances in 
lipid research 25, 189-211. 
 
Lingwood, C. A. (1996). Role of verotoxin receptors in pathogenesis. Trends in 
Microbiology 4, 147-153. 
 
Lister, S. (1988). Salmonella enteritidis infection in broilers and broiler breeders. 
The Veterinary Record 123, 350. 
 
Lo, D., Tynan, W., Dickerson, J. & other authors (2004). Cell culture modeling of 
specialized tissue: identification of genes expressed specifically by follicle-
associated epithelium of Peyer's patch by expression pr filing of Caco-2/Raji co-
cultures. International immunology 16, 91-99. 
 
Low, A. S., Dziva, F., Torres, A. G. & other authors (2006). Cloning, expression, 
and characterization of fimbrial operon F9 from enterohemorrhagic Escherichia coli 
O157: H7. Infection and immunity 74, 2233-2244. 
 
Ludwig, K., Ruder, H., Bitzan, M., Zimmermann, S. & Karch, H. (1997). 
Outbreak of Escherichia coli O157: H7 infection in a large family. European Journal 
of Clinical Microbiology & Infectious Diseases 16, 238-241. 
 
Lundmark, R. & Carlsson, S. R. (2003). Sorting nexin 9 participates in clathrin-
mediated endocytosis through interactions with the core components. Journal of 
Biological Chemistry 278, 46772-46781. 
 
Ly, K. T. & Casanova, J. E. (2007). Mechanisms of Salmonella entry into host 
cells. Cellular Microbiology 9, 2103-2111. 
 
 
Mach, J., Hshieh, T., Hsieh, D., Grubbs, N. & Chervonsky, A. (2005). 




Macnab, R. M. (1992). Genetics and biogenesis of bacterial flagella. Annual review 
of genetics 26, 131-158. 
 
Mahajan, A., Naylor, S., Mills, A. D. & other authors (2005). Phenotypic and 
functional characterisation of follicle-associated epithelium of rectal lymphoid tissue. 
Cell and tissue research 321, 365-374. 
 
Mahajan, A., Currie, C. G., Mackie, S. & other authors (2009). An investigation 
of the expression and adhesin function of H7 flagell  in the interaction of 
Escherichia coli O157: H7 with bovine intestinal epithelium. Cellular Microbiology 
11, 121-137. 
 
Mainil, J., Duchesnes, C., Whipp, S., Marques, L., O'Brien, A., Casey, T. & 
Moon, H. (1987). Shiga-like toxin production and attaching effacing activity of 
Escherichia coli associated with calf diarrhea. American journal of veterinary 
research 48, 743-748. 
 
 
Marcato, P., Griener, T. P., Mulvey, G. L. & Armstrong, G. D. (2005). 
Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine 
protects mice from Shigatoxemia. Infection and immunity 73, 6523-6529. 
 
Marchès, O., Batchelor, M., Shaw, R. K. & other authors (2006). EspF of 
enteropathogenic Escherichia coli binds sorting nexin 9. Journal of bacteriology 
188, 3110-3115. 
 
Marchès, O., Covarelli, V., Dahan, S., Cougoule, C., Bhatta, P., Frankel, G. & 
Caron, E. (2008). EspJ of enteropathogenic and enterohaemorrhagic Escherichia 
coli inhibits opsono phagocytosis. Cellular Microbiology 10, 1104-1115. 
 
Martinez-Argudo, I., Sands, C. & Jepson, M. A. (2007). Translocation of 
enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its 
type III secretion system. Cellular microbiology 9, 1538-1546. 
 
Martínez-Estrada, O. M., Cullerés, A., Soriano, F. X. & other authors (2006). 
The transcription factors Slug and Snail act as repressors of Claudin-1 expression in 
epithelial cells. Biochemical Journal 394, 449-457. 
 
Mayer, B. J. (2001). SH3 domains: complexity in moderation. Journal of Cell 
Science 114, 1253-1264. 
 
McDaniel, T. K. & Kaper, J. B. (1997). A cloned pathogenicity island from 
enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E.
coli K 12. Molecular microbiology 23, 399-407. 
 
McGhie, E. J., Hayward, R. D. & Koronakis, V. (2004). Control of actin turnover 




McNamara, B., Koutsouris, A., O’Connell, C., Nougayréde, J., Donnenberg, M. 
& Hecht, G. (2001). Translocated EspF protein from enteropathogenic Es herichia 
coli disrupts host intestinal barrier function. Journal of Clinical Investigation 107, 
621-629. 
 
McNamara, B. P. & Donnenberg, M. S. (1998). A novel proline-rich protein, EspF, 
is secreted from enteropathogenic Escherichia coli via the type III export pathway. 
FEMS microbiology letters 166, 71-78. 
 
McNeilly, T. N., Naylor, S. W., Mahajan, A. & other authors (2008). Escherichia 
coli O157: H7 colonization in cattle following systemic and mucosal immunization 
with purified H7 flagellin. Infection and immunity 76, 2594-2602. 
 
Mead, P. S., Slutsker, L., Dietz, V., McCaig, L. F., Bresee, J. S., Shapiro, C., 
Griffin, P. M. & Tauxe, R. V. (1999). Food-related illness and death in the United 
States. Emerging Infectious Diseases 5, 607-625. 
 
Mecsas, J. & Strauss, E. J. (1996). Molecular mechanisms of bacterial virulence: 
type III secretion and pathogenicity islands. Emerging Infectious Diseases 2, 270-
288. 
 
Menard, R., Sansonetti, P. & Parsot, C. (1994). The secretion of the Shigella 
flexneri IpaB invasins is activated by epithelial cells and controlled by IpaB and 
IpaD. The EMBO Journal 13, 5293-5302. 
 
Merrifield, C., Feldman, M., Wan, L. & Almers, W. (2002). Imaging actin and 
dynamin recruitment during invagination of single cathrin-coated pits. Nature cell 
biology 4, 691-698. 
 
Meynell, H. M., Thomas, N. W., James, P. S., Holland, J., Taussig, M. J. & 
Nicoletti, C. (1999a). Up-regulation of microsphere transport across the follicle-
associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae 
R36a. The FASEB journal 13, 611-619. 
 
 
Miao, E. A. & Miller, S. I. (2000). A conserved amino acid sequence directing 
intracellular type III secretion by Salmonella Typhimurium. Proceedings of the 
National Academy of Sciences of the United States of America 97, 7539-7544. 
 
Miyao, Y., Kataoka, T., Nomoto, T., Kai, A., Itoh, T. & Itoh, K. (1998). 
Prevalence of verotoxin-producing Escherichia coli harbored in the intestine of cattle 
in Japan. Veterinary microbiology 61, 137-143. 
 
Moon, H., Whipp, S., Argenzio, R., Levine, M. & Giannella, R. (1983). Attaching 
and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig 




Mori, K., Kitazawa, R., Kondo, T., Maeda, S., Yamaguchi, A. & Kitazawa, S. 
(2006). Modulation of mouse RANKL gene expression by Runx2 and PKA pathway. 
Journal of cellular biochemistry 98, 1629-1644. 
 
Murata-Kamiya, N., Kurashima, Y., Teishikata, Y. & other authors (2007). 
Helicobacter pylori CagA interacts with E-cadherin and deregulates the -catenin 
signal that promotes intestinal transdifferentiation in gastric epithelial cells. 
Oncogene 26, 4617-4626. 
 
Murli, S., Watson, R. O. & Galan, J. E. (2001). Role of tyrosine kinases and the 
tyrosine phosphatase SptP in the interaction of Salmonella with host cells. Cellular 
Microbiology 3, 795-810. 
 
Naessens, J. & Howard, C. (1991). Individual antigens of cattle. Monoclonal 
antibodies reacting with bovine B cells (BoWC3, BoWC4 and BoWC5). Veterinary 
Immunology and Immunopathology (Netherlands). 27, 77-85. 
 
Nagai, T., Abe, A. & Sasakawa, C. (2005). Targeting of enteropathogenic 
Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis. 
Journal of Biological Chemistry 280, 2998-3011. 
 
Naishiro, Y., Yamada, T., Takaoka, A. S., Hayashi, R., Hasegawa, F., Imai, K. 
& Hirohashi, S. (2001). Restoration of epithelial cell polarity in a colorectal cancer 
cell line by suppression of -catenin/T-cell factor 4-mediated gene transactivation. 
Cancer research 61, 2751-2758. 
 
Nataro, J. P. & Kaper, J. B. (1998). Diarrheagenic Escherichia coli. Clinical 
Microbiology Reviews 11, 142-201. 
 
Naylor, S. W., Low, J. C., Besser, T. E., Mahajan, A., Gunn, G. J., Pearce, M. 
C., McKendrick, I. J., Smith, D. G. E. & Gally, D. L. (2003). Lymphoid follicle-
dense mucosa at the terminal rectum is the principal site of colonization of 
enterohemorrhagic Escherichia coli O157: H7 in the bovine host. Infection and 
immunity 71, 1505-1512. 
 
Naylor, S. W., Gally, D. L. & Christopher Low, J. (2005a). Enterohaemorrhagic 
E. coli in veterinary medicine. International Journal of Medical Microbiology 295, 
419-441. 
 
Naylor, S. W., Roe, A. J., Nart, P., Spears, K. & Smith, D. (2005b). Escherichia 
coli O157: H7 forms attaching and effacing lesions at the terminal rectum of cattle 
and colonization requires the LEE4 operon. Microbiology 151, 2773-2781. 
 
Neutra, M., Pringault, E. & Kraehenbuhl, J. (1996). Antigen sampling across 
epithelial barriers and induction of mucosal immune responses. Annual review of 




Neutra, M. R., Mantis, N. J. & Kraehenbuhl, J. P. (2001). Collaboration of 
epithelial cells with organized mucosal lymphoid tissues. nature immunology 2, 
1004-1009. 
 
Newton, H. J., Pearson, J. S., Badea, L. & other authors (2010). The type III 
effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella 
block nuclear translocation of NF-kappaB p65. PLoS Pathog 6, e1000898. 
 
Norimatsu, M., Harris, J., Chance, V., Dougan, G., Howard, C. & Villarreal 
Ramos, B. (2003). Differential response of bovine monocyte derived macrophages 
and dendritic cells to infection with Salmonella Typhimurium in a low dose model in 
vitro. Immunology 108, 55-61. 
 
Norris, F. A., Wilson, M. P., Wallis, T. S., Galyov, E. E. & Majerus, P. W. 
(1998). SopB, a protein required for virulence of Salmonella dublin, is an inositol 
phosphate phosphatase. Proceedings of the National Academy of Sciences of the 
United States of America 95, 14057-14059. 
 
Nougayrede, J., Boury, M., Tasca, C., Marches, O., Milon, A., Oswald, E. & De 
Rycke, J. (2001). Type III secretion-dependent cell cycle block caused in HeLa cells 
by enteropathogenic Escherichia coli O103. Infection and immunity 69, 6785-6795. 
 
Nougayrède, J. P. & Donnenberg, M. S. (2004). Enteropathogenic Escherichia coli 
EspF is targeted to mitochondria and is required to initiate the mitochondrial death 
pathway. Cellular microbiology 6, 1097-1111. 
 
Nougayrède, J. P., Foster, G. H. & Donnenberg, M. S. (2007). Enteropathogenic 
Escherichia coli effector EspF interacts with host protein Abcf2. Cellular 
microbiology 9, 680-693. 
 
O'Brien, A. D. & Holmes, R. K. (1987). Shiga and Shiga-like toxins. Microbiology 
and Molecular biology reviews 51, 206-220. 
 
Odero-Marah, V. A., Wang, R., Chu, G., Zayzafoon, M., Xu, J., Shi, C., 
Marshall, F. F., Zhau, H. E. & Chung, L. W. K. (2008). Receptor activator of NF- 
B Ligand (RANKL) expression is associated with epithelial to mesenchymal 
transition in human prostate cancer cells. Cell research 18, 858-870. 
 
Ogden, I. D., MacRae, M. & Strachan, N. J. C. (2004). Is the prevalence and 
shedding concentrations of E. coli O157 in beef cattle in Scotland seasonal? FEMS 
microbiology letters 233, 297-300. 
 
Ogra, P. L. (1994). Handbook of mucosal immunology: Academic Press. 
 
Orth, K. (2007). Versatile Type III effector mechanisms can disrupt target-cell 




Ostroff, S., Griffin, P., Tauxe, R., Shipman, L., Greene, K., Wells, J., Lewis, J., 
Blake, P. & Kobayashi, J. (1990). A statewide outbreak of Escherichia coli O157: 
H7 infections in Washington State. American journal of epidemiology 132, 239-247. 
 
Owen, R. & Bhalla, D. (1983). Cytochemical analysis of alkaline phosphatase and 
esterase activities and of lectin-binding and anionic sites in rat and mouse Peyer's 
patch M cells. American Journal of Anatomy 168, 199-212. 
 
Owen, R., Apple, R. & Bhalla, D. (1986a). Morphometric and cytochemical 
analysis of lysosomes in rat Peyer's patch follicle epithelium: their reduction in 
volume fraction and acid phosphatase content in M cells compared to adjacent 
enterocytes. The Anatomical Record 216, 521-527. 
 
Owen, R. (1999). Uptake and transport of intestinal macromolecules and 
microorganisms by M cells and Peyer's patches—a historical and personal 
perspective. Semin Immunol 11, 157-163. 
 
Owen R.L. and Jones, A. L. (1974). Epithelial cell specialization within human 
Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. 
Gastroenterology 66, 189-203. 
 
Owen, R. L., Pierce, N. F., Apple, R. & Cray, W. C. (1986b). M Cell Transport of 
Vibrio cholerae from the Intestinal. Lumen into Peyer's Patches: A Mechanism for 
Antigen Sampling and for Microbial Transepithelial Migration. Journal of Infectious 
Diseases 153, 1108-1118. 
 
Owen, R. L. (1994). M cells--entryways of opportunity for enteropathogens. The 
Journal of experimental medicine 180, 7-9. 
 
Paiba, G., Pascoe, S., Wilesmith, J. & other authors (2002). Faecal carriage of 
verocytotoxin-producing Escherichia coli O157 in cattle and sheep at slaughter in 
Great Britain. Veterinary Record 150, 593-598. 
 
Paton, A. W., Ratcliff, R. M., Doyle, R. M., Seymour-Murray, J., Davos, D., 
Lanser, J. A. & Paton, J. C. (1996). Molecular microbiological investigation of an 
outbreak of hemolytic-uremic syndrome caused by dry fermented sausage 
contaminated with Shiga-like toxin-producing Escherichia coli. Journal of Clinical 
Microbiology 34, 1622-1627. 
 
Paton, A. W., Srimanote, P., Woodrow, M. C. & Paton, J. C. (2001). 
Characterization of Saa, a novel autoagglutinating adhesin produced by locus of 
enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are 
virulent for humans. Infection and immunity 69, 6999-7009. 
 





Pavia, A. T., Nichols, C. R., Green, D. P., Tauxe, R. V., Mottice, S., Greene, K. 
D. & Wells, J. G. (1990). Hemolytic-uremic syndrome during an outbreak of 
Escherichia coli O157: H7 infections in institutions for mentally retarded persons: 
clinical and epidemiologic observations. The Journal of Pediatrics 116, 544-551. 
 
Pearce, J., Bettelheim, K. A., Luke, R. & Goldwater, P. N. (2010). Serotypes of 
Escherichia coli in Sudden Infant Death Syndrome. Journal of applied microbiology 
108, 731-735. 
 
Pearson, G., Bazeley, K., Jones, J., Gunning, R., Green, M., Cookson, A. & 
Woodward, M. (1999). Attaching and effacing lesions in the large intestine of an 
eight-month-old heifer associated with Escherichia coli O26 infection in a group of 
animals with dysentery. The Veterinary Record 145, 370-373. 
 
Peralta-Ramirez, J., Hernandez, J. M., Manning-Cela, R., Luna-Munoz, J., 
Garcia-Tovar, C., Nougayrede, J. P., Oswald, E. & Navarro-Garcia, F. (2008). 
EspF Interacts with nucleation-promoting factors to recruit junctional proteins into 
pedestals for pedestal maturation and disruption of paracellular permeability. 
Infection and immunity 76, 3854-3868. 
 
Perna, N. T., Mayhew, G. F., Posfai, G., Elliott, S., Donnenberg, M. S., Kaper, J. 
B. & Blattner, F. R. (1998). Molecular evolution of a pathogenicity island from 
enterohemorrhagic Escherichia coli O157: H7. Infection and immunity 66, 3810-
3817. 
 
Peter, B. J., Kent, H. M., Mills, I. G., Vallis, Y., Butler, P. J. G., Evans, P. R. & 
McMahon, H. T. (2004). BAR domains as sensors of membrane curvature: the 
amphiphysin BAR structure. Science 303, 495-499. 
 
Pfleger, C. M., Salic, A., Lee, E. & Kirschner, M. W. (2001). Inhibition of Cdh1–
APC by the MAD2-related protein MAD2L2: a novel mechanism for regulating 
Cdh1. Genes & development 15, 1759-1764. 
 
Pohlner, J., Halter, R., Beyreuther, K. & Meyer, T. F. (1987). Gene structure and 
extracellular secretion of Neisseria gonorrhoeae IgA protease. Nature 4, 458-462. 
 
 
Pruimboom-Brees, I. M., Morgan, T. W., Ackermann, M. R., Nystrom, E. D., 
Samuel, J. E., Cornick, N. A. & Moon, H. W. (2000). Cattle lack vascular 
receptors for Escherichia coli O157: H7 Shiga toxins. Proceedings of the National 
Academy of Sciences of the United States of America 97, 10325-10329. 
 
Pukatzki, S., Ma, A. T., Sturtevant, D., Krastins, B., Sarracino, D., Nelson, W. 
C., Heidelberg, J. F. & Mekalanos, J. J. (2006). Identification of a conserved 
bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host 
____________________________________________________References 
 230 
model system. Proceedings of the National Academy of Sciences of the United States 
of America 103, 1528-1533. 
 
Pullinger, G. D., Paulin, S. M., Charleston, B. & other authors (2007). Systemic 
translocation of Salmonella enterica serovar Dublin in cattle occurs predominantly 
via efferent lymphatics in a cell-free niche and requires type III secretion system 1 
(T3SS-1) but not T3SS-2. Infection and immunity 75, 5191-5199. 
 
Quitard, S., Dean, P., Maresca, M. & Kenny, B. (2006). The enteropathogenic 
Escherichia coli EspF effector molecule inhibits PI 3 kinase mediated uptake 
independently of mitochondrial targeting. Cellular Microbiology 8, 972-981. 
 
Ragnarsson, E. G. E., Schoultz, I., Gullberg, E., Carlsson, A. H., Tafazoli, F., 
Lerm, M., Magnusson, K. E., Söderholm, J. D. & Artursson, P. (2008). Yersinia 
pseudotuberculosis induces transcytosis of nanoparticles across human intestinal 
villus epithelium via invasin-dependent macropinocyt sis. Laboratory Investigation 
88, 1215-1226. 
 
Rain, J. C., Selig, L., De Reuse, H. & other authors (2001). The protein–protein 
interaction map of Helicobacter pylori. Nature 409, 211-215. 
 
Reida, P., Wolff, M., Pöhls, H., Kuhlmann, W., Lehmacher, A., Aleksi , S., 
Karch, H. & Bockemühl, J. (1994). An outbreak due to enterohaemorrhagic 
Escherichia coli O157: H7 in a children day care centre characterized by person-to-
person transmission and environmental contamination. Zentralblatt für 
Bakteriologie: international journal of medical microbiology 281, 534-543. 
 
Reimann, J. D. R., Gardner, B. E., Margottin-Goguet, F. & Jackson, P. K. 
(2001). Emi1 regulates the anaphase-promoting complex by adifferent mechanism 
than Mad2 proteins. Genes & development 15, 3278-3285. 
 
Renter, D. G., Sargeant, J. M., Hygnstorm, S. E., Hoffman, J. D. & Gillespie, J. 
R. (2001). Escherichia coli O157: H7 in free-ranging deer in Nebraska. Journal of 
Wildlife Diseases 37, 755-760. 
 
Renwick, S., Wilson, J., Clarke, R. & other authors (1993). Evidence of direct 
transmission of Escherichia coli O157: H7 infection between calves and a human. 
The Journal of infectious diseases 168, 792-793. 
 
Richardson, S. E., Karmali, M. A., Becker, L. E. & Smith, C. R. (1988). The 
histopathology of the hemolytic uremic syndrome associated with verocytotoxin-
producing Escherichia coli nfections*. Human pathology 19, 1102-1108. 
 
Riley, L. W., Remis, R. S., Helgerson, S. D. & other authors (1983). Hemorrhagic 
colitis associated with a rare Escherichia coli serotype. New England Journal of 




Robins Browne, R. M. & Hartland, E. L. (2002). Escherichia coli as a cause of 
diarrhea. Journal of gastroenterology and hepatology 17, 467-475. 
 
Robinson, C. M., Sinclair, J. F., Smith, M. J. & O’Brien, A. D. (2006). Shiga 
toxin of enterohemorrhagic Escherichia coli type O157: H7 promotes intestinal 
colonization. Proceedings of the National Academy of Sciences 103, 9667-9672. 
 
Roe, A., Hoey, D. & Gally, D. (2003). Regulation, secretion and activity of type III-
secreted proteins of enterohaemorrhagic Es herichia coli O157. Biochem Soc Trans 
31, 98-103. 
 
Roe, A., Tysall, L., Dransfield, T. & other authors (2007). Analysis of the 
expression, regulation and export of NleA-E in Escherichia coli O157: H7. 
Microbiology 153, 1350-1360. 
 
Rohde, J. R., Breitkreutz, A., Chenal, A., Sansonetti, P. J. & Parsot, C. (2007). 
Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host & 
Microbe 1, 77-83. 
 
Rytkönen, A., Poh, J., Garmendia, J., Boyle, C., Thompson, A., Liu, M., 
Freemont, P., Hinton, J. C. D. & Holden, D. W. (2007). SseL, a Salmonella 
deubiquitinase required for macrophage killing and virulence. Proceedings of the 
National Academy of Sciences 104, 3502-3507. 
 
Saegusa, M., Hashimura, M., Kuwata, T. & Okayasu, I. (2009). Requirement of 
the Akt/{beta}-Catenin Pathway for Uterine Carcinosarcoma Genesis, Modulating E-
Cadherin Expression Through the Transactivation of Slug. American Journal of 
Pathology 174, 2107-2115. 
 
Sansonetti, P. (2002). Host–pathogen interactions: the seduction of molecular cross 
talk. Gut 50, III2-8. 
 
Savidge, T., Smith, M., James, P. & Aldred, P. (1991). Salmonella-induced M-cell 
formation in germ-free mouse Peyer's patch tissue. The American journal of 
pathology 139, 177-184. 
 
Savidge, T. & Smith, M. (1995). Evidence that membranous (M) cell genesis is 
immuno-regulated. Advances in experimental medicine and biology 371, 239-241. 
 
Savidge, T. (1996). The life and times of an intestinal M cell. Trends in 
Microbiology 4, 301-306. 
 
Scheutz, F., Nielsen, E. M., Frimodt-Møller, J., Boisen, N., Morabito, S., Tozzoli, 
R., Nataro, J. & Caprioli, A. (2011). Characteristics of the enteroaggregative Shiga 
toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of 
____________________________________________________References 
 232 




Schmidt, H., Karch, H. & Beutin, L. (1994). The large-sized plasmids of 
enterohemorrhagic Escherichia coli O157 strains encode hemolysins which are 
presumably members of the E. coli [alpha]-hemolysin family. FEMS microbiology 
letters 117, 189-196. 
 
Schmidt, H., Kernbach, C. & Karch, H. (1996). Analysis of the EHEC hly operon 
and its location in the physical map of the large plasmid of enterohaemorrhagic 
Escherichia coli O157: H7. Microbiology 142, 907-914. 
 
Schmidt, H., Scheef, J., Morabito, S., Caprioli, A., Wieler, L. H. & Karch, H. 
(2000). A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from 
pigeons. Applied and Environmental Microbiology 66, 1205-1208. 
 
Shames, S. R., Deng, W., Guttman, J. A. & other authors (2010). The pathogenic 
E. coli type III effector EspZ interacts with host CD98 and facilitates host cell 
prosurvival signalling. Cellular Microbiology 12, 1322-1339. 
 
Shaw, R. K., Daniell, S., Ebel, F., Frankel, G. & Knutton, S. (2001). EspA 
filament mediated protein translocation into red blood cells. Cellular Microbiology 3, 
213-222. 
 
Shaw, R. K., Cleary, J., Murphy, M. S., Frankel, G. & Knutton, S. (2005). 
Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role 
of effector proteins in brush border remodeling and formation of attaching and 
effacing lesions. Infection and immunity 73, 1243-1251. 
 
Shin, C. S., Her, S. J., Kim, J. A. & other authors (2005). Dominant Negative N 
Cadherin Inhibits Osteoclast Differentiation by Interfering With Catenin Regulation 
of RANKL, Independent of Cell Cell Adhesion. Journal of Bone and Mineral 
Research 20, 2200-2212. 
 
Shotland, Y., Krämer, H. & Groisman, E. A. (2003). The Salmonella SpiC protein 
targets the mammalian Hook3 protein function to alter cellular trafficking. Molecular 
microbiology 49, 1565-1576. 
 
Shukla, R., Slack, R., George, A., Cheasty, T., Rowe, B. & Scutter, J. (1995). 
Escherichia coli O157 infection associated with a farm visitor centr. Communicable 
disease report CDR review 5, R86-90. 
 
Simonovic, I., Rosenberg, J., Koutsouris, A. & Hecht, G. (2000). 
Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from 




Sinclair, J. F. & O'Brien, A. D. (2002). Cell Surface-localized Nucleolin Is a 
Eukaryotic Receptor for the Adhesin Intimin- of Enterohemorrhagic Escherichia coli 
O157: H7. Journal of Biological Chemistry 277, 2876-2885. 
 
Smith, D. G. E., Naylor, S. W. & Gally, D. L. (2002). Consequences of EHEC 
colonisation in humans and cattle. International Journal of Medical Microbiology 
292, 169-183. 
 
Smith, H. W. (1963). The haemolysins of Escherichia coli. The Journal of 
Pathology and Bacteriology 85, 197-211. 
 
Smith, M. & Peacock, M. (1980). “M” cell distribution in follicle-associated 
epithelium of mouse peyer's patch. American Journal of Anatomy 159, 167-175. 
 
Smith, S. G. J., Mahon, V., Lambert, M. A. & Fagan, R. P. (2007). A molecular 
Swiss army knife: OmpA structure, function and exprssion. FEMS microbiology 
letters 273, 1-11. 
 
Sojka, W. J., Wray, C., Shreeve, J. & Benson, A. J. (1977). Incidence of  
Salmonella infection in animal in England and Wales1968-1974. Journal of Hygiene 
78, 43-56. 
 
Soulet, F., Yarar, D., Leonard, M. & Schmid, S. L. (2005). SNX9 regulates 
dynamin assembly and is required for efficient clathrin-mediated endocytosis. 
Molecular biology of the cell 16, 2058-2067. 
 
Spears, K. J., Roe, A. J. & Gally, D. L. (2006). A comparison of enteropathogenic 
and enterohaemorrhagic Escherichia coli pathogenesis. FEMS microbiology letters 
255, 187-202. 
 
Stambolic, V., Ruel, L. & Woodgett, J. R. (1996). Lithium inhibits glycogen 
synthase kinase-3 activity and mimics wingless signalling in intact cells. Current 
Biology 6, 1664-1669. 
 
Steele-Mortimer, O., Knodler, L. A., Marcus, S. L., Scheid, M. P., Goh, B., 
Pfeifer, C. G., Duronio, V. & Finlay, B. B. (2000a). Activation of Akt/Protein 
Kinase B in Epithelial Cells by the Salmonella Typhimurium Effector SigD. Journal 
of Biological Chemistry 275, 37718-37727. 
 
Stender, S., Friebel, A., Linder, S., Rohde, M., Mirold, S. & Hardt, W. D. 
(2000). Identification of SopE2 from Salmonella Typhimurium, a conserved guanine 
nucleotide exchange factor for Cdc42 of the host cell. Mol Microbiol 36, 1206-1221. 
 
Stephens, D. J. & Banting, G. (2000). The Use of Yeast Two Hybrid Screens in 




Steve Yan, S., Pendrak, M. L., Abela-Ridder, B., Punderson, J. W., Fedorko, D. 
P. & Foley, S. L. (2004). An overview of Salmonella typing: Public health 
perspectives. Clinical and Applied Immunology Reviews 4, 189-204. 
 
Stone, A., Shaffer, M. & Sautter, R. L. (1993). Salmonella infection and 
surveillance in a neonatal nursery. American Journal of Infection Control 21, 270-
273. 
 
Stordeur, P., China, B., Charlier, G., Roels, S. & Mainil, J. (2000). Clinical signs, 
reproduction of attaching/effacing lesions, and enterocyte invasion after oral 
inoculation of an O118 enterohaemorrhagic Escherichia coli in neonatal calves. 
Microbes and infection 2, 17-24. 
 
Suzuki, T., Saga, S. & Sasakawa, C. (1996). Functional analysis of Shigella VirG 
domains essential for interaction with vinculin and actin-based motility. Journal of 
Biological Chemistry 271, 21878-21885. 
 
Swerdlow, D. L., Woodruff, B. A., Brady, R. C. & other authors (1992). A 
waterborne outbreak in Missouri of Escherichia coli O157: H7 associated with 
bloody diarrhea and death. Annals of Internal Medicine 117, 812-819. 
 
Synge, B. A. (2000). Veterinary significance of verocytotoxin-producing 
Escherichia coli O157. World Journal of Microbiology and Biotechnology 16, 725-
732. 
 
Tafazoli, F., Magnusson, K. E. & Zheng, L. (2003). Disruption of epithelial barrier 
integrity by Salmonella enterica serovar Typhimurium requires geranylgeranylated 
proteins. Infection and immunity 71, 872-881. 
 
Takizawa, N. & Murooka, Y. (1985). Cloning of the pullulanase gene and 
overproduction of pullulanase in Escherichia coli and Klebsiella aerogenes. Applied 
and Environmental Microbiology 49, 294-298. 
 
Tarr, P. I. (1995). Escherichia coli O157: H7: clinical, diagnostic, and 
epidemiological aspects of human infection. Clinical Infectious Diseases 20, 1-8. 
 
Taylor, K. A., O'Connell, C. B., Luther, P. W. & Donnenberg, M. S. (1998). The 
EspB protein of enteropathogenic Escherichia coli is targeted to the cytoplasm of 
infected HeLa cells. Infection and immunity 66, 5501. 
 
Teale, A., Baldwin, C., Morrison, W., Ellis, J. & MacHugh, N. (1987). 
Phenotypic and functional characteristics of bovine T lymphocytes. Veterinary 
immunology and immunopathology 17, 113-123. 
 
Terebiznik, M. R., Vieira, O. V., Marcus, S. L., Slade, A., Yip, C. M., Trimble, 
W. S., Meyer, T., Finlay, B. B. & Grinstein, S. (202). Elimination of host cell 
____________________________________________________References 
 235 
PtdIns (4, 5) P 2 by bacterial SigD promotes membrane fission during invasion by 
Salmonella. Nature cell biology 4, 766-773. 
 
Tesh, V. & O'brien, A. (1991). The pathogenic mechanisms of Shiga toxin and the 
Shiga like toxins. Molecular microbiology 5, 1817-1822. 
 
Tétaud, C., Falguières, T., Carlier, K. & other authors (2003). Two distinct 
Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 
mAb and verotoxin-1. Journal of Biological Chemistry 278, 45200-45208. 
 
Thanabalu, T., Koronakis, E., Hughes, C. & Koronakis, V. (1998). Substrate-
induced assembly of a contiguous channel for protein export from E. coli: reversible 
bridging of an inner-membrane translocase to an outer membrane exit pore. The 
EMBO Journal 17, 6487-6496. 
 
Thiery, J. P., Acloque, H., Huang, R. Y. J. & Nieto, M. A. (2009). Epithelial-
mesenchymal transitions in development and disease. Cell 139, 871-890. 
 
Tindall, B., Grimont, P., Garrity, G. & Euzeby, J. (2005). Nomenclature and 
taxonomy of the genus Salmonella. International journal of systematic and 
evolutionary microbiology 55, 521-524. 
 
Tobe, T., Beatson, S., Taniguchi, H. & other authors (2006). An extensive 
repertoire of type III secretion effectors in Escherichia coli O157 and the role of 
lambdoid phages in their dissemination. Proceedings of the National Academy of 
Sciences 103, 14941-14946. 
 
Trabulsi, L. R., Keller, R. & Tardelli Gomes, T. A. (2002). Typical and atypical 
enteropathogenic Escherichia coli. Emerging Infectious Diseases 8, 508-513. 
 
Tree, J. J., E. B. Wolfson, et al. (2009). "Controlling injection: regulation of type 
III secretion in enterohaemorrhagic Escherichia coli." Trends in Microbiology 17, 
361-370. 
 
Tu, X., Nisan, I., Yona, C., Hanski, E. & Rosenshine, I. (2003). EspH, a new 
cytoskeleton modulating effector of enterohaemorrhagic and enteropathogenic 
Escherichia coli. Molecular microbiology 47, 595-606. 
 
Uchiya, K., Barbieri, M. A., Funato, K., Shah, A. H., Stahl, P. D. & Groisman, 
E. A. (1999). A Salmonella virulence protein that inhibits cellular trafficking. The 
EMBO Journal 18, 3924-3933. 
 
Vaira, S., Johnson, T., Hirbe, A. C. & other authors (2008). RelB is the NF- B 
subunit downstream of NIK responsible for osteoclast differentiation. Proceedings of 




Vallance, B. & Finlay, B. (2000). Exploitation of host cells by enteropathogenic 
Escherichia coli. Proceedings of the National Academy of Sciences of the United 
States of America 97, 8799-8806. 
 
Vallin, J., Thuret, R., Giacomello, E., Faraldo, M. M., Thiery, J. P. & Broders, 
F. (2001). Cloning and Characterization of ThreeXenopus Slug Promoters Reveal 
Direct Regulation by Lef/ -Catenin Signaling. Journal of Biological Chemistry 276, 
30350-30358. 
 
Van De Kar, N., Monnens, L., Karmali, M. & Van Hinsbergh, V. (1992). Tumor 
necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor 
globotriaosylceramide on human endothelial cells: impl cations for the pathogenesis 
of the hemolytic uremic syndrome. Blood 80, 2755-2764. 
 
Van Houdt, R. & Michiels, C. W. (2005). Role of bacterial cell surface structures in 
Escherichia coli biofilm formation. Research in microbiology 156, 626-633. 
 
Verbrugghe, P., Waelput, W., Dieriks, B., Waeytens, A., Vandesompele, J. & 
Cuvelier, C. (2006). Murine M cells express annexin V specifically. The Journal of 
Pathology 209, 240-249. 
 
Viboud, G. I., So, S. S. K., Ryndak, M. B. & Bliska, J. B. (2003). Proinflammatory 
signalling stimulated by the type III translocation factor YopB is counteracted by 
multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis. 
Molecular microbiology 47, 1305-1315. 
 
Viswanathan, V., Koutsouris, A., Lukic, S., Pilkinton, M., Simonovic, I., 
Simonovic, M. & Hecht, G. (2004a). Comparative analysis of EspF from 
enteropathogenic and enterohemorrhagic Es herichia coli in alteration of epithelial 
barrier function. Infection and immunity 72, 3218-3227. 
 
Viswanathan, V. K., Lukic, S., Koutsouris, A., Miao, R., Muza, M. M. & Hecht, 
G. (2004b). Cytokeratin 18 interacts with the enteropathogenic Escherichia coli 
secreted protein F (EspF) and is redistributed after inf ction. Cellular Microbiology 
6, 987-997. 
 
Walhout, A. J., Temple, G. F., Brasch, M. A., Hartley, J. L., Lorson, M. A., Van 
Den Heuvel, S. & Vidal, M. (2000). Gateway recombinational cloning: application 
to the cloning of large numbers of open reading frames or ORFeomes. Methods in 
enzymology 328, 575-592. 
 
Walker, K., Skelton, H. & Smith, K. (2002). Cutaneous lesions showing giant 
yeast forms of Blastomyces dermatitidis. Journal of cutaneous pathology 29, 616-
618. 
 
Wallis, T. S., Barrow P.A. (2005). Salmonella epidemiology and pathogenesis in 
food-producing animals. In A Böck, R Curtiss III, J B Kaper, P D Karp, F C 
____________________________________________________References 
 237 
Neidhardt, T Nyström, J M Slauch, C L Squires, and D Ussery (ed), EcoSal-
Escherichia coli and Salmonella: Cellular and Molecular Biology 
<http://wwwecosalorg> ASM Press, Washington, DC. 
 
WALTON, J. & SMITH, D. (1969).  New hemolysin (g) produced by Escherichia 
coli J. Bacteriol. 98: 304-305.  
 
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D. & Yu, H. (2009). IL-
17 can promote tumor growth through an IL-6–Stat3 signaling pathway. The Journal 
of experimental medicine 206, 1457-1464. 
 
Watarai, M., Tobe, T., Yoshikawa, M. & Sasakawa, C. (1995). Contact of 
Shigella with host cells triggers release of Ipa invasins ad is an essential function of 
invasiveness. The EMBO Journal 14, 2461-2470.  
 
Waterman, M. L. (2004). "Lymphoid enhancer factor/T cell factor expression in 
colorectal cancer." Cancer and Metastasis Reviews 23, 41-52. 
 
Waterman, S. R. & Holden, D. W. (2003). Functions and effectors of the 
Salmonella pathogenicity island 2 type III secretion system. Cellular Microbiology 5, 
501-511. 
 
Weih, D. S., Yilmaz, Z. B. & Weih, F. (2001). Essential role of RelB in germinal 
center and marginal zone formation and proper expression of homing chemokines. 
The Journal of Immunology 167, 1909-1919. 
 
Wells, J., Shipman, L., Greene, K. & other authors (1991). Isolation of 
Escherichia coli serotype O157: H7 and other Shiga-like-toxin-producing E. coli 
from dairy cattle. Journal of Clinical Microbiology 29, 985-989. 
 
Wolff, C., Nisan, I., Hanski, E., Frankel, G. & Rosenshine, I. (1998). Protein 
translocation into host epithelial cells by infecting enteropathogenic Escherichia coli. 
Molecular microbiology 28, 143-155. 
 
Wood, M. W., Jones, M. A., Watson, P. R., Siber, A. M., McCormick, B. A., 
Hedges, S., Rosqvist, R., Wallis, T. S. & Galyov, E. E. (2000). The secreted 
effector protein of Salmonella Dublin, SopA, is translocated into eukaryotic cells and 
influences the induction of enteritis. Cell Microbiol 2, 293-303. 
 
Wray C., D. R. H. a. C. J. D. (1996). Enterobacteriaceae. in: Jordan F.T.W. and 
pattison M. (Eds). Poultry Diseases. 4th Ed WB Saunders Company Ltd, London  
 
Yarze, J. C. & Chase, M. P. (2000). E. coli O157: H7—another waterborne 




Yilmaz, Z. B., Weih, D. S., Sivakumar, V. & Weih, F. (2003). RelB is required for 
Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and 
TNF. The EMBO journal 22, 121-130. 
 
Yokoyama, K., Kamata, N., Fujimoto, R., Tsutsumi, S., Tomonari, M., Taki, M., 
Hosokawa, H. & Nagayama, M. (2003). Increased invasion and matrix 
metalloproteinase-2 expression by Snail-induced mesenchymal transition in 
squamous cell carcinomas. International journal of oncology 22, 891-898. 
 
Yoshida, S., Katayama, E., Kuwae, A., Mimuro, H., Suzuki, T. & Sasakawa, C. 
(2002). Shigella deliver an effector protein to trigger host microtubule 
destabilization, which promotes Rac1 activity and effici nt bacterial internalization. 
The EMBO Journal 21, 2923-2935. 
 
Zhou, D., Mooseker, M. S. & Galán, J. E. (1999). An invasion-associated 
Salmonella protein modulates the actin-bundling activity of plastin. Proceedings of 
the National Academy of Sciences of the United States of America 96, 10176-10181. 
 
Zhou, D., Chen, L. M., Hernandez, L., Shears, S. B. & Galan, J. E. (2001). A 
Salmonella inositol polyphosphatase acts in conjunction with ot er bacterial effectors 
to promote host cell actin cytoskeleton rearrangements and bacterial internalization. 
Molecular Microbiology 39, 248-260. 
 
 
 
